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General introduction
History of acute medicine
In the midst of the previous century, the emergency department (ED) started to evolve 
from ‘accident rooms’ to emergency units with most specialties present, and who work 
in multidisciplinary teams.1 During these years, the majority of patients were sent home 
after treatment.1 The role of ambulances changed in the following decades from merely 
being modes of patient transportation to mobile hospitals with skilled staff, which 
resulted in patients reaching the hospital alive, who would have previously died. This 
required a change in staffing of the ED accordingly. Initially, physicians in the ED were 
not adequately trained and were often more junior and largely unsupervised. When the 
conditions were too complex, surgeons and other specialists, such as internists, were 
consulted and care was then handed over.1 Increase in both complexity and severity 
of illness of patients presenting to the ED resulted in the introduction of emergency 
physicians approximately 70 years ago in the United States and the United Kingdom, 
and only 10 years ago in the Netherlands.2 Dutch emergency physicians have a three-
year training program consisting of training in the ED, intensive care medicine, 
anaesthesiology, cardiology and paediatrics. The first task of these emergency physicians 
was to assess whether a patient is critically ill; subsequently they initiated treatment and 
decided if – and which – medical specialist should be consulted.  
It was not until the end of the previous century that realization came that there was a 
need for skilled senior medical presence in the ED, and in recently introduced acute 
medical units (AMU).3,4 This was the result of increasing numbers of patients with 
growing complexity due to more chronic illnesses and advanced age. In 2003, the 
Specialist Training Authority of the Medical Royal Colleges in the United Kingdom 
recognized acute medicine as a subspecialty of internal medicine. The Netherlands 
followed in 2012, and acute medicine was likewise recognized as a subspecialty of internal 
medicine, requiring a training of six years. In the Netherlands, internists specialized 
in acute medicine, i.e. acute physicians, are increasingly manning EDs to improve care 
for medical patients where they encounter overcrowding, patients with more complex 
diseases, multiple chronic illnesses and complications of novel therapies. These acute 
physicians try to predict which patient is most ill and who can be safely discharged, 
and which therapy will be most beneficial for which patient. For this process they use 
medical history, physical examination, results of additional testing as well as guidelines 
and prediction models. A recent survey in 76 of 90 Dutch hospitals with an ED showed 
that approximately 67% of the Dutch hospitals have acute physicians (i.e. internists), 
and 84% have emergency physicians. The working arrangements between internists 
and emergency physicians vary between hospitals. In 85% of the hospitals internists are 
present on the work floor as consultant, coordinator or as manager.5 
Triage, Prediction Models and Early Warning Systems
To ensure that the most gravely ill patient requiring urgent care is treated first, physicians 
rely on triage. Triage is employed not only in the ED but also in prehospital mass-casualty 
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disasters; its aim is to identify which patient needs immediate care and which patient 
can wait. The word triage originates from the French word trier, which means to select 
or to separate and its modern form was invented by the French surgeon Dominique 
Jean Larrey (1766-1842) of the Napoleonic Grand Armee.6 Simple prehospital triage 
uses only vital signs whilst in-hospital triage systems use a combination of vital signs 
and presenting symptoms, which most often result in a 5-step triage level. Examples are 
the Manchester Triage System (MTS) and Emergency Severity Index (ESI).6 A frequent 
problem with these models is under- and over triage, in which the severity of the condition 
of the patient is either under- or overestimated. Undertriage results in delayed care with 
potential detrimental effects on outcomes and costs; overtriage allocates care to patients 
who do not critically need it, potentially delaying care for patients who do need it most.7 
Patients who are at the extremes of age (i.e. children and the elderly), especially those with 
chronic illness, are most at risk for incorrect triage. The elderly are mostly undertriaged 
and the risk increases with age.8,9 Reasons for over- and undertriage are complex and 
multifactorial. For example, elderly patients often have atypical presentation of illness as 
well as multiple comorbidities – resulting in polypharmacy; making it more challenging 
to identify the acute problem.10
Therefore, as a complement to triage, physicians in the ED developed clinical prediction 
models to support decision making. A prediction model quantifies the individual 
contribution to predicting the diagnosis, prognosis, or therapeutic effect from a 
combination of factors such as history, physical examination, and laboratory results.11 
In their optimal form, these models improve clinical judgment, save costs, and change 
medical behaviour with minimal risk for the patient.11 Steyerberg and Vergouwe proposed 
a seven-step framework for developing prediction models. The steps are summarized in 
Table 1.  
The first step is to consider the problem, define the research question and inspect the 
data. The second step is to code (and recode) predictors. In the third step the model 
should be specified and predictors for the model should be chosen. In the fourth 
step the regression coefficients need to be estimated. In the fifth step the quality and 
performance of a model need to be determined. In the sixth step the model should be 
validated. Ideally, the validity of a prediction model is assessed using independent data. 
There are four key measures to evaluate the performance of a prediction model, namely 
Table 1: 7 steps for developing a prediction model
Step Action
1 Problem definition and data inspection
2 (Re)coding of predictors
3 Model specification
4 Model estimation 
5 Model performance
6 Model validation
7 Model presentation
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the model intercept, calibration slope, discrimination and clinical usefulness.  As a 
final step the model should be presented in a form appropriate for the potential users.12 
Prediction models are probably underused in clinical practice. This may be the result of 
inappropriate model development, lack of validation, and no impact analysis.
There are many prediction models used in the ED by various specialties to predict 
diagnosis, prognosis, or treatment effect. An example of a diagnostic prediction model 
used by acute physicians is the Wells' criteria for deep vein thrombosis.13 This score uses 
findings from history and physical examination, combined with a laboratory test (i.e. 
d-dimer) to rule out deep vein thrombosis, or to recommend further testing. Other 
examples include the YEARS criteria and Wells’ criteria for pulmonary embolism.13,14 
An example of a prognostic decision tool is the Acute Presenting Older Patient (APOP) 
screener, which predicts functional decline after 90 days in elderly patients presenting in 
the ED based on eight items. This results in a recommendation specific for the vulnerable 
elderly patients, and advises the physician on additional measures to improve outcome.15 
In patients with suspected sepsis the quick Sepsis Related Organ Failure Assessment 
(qSOFA) is used to predict sepsis-related mortality. Patients who meet 2 of the 3 items 
of the qSOFA (Table 2), have a 30-day mortality of approximately 10 percent.16 There 
are also several prediction models that prognosticate effect of therapy. In patients with 
pneumonia, the severity and the subsequent risk of dying can be determined using the 
CURB-65 score or the Pneumonia Severity Index (PSI). These prognostic models provide 
guidance to the physician with respect to patient disposition and choice of antibiotic 
therapy. In patients with febrile neutropenia the MASCC score and the CISNE score can 
be used; these instruments identify patients at low risk of dying who can be treated at 
home with oral instead of intravenous antibiotics.17
Table 2: Items of the quick Sepsis Related Organ Failure Assessment (qSOFA) score
Systolic blood pressure < 100 mmHg
Respiratory rate > 22 per minute
Glasgow Coma Scale < 15
Another example of a prediction rule is the Early Warning Score (EWS). These scores 
(there are several variants) were introduced to detect patients at risk for catastrophic 
deterioration based on progressive worsening of physiological parameters, and 
indicate the need for an early medical intervention to prevent further harm.18 Details 
of the National Early Warning Score (NEWS) are provided as an example in Table 3. 
Throughout the years the scores have been revised and adapted for specific patient groups 
(e.g. pregnant women, children).19,20 Although these scores were derived at hospital 
wards, they were also introduced in the ED and may aid physicians to prognosticate 
the outcome of patients upon arrival in the ED, as well as a method for evaluation of 
subsequent assessments or interventions. 
Prediction models incorporating parameters that are more specific and therefore often 
more difficult to obtain (e.g. laboratory results) perform better than models that use 
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standard, readily available parameters (e.g. age, sex, vital signs).  However, the improved 
prediction also requires more waiting time prior to decision making.21 
Table 3: Items of the NEWS score
 
Parameter
 
3
 
2
 
1
Score 
0
 
1
 
2
 
3
Respiration Rate per minute ≤8 9-11 12-20 21-24 ≥25
Oxygen saturations in % ≤91 92-93 94-95 ≥96
Any supplemental oxygen Yes No
Temperature in °C ≤25 35.1- 36.0 36.1-38.0 38.1-39.0 ≥39.1
Systolic Blood Pressure (mmHg) ≤90 91-100 101-110 111-219 ≥220
Heart Rate per minute ≤ 40 41-50 51-90 91-110 111-130 ≥131
Level of consciousness (AVPU) A V, P or U
AVPU: Alert Verbal Pain Unresponsive
Assessment and treatment of patients with potentially critical illness 
When assessing patients in the ED who are potentially critically ill, healthcare 
professionals rely on the ABCDE approach (i.e. Airway, Breathing, Circulation, Disability, 
Exposure). This structured method to evaluate a patient was introduced in 1978 in  the 
Advanced Trauma Life Support course22 and likely improves outcome by detecting and 
treating the most life-threatening clinical problems first. In the Netherlands, training 
in this systematic approach is obligatory for all residents who work in the ED. Diseases 
that acute physicians encounter that benefit from early identification and treatment are, 
amongst others, shock and sepsis.23 
Shock 
In the assessment of the ‘C’ (i.e. ‘circulation’) healthcare professionals assess the patient 
for signs of shock. Shock is a state of hypoxia at cellular and tissue level due to imbalance 
of oxygen delivery and oxygen consumption, and is the result of circulatory failure. 
There are four types of shock: hypovolemic, distributive, cardiogenic, and obstructive 
shock (Table 4). Many patients with circulatory failure have a combination of more 
than one form of shock. The types of shock encountered in the ED depends the services 
provided by the ED (e.g. level 1 trauma centre, percutaneous coronary intervention (PCI) 
centre, tertiary referral centre), as well as the population served by the ED (e.g. rural or 
urban, socioeconomic characteristics). The prevalence and aetiology of non-traumatic 
undifferentiated shock in the ED is not well described, but has an in-hospital mortality 
of more than 10 percent.24,25 In its initial stage shock can be reversible, but unrecognized 
and untreated it can progress to irreversible organ dysfunction and subsequent organ 
failure. Therefore, it is paramount that shock is recognized early and treated adequately. 
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Hypovolemia can be caused by ‘volume depletion’ and ‘dehydration’. Volume depletion 
is the loss of sodium from the extracellular space (i.e. intravascular and interstitial 
fluids), which can result in hemodynamic instability. ‘Dehydration’ is the loss of water, 
which results in a rise of plasma sodium and osmolality. Assessment of a patient for the 
initial signs of hypovolemia is difficult and few findings from physical examination are 
of proven value.26 Most studies have shown that physical examination has low sensitivity 
and specificity in the assessment of cardiac output and timely detection of shock.27,28 
Therefore there is a need for novel indices (e.g. clinical parameters, biomarkers) that aid 
physicians in detecting shock in an earlier stage.
Table 4: Types of shock and characteristics
Type of Shock Cause Preload Cardiac Output Afterload
Hypovolemic Haemorrhage
Dehydration
↓ ↓ ↑
Cardiogenic Acute myocardial infarction
Valvular disease
Arrhythmia
↑ ↓ ↑
Distributive Sepsis
Anaphylaxis
CNS injury
↓/ - ↑ ↓
Obstructive Cardiac tamponade
Pulmonary embolism
Tension pneumothorax
↑ ↓ - /↑
CNS: central nerve system
Sepsis
Infections are frequently encountered at the ED. Infections range from mild, self-
limiting to the life-threatening condition sepsis. In developed countries, sepsis occurs 
in approximately 2% of all admitted patients. In patients admitted to the intensive care 
unit (ICU), sepsis occurs in between 6 and 30% of all patients, depending on the type 
of ICU.29 In the Netherlands, there were more than 3,500 deaths due to sepsis in 2012.30
Sepsis is derived from the Greek term 'σήψις' meaning decay and putrefaction of meat, 
and was introduced in the fourth century BC by the Greek physician Hippocrates.31-33 In 
1914, the term sepsis was changed when Schottmueller defined septicaemia as “a state 
of microbial invasion from a portal of entry into the blood stream which causes signs of 
illness”. Terms such as “bacteraemia”, “septicaemia”, “sepsis”, and “septic shock” were 
used to describe patients who were severely ill due to an infection, without any predefined 
criteria.34 Nowadays sepsis is considered a complex process in which an infection induces 
a variable, prolonged host response to clear infection and recover damaged tissue. The 
proinflammatory mechanisms in this process can induce organ damage on the one 
hand, whilst the anti-inflammatory mechanisms can cause secondary infections on the 
Chapter 1
20
other hand; imbalance in either direction leads to harm.33,35 
Sepsis definitions and sepsis management
In order to assist both physicians treating and researchers studying sepsis, uniform sepsis 
definitions were introduced in 1992. Sepsis was defined as a systemic inflammatory 
response to an infection.34 Systemic inflammation, defined as a systemic inflammatory 
response syndrome (SIRS) consisted of four criteria (i.e. body temperature < 36 °C or 
> 38 °C, heart rate > 90 beats per minute, respiratory rate > 20 breaths per minute, white 
blood cell count < 4 or > 12 x 109/L). The combination of two or more SIRS criteria 
Figure 1 a: Presentation of Sepsis, Severe Sepsis and Septic Shock 
guidelines to improve outcomes in severe sepsis and septic shock were published.37 
These guidelines were developed by a group of experts on sepsis and were supported 
by 11 medical societies. The SSC introduced a 6-hour resuscitation bundle specifically 
for the ED and a 24-hour management bundle, specifically for the intensive care. The 
components of the first resuscitation bundle are given in Table 5.37,38 
These guidelines endorsed the early goal directed therapy (EGDT) of Rivers et al., who 
showed that hemodynamic optimization before admission to the intensive care unit 
Figure 1b: Sepsis continuum
and an infection defined sepsis. 
SIRS however is not specific for 
infection, but can also be the 
result of non-infectious causes, 
such as pancreatitis, burns and 
trauma (Figure 1a). With the 
introduction of these uniform 
sepsis definition, severe sepsis 
(i.e. sepsis with acute organ 
dysfunction), and septic shock 
(i.e. severe sepsis with refractory 
shock) were also introduced, 
and these were proposed as 
comprising a disease continuum 
(Figure 1b). The further the disease 
progressed in this continuum, the 
higher the chance of mortality.34 
In 2001 these definitions were 
slightly revised, incorporating 
additional signs and symptoms 
for the diagnosis of sepsis.36 
In 2002 the surviving sepsis 
campaign (SSC) was launched to 
reduce sepsis-related mortality by 
25% in the next five years. In 2004, 
the first internationally accepted 
21
General introduction
(i.e. at the ED) improved outcome in patients with severe sepsis and septic shock.39 This 
subsequently led to development of standards for early management of severe sepsis 
and septic shock in the ED. The SSC also stressed the importance of early initiation 
of antibiotics in sepsis, which was reinforced by Kumar et al. in 2006 who showed that 
Table 5: Initial items in the Surviving Sepsis Campaign 
1. Measure (and when elevated, remeasure) serum lactate 
2. Blood cultures prior to antibiotics 
3. Broad spectrum antibiotics within 3 hours after presentation, within 1 hour in hospital 
4. Fluid resuscitation, followed by vasopressors guided by the mean arterial pressure if a patient is 
    unresponsive to fluid therapy. 
5. Maintain adequate central venous pressure  and adequate central venous oxygen saturation in persistent  
    arterial hypotension using vasopressors, inotropes or blood transfusion
every hour of delay in the initiation of antibiotics in patients with septic shock resulted 
in a 7.6% increase in mortality.40 Compliance to the surviving sepsis bundles have been 
shown to lower mortality rates.38,41
As a result of studies with either new findings or that failed to reproduce results of 
previous studies the content of, and suggested timeframe in which these bundles needed 
to be completed, changed over the following years.41 In 2012, the resuscitation bundle was 
modified into two bundles, a 3-hour and a 6-hour bundle, and the management bundle 
was discarded. The ‘severe sepsis 3-hour resuscitation bundle’ contained therapeutic 
goals that had to be completed within 3 hours after presentation of septic shock, whereas 
the 'the 6-hour septic shock bundle' contained the goals that needed to be completed 
within 6 hours.42 In 2014 and 2015 three large trials (ProCESS, ARISE, and ProMISe) 
were published in which ‘usual care’ was shown to be as good as EGDT in patients with 
severe sepsis and septic shock,41,43 and in 2015 the SSC bundles were revised based on 
these findings.44 
In 2016, the definition of sepsis changed as a result of improved knowledge on 
pathobiology, management, and epidemiology of sepsis. Sepsis is now defined as "life-
threatening organ dysfunction caused by a dysregulated host response to infection’, and 
septic shock as ‘a subset of sepsis in which particularly profound circulatory, cellular, and 
metabolic abnormalities are associated with a greater risk of mortality than with sepsis 
alone". The term severe sepsis was abandoned.16 The qSOFA (Table 2) was introduced 
as a bedside prompt to screen for organ dysfunction, and should be followed by the 
Sepsis associated Organ Failure Assessment (SOFA, Table 6) if the qSOFA is positive 
(> 1 item). In 2018, the SSC updated its bundle to its current form, combining the 3-hours 
and 6-hours into a single '1-hour bundle' with the explicit goal to initiate resuscitation 
immediately.23,45 
Despite the advantages of standard sepsis definitions and the SSC, criticisms remains. 
SIRS was too sensitive and not specific enough, resulting in overtreatment. This could 
lead to antibiotic resistance, as well as side effects of antibiotics.46,47 The benefit of EGDT 
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Table 6:  SOFA score
SOFA score
Variable 0 +1 +2 +3 +4
Respiratory ≥400 <400 <300 <200 and  
mechanically 
ventilated
<100 and  
mechanically  
ventilated
PaO2/FiO2 (mmHg)
>302 <302 <221 <142 <67 SpO2/FiO2 (mmHg)
Cardiovas-
cular
MAP 
≥70 
MAP  
<70 
dopamine  
≤5
dopamine 
 >5 
epinephrine 
≤0.1 
norepinephrine 
≤ 0.1
dopamine  
>15 
epinephrine  
>0.1 
norepinephrine 
>0.1
MAP in mmHg 
Doses in mcg/kg/min
Liver <20 20-32 33-101 102-204 >204 Bilirubin in μmol/L
Renal <110 110-170 171-299 300-440 >440 Creatinine in μmol/L
Urine output 
<500
Urine output  
<200
Ml/day
Coagulation ≥150 <150 <100 <50 <20 Platelets ×103/µl
Neurologic 15 13-14 10-12 6-9 <6 Glasgow Coma Scale
A new increase in SOFA score of 2 or more in the presence of infection makes the diagnosis of sepsis. Increasing SOFA scores 
are associated with increases in mortality.
was already questioned by the outcome of studies that showed usual care is as good as 
EGDT. The value of early initiation of antibiotic therapy in all patients with sepsis is 
also being questioned, as a recent trial on prehospital antibiotics failed to demonstrate 
reduced mortality.48  Even though qSOFA is more specific than SIRS, it lacks sensitivity 
and therefore is not effective as a screening tool for sepsis. Furthermore, it is not 
universally supported by all medical societies.49  
Despite the changes in the severe sepsis and septic shock management guidelines 
and the criticism that surrounds it, the cornerstone of surviving sepsis remains early 
identification of sepsis and septic shock, and subsequent early initiation of antibiotics 
and aggressive hemodynamic stabilization. However, there is ongoing need to identify 
those patients who truly benefit from early antibiotic treatment, and distinguish them 
from those who can await further diagnostics to inform more targeted antibiotic therapy. 
This is all the more relevant in an era of growing antibiotic resistance, which physicians 
also need to take into account. 
Aims and outline of this thesis
This thesis covers studies that investigate clinical research questions relevant to acute and 
emergency physicians. This thesis consists of three main parts. The first part includes 
Chapters 2 to 7 where we focus on the value of history, clinical examination and additional 
testing in the identification of severity of illness in patients in the ED. In Chapter 2 we 
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take a closer look at capillary refill time (CRT) using a novel research method called Flash 
Mob Research, to determine interobserver agreement between various methods used to 
measure CRT, as well as to relate CRT measurements with hemodynamic parameters. 
In Chapter 3 we demonstrate how axillary humidity, peripheral temperature gradient, 
perfusion index (PI) and pleth variability index (PVI) can serve as potential indices of 
fluid deficit. In Chapter 4 we investigate, both retrospectively and prospectively, the 
role of drug non-adherence as a cause of hypertensive urgency in the ED. In Chapter 
5 we describe characteristics of patients who visit the ED with medically unexplained 
physical symptoms and compare these characteristics to patients with explained physical 
symptoms. In Chapter 6 we describe two cases of postural orthostatic tachycardia 
syndrome (POTS). In POTS, a change from a supine to an upright position causes an 
abnormally large increase in heart rate and orthostatic hypotension. We provide a review 
of the current literature on the subject. In Chapter 7 we study the quality of sleep of 
hospitalized patients, and show how decisions made in the ED influence the course of 
hospitalization.
In the second part of this thesis, covering Chapters 8 to 10, we focus on prediction 
models and early warning scores. In Chapter 8 we provide an extensive overview of the 
literature concerning models to predict mortality in the ED. In Chapter 9 we describe 
how we develop and validate a clinical prediction tool for hospital admission, applicable 
to the elderly in the ED. In Chapter 10 we evaluate the performance of qSOFA, SIRS 
criteria and NEWS in predicting mortality among patients with suspected infection 
presenting to the ED. 
The third part of this thesis zooms in on factors that influence of antibiotic susceptibility 
(Chapters 11 to 13). In Chapter 11 we determine the impact of international travel on the 
risk of post-travel faecal carriage of multidrug-resistant Enterobacteriaceae. In Chapter 
12 we study pathogens causing urinary tract infections and their antibiotic susceptibility. 
In Chapter 13 we re-evaluate whether administration of empiric antibiotics is associated 
with reduced mortality among adult patients with blood stream infections consulting 
at the ED. We particularly focus on why previous studies were unable to confirm this 
supposedly well-established biological rationale.
In Chapter 14 we discuss the main finding of the studies we performed, provide 
conclusions per part and we provide suggestions for future research.  In Chapter 15 we 
summarize the results of these studies. 
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Abstract
Background
Capillary refill time (CRT) is a clinical test used to evaluate the circulatory status of 
patients, and there are various methods to assess CRT. Conventional clinical research 
often demands large numbers of patients, making it costly, labour-intensive and time 
consuming. We studied the interobserver agreement on CRT in a nationwide study using 
a novel methodology of research called flash mob research (FMR).
Methods
Physicians in the Netherlands were recruited by word-of-mouth, conventional media 
and social media to participate in a nationwide, single-day, “nine-to-five”, multi-centre, 
cross-sectional, observational study to evaluate CRT. Patients ≥ 18 years presenting to ED 
or who were hospitalized were eligible for inclusion. CRT was measured independently 
(by two investigators) at the patient’s sternum and distal phalanx after application of 
pressure for 5 (5s) and 15 s (15s).
Results
On October 29th 2014, a total of 458 investigators in 38 Dutch hospitals enrolled 1,734 
patients. The mean CRT measured at the distal phalanx was 2.3 s (5s, SD 1.1) and 2.4 s 
(15s, SD 1.3). The mean CRT measured at the sternum was 2.6 s (5s, SD 1.1) and 2.7 s (15s, 
SD 1.1). Interobserver agreement was higher for the distal phalanx (κ-value 0.40) than for 
the sternum (κ-value 0.30).
Conclusions
Interobserver agreement on CRT is, at best, moderate. CRT measured at the distal phalanx 
yielded higher interobserver agreement compared with sternal CRT measurements. 
FMR proved a valuable instrument to investigate a relative simple clinical question in an 
inexpensive, quick and reliable manner. 
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The power of Flash Mob Research
Background
Evidence assessing the usefulness and reliability of commonly used bedside diagnostic 
tests is not always available or easily obtained. Capillary refill time (CRT) is frequently 
used to judge a patient’s circulatory status: a prolonged CRT is thought to be associated 
with an inadequate perfusion.50,51 Despite few outcome data to support the use of CRT 
in adults outside of the ICU, the use of CRT is widespread.52-54 CRT is a standard part 
of rapid primary assessment of critically ill patients in various advanced life support 
guidelines.51,55
Originally, CRT was defined without strict time limits (as “normal”, “definite 
slowing”, and “very sluggish”)56 which left room for subjective interpretation, making 
reproducibility difficult. In the 1980s, an operational definition of 2 seconds as upper 
limit of normal CRT was recommended, which was replaced in 1988 with less used 
upper limits of normal adjusted for age and sex.50,57  Despite these recommendations, 
the measurement and interpretation of CRT remain inconsistent.58,59 CRT is measured 
at different sites and with different pressure times. In adult ICU settings, application of 
pressure at the fingertip for 15 s is considered the standard; in children, CRT is mostly 
measured at the sternum.54,59-61 Interpretation is hindered by ambient and patient factors 
that are not always easy to control (e.g. ambient temperature, light, patient peripheral 
temperature).26,51,62-64 Even in controlled circumstances, the interobserver reliability of 
CRT measurements has been questioned.51,60,65-67 In addition, the different methods to 
measure CRT have been never compared in adults.
CRT is used in daily clinical practice worldwide, but it remains questionable which 
method should be used to measure CRT (sternum or phalanx) and whether the results 
are reproducible. The present study was therefore designed to compare the most 
frequently used methods to measure CRT in adult patients with variable hemodynamic 
status; the study setting resembled daily practice to determine which measurement has 
the highest interobserver agreement and to determine if the sternum and distal phalanx 
measurements can be used interchangeably. 
Conventional clinical research used for answering clinically oriented research questions 
often demands large numbers of patients, making it costly, labour-intensive, and time-
consuming. We saw a possible solution in flash mob research (FMR). This technique is 
a novel method of organizing research and allows the investigation of clinically relevant 
questions on a large scale in an abbreviated time course.68 FMR is based on the concept 
of flash mobs: “a sudden and planned gathering of many people at a particular place 
that has been arranged earlier on an internet website.”69 Using the numerical strength of 
multiple hospitals, as well as the professional and social networks of their medical staff, 
it is possible to obtain sufficient data with FMR in a short time course68 while upholding 
the same quality standards.
The primary objective of the present study was to determine the interobserver 
agreement of CRT measurements as measured at the sternum and at the distal phalanx 
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using pressure times of 5 and 15 s and to relate the measurements with hemodynamic 
characteristics. Our secondary aim was to establish the feasibility of using FMR as a 
fast, inexpensive, and robust method to investigate clinical questions by using the power 
of social networks and new and conventional media to gather as many relevant data as 
possible in a short period of time.
Patients and Methods
Study Design
This trial was a nationwide, single-day, “nine-to-five,” multicentre, cross-sectional 
observational study.
Setting up an FMR
As in flash mobs, preparations for FMR were made in a small group. The research 
question and study design were conceived in the Erasmus University Medical Center 
(Erasmus MC) in Rotterdam, the Netherlands. The Erasmus MC acted as coordination 
centre for the duration of the study. A steering committee with members from all of 
the Netherlands further elaborated the research question and study protocol. The 
protocol was approved by the medical ethics committee of the Erasmus MC. Members 
of the steering committee invited physicians from their professional networks from all 
eight Dutch university hospitals, and subsequently physicians from affiliated regional 
hospitals, to participate; the result was nationwide participation. In each participating 
hospital, a local investigator, designated the “ambassador,” coordinated the study; 
ambassadors were either medical specialists or residents. Ambassadors obtained local 
ethical board approval of the protocol, recruited and instructed investigators, and were 
responsible for handling data. Similar to flash mobs, communication with participating 
investigators, public, and peers was mainly conducted by using e-mail, social media, and 
our Website. 
Setting, Patients, and Variables
On October 29th, 2014, between 9:00 AM and 5:00 PM, data were simultaneously 
collected in all participating hospitals. Patients aged ≥ 18 years who were able to 
provide informed consent and who presented to the ED or were hospitalized within this 
period were eligible for enrolment. After providing consent, patients were examined 
independently by two investigators working within a 5-min interval. Investigators 
were physicians (medical specialists or residents), nurses, and medical students in their 
clinical rotations. Investigators were instructed on (and worked according to) standard 
operating procedures, which described the order of the tests. Investigators measured 
CRT at two sites twice: the sternum (CRTs) and the distal phalanx of the finger (CRTp). 
The first measurement occurred after application of pressure for 5 s (CRTs5 and CRTp5, 
respectively), and the second after application of pressure for 15 s (CRTs15 and CRTp15). 
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CRTp was measured by applying sufficient pressure at the distal phalanx of the finger 
with the hand held at heart level to cause blanching of the skin, and CRT was defined as 
the time necessary for the skin to regain its colour.50 CRTs were measured by applying 
sufficient pressure to achieve blanching of the skin of the sternum, and again CRT was 
defined as the time necessary for the skin to regain its colour. Investigators were advised 
to determine CRT by counting, and no timing devices were advised, mimicking daily 
practice. CRT was measured in seconds, and the results were rounded off to the nearest 
half-second. This resolution allowed categorization of the outcome by using upper 
values of normal as suggested in other studies50,54,57 this method was previously used by 
Anderson et al.65
Investigators subjectively assessed the peripheral temperature by placing the back of the 
hand on the patients’ hand (cold vs not cold). Investigators provided their subjective 
conclusion of the patient’s hemodynamic status (adequate vs inadequate) using all 
available clinical information. Investigators also provided their subjective conclusion 
of the observed CRT (normal vs prolonged), without predefining normality. The 
subjective conclusion was chosen to resemble daily practice, as clinicians often present 
measured CRT with a dichotomous outcome. Pulse rate, blood pressure, respiratory rate, 
temperature, and oxygen saturation were measured by using local standard procedures. 
All data were entered into local databases, which were subsequently combined at the 
Erasmus MC. All patients with CRT measured by two investigators were included in 
the final analysis. Mean arterial pressure (MAP) was calculated and dichotomized (< 65 
mmHg vs ≥ 65 mmHg). MAP < 65 mmHg was considered inadequate.42 Pulse rate was 
categorized into one of the following three groups: < 60 beats/min, 60 to 100 beats/min, 
and > 100 beats/min. CRT was categorized by using definitions found in the literature. 
CRTs5 and CRTp5 were categorized using the upper limits of normal (2.0 s) as defined by 
Champion et al.57 and the age and sex adjusted upper values of normal (male subjects, 
aged < 62 years: CRTs5 and CRTp5 2.0 s; female subjects, aged < 62 years: CRTs5 and 
CRTp5 3.0 s; male and female subjects aged ≥ 62 years: CRTs5 and CRTp5 4.0 s) as defined 
by Schriger and Baraff.50 For CRTs15 and CRTp15, an upper limit of normal of 4.0 s was 
used.54
Study Size
The study size could not be predicted due to the FMR design. In principle, a successful 
FMR should include a large sample size for reliable conclusions. 
Statistical Methods
Data were summarized in terms of mean, median, 95% CIs, and SD when appropriate. 
Categorical data were analysed by using χ2 tests. The means of two groups were 
compared by using the Student t-test (normal distribution) or the Mann-Whitney U 
test (non-normal distribution); the means of three groups were compared by using the 
Kruskal-Wallis test. Differences between continuous data with non-normal distribution 
were analysed by using Wilcoxon signed-rank sum tests. Interobserver agreement was 
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analysed for discrete values of CRT by using the intraclass correlation coefficient. In 
addition, interobserver agreement was analysed for categorical values of CRT by using 
k statistics. The variation of CRT with age and sex was analysed with the use of linear 
regression. Missing data were considered missing at random and were therefore ignored. 
A difference of 0.5 s between CRTs and CRTp was considered clinically relevant.59,65 
A P value < .05 was considered statistically significant. Statistical analyses were performed 
by using SPSS version 21.0 (IBM SPSS Statistics, IBM Corporation).
Results
Participating Hospitals
A total of 38 hospitals, located all over the Netherlands, participated in the study 
(representing 45% of the total number of 85 Dutch hospital organizations); this total 
included all eight university hospitals, 29 teaching hospitals (56% of non-academic 
teaching hospitals), and one nonteaching hospital. Mean inclusion was 46 patients per 
hospital (median, 39; range, 3-130). Of the participating hospitals, almost 40% provided 
data within 24 h and 76% within 1 week. All data were available within 19 days.
Participating Investigators
A total of 458 investigators participated in the study (33 medical specialists, 246 residents, 
122 medical students, and 57 nurses).The mean number of enrolments was seven patients 
per investigator (range, 1-65). Most enrolments were done by residents (n = 1,916; mean, 
8), followed by medical students (n = 1,096; mean, 9), medical specialists (n = 288; mean, 
9), and nurses (n = 168; mean, 3).
Patient Characteristics
A total of 1,734 patients (3,468 examinations) were included in the study, with a slight 
preponderance of male subjects (51.6%; n = 894). Patients overall had a mean age of 
65 years. The majority (78.1%) were inpatients. Patient characteristics are presented in 
Table 1.
Capillary Refill Time
The mean peripheral CRT was 2.3 s (CRTp5, SD 1.1) and 2.4 s (CRTp15, SD 1.3) and mean 
sternal CRT was 2.6 s (CRTs5, SD 1.1) and 2.7 s (CRTs15, SD 1.1). CRTp5 was shorter in 
women (2.2 s, SD 1.0) than in men (2.4 s, SD 1.2; P = .006) and increased with age (0.16 
s per 10 years; P < .001) (Figure 1). On average, CRTp5 was 0.3 s shorter than CRTs5 (P < 
.001), and  CRTp15 was 0.3 s shorter than CRTs15 (P < .001). CRT correlated positively with 
MAP, subjective peripheral temperature, and subjective assessment of the hemodynamic 
status. There was no correlation with pulse rate (Table 2).
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Figure 1:  Mean CRT in seconds for different age categories in years.
CRT: capillary refill time; P5: peripheral measurement after application of pressure for 5 s; P15: peripheral measurement after 
application of pressure for seconds; S5: sternal measurement after application of pressure for 5 s; S15 : sternal measurement 
after application of pressure for 15 s.
Table 1: Patient Characteristics 
Characteristic Male 
(n = 894 [51.6%])
Female 
(n = 840 [48.4%])
Total 
(N=1,734)
Age,a y (n = 1,734) 65 ± 16 65 ± 18 65 ± 17
Systolic blood pressure,a mmHg (n = 1,728) 131 ± 21 133 ± 23 132 ± 22
Diastolic blood pressure,b mmHg (n = 1,728) 75 ± 12 72 ± 13 173 ± 13
Mean arterial pressurea (n = 1,728) 93 ± 14 92 ± 14 93 ± 14
Pulse,c frequency/min (n = 1,731) 79 ± 16 81 ± 16 80 ± 16
Oxygen saturation in percentagea (n = 1,628) 96 ± 3 96 ± 3 96 ± 3
Respiratory rate,a breaths/min (n = 1,598) 17 ± 4 16 ± 4 17 ± 4
Temperature,b °C (n = 1,723) 36.8 ± 0.7 36.9 ± 0.7 36.9 ± 0.7
Data are expressed as mean SD. a: Not significant. b: P < .001. c: P = .008.  
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Table 2: Mean Capillary Refill Times
Parameter CRTp5 (95% CI) CRTp15 (95% CI) CRTs5 (95% CI) CRTs15 (95% CI)
Total 2.3 (2.2-2.3) 2.4 (2.4-2.5) 2.6 (2.5-2.6) 2.7 (2.7-2.8)
Subjective peripheral temperature
  Cold 3.2 (3.0-3.4) 3.3 (3.1-3.6) 2.9 (2.5-2.6) 3.0 (2.9-3.2)
  Warm 2.1 (2.1-2.2) 2.3 (2.2-2.3) 2.5 (2.8-3.1) 2.6 (2.6-2.7)
  Pa < .001 < .001 < .001 < .001
Subjective hemodynamic status
  Inadequate 3.2 (2.8-3.5) 3.6 (3.1- 4.2) 3.2 (2.9-3.5) 3.5 (3.2-3.8)
  Adequate 2.2 (2.2-2.3) 2.4 (2.3-2.4) 2.6 2(.5-2.6) 2.7 (2.6-2.7)
  Pª < .001 < .001 < .001 < .001
Mean arterial pressure, mmHg
  < 65 3.0 (2.6-3.5) 3.3 (2.7-3.9) 3.4 (2.7-4.1) 3.6 (3.0-4.2)
  ≥ 65 2.3 (2.2-2.3) 2.4 (2.3-2.5) 2.6 (2.5-2.6) 2.7 (2.6-2.7)
  Pa .001 < .001 .01 .002
Pulse rate per minute
  < 60 2.3 (2.1-2.5) 2.6 (2.3-2.9) 2.6 (2.5-2.9) 2.8 (2.5-3.0)
  60-100 2.3 (2.2-2.3) 2.4 (2.3-2.5) 2.6 (2.5-2.6) 2.7 (2.6-2.8)
  > 100 2.2 (2.0-2.4) 2.4 (2.2-2.6) 2.6 (2.4-2.7) 2.7 (2.5-2.9)
  Pb .407 .397 .800 .862
Subjective conclusion of the CRT
  Prolonged 3.5 (3.3-3.7) 3.9 (3.6-4.1) 3.6 (3.4-3.7) 3.8 (3.6-4.0)
  Normal 2.1 (2.1-2.1) 2.2 (2.2-2.3) 2.5 (2.4-2.5) 2.6 (2.5-2.6)
  Pa < .001 < .001 < .001 < .001
Temperature, °C
  < 36 2.6 (2.4-2.9) 2.8 (2.6-3.1) 2.6 (2.4-2.8) 2.8 (2.5-3.0)
  36-38 2.3 (2.2-2.3) 2.4 (2.3-2.5) 2.6 (2.5-2.6) 2.7 (2.6-2.8)
  > 38 2.2 (1.9-2.5) 2.5 (2.1-2.8) 2.5 (2.3-2.8) 2.7 (2.4-3.0)
  Pb .003 .002 .907 .870
95% CI 95% CI of the mean (lower bound and upper bound); CRT capillary refill time; CRTp5 peripheral capillary refill 
time, application of pressure 5 s; CRTp15  peripheral capillary refill time, application of pressure 15 s; CRTs5 sternal capil-
lary refill time, application of pressure 5 s; CRTs15 sternal capillary refill time, application of pressure 15 s. a: Determined by 
using the Mann-Whitney U test. b: Difference between groups as determined by using the Kruskal-Wallis test.
The mean difference between measurements of the first and second investigator was 0.1 
s (CRTp5, 0.1 s [95% CI, 0.0-0.1]; CRTp15, 0.1 [95% CI, 0.0-0.1]; CRTs5, 0.1 [95% CI, 0.0-
0.1]; and CRTs15, 0.1 [95% CI, 0.0-0.1]). The median difference was 0 s in all groups. 
Interobserver agreement, assessed by calculating the intraclass correlation coefficient 
between the CRTp measurements of both investigators, was 0.52 for CRTp5 (95% CI, 0.49-
0.56) and 0.54 for CRTp15 (95% CI, 0.50-0.57) (P < .001), and interobserver agreement on 
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Table 3: Agreement Between Two Investigators Assessed by Using the Intraclass Correlation 
Coefficient
Variable Intraclass Correlation Coefficient 95% CI Interpretation
CRTp5 0.52 0.49-0.56 Moderate correlation
CRTp15 0.54 0.50-0.57 Moderate correlation
CRTs5 0.43 0.39-0.47 Low correlation
CRTs15 0.46 0.42-0.49 Low correlation
All results, P < .001. See Table 2 legend for expansion of abbreviations.
Table 4: Agreement Between Two Investigators Assessed by Using κ Statistics
Variable κ Statistic 95% CI Interpretation
CRTp5, upper range of normal 2 s 0.40 (0.36-0.45) Fair agreement
CRTs5, upper range of normal 2 s 0.30 (0.26-0.35) Fair agreement
CRTp5, upper range of normal based on age and sex 0.20 (0.12-0.29) Slight agreement
CRTs5, upper range of normal based on age and sex 0.13 (0.04-0.22) Slight agreement
CRTp15, upper range of normal of 4 s 0.32 (0.24-0.41) Fair agreement
CRTs15, upper range of normal of 4 s 0.23 (0.15-0.31) Fair agreement
Subjective conclusion on CRT 0.44 (0.37-0.51) Moderate agreement
All results, P < .001. See Table 2 legend for expansion of abbreviations.
measurements of CRTs was 0.43 for CRTs5 (95% CI, 0.39-0.47) and 0.46 for CRTs15 (95% 
CI, 0.42-0.49) (P < .001) (Table 3).
The agreement between the two investigators on whether the subjective CRT was normal 
or prolonged was assessed by using κ statistics. Application of pressure for 5 s yielded a 
κ value of 0.40 for CRTp (95% CI, 0.36-0.45) and 0.30 for CRTs (95% CI, 0.26-0.35) (both 
fair agreement)70 when using 2 s as the upper value of normal, and a κ value of 0.20 for 
CRTp (95% CI, 0.12-0.29) and 0.13 for CRTs (95% CI, 0.04-0.22) (both slight agreement)70 
when using upper limits of normal based on age and sex. 
The agreement between the two investigators on whether the subjective CRT was normal 
or prolonged was assessed by using κ statistics. Application of pressure for 5 s yielded 
a κ value of 0.40 for CRTp (95% CI, 0.36-0.45) and 0.30 for CRTs (95% CI, 0.26-0.35) 
(both fair agreement)70 when using 2 s as the upper value of normal, and a κ value of 
0.20 for CRTp (95% CI, 0.12-0.29) and 0.13 for CRTs (95% CI, 0.04-0.22) (both slight 
agreement)70 when using upper limits of normal based on age and sex. Using 4 s as the 
upper value of normal after application of 15 s of pressure yielded a κ value of 0.32 for 
CRTp measurements (95% CI, 0.24-0.41) and 0.23 for CRTs measurements (95% CI, 
0.15-0.31) (both fair agreement). Agreement between two investigators on the subjective 
conclusion of whether the CRT was normal or prolonged yielded a κ value of 0.44 (95% 
CI, 0.37-0.51) (moderate agreement) (Table 4).70
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Discussion
To our knowledge, our nationwide, single-day, nine-to-five, multicentre, cross-
sectional observational study is the first to analyse the interobserver agreement of four 
frequently used methods to measure CRT. These measurements were performed in a 
setting specifically designed to resemble daily practice at the ED and the ward, with 
two observers using identical methods under similar conditions. CRT measurements 
had slight to moderate agreement at best using a dichotomous outcome (normal vs 
prolonged) and moderate correlation using a continuous outcome (seconds).
To be of use in clinical practice, the interpretation of the results of CRT measurements 
should be easily reproducible. To date, there are only three studies in adults that report 
on interobserver agreement of CRT measurement at the distal phalanx after 5 s of 
pressure.65-67 These studies show moderate agreement at best. In only one study was CRT 
measured without a timing device.65 The other studies either showed a video with CRT66 
or used healthy volunteers in controlled circumstances, and CRT was determined with 
a chronometer or a video,67 which does not reflect the worldwide use and interpretation 
of CRT in daily practice.58
To our knowledge, our study is the first to assess the optimal site and duration of pressure 
for CRT measurement in adults. As expected, our study found a correlation between the 
CRT measured at the distal phalanx and sternum. CRT measured at the distal phalanx was 
shorter than that measured at the sternum, as was found in children,59 and we concluded 
that the phalanx and the sternum cannot be used interchangeably. The interobserver 
agreement on CRT was higher for the distal phalanx than for the sternum. A prolonged 
application of pressure (15 s), as used solely in the ICU, only resulted in a slightly higher 
interobserver correlation.54,61 Application of pressure for 5 s at the distal phalanx is easier 
to use, and most studies on CRT in the ED and the ward use 5 s application of pressure. 
Therefore, based on these findings, we recommend uniform use of CRT and propose that 
CRT should only be measured at the distal phalanx with 5 s of pressure.
However, why measure CRT? CRT was introduced by Beecher in World War II to identify 
shock in battlefield survivors56 it is still used today to assess peripheral circulation and 
in early detection of shock.51,55 Although our study showed a correlation between CRT 
and a MAP < 65 mmHg, we found no correlation between CRT and an abnormal pulse 
rate, which is an early indicator of shock. In the detection of shock in its early stages, 
the additional value of CRT seems limited, which is supported by previous research.26,63 
However, some studies show the predictive value of CRT on long- and short-term 
mortality. In a retrospective study in oncology patients, a prolonged CRT (≥ 2 s) was 
predictive for both coronary care unit admission and 30-day mortality.52 A prospective 
study in ED patients found that a prolonged CRT as a continuous variable was associated 
with an increased risk of mortality at 1 and 7 days.53
The present study also illustrated the power of FMR study design and its potential as 
a methodologic tool for clinical research. Compared with conventional studies, FMR 
has multiple similarities. In preparation of the study, FMR requires the same steps in 
37
The power of Flash Mob Research
designing and setting up (e.g. protocol development, ethical board approval, instruction 
of collaborators). However, FMR exhibited many additional advantages. It facilitated 
inclusion of large numbers of patients from multiple centres (and the resulting data) 
within a short period of time. This inspiring and new research method, combined with 
an appealing research question, led to high participation of hospitals. The FMR approach 
also encouraged all the members of the medical team to participate in research. Most 
investigators in our study and almost one-half of the ambassadors were residents, who 
are often mainly focused on patient care and otherwise not regular participants of 
research. FMR engaged them in the process of research and exposed them to its various 
aspects. All these advantages come with limited time investment and low costs. 
Our study has limitations. Given the cross-sectional nature of this study, no follow-
up data were collected. Therefore, no associations with outcomes of disease, including 
mortality, were examined. Data collection was performed by using standardized 
procedures after provision of standardized instructions; however, given the large number 
of centres and investigators, it is inevitable that small differences exist in the collection of 
data. Many of the collected variables are subjective and therefore open to interpretation, 
and they can be influenced by the clinical experience of the investigator. The application 
of pressure could differ between investigators, which could also affect CRT. In children, 
light pressure resulted in shorter CRT,51 but in adults this effect has not been studied. 
We propagated counting, instead of using timing devices, to a resolution of one-half 
second, which could have led to lower agreement. Because the mean difference between 
all measurements was 0.1 s, the influence on our results was negligible while enabling 
us to compare various upper limits of normal. We believe that our study represents how 
CRT is used as a bedside test in daily practice worldwide, with all its shortcomings that 
hinder its users. In addition, with 45% of the Dutch hospital organizations involved, our 
results are generalizable.
Conclusions
Based on the results of our study, especially the low interobserver agreement on a test 
that is difficult to standardize, combined with the currently available evidence, we 
concluded that the value of CRT in clinical practice is limited, and its routine use should 
be reconsidered. When CRT is used, it should be measured at the distal phalanx after 
applying pressure for 5 s. The practice of using the sternum for CRT measurement should 
be discarded. In addition, the FMR method proved to be an inexpensive, quick, and 
reliable method to investigate “simple” clinical questions. FMR was used to recruit 1,734 
participants in 1 day, and the majority of the data were ready for analysis within 24 h. We 
therefore believe this study exemplifies the power of FMR.
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Niels van der Hoeven  Rode Kruis Ziekenhuis, Beverwijk
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Abstract
Objectives 
Over 70% of patients who visit the emergency department with a hypertensive emergency 
or a hypertensive urgency have previously been diagnosed with hypertension. Drug 
nonadherence is assumed to play an important role in development of hypertensive 
urgency and hypertensive emergency, but exact numbers are lacking. We aimed 
to retrospectively compare characteristics of patients with hypertensive urgency 
and hypertensive emergency and to prospectively quantify the attribution of drug 
nonadherence.
Methods
We retrospectively analysed clinical data including information on nonadherence 
obtained by treating physicians of patients with systolic blood pressure (SBP) at least 180 
mmHg and diastolic blood pressure (DBP) at least 110 mmHg visiting the emergency 
department between 2012 and 2015. We prospectively studied drug adherence among 
patients admitted to the emergency department with severely elevated BP by measuring 
plasma drug levels using liquid chromatography tandem mass spectrometry from 
September 2016 to March 2017.
Results
Of the 1,163 patients retrospectively analysed, 257 (22.0%) met the criteria for 
hypertensive urgency and 356 (30.6%) for hypertensive emergency. Mean SBP (SD) was 
203 (19) mmHg and mean DBP 121 (12) mmHg.
Mean age was 60.1 (14.6) years; 55.1% were men. In 6.3% of patients with hypertensive 
urgency or hypertensive emergency, nonadherence was recorded as an attributing factor. 
Of the 59 patients prospectively analysed, 18 (30.5%) were nonadherent for at least one of 
the prescribed antihypertensive drugs.
Conclusion
Hypertensive urgency and hypertensive emergency are common health problems 
resulting in frequent emergency department admissions. Workup of patients with a 
hypertensive urgency or hypertensive emergency should include an assessment of drug 
adherence to optimize treatment strategy.
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Introduction
A markedly elevated blood pressure (BP) is a common finding at the emergency 
department (ED): at least 5% of patients in the ED have one or more severely elevated 
measurements, usually defined as systolic blood pressure (SBP) at least 180 mmHg or 
diastolic blood pressure (DBP) at least 120 or 110 mmHg, although terminology and cut-
offs differ between studies.91,92 In most of these patients, the high BP is transient and is a 
reaction to pain, anxiety or stress. This is sometimes referred to as a pseudo hypertensive 
crisis, and warrants no further action.93 Around 0.5% of ED visits are primarily for 
severe hypertension. In such cases, the most important aim is to differentiate between 
a ‘hypertensive emergency’, when acute target organ damage is present or impending, 
and a ‘hypertensive urgency’ when this is not the case.94-96 Hypertensive urgency and 
hypertensive emergency were previously summarized as ‘hypertensive crisis’ but 
as this terminology seems outdated, we will use the terms hypertensive urgency and 
hypertensive emergency.97,98 Hypertensive emergency requires immediate action to 
lower the BP using intravenous antihypertensive drugs in an intensive or high care unit, 
whereas hypertensive urgency allows BP regulation using oral therapy in an outpatient 
setting.92,96 When patients visit the ED primarily for severe hypertension, depending 
on complaints and findings   of   a   physical   examination,   extensive   tests (e.g. 
laboratory testing, ophthalmoscopy) may be needed to distinguish between hypertensive 
urgency and hypertensive emergency and to determine whether hospital admission is 
necessary.95,99
Hypertensive urgency and hypertensive emergency can occur in patients with previously 
unidentified hypertension as a first presentation of their hypertensive condition. 
However, over 70% of patients presenting at the ED have been previously diagnosed 
with hypertension and have been prescribed antihypertensive drugs.92,99-101 Drug 
nonadherence, defined as not taking drugs as previously agreed on with the treating 
physician, is assumed to play an important role in the development of a hypertensive 
emergency and hypertensive urgency, but exact numbers are lacking. Poor drug 
adherence of antihypertensive and other cardiovascular drugs is associated with a higher 
risk of developing cardiovascular disease.102,103
When a patient presents at the ED with severe hypertension, it is crucial to distinguish 
nonadherence to therapy from treatment failure. In nonadherent patients, physicians 
should discuss reasons for nonadherence and methods to improve adherence, whereas 
in adherent patients, drug therapy should be optimized.
In this study, we combined a retrospective and a prospective study to answer two related 
and important research questions considering severely elevated BP at the emergency 
department. The first objective was to compare characteristics of patients with 
hypertensive urgency and those with hypertensive emergency, including assessment 
of drug adherence by the treating physician. The second objective was to prospectively 
determine the incidence of nonadherence to prescribed antihypertensive drugs in 
patients with severely elevated BP at the ED by measuring plasma drug levels.
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Methods
Study design
In this manuscript we describe two studies. We performed a retrospective cross-sectional 
study among patients who visited the ED from 1 January 2012 to 31 December 2015 with 
at least one BP measurement. Due to the large number of patients with elevated BP caused 
by stress, anxiety or pain, we restricted the number of cases for analysis by choosing to 
only include patients who met both the SBP and DBP cut-off values. We performed a 
prospective study in which we analysed plasma drug levels of prescribed antihypertensive 
drugs in patients who visited the ED from 1 September 2016 with severely elevated BP 
suspected of hypertensive urgency or hypertensive emergency. Here we used the formal 
cut-offs for hypertensive emergency described in the current American and European 
guidelines (SBP at least 180 mmHg or DBP at least 120 mmHg).98
Study population
The studies were performed at Erasmus University Medical Center in Rotterdam, the 
Netherlands (Erasmus MC), which is a large urban tertiary care hospital. The ED is an 
open access department located in the city centre, and has visits from approximately 
30,000 patients annually. 
Retrospective study
We used a database containing all patient records from ED visits in the period from 
1 January 2012 to 31 December 2015 to select patients who had a SBP at least 180 mmHg 
and a DBP at least 110 mmHg at triage. Patients 18 years of age and older were included. 
For patients with multiple visits to the ED during the inclusion period, only the first visit 
was included.
Prospective study
Inclusion commenced from 1 September 2016 until the number of patients required 
was reached as determined   in sample size calculations. We included all patients aged 
18 years or older presenting to the ED or the fast-track program with a SBP at least 
180 mmHg or a DBP at least 120 mmHg at triage, who were prescribed one or more 
antihypertensive drugs that we were able to measure in plasma at least 24 h after intake 
using a validated liquid chromatography - tandem mass spectrometry (LC-MS/MS), 
and from whom routine blood samples were obtained.104 We excluded patients who were 
unable to give informed consent or when severe hypertension was likely to have been 
caused by severe pain or stress.
Variables and measurement
We defined hypertensive emergency as a severely elevated BP according to the inclusion 
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criteria with the presence of acute end-organ damage (i.e. ischemic stroke, haemorrhagic 
stroke, myocardial infarction, unstable angina, acute aortic dissection, acute pulmonary 
enema, hypertensive encephalopathy and bilateral hypertensive retinopathy grade 
3 or 4).93,97 Hypertensive urgency was defined as severely elevated BP without acute 
or impending end- organ damage.92,93,97 Patients were labelled as ‘non-hypertensive 
emergency and non-hypertensive urgency severe hypertension’ when the BP was a 
result of extreme pain, anxiety or stress. This was based upon reasons for referral or 
presentation (other than hypertension) to the emergency department, on physicians’ 
remarks in patient files and spontaneous recovery of BP after pain or stress relief.
We manually extracted data from electronic patient records including demographic data 
(i.e. age, sex), complaints (specifically headache, distorted vision, chest pain, palpitations, 
paraesthesia, paresis, gastrointestinal complaints, pain at any location), medical history, 
information on use of drugs and on drugs of abuse. Whenever available, we collected 
test results including laboratory measurements, ECGs focusing on left ventricular 
hypertrophy (LVH) using Sokolow-Lyons criteria105 and radiological examinations 
(i.e. chest radiography for cardiothoracic ratio (CTR) assessment: > 0.5 was considered 
enlarged). The working diagnosis and patient disposition after discharge from the ED 
were recorded.
Measuring drug levels and definition of nonadherence
All patients received standard care in the emergency department. In this workup, routine 
blood samples were taken to diagnose or exclude end-organ damage (e.g. measurement of 
serum creatinine level, presence of schistocytes).97 For the prospective study, we used the 
remainder of these blood samples to measure levels of prescribed antihypertensive drugs 
in plasma using a validated LC-MS/MS multimethod.104 Using this method, we were 
able to detect losartan, valsartan, enalapril, perindopril, spironolactone, amlodipine and 
nifedipine and four active metabolites perindoprilate, enalaprilate, losartan carboxylic 
acid and canrenone. With this method, drug levels are detectable for 24 h or more after 
intake, allowing an objective assessment on adherence without knowledge of last moment 
of drug intake. Partial nonadherence was defined as self-reported nonadherence or 
nondetectable (concentration less than lower limit of detection) drug levels of one of the 
prescribed drugs or its active metabolite, and complete nonadherence as self-reported 
nonadherence to all drugs or nondetectable drug levels of all tested drugs. Drug levels 
exactly at the lower level of detection, in other words extremely low drug levels, were 
scored based on time of last ingestion, drug levels of other antihypertensive drugs taken 
at the same time and discussion of (non)adherence during stay in the hospital.
Statistical methods
Patient characteristics were presented as mean and standard deviation (SD), or as an 
absolute number (proportion). For the retrospective study, continuous variables were 
compared with one-way analysis of variance (ANOVA). Categorical variables were 
compared using the Pearson chi-squared test. For all variables for which more than 
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10% was missing, ‘missingness’ is shown separately. A P value < 0.05 was considered 
significant. All analyses were conducted with IBM SPPS Statistics for Windows version 
21 (IBM Corp., Armonk, New York, USA). For the prospective study, we performed 
a pre-emptive power calculation based on assumptions, as this was the first study to 
assess nonadherence at the ED in patients with a suspicion of a hypertensive emergency. 
Assuming 50% nonadherence, 50 patients needed to be included to have 80% power 
(one-sample t test).
Ethical approval
For the retrospective study, the Medical Ethics Committee of Erasmus MC concluded that 
the study did not fall under the scope of the Medical Research Involving Human Subjects 
Act (WMO), because of its retrospective nature and the anonymization of patient details, 
therefore no informed consent needed to be obtained. For the prospective study, the 
Medical Ethics Committee concluded that the study did not fall under the scope of the 
Medical Research Involving Human Subjects Act, as previously obtained blood samples 
were used. Informed consent was only deemed necessary for the collection and analyses 
of clinical data. Patients were informed about the study and informed consent was 
obtained from all eligible patients, and a withdrawal of consent form was given because 
of the short consideration time. To prevent a potential bias assuming nonadherent 
patients are less likely to give consent, we anonymously analysed samples of patients 
who did not give or withdrew consent after registering the expected drugs. For patients 
who gave consent, data were collected from the electronic patient records.
Results
Retrospective study
A total of 123,552 patients visited the ED in the 4-year inclusion period, of whom 64,979 
had a recorded BP measurement. Of these ED visits, 1237 (1.9%) had SBP at least 180 
mmHg and DBP at least 110 mmHg. As 75 patients visited the ED at least two times, we 
analysed a total of 1,163 patients (Figure 1).
Incidence of patients visiting the ED with BP at least 180/110 mmHg, increased from 
136 patients (0.6% of all ED visits) in 2012 to 414 patients (1.9%) in 2015. Patients were 
predominantly men with a mean age of 60 years (SD 15 years). Mean SBP was 203 mmHg 
(SD 19 mmHg) and mean DBP was 121 mmHg (SD 12 mmHg) (Table 1).
Of all patients presenting with severely elevated BP, the combined incidence of 
hypertensive urgency and hypertensive emergency was 52.7%, of which hypertensive 
emergency was diagnosed more frequently than hypertensive urgency (30.6 vs 22.1%; 
P < 0.001). Patients with hypertensive emergency were older than patients with 
hypertensive urgency (64 vs 58 years; P < 0.001) and had a higher BPs (SBP: 209 vs 203 
mmHg; P < 0.001 and DBP: 124 vs 121 mmHg; P < 0.001).
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Figure 1: Flow chart retrospective study.   
ED: emergency department; SBP: systolic blood pres-
sure DBP: diastolic blood pressure; HE: hypertensive 
emergency; HU: hypertensive urgency .
Figure 2: Flow chart prospective study.   
SBP: systolic blood pressure DBP: diastolic blood 
pressure; HE: hypertensive emergency; HU: hyperten-
sive urgency .
The most frequent diagnoses in patients with hypertensive emergency were stroke 
(10.7% ischemic, 8.5% haemorrhagic), acute pulmonary enema (4.1%) and myocardial 
infarction (4.0%) (Table 1). As women suspected of (pre)eclampsia were according to 
local guidelines referred to the obstetric clinic, no preeclampsia was recorded.
Seventy-nine patients (6.8%) were referred primarily for hypertension to exclude 
hypertensive emergency. Of these, 57 patients (72.2%) met the criteria of hypertensive 
urgency and seven (8.9%) of hypertensive emergency. The most frequently reported 
symptoms were headache, symptoms of the gastrointestinal tract, chest pain and 
dyspnoea (Table 2). Sixty-four patients with either hypertensive emergency or 
hypertensive urgency were asymptomatic. Of this group, 55 patients had hypertensive 
emergency (85.9%) and nine (14.1%) had hypertensive urgency. In most cases (90.3%), 
laboratory tests were performed. An ECG was made for 65.3% of patients, which showed 
left ventricular hypertrophy in 19.1% of patients (Table 3). Of all patients, 572 (49.2%) 
patients were not prescribed any antihypertensive drugs, 272 (23.3%) patients were 
prescribed one antihypertensive drug and 319 (27.4%) patients were prescribed two or 
more. Of the patients using antihypertensive drugs, 26.1% used beta blockers, 18.4% 
angiotensin-converting enzyme (ACE)-inhibitors,   16%   diuretics,   14.5% calcium 
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Table 1: Patient characteristics retrospective study
Total
n=1,163
No  HE/HU 
(e.g. severe pain)
n=550
Hypertensive 
urgency 
n=257
Hypertensive 
emergency 
n=356
Mean (SD) age (years) 60.1 (14.6) 58.8 (14.9) 58.2 (13.4) 63.5 (14.7)
Male 641 (55.1) 301 (54.7) 125 (48.6) 215 (60.4)
Mean (SD) SBP (mmHg) 203 (19) 199 (16) 203 (17) 209 (20)
Mean (SD) DBP (mmHg) 121 (12) 119 (10) 121 (12) 124 (14)
Mean (SD) BMI (kg/m2) 27 (5.6) 26.7(5.4) 28.0 (5.8) 27.3 (5.7)
History Hypertension 695 (59.8) 292 (53.0) 173 (67.3) 230 (64.4)
History Hypertensive crisis 
  Yes 
  No 
  Missing
 
57 (4.9) 
411 (35.3) 
695 (59.8)
 
14 (2.5) 
212 (38.5) 
324 (58.9)
 
21 (8.2) 
89 (34.6) 
147 (57.2)
 
22 (6.2) 
110 (30.9) 
224 (62.9)
Diabetes 208 (17.9) 103 (18.7) 31 (12.1) 74 (21.2)
Alcohol use 
  Yes 
  No 
  Missing
 
284 (24.4) 
317 (27.3) 
561 (58.3)
 
125 (23.3) 
121 (22.0) 
303 (55.3)
 
73 (28.4) 
88 (34.2) 
96 (37.4)
 
86 (24.3) 
108 (30.3) 
162 (45.5)
Smokers 
  Yes 
  No  
  Missing
 
270 (23.2) 
454 (39.1) 
438 (37.7)
 
97 (17.7) 
186 (33.9) 
266 (48.5)
 
70 (27.2) 
124 (48.2) 
63 (24.5)
 
103 (28.9) 
144 (40.4) 
109 (30.6)
Previously reported non-adher-
ence 
  Yes 
  No  
  Missing
 
111 (9.5) 
355 (30.5) 
697 (59.9)
 
35 (6.4) 
167 (30.4) 
348 (63.3)
 
38 (14.8) 
92 (35.8) 
127 (49.4)
 
38 (10.7) 
96 (27.0) 
222 (62.4)
Chronic kidney disease 92 (7.9) 41 (7.4) 18 (7.0) 33 (9.3)
Previous stroke or TIA 136 (11.7) 41 (7.4) 26 (10.2) 69 (19.5)
Previous coronary artery disease 110 (9.5) 39 (7.1) 29 (11.2) 42 (11.8)
Antihypertensive drugs pre-
scribed
 591 (50.8) 256 (50.6) 147 (57.2) 191 (53.6)
Number antihypertensive drugs 
  Mean (SD) overall 
  Mean (SD) users only
 
1 (1.1) 
2 (1.0)
 
1 (1.4) 
1.7 (0.95)
 
1.1 (1.2) 
2 (1.0)
 
1.2 (1.6) 
2 (1)
Taking ≥ 2 antihypertensive drugs 319 (27.4) 126 (22.9) 87 (33.9) 106 (29.7)
Taking ≥ 3 antihypertensive drugs 150 (12.8) 59 (10.7) 40 (15.6) 51 (14.3)
Angiotensin II receptor blocker 
ACE-inhibitor 
Calcium channel blocker 
Diuretic 
Beta blocker 
Fixed-dose combination
129 (11.1) 
217 (18.4) 
169 (14.5) 
186 (16.0) 
304 (26.1) 
57 (4.9)
55 (10.0) 
91 (16.5) 
79 (14.3) 
76 (13.8) 
117 (21.2) 
26 (4.7)
29 (11.3) 
51 (19.9) 
44 (17.2) 
46 (17.9) 
80 (31.1) 
15 (5.9)
45 (12.6) 
75 (21.2) 
46 (13.0) 
64 (17.9) 
107 (30.0) 
16 (4.5)
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channel blockers and 11.1% angiotensin-II receptor blockers. Only 4.9% of prescribed 
antihypertensive drugs were a fixed-dose combination.
Labetalol was used most often when treatment with an intravenous antihypertensive 
drug was needed and was given to 23.1% of all patients, and to 59.2% of patients with 
hypertensive emergency. The most commonly administered oral antihypertensive drug 
was nifedipine retard (10.4%). Oral therapy was mostly given in case of a hypertensive 
urgency, although a limited number of patients with a hypertensive emergency (9%) 
also received oral therapy. Suspicion of nonadherence was documented more often in 
patients with hypertensive urgency than those with hypertensive emergency (9.4 vs 4.2%; 
P < 0.001).
Prospective study
During the inclusion period, 59 patients met our inclusion criteria (Figure 2). Four patients 
spontaneously reported nonadherence. Of the remaining 55 patients, plasma drug levels 
were analysed. On the basis of drug levels, 14 out of 55 patients (25.5%) were deemed 
nonadherent for at least one drug. Of these 14, seven patients were completely nonadherent 
for all measured drugs. Combined with the four patients who spontaneously reported 
nonadherence for all prescribed drugs, this means 30.5% of patients was nonadherent 
Target organ damage 
  Haemorrhagic Stroke 
  Ischemic Stroke 
  Pulmonary edema 
  Myocardial infarction 
  Aortic dissection  
  Acute kidney failure 
  Retinopathy grade III/IV 
  Thrombotic microangiopathy
 
99 (8.5) 
124 (10.7) 
48 (4.1) 
46 (4.0) 
9 (0.8) 
4 
0 
1
  
- 
- 
- 
- 
- 
- 
- 
-
 
99 (8.5) 
124 (10.7) 
48 (4.1) 
46 (4.0) 
9 (0.8) 
4 
0 
1
Suspicion non-adherence  
  Yes 
  Missing
 
54 (4.6) 
1108 (95.3)
 
15 (2.7) 
535 (97.3)
 
24 (9.3) 
233 (90.7)
 
15 (4.2) 
341 (95.8)
Hospital admission 
Mean (SD) days 
ICU admission
764 (65.6) 
6 (12) 
103 (8.9)
166 (51.7) 
4.9 (7.4) 
23 (7.7)
92 (35.6) 
2.1 (4) 
0
335 (93.8) 
8.3 (14) 
61 (17.2)
Change in drug regime after  
discharge (ED/hospital)
388 (28.7) 80 (14.5) 115 (60.5) 191 (54.2)
Drugs first 24 hours 
  Labetalol intravenously 
  Nitroglycerin intravenously  
  Nifedipine retard 
  Captopril
 
145 (12.5) 
89 (7.7) 
121 (10.4) 
32 (2.8)
 
18 (3.3) 
12 (2.2) 
27 (4.9) 
0
 
8 (3.1) 
16 (6.3) 
69 (27.0) 
25 (9.8)
 
119 (33.7) 
61 (17.1) 
25 (7.1) 
7 (2.0)
Died after admission  
In-hospital mortality
92 (8) 
108 (9.2)
 
47 (5.3)
 
0
 
57 (16.2)
Values are numbers (percentages) unless stated otherwise. HE: hypertensive emergency; HU: hypertensive urgency; ACE: 
angiotensin-converting enzyme; SD: standard deviation; TIA: transient ischemic attack.
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of which more than half (61%) fully nonadherent and 39% partially nonadherent. Of the 
41 patients who gave informed consent for collection of clinical data, 11 (26.8%) were 
partially or totally nonadherent (Table 4), so there was no significant correlation between 
giving or withdrawing informed consent and adherence. Nonadherence was found in 
both hypertensive urgency (64%) and hypertensive emergency (36%). The difference 
in nonadherence between hypertensive urgency and hypertensive emergency was not 
statistically significant.
Nonadherence was the highest for spironolactone and amlodipine (Figure 3). No 
significant differences in clinical characteristics between the adherent and nonadherent 
Table 2: Symptoms retrospective study
Symptoms Total
(n=1,163)
No  HE/HU 
 
(n = 550)
Hypertensive 
urgency 
(n = 257)
Hypertensive 
emergency 
(n = 356)
Headache 
  Yes 
  No 
  Missing 
 
266 (22.9) 
161 (13.8) 
736 (63.3)
 
94 (17.1) 
70 (12.7) 
386 (70.2)
 
96 (37.5) 
37 (14.4) 
124 (48.2)
 
76 (21.3) 
54 (15.2) 
226 (63.5)
Blurred vision 
  Yes 
  No 
  Missing
 
69 (5.9) 
181 (15.6) 
913 (78.5)
 
18 (3.3) 
62 (11.3) 
470 (85.5)
 
29 (11.3) 
75 (29.2) 
153 (59.5)
 
22 (6.2) 
44 (12.4) 
290 (81.5)
Dizziness 
  Yes 
  No  
  Missing
 
113 (9.7) 
56 (4.8 
994 (85.5)
 
27 (4.9) 
19 (3.5) 
504 (91.6)
 
56 (21.8) 
24 (9.3) 
177 (68.9) 
 
30 (8.4) 
13 (3.7) 
313 (87.9)
Neurological deficit  
  Yes 
  No 
  Missing
 
128 (11.0) 
602 (51.8) 
433 (37.2)
 
19 (3.5) 
301 (54.7) 
230 (41.8)
 
12 (4.7) 
150 (58.4) 
95 (37.0)
 
97 (27.2) 
151 (42.4) 
108 (30.3)
Altered consciousness 
  Yes 
  No 
  Missing
 
191 (16.4) 
624 (53.7) 
348 (29.9)
 
85 (15.5) 
285 (51.8) 
180 (32.7)
 
15 (5.8) 
158 (61.5) 
84 (32.7)
 
91 (25.6) 
181 (50.8) 
84 (23.6)
Chest pain 
  Yes 
  No 
  Missing
 
216 (18.6) 
311 (26.7) 
636 (54.7)
 
51 (9.3) 
131 (23.8) 
368 (66.9)
 
97 (37.7) 
97 (37.7) 
63 (24.5)
 
68 (19.1) 
83 (23.3) 
205 (57.6)
Palpitations 
  Yes 
  No 
  Missing
 
71 (6.1) 
244 (21.0) 
848 (72.9)
 
14 (2.5) 
92 (16.7) 
444 (80.7)
 
45 (17.5) 
84 (32.7) 
128 (49.8)
 
12 (3.4) 
68 (19.1) 
276 (77.5)
Dyspnoea  
  Yes 
  No 
  Missing
 
200 (17.2) 
272 (23.4) 
691 (59.4)
 
73 (13.3) 
112 (20.4) 
365 (66.4)
 
51 (19.8) 
107 (41.6) 
99 (38.5)
 
76 (21.3) 
53 (14.9) 
227 (63.8)
Values are numbers (percentages). HU: hypertensive urgency; HE: hypertensive emergency.
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group could be identified, aside from the higher number of previously prescribed 
antihypertensive drugs in the non- adherent group (3.7 vs 2.7 antihypertensive drugs; P 
= 0.04). At discharge, the medication regime was changed in half of the patients. During 
subsequent visits to the outpatient clinic, two nonadherent patients had symptomatic 
hypotension, probably because of adherence. None of the patients visited the ED with a 
recurrent hypertensive crisis during the 1-year follow-up period.
Discussion
In this study, we showed that severely elevated BP is common in the ED and that the 
incidence is rising. Approximately half of the patients with severely elevated BP met 
the criteria of hypertensive urgency or hypertensive emergency, accounting for one 
in 200 ED visits. Hypertensive emergency was more prevalent than hypertensive 
urgency. As expected, patients with hypertensive emergency were older and had 
more comorbidities (e.g. diabetes, hypertension, previous stroke). In only 5% of the 
patients, suspicion of nonadherence was documented in the medical records, whereas 
in our prospective cohort, we observed nonadherence in 30.5% of the patients. This 
discrepancy has important clinical implications, as an intervention improving 
adherence might be more beneficial than extending drug therapy by increasing 
doses or adding drugs. This latter strategy may potentially lead to severe side effects 
such as hypotension, as was seen in two of the patients in the prospective study. 
Table 3: Additional investigations and results retrospective study
Additional investigations  
and findings
Total 
 
(n =1,163)
No  HE/HU 
 
(n = 550)
Hypertensive 
urgency 
(n = 257)
Hypertensive 
emergency 
(n = 356)
Laboratory investigation 
Cardiac markers
1,053 (90.3) 
90 (7.6)
454 (82.5%) 
16 (2.9%)
246 (95.7%) 
13 (5.1%)
353 (99.2%) 
61 (17.2%)
Urinalysis performed 260 (22.4) 100 (18.2) 105 (40.9) 55 (15.4)
Proteinuria present 97 (8.3) 42 (7.6) 24 (9.3) 31 (8.7)
Chest radiography 
Increased CTR
424 (36.5) 
82
185 (33.6) 
17
99 (38.5) 
31
140 (39.3) 
34
Ophthalmoscopy 
Retinopathy 
116 (10) 
10
11 (2.0) 77 (29.9) 28 (8.2) 
10
ECG  
ECG abnormalities 
 Left ventricular hypertrophy 
 Signs of ischemia
760 (65.3) 
 
221 
104 
234 (42.5)
254 (9.9) 
29 (5.3)
225 (87.5)
60 (23.3) 
21 (8.2)
301 (84.6)
107 (30.1) 
54 (15.2)
Echocardiography  
Left ventricular hypertrophy
90 (7.7) 
40
14 (2.5) 
5
23 (9.0) 
12
53 (14.9) 
23
Head CT scan 304 (26.1) 44 (17.1) 26 (17.2) 234 (65.7)
Values are numbers (percentages). CTR: cardiothoracic ratio; CT-scan: computed tomography scan.
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In our study, the incidence of hypertensive urgency and hypertensive emergency 
together (0.5%) is in line with most other studies, where reported incidences range 
from 0.45 to 3.0%.93,95,99,106 The incidence of hypertensive emergency was higher than 
of hypertensive urgency, whereas most other investigators found a greater incidence 
of hypertensive urgency than hypertensive emergency.95,99,106,107 This probably relates 
to the fact that our hospital is a tertiary referral centre for specialized treatment, such 
as thrombectomy for ischemic stroke,108 craniotomy for intracerebral haemorrhage or 
thoracic surgery for aneurysms. Only one other study on hypertensive crisis in the ED 
found more hypertensive emergency than hypertensive urgency with comparable patient 
and hospital characteristics.93
Table 4: Patient characteristics including one year follow-up data prospective study
Total (n = 41) Adherent (n = 30) Non-adherent (n = 11)
Male 19 (46.3) 14 (46.7) 5 (45. 5)
Mean (SD) age 65 (11) 66 (12) 62 (11)
Mean (SD) SBP (mmHg) 198 (16) 196 (17) 202 (17)
Mean (SD) DBP (mmHg) 106 (15) 104 (15) 111 (14)
Mean (SD) BMI 29.0 (5) 30.0 (5) 25.3 (4) 
Diabetes 10 (24) 8 (27) 2 (18)
Previous cardiovascular disease 22 (54) 17 (57) 5 (46)
Chronic kidney disease 10 (24) 5 (17) 4 (46)
Non-adherence earlier reported 6 (15) 3 (10) 3 (27)
Hypertensive urgency 
Hypertensive emergency
20 (49) 
12 (29)
13 (43) 
8 (27)
7 (64) 
4 (36)
Hospital admission 26 (63) 19 (63) 7 (64)
Change in drug regime after discharge  
(ED / hospital)
19 (48) 14 (47) 5 (50)
Number (SD) antihypertensive drugsa 2.9 (1.4) 2.7 (1.0) 3.7 (2.0)
Taking at least  3 antihypertensive drugs 22 (54) 14 (47) 8 (73)
Prescribed antihypertensive drugs 
 ACE inhibitor 
 Angiotensin II receptor blocker 
 Calcium channel blocker 
 Diuretic 
 Beta blocker
 
20 (49) 
13 (32) 
20 (49) 
21 (51) 
25 (61)
 
15 (50) 
11 (37) 
14 (47) 
14 (47) 
17 (57)
 
5 (46) 
2 (18) 
6 (55) 
 (64) 
8 (73)
Follow-up after one year 
  Dead  
  Alive, good BP regulation 
  Alive, poor BP regulation 
  Alive, BP regulation unknown
 
2 (7)b 
19 (63) 
6 (20) 
3 (10)
 
0 (0) 
4 (36) 
7 (64) 
0 (0)
Values are numbers (percentages) unless stated otherwise. ACE: angiotensin-converting  enzyme; BP: blood pressure; 
ED: emergency department; SD: standard deviation. a Student’s t test between adherent and nonadherent group differed 
significantly (P value  0.04). b Both unrelated to blood pressure (cancer). 
63
Drug nonadherence and hypertensive urgency and emergency
We noted an increase in incidence of hypertension-related visits to the ED of 7.7% per year, 
which is probably because of the increase in hypertension in the general population.109 
This percentage is comparable to the increase reported by McNaughton et al. in 2015, 
who reported an increase of hypertension related emergency  department visits of 5% per 
year in  the period 2006 – 2012.94
Patients with hypertensive emergency presented most often with ischemic and 
haemorrhagic stroke, acute pulmonary enema and myocardial infarction. Their clinical 
symptoms mostly fitted the subtype of hypertensive emergency. Headache was the 
most common symptom and was, in most cases, a sign of hypertensive urgency and 
not of hypertensive emergency in line with earlier studies.99,110 Approximately 5% of the 
patients with severe hypertension had no clinical symptoms of organ damage, but were 
diagnosed with either hypertensive urgency (29%) or hypertensive emergency (7%) after 
extensive testing. This implies that assessment of symptoms alone is insufficient to rule 
out hypertensive urgency and hypertensive emergency. Previous studies reported higher 
proportions of patients without symptoms, which may be partly explained by the BP 
criteria used.92 Comparing hypertensive emergency and hypertensive urgency, we found 
that hypertensive emergency patients were older, had higher SBP and DBP, and more 
often smoked, which is in line with earlier studies.92,100,101,106 Approximately two-third of 
patients with hypertensive emergency or hypertensive  urgency  had a previous history 
of hypertension, which is relatively low compared to percentages found in earlier studies 
(70 – 90%).92,99-101 Despite the differences between hypertensive urgency and hypertensive 
emergency, no (combination of) factors could be identified that distinguishes hypertensive 
emergency from hypertensive urgency without the use of additional testing. Therefore, 
the standard workup, which includes blood tests and ophthalmoscopy, should always 
be followed in order to differentiate between hypertensive emergency and hypertensive 
urgency, if clinical signs do not yield the diagnosis hypertensive emergency. In our 
hospital, the guideline was not consistently followed. Especially ophthalmoscopy was 
performed in a low percentage of cases. It should be kept in mind that in hypertensive 
emergency, it might not have been necessary to confirm the diagnosis when another kind 
of organ damage was identified, but in hypertensive urgency it should have been 100% 
to rule out hypertensive emergency. This low percentage of following the guidelines is 
in line with an earlier study that found even lower numbers: in only 6% of all patients 
presenting with severe hypertension, all tests were performed as recommended in the 
local guideline.91 Standard workup should include repeated measurements of blood 
pressure as blood pressure often lowers spontaneously and/or in response to pain or stress 
relief;111 although repeated measurements were performed in most instances, enabling 
us to select patients with spontaneous blood pressure reduction as a separate category 
‘non-hypertensive urgency non-hypertensive emergency,’ follow-up measurements were 
not always reported in the electronic patient record. Since carrying out this study, the 
American guideline has been altered to consider all severe hypertension not hypertensive 
emergency as ‘markedly elevated blood pressure,’ thus abandoning the terminology of 
hypertensive urgency. In this study, we employed the existing categorization according 
to the guidelines valid at the time.96-98
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Many studies reporting about the incidence of hypertensive urgency and hypertensive 
emergency suggest that nonadherence is a contributing factor to the development of 
hypertensive urgency or hypertensive emergency, but studies directly assessing this 
possibility are limited. In a recent study, drug levels of all patients on antihypertensive 
drugs visiting the ED (for any reason) showed 28% nonadherence (undetectable drug 
levels), and nonadherence was associated with higher BP levels.112 The assay used in this 
study, however, was validated using clinical samples from hospitalized patients obtained 
shortly after drug intake, and as a consequence, drug levels measured at time points 
more than 12 h after intake could have been false negative, overestimating the prevalence 
of nonadherence.113
In a study including patients with stroke, the odds ratio for developing a stroke as a result 
of nonadherence to antihypertensive drugs ranged from 1.7 to 2.7, depending on the 
number of years antihypertensive drugs had been prescribed.99,103 A small prospective 
study defined nonadherence as a risk factor for the development of hypertensive crises, 
where nonadherence was defined solely on reporting by patients and physicians.114
Our study is the first study focusing on patients with severe hypertension in the ED 
using a well validated LC-MS/MS method, which is the most reliable method to assess 
adherence.115 We found that 30.5% of the patients were indisputably nonadherent, when 
also taking into account the patients who self-reported nonadherence at inclusion. 
This rate is in line with earlier studies performed in uncomplicated hypertension and 
resistant hypertension.116-122 Therefore, our findings imply that improving adherence 
is of major importance, especially as suspected nonadherence was documented in the 
electronic medical record in only 5% of patients in the retrospective study. Two out of 
nine patients who received follow-up in the outpatient clinic developed hypotension 
after the ED visit. These complications, presumably caused by using all previously and 
newly prescribed drugs, might be prevented by adequate assessment of adherence in the 
emergency department. Two observational studies indicate an improved BP control when 
providing feedback on undetectable drug levels.123,124 Although this was not studied in a 
controlled way, it implies that immediate measurement and feedback at the ED might be 
an efficacious approach to improve adherence and consequently BP control.
When investigating the differences between the adherent and nonadherent patients, we 
found that nonadherent patients had been prescribed more antihypertensive drugs than 
adherent patients. Studies have shown that an increase in the number of prescribed drugs 
results in more nonadherence.125,126 The drug for which most patients were nonadherent 
was spironolactone. Spironolactone is commonly used in resistant hypertension after the 
PATHWAY-2 trial.127 Our findings suggest that the reason the BP target in these patients 
was not previously reached is nonadherence, whereas not reaching the BP target urges 
the physician to prescribe spironolactone.
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Strengths and weaknesses
This study has strengths and limitations. The first strength of our retrospective study 
is the large number of patients for whom most of the relevant parameters were known. 
Secondly, the results from our retrospective analyses can easily be generalized to other 
countries, as the Dutch population is comparable with populations of most western 
countries, including the USA in terms of ethnicity, lifestyle, habits and disease incidence 
and prevalence. Our study population constituted of multiple ethnicities with patients 
born in more than 41 countries.
Our study also has limitations. First, in the retrospective study, we included only patients 
with both high SBP and DBP using cut-off points of at least 180 mmHg and DBP at 
least 110 mmHg, respectively. With this approach, we potentially missed patients with 
hypertensive urgency or hypertensive emergency with an isolated high SBP or DBP, 
resulting in an underestimation of the incidence. However, by applying both SBP and 
DBP, we limited the number of patients with increased BP because of pain or stress. In 
the prospective study, we chose threshold values of SBP at least 180 mmHg or DBP at 
least 120 mmHg, limiting direct comparison of the retrospective and prospective study. 
However, these threshold values did not influence the percentage of nonadherence. Also, 
there are no clearly defined cut-off values at which the risk of acute end-organ damage is 
absent or present. The acceleration of BP rise is more important than absolute BP values.
Secondly, because of the nature of care in the emergency setting, we encountered 
missing data. This may have led to underestimation of suspicion of nonadherence, 
although spontaneous report is more likely in presence than in absence of suspicion 
of nonadherence. However, lack of spontaneous reporting of suspected drug (non)
adherence also gives important information on physicians’ awareness of this problem. 
In addition, even when physicians are at least considering the chance of nonadherence as 
underlying cause, they tend to overestimate their patients’ drug adherence.128 Therefore, 
we think the retrospective study is representative for how the issue of drug adherence is 
handled in daily clinical practice. Finally, the study was executed in an urban hospital 
that also functions as a tertiary care centre. In that capacity, a proportion of the patients 
had a complex medical history with multiple comorbidities, and may therefore not be 
generalizable to secondary care centres, as also reflected by the higher incidence of 
hypertensive emergency than of hypertensive urgency.
Considering the prospective study, we were the first to prospectively investigate drug 
nonadherence in patients with a severely elevated blood pressure at the ED using a 
well validated LC-MS/MS. By ensuring that drug levels were analysed independent 
of obtaining informed consent, we were able to avoid a potential selection bias. The 
number of patients not giving and especially withdrawing consent was surprisingly 
low. However, this study also has several limitations. The study was underpowered 
to compare characteristics of adherent and nonadherent patients, as the proportion 
of nonadherence was lower than expected. Using our assay, we could measure seven 
antihypertensive drugs. We chose this specific selection of most commonly prescribed 
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antihypertensive drugs, because to use plasma drug levels in clinical practice, the assay 
needs to be extensively validated. Diuretics other than spironolactone were not measured 
as they are not detectable for 24 h after intake allowing measurement at a random time 
point (the ED visit). By not measuring diuretics and beta-blockers, drugs known to be 
associated with considerable nonadherence because of side effects, nonadherence might 
have been underestimated.129 However, all measured drugs are in the top 100 of most 
used drugs in The Netherlands and all of the chosen ACE inhibitors and angiotensin II 
receptor blockers are available in fixed-dose combinations. Being nonadherent for one of 
the measured drugs implies that adherence to unmeasured drugs is also questionable. In 
addition, as both the nominator and the denominator of the calculation of nonadherence 
depend on the choice of antihypertensive drugs, this limitation did not lead to a bias. A 
final issue to discuss is white-coat adherence: in theory, patients could have taken their 
antihypertensive drugs just before going to the emergency department, but this might 
be more common during regular visits to the clinic than to the emergency department.
In conclusion, severely elevated BP is a common health problem and the incidence is 
increasing, resulting in frequent ED visits and high economic burden. We showed that 
all patients visiting the ED for suspicion of hypertensive emergency should receive a 
full workup, regardless of their clinical symptoms. We found in the prospective study 
that three in 10 patients were nonadherent for antihypertensive drugs, whereas in the 
retrospective study only one in 20 patient’s physicians actively recorded nonadherence as 
a potential cause. Distinguishing between nonadherent and adherent patients is crucial, 
as treatment strategies differ. Therefore, ideally a point-of-care-test would be developed 
to enable direct assessment of adherence in order to adjust the treatment strategy 
accordingly.
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Abstract 
Objective
The objective of this study was to assess the incidence and characteristics of patients 
presenting with physical symptoms that remain medically unexplained at the emergency 
department (ED).
Patients and methods
A retrospective chart study was carried out in three hospitals in The Netherlands and 
Belgium. All patients (age > 18 years) visiting the ED in 4 selected weeks in 2013 at the 
Erasmus University Medical Center (Erasmus MC) in Rotterdam, The Netherlands, 
and 1 selected week in 2013 at the Haaglanden Medical Centre, Westeinde HMC in 
The Hague, The Netherlands, and the University Hospital Ghent (UZG), Belgium, were 
included. Descriptive statistics were used for data analysis.
Results
A total of 2,869 patients (Erasmus MC 1,674, HMC 691, UZG 504) were included. 
Medically unexplained physical symptoms in the emergency department (EDMUPS) 
were present in 13.4% of all ED visits (Erasmus MC 12.5%, HMC 18.7%, UZG 9.1%). 
No EDMUPS were identified in trauma patients. When excluding trauma patients, 
EDMUPS were present in 18.5% (Erasmus MC 16.8%, HMC 26.5%, UZG 13.3%) of the 
visits. The characteristics of patients with and without EDMUPS differed significantly; 
patients with EDMUPS were more often younger, female, self-referred, frequent visitors, 
were prescribed less medication and more often had a psychiatric disease. Dutch and 
Belgian Hospital differed in the distribution of patients in triage categories and in the 
incidence of psychiatric illnesses.
Conclusion 
Physical symptoms remain unexplained in a significant number of patients at the time 
of ED assessment. 
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Introduction
Medically unexplained physical symptoms (MUPS) are symptoms that cannot be fully 
explained by physical examination or by further testing.130 Patients with persistent MUPS 
often have significantly reduced health-related quality of life with impaired physical, 
mental or social functioning.131,132 To diagnose MUPS, a patient must experience physical 
symptoms for weeks, without underlying physical abnormalities found by a physician. 
MUPS are divided into clusters of symptoms. The secondary care system, (university) 
hospitals and psychiatric hospitals in The Netherlands use two clusters (i.e. pain-fatigue 
and cardiorespiratory complaints).
In primary care, about 30–50% of patients visiting a general practitioner (GP) have 
MUPS.133,134 This percentage is approximately the same in secondary care, and MUPS 
occur within every medical specialty.135,136 Patients with MUPS have up to two-fold 
higher healthcare consumption compared with patients whose complaints are fully 
medically explained. Also, their illnesses lead to more sick leave.131,132 Preferred treatment 
strategies for patients with MUPS include a patient-centred approach, with a focus on 
symptom exploration, information on MUPS and reassurance rather than performing 
diagnostic investigations.137,138 The GP should be responsible for case management, and 
clear communication between primary and secondary care is paramount.
GPs refer most patients with MUPS to outpatient clinics; however, patients also present 
at the emergency department (ED). The exact burden of  MUPS  in  the  ED (EDMUPS) 
is unknown.138 Treatment strategies differ between the ED and (outpatient) clinic.138 In 
the ED, the focus is often to rule out (serious) pathology in a brief time period, using 
additional examination, such as laboratory and radiographic studies. Not finding a viable 
somatic explanation for physical symptoms without the presence of alarming symptoms 
might lead to additional diagnostic tests, although guidelines suggest otherwise. This 
contributes towards higher healthcare costs.138,139 Specific knowledge and tools to 
properly distinguish MUPS patients at the ED are lacking, and management of patients 
with EDMUPS remains challenging.138 Therefore, the aim of this study is to determine 
the prevalence and characteristics of patients with EDMUPS.
Patients and methods
Study design
We performed an international multicentre retrospective study.
Setting
Data were collected from March to June 2014 at EDs from: 1) Erasmus University Medical 
Center, Rotterdam, the Netherlands (Erasmus MC), which is the largest university 
hospital of the Netherlands, with 1,320 beds and approximately 30,000 adult (≥ 18 years) 
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ED visits a year. It provides secondary and tertiary care. 2) Haaglanden Medical Centre 
Westeinde, The Hague, the Netherlands (HMC), is an 825-bed teaching hospital located 
in the city centre of The Hague with about approximately 56,000 adults ED visits a year. 
The hospital service area is mostly local, with a large population of immigrants with 99 
different nationalities. Data were collected from July 2014 to March 2015 at the ED of 3) 
Ghent University Hospital in Ghent, Belgium (UZG) is a 1068-bed tertiary university 
hospital with approximately 35,000 adults visiting ED. The hospital service area is 
nationwide, and UZG offers complex regional care. All hospitals use the Manchester 
Triage System. In both countries, ambulance services are allocated to patients after 
contact with an emergency dispatch centre. Ambulance services can treat patients on-site, 
refer to a GP or transport patients to a hospital. Ambulance services also provide patient 
transport on GPs’ request. The study was approved by the local Medical Ethic Boards of 
all hospitals.
Patients
Patients, 18 years and older, who visited the ED of the 1) Erasmus MC in the first week of 
February, May, August and November 2013, 2) HMC in the last week of January 2013 and 
3) UZG in the first week of February 2013 were included in the study. The months in the 
Erasmus MC were selected to evaluate seasonal differences and public holidays. After 
initial evaluation of the data of the Erasmus MC, no difference in prevalence in terms 
of the season was found, and to obtain a sample size of minimum of 2,500 patients, we 
decided to only investigate 1 week, the first week of February, in the other hospitals. As 
the ED of HMC was reorganized in that month, we choose to investigate 1 week earlier. 
Patients were excluded when no data on their visit were available or if they left before 
contact with a physician.
Variables
The following data were retrieved from the electronic patient records: demographic 
data [i.e. age, sex, previous medical history, substance abuse (i.e. alcohol, smoking, illicit 
drugs)], frequent ED visit (defined as > 2 visits in last 2 years) and psychiatric diagnosis/
history, as well as data on their actual ED visit [e.g. Manchester Triage System Triage class, 
referral (referred by a physician, ambulance, self-referral), date, time and duration of 
visit, treating specialist, trauma or nontrauma, medical tests performed] and ED diagnosis 
were recorded. Data on treatment and aftercare [e.g. discharge disposition, medication 
at ED, prescription, discharge orders or explanations about the diagnosis given to the 
patient, correspondence (i.e. to the GP or other involved physicians), discharge orders to 
GPs and outpatient clinic appointments] were also recorded.
Data were extracted by one abstractor in the Netherlands and two abstractors in Belgium 
following standard operational procedures. Abstractors did not receive any additional 
training and blinding did not occur. Performance in the Netherlands was not monitored, 
but was evaluated by checking random samples. Performance in Belgium was not 
monitored or evaluated. EDMUPS were defined as presenting symptoms without an 
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adequate explanation despite adequate assessment of history and physical examination, 
diagnostic testing in the ED or during follow-up. In case of doubt, cases were discussed 
in consensus meetings. The follow-up period was the time between the ED visit and 
inclusion in the study (varying from 3 months to 2 years), and only data from the 
following admission, outpatient clinic appointment or second ED visit were used, 
if available. Patients for whom   a descriptive diagnosis (e.g. atypical chest pain) or a 
known MUPS-syndrome (e.g. irritable bowel syndrome) was used, or when no diagnosis 
was made, and only the excluded diagnosis was stated (‘rule-out medicine’, e.g. no 
pulmonary embolism138) were classified as having EDMUPS. EDMUPS differs from the 
MUPS definition used by specialists in outpatient clinics or by GPs as it is based solely 
on the absence of a clarifying diagnosis after a single assessment by a physician at the 
ED, in contrast to the MUPS definition used by the Dutch healthcare organizations, 
which requires symptoms to be present for several weeks without a somatic explanation 
despite adequate assessment of medical history, physical examination and diagnostics. 
EDMUPS were clustered using two clusters: pain-fatigue, including complaints such as 
chronic fatigue, joint pain, or fibromyalgia and cardiorespiratory, including complaints 
such as thoracic pain, hyperventilation and palpitations. We hypothesized that EDMUPS 
fall within the spectrum of unexplained physical symptoms.
Statistical methods
Descriptive statistics were used for most categorical data. Categorical data were analysed 
using a χ2-test. Continuous data, which were not normally distributed, were analysed 
using a Mann-Whitney (two groups with equal variances) or a Kruskal-Wallis test (three 
groups with equal variances). A P value less than 0.05 was considered significant. The 
prevalence of psychiatric diagnoses was described as an odds ratio. Data were analysed 
using SPSS Statistics 21 (IBM; IBM Corp., Armonk, New York, USA).
Results
Patients
A total of 3,199 patients, 18 years of age and older (Erasmus MC 1,812, HMC 761, 
UZG 626) visited EDs in the selected periods; 330 patients were excluded, resulting in 
the enrolment of 2,869 patients (Erasmus MC 1,674, HMC 691, UZG 504) in the study 
(Figure 1).
Patient characteristics
All patient characteristics per hospital are presented in Table 1. Patients visiting the ED 
were predominantly male (53.5%), with a mean age of 46 years (SD: 19.3, range: 18–97). 
There were more nontrauma patients (72.4%) than trauma patients (27.6%). Almost 
half were self-referrals (49.3%, range: 42.2–59.7%) and were triaged into the green 
triage category ranging from 2.0 to 35.9%. EDMUPS were present in 13.4% of all ED 
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Table 1: Patient characteristics of all patients per medical center
Erasmus MC
(n = 1,674)
Haaglanden Medical 
Centre Westeinde 
(n = 691)
Ghent University 
Hospital 
(n = 504)
Age
  Mean (range) 46 (18–97) 46 (18–94) 47 (18–93)
  Median 45 44 43
Trauma/nontrauma
  Trauma patients 430 (25.6) 204 (29.5) 158 (31.3)
  Nontrauma patients 1,244 (74.4) 487 (70.5) 346 (68.7)
  EDMUPS 209 (12.5) 129 (18.7) 46 (9.1)
Sex
  Male 906 (54.1) 352 (50.9) 278 (55.2)
  Female 768 (45.9) 339 (49.1) 226 (44.8)
Triage color
  Green < 120 min 549 (32.8) 248 (35.9) 10 (2.0)
  Yellow < 60 min 809 (48.3) 272 (39.4) 79 (15.7)
  Orange < 10 min 140 (8.4) 138 (20.0) 235 (46.6)
  Red < 0 min 36 (2.2) 8 (1.2) 171 (33.9)
  White, not-triaged 140 (8.4) 25 (3.6) 9 (1.8)
Referral
  Self-referral 709 (42.4) 404 (58.5) 301 (59.7)
  Ambulance 310 (18.5) 94 (13.6) 82 (16.3)
  Referred 655 (39.1) 193 (27.9) 121 (24.0)
Admission to ward
  Yes 630 (37.6) 144 (20.8) 226 (44.8)
  No 1,044 (62.4) 547 (79.2) 278 (55.2)
Laboratory studies performed
  Yes 1,042 (62.2) 365 (52.8) 285 (56.5)
  No 632 (37.8) 326 (47.2) 219 (43.5)
Radiographic studies performed
  Yes 1,144 (68.3) 355 (51.4) 299 (59.3)
  No 530 (31.7) 336 (48.6) 205 (40.7)
Medication given at ED
  Yes 907 (54.1) 261 (37.8) 264 (52.4)
  No 767 (45.9) 430 (62.2) 240 (47.6)
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Prescription of medication at discharge
  Yes 1,005 (60.0) 426 (61.6) 224 (44.4)
  No 669 (40.0) 265 (38.4) 280 (55.6)
Follow-up appointment
  Yes 930 (55.6) 360 (52.1) 219 (43.5)
  No 744 (44.4) 331 (47.9) 285 (56.5)
Frequent visitors
  Yes 300 (17.9) 235 (34.0) 72 (14.3)
  No 1374 (82) 465 (66.0) 432 (85.7)
Psychiatric disorder
  Yes 103 (6.1) 65 (9.4) 92 (18.3)
  No 1,571 (93.9) 626 (90.6) 412 (81.7)
Values are represented as n (%) of patients. ED: emergency department: EDMUPS, medically unexplained physical 
symptoms in the emergency department. 
Figure 1: Flowchart showing the inclusion of study participants and the prevalence of EDMUPS. 
ED: emergency department; EDMUPS: medically unexplained physical symptoms in the ED.
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Table 2. Patient characteristics of patients with and without medically unexplained physical  
symptoms in the emergency department per medical center
Erasmus MC Haaglanden Medical  
Centre Westeinde
Ghent University Hospital
 
EDMUPS
Non- 
EDMUPS
 
EDMUPS
Non- 
EDMUPS
 
EDMUPS
Non- 
EDMUPS
(n= 209) (n= 1,465) P-value (n= 129) (n= 562) P-value (n= 46) (n= 458) P-value
Age
  Mean 
  (range)
42 
(18–86)
47 
(18–97)
0.001 44 
(18–92)
46 
(18–94)
0.253 38 
(18–77)
47 
(18–93)
0.006
  Median 40 47 43 44 38 45
Sex
  Male 90 
(43.1)
816 
(55.7)
0.001 52 
(40.3)
300 
(53.4)
0.007 20 
(43.5)
258 
(56.5)
0.095
  Female 119 
(56.9)
649 
(44.3)
<0.001 77 
(59.7)
262 
(46.6)
0.082 26 
(56.3)
200 
(43.7)
0.656
Triage color
  Green 
  < 120 min
63 
(30.1)
486 
(33.2)
35 
(27.1)
213 
(37.9)
0 (0.0) 10 (2.2)
 Yellow  
 < 60 min
127 
(60.8)
682 
(46.6)
59 
(45.7)
213 
(37.9)
9 
(19.6)
79 
(15.3)
 Orange  
  < 10 min
10 
(4.8)
130 
(8.9)
31 
(24)
107 
(19)
22 
(47.8)
213 
(46.5)
  Red  
  < 0 min 
1 
(0.5)
35 
(2.4)
0 
(0)
8 
(1.4)
15 
(32.6)
171 
(34.1)
  White 
  not-triaged 
8 
(3.8)
132 
(9.0)
4 
(3.1)
21 
(3.7)
0 
(0)
9 
(1.8)
Referral
  Self-referral 113 
(53.6)
597 
(40.8)
0.002 80 
(62)
324 
(57.7)
0.118 33 
(71.7)
268 
(58.5)
0.118
  Ambulance 28 
(13.4)
282 
(19.2)
14 
(10.9)
110 
(19.6)
2 
(4.3)
80 
(17.5)
  Referred 69 
(33)
586 
 (40)
35 
(27.1)
128 
 (22.7)
11 
 (24)
110 
(24)
Admission to ward
  Yes 19 
(9.1)
611 
(41.7)
<0.001 14 
 (10.9)
130 
(23.1)
0.002 11 
 (23.9)
215 
 (46.9)
0.003
  No 190 
(90.9)
854 
(58.3)
115 
 (89.1)
432 
(76.9)
35 
 (76.1)
243 
(53.1)
Laboratory studies performed
  Yes 161 
(77)
881 
(60.1)
<0.001 91 
(70.5)
274 
(48.8)
< 
0.001
35 
(76.1)
250 
(54.6)
0.005
  No 48 
(23)
584 
(39.9)
38 
(29.5)
288 
(51.2)
11 
(23.9)
208 
(45.4)
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Radiographic studies performed
  Yes 155 
(74.2)
989 
(67.5)
0.053 61 
(47.3)
294 
(52.3)
0.303 27 
(58.7)
272 
(59.4)
0.927
  No 54 
(25.8)
476 
(32.5)
68 
(52.7)
268 
(47.7)
19 
(41.3)
186 
(40.6)
MUPS cluster
  Cardio 
  respiratory
118 
(56.5)
50 
(38.8)
18 
(39.1)
  Pain- 
  fatigue
91 
(43.5)
79 
(61.2)
28 
(60.9)
Medication given at ED
  Yes 70 
(33.5)
837 
(57.1)
<0.001 28 
 (21.7)
233 
 (41.5)
<0.001 15 
(32.6)
249 
 (54.4)
0.005
  No 139 
(66.5)
628 
(42.9)
101 
(78.3)
329 
 (58.5)
31 
(67.4)
209 
(45.6)
Prescription of medication at discharge of the ED
  Yes 87 
(41.6) 
918 
(62.7)
<0.001 63 
 (48.8)
363 
(64.6)
0.001 13 
(28.3)
211 
(46.1)
0.020
  No 122 
(58.4) 
547 
 (37.3)
66 
(51.2)
199 
 (35.4)
33 
 (71.7)
247 
(53.9)
Follow-up appointment
  Yes 68 
 (32.5)
862 
 (58.8)
<0.001 49 
(38)
311 
(55.3)
<0.001 19 
 (41.3)
200 
(43.7)
0.758
  No 141 
 (67.5)
603 
 (41.2)
80 
(62)
251 
(44.7)
27 
(58.7)
258 
(56.3)
Frequent visitor
  Yes 59 
 (28.2)
241 
(16.5)
<0.001 60 
(46.5)
175 
(31.3)
0.001 10 
(21.7)
62 
(13.5)
0.130
  No 150 
(71.8)
1,224 
(83.5)
69 
(53.5)
387 
(68.9)
36 
(78.3)
396 
(86.5)
Psychiatric diagnosis
  Yes 31 
 (14.8)
72 
(4.9)
<0.001 22 
(17.1)
43 
 (7.7)
0.001 6 
 (13)
86 
(18.8)
0.337
  No 178 
 (85.2)
1,393 
(95.1)
107 
(82.9)
519 
(92.3)
40 
(87)
372 
(81.2)
Values are represented as n (%). ED, emergency department; EDMUPS, medically unexplained physical symptoms in the 
emergency department; MUPS, medically unexplained physical symptoms.
visits (Erasmus MC 12.5%, HMC 18.7%, UZG 9.1%, P < 0.001). After excluding trauma 
patients, EDMUPS were present in 18.5% (Erasmus MC 16.8%, HMC 26.5%, UZG 13.3%) 
of patients (Figure 1). No difference was found in EDMUPS incidence between office 
hours (08: 00–18: 00) (11.4%) and outside office hours (13.3%) (P = 0.25). In the Erasmus 
MC, no seasonal difference in the incidence of EDMUPS was found (February 14.8%, 
May 13.2%, August 10.8% and November 10.7%, P = 0.203). A significant (P < 0.001) 
difference was found in the distribution of patients in triage allocation when comparing 
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the Dutch hospitals with UZG. Significantly more ED patients were categorized in the 
orange class, requiring more urgent management in the UZG compared with the Dutch 
hospitals. Also, the prevalence of psychiatric disorders was higher in the UZG compared 
with the Dutch hospitals.
Comparison of EDMUPS and non-EDMUPS patients
Patient characteristics of EDMUPS and non-EDMUPS patients are presented in Table 
2. Patients with EDMUPS were more often female (57.6%, range: 56.3–59.7%, P < 0.001) 
and younger, with a mean age of 42 years (SD: 16.6, range: 18–92, P = 0.006). They were 
more often frequent visitors (35.4%) than patients without EDMUPS (21.4%) (P < 0.001). 
Overall, they were significantly more often self-referred, less likely to be subsequently 
admitted to a hospital ward and more intensely investigated. Self-referred patients 
mostly presented with symptoms fitting the pain-fatigue cluster, in contrast to referred 
patients, who mostly presented with symptoms fitting the cardiorespiratory complaints 
cluster. Furthermore, patients with EDMUPS were less likely to receive medication at 
the ED and to be discharged with a prescription. Only a small proportion received a 
follow-up appointment, although they were more frequent ED visitors. A psychiatric 
diagnosis was present in 15,3% of patients with EDMUPS. The most reported diagnoses 
were depression (32.2%), panic disorder (32.2%) and anxiety disorder (19.4%). In patients 
without EDMUPS, 8.2% had a psychiatric diagnosis (odds ratio = 2.01, 95% confidence 
interval: 1.47–2.74, P = 0.001). Patients with a psychiatric diagnosis received fewer follow-
up appointments, but were more often frequent visitors of the ED. Follow-up data were 
not available for the Belgian hospital, except for patients who were hospitalized following 
the ED visit.
Discussion
This study shows that in a significant number of nontrauma patients visiting the 
ED, presenting symptoms remained unexplained, with clear differences in patient 
characteristics. Patients with EDMUPS are more often younger, female and self-referred, 
compared with patients with non-EDMUPS. This is in line with  studies  on  MUPS.135 Self-
referred patients mostly presented with pain-fatigue symptoms, in contrast to referred 
patients, who mostly presented with cardiorespiratory symptoms. Differences between 
the participating hospitals were probably because of the locations of the hospitals, 
hospital type (secondary/tertiary referral) and number of self-referred patients.
Symptoms that remain unexplained are present in 25-50% of patients in general practice 
and specialist outpatient clinics, and were present in our study in approximately 18.5% 
of nontrauma patients visiting the ED.133-136,140 In EDs, which are by definition focused on 
acute care, inappropriate (self)referrals might unnecessarily increase patient burden and 
costs in the ED. Giesen et al., 141 concluded that the majority of self-referrals to Dutch EDs 
should not be visiting the ED, but their GP. The differences in referral between two MUPS 
clusters suggest that GPs succeed in preventing referral of patients with pain-fatigue to 
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the ED, presumably by either treating them or by elective referral to outpatient clinics. 
However, it is difficult to rule out possible emergencies in patients with cardiorespiratory 
symptoms.141 Patients with EDMUPS were more often frequent visitors of the ED.133,142 
In a study by Theadom et al.,142 approximately 31.1% of the patients who were frequent 
visitors of the ED had unexplained symptoms, which is in line with our results. We also 
found a threefold higher likelihood of psychiatric disorders compared with nonfrequent 
visitors, and this was even larger when EDMUPS were present. This is comparable with 
other studies in the ED,143-146 but was also found in studies in primary care and outpatient 
clinics.136,144 Depression, anxiety disorders and panic disorders were the most frequent 
psychiatric diagnoses documented in the group with EDMUPS. Multiple studies showed 
a link between anxiety, depression, panic attacks and MUPS.145,146 They also showed a 
comparable prevalence of psychiatric disorders compared with our data.136 The higher 
prevalence of psychiatric disorders diagnosed or detected at UZG (18.3%) may be because 
of differences in healthcare organization.
Dutch acute psychiatric care is often organized on an ambulatory basis, whereas the ED 
of the UZG also has an acute psychiatry unit, and psychiatric assessment is more likely. 
As such, the percentage of psychiatric disorders in the Dutch hospitals (6.1 and 9.4%) 
might be an underestimate. Identification of the patients with EDMUPS, especially those 
who are likely to become frequent visitors, could lead to different treatment strategies. 
Better treatment strategies may not only increase quality of patient care; they may also 
have a beneficial effect on the workload of the EDs, and potentially reduce unnecessary 
examinations and thereby reduce costs. As there are many similarities between patient 
with EDMUPS and patients with MUPS in GP and outpatient clinic setting, it seems 
logical to apply strategies for patients with EDMUPS. It is more often not the demand 
of the patient for somatic intervention, but the combination of patient presentations 
and the physicians’ response that leads to more somatic interventions.147 Treatment of 
patients with MUPS differs from regular care and this group of patients benefits from 
regular contact and good communication by a trusted physician. Other studies showed 
that patients indicate that they provide cues on when they want somatic interventions 
and when they want to receive emotional support.148 Focusing on the treatment of a 
psychiatric disorder can be useful for the resolution of physical symptoms.140 The GP 
should therefore be the principal manager of patients with MUPS, and this should 
be clearly communicated to the GP and the patient. This strategy is acknowledged 
in the Dutch multidisciplinary guideline on MUPS, which stresses the importance 
of good communication through consultation letters. A quality letter contains the 
acknowledgment of a medically unexplained physical symptom and advice to the GP 
about follow-up. However, specialists’ reply letters to GPs about MUPS patients often 
do not provide answers to referral questions or clear explanations about MUPS and 
perpetuating factors.149 Another study showed that a training program for specialists 
in communicating with patients with MUPS is beneficial when treating MUPS 
patients.137 This study has several limitations. First, retrospective data do not provide 
information on follow-up of all patients, and during follow-up presenting symptoms 
can be explained or may disappear. Therefore, we cannot indicate which percentage of 
patients with EDMUPS will eventually develop MUPS or in which patients symptoms 
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may be explained. In some cases, the follow-up period might be too short to correctly 
evaluate whether an explanation for the symptoms can be found. EDMUPS and MUPS 
are working diagnoses, and can be used in outpatient clinics. Unfortunately, there is 
no linked electronic health record in The Netherlands or Belgium. This makes the role 
of the GP important in communication and management of symptoms. Second, only 
visits to the hospitals included in the study were documented, without information on 
medical consumption in other hospitals in the time period assessed. This might lead 
to an underestimation of the percentage of frequent visitors as patients might visit 
other EDs. This study on patients with EDMUPS has multiple strengths as it focuses 
on patients visiting the ED, in contrast to the previous literature on MUPS in primary 
and secondary care. This study was carried out in three hospitals in two countries with 
different sizes and functions and even enabled a comparison of different healthcare 
systems. Nevertheless, similar patient characteristics were documented, indicating the 
validity of the findings. 
Conclusion
Patients with MUPS represent a major burden to EDs as they do for primary and 
secondary healthcare. Further research should focus on the longitudinal follow-up of 
the natural evolution and use of medical services of this patient group.
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Abstract
Postural orthostatic tachycardia syndrome (POTS) is a condition in which a change from 
a supine to an upright position causes an abnormally large increase in heart rate which 
may be accompanied by a variety of physical complaints. We report two cases illustrating 
the heterogeneity of this syndrome. We give an update on the aetiology of POTS, which 
is still poorly understood, and its overlap with other syndromes such as chronic fatigue 
syndrome. Clinicians should be aware of POTS, a fairly common clinical entity that can 
result in significant impairments to a patient’s quality of life. Lifestyle measures (under 
which adequate fluid and salt intake, exercise) are a first line of treatment; if insufficient, 
pharmacotherapy can be considered to improve quality of life.
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Introduction
Postural orthostatic tachycardia syndrome (POTS) is a condition in which a change 
from a supine to an upright position causes an abnormally large increase in heart rate.150 
A POTS diagnosis is made when patients meet all criteria shown in Table 1. Common 
complaints, not all explained by the increase in heart rate only, are light-headedness, 
palpitations, (pre-)syncope, fatigue, tremulousness and weakness or heaviness (especially 
of the legs).151,152
 POTS is probably underdiagnosed due to the heterogeneity in both presentation and 
aetiology, and therefore the prevalence of POTS is still unsure. Three studies report a 
prevalence of approximately 170/100,000 in the United States.153-155 Mean age of onset of 
POTS is approximately 30 years and most patients are between the ages of 20-40 years. 
There is a clear overrepresentation of women with a corresponding female:male ratio of 
5:1.155 
We describe two illustrative cases, followed by considerations regarding pathophysiology 
and treatment consisting of lifestyle advice. This advice may include psychological 
interventions which, if necessary, may be combined with pharmacotherapy.
Table 1: Criteria for the postural orthostatic tachycardia syndrome150,165 
Heart rate increases ≥ 30 (40 in children 12-19 years) beats per minute  from supine to standing (10 minutes)
Symptoms worsen with standing and improve with recumbence
Symptoms last ≥ 6 months
Absence of orthostatic hypotension (≥ 20 mmHg drop in systolic blood pressure)
Absence of other overt cause of orthostatic symptoms or tachycardia
Case Reports
Case 1
A 24-year-old Caucasian woman with an unremarkable medical history was referred to 
the outpatient clinic of internal medicine. Her referring cardiologist suspected POTS 
based on complaints of vertigo and postural-dependent sinus tachycardia; the patient 
had no severe orthostatic hypotension and a structurally normal heart as imaged 
by echocardiography. Her complaints, which also included flushing, malaise and 
concentration problems, started approximately three months earlier and improved when 
lying down and worsened when standing. Her sister and father had similar symptoms at 
the same age.
We performed a tilt table test. Her supine blood pressure was 141/84 mmHg and her 
heart rate was 111 beats per minute (bpm). After being tilted, physical complaints such 
as flushing and palpitations developed progressively and after seven minutes, the test was 
stopped. Her heart rate rose to 150 bpm while blood pressure increased slightly to 148/96 
mmHg. At this point, blood tests were conducted. Serum noradrenaline level was 887 pg/
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ml (baseline 292 pg/ml) and adrenaline level was 509 pg/ml (baseline 44 pg/ml). These 
complaints and findings, in absence of another explanation such as adrenal insufficiency, 
confirmed the diagnosis of POTS (Table 1). Since she had such a severe rise in heart 
rate and two first-degree relatives had similar symptoms, whole exome sequencing was 
performed after pretest counselling. No pathogenic variant, not even in the SLC6A2 gene 
(a gene that causes orthostatic intolerance), 156 was identified.
We advised lifestyle changes, including substantial fluid and salt intake, compression 
stockings and supervised physical reconditioning (horizontally; for example, cycling). 
Simultaneously, as part of the recommended dual policy of physical and psychological 
treatment, we referred her to a psychologist to discuss psychological factors that could 
contribute to her POTS symptoms.152,157-159
As her symptoms did not improve within weeks, we prescribed short-acting beta blocker 
propranolol (uptitrated to 40 mg three times a day) and fludrocortisone (62.5 mcg once 
daily), combined with extra salt (Sodium chloride tablets, 1000 mg three times a day). 
This resulted in good response, but the fludrocortisone led to severe insomnia. The 
patient herself suggested modafinil (100 mg bidaily) after reading Raj et al., 150 which 
was prescribed for her difficulty with concentration. This improved her so-called ‘’brain 
fog’’.150 For exceptional occasions such as her wedding, she was prescribed desmopressin 
(DDAVP) after a test-dose including control of sodium levels was conducted, which 
improved her symptoms substantially. Over time, and considering all lifestyle measures, 
her condition improved and medication could be tapered after six months to propranolol 
40 mg three times a day and salt supplementation only. Currently, her symptoms are well 
under control with lifestyle measures and propranolol has been further tapered. 
Case 2
A 44-year-old Caucasian male visited the general practitioner with complaints of syncope 
while standing. These complaints were present for approximately five to six months and 
started after an intentional weight reduction of 30 kg (weight at presentation: 95 kg, 
height: 1.97 m). Simultaneously, he developed paraesthesia of his legs. He was referred 
to an internist and a cardiologist for further investigation. The cardiologist excluded 
underlying cardiac pathology. The internist referred him to our hospital for further 
diagnostics, in particular, a tilt table test. This was performed, and showed an increase 
in heart rate from 58 bpm in supine position to 90 bpm when tilted, whereas his blood 
pressure remained around 154/98 mmHg. Noradrenaline rose to 229 pg/ml from a 
relatively low baseline level of 69 pg/ml. These measurements fit the criteria of POTS 
(Table 1). 
The neurologist we consulted in our centre concluded the paraesthesia to be meralgia 
paresthetica of the right femoral cutaneous nerve and the left peroneal nerve, possibly 
triggered by the patient’s weight loss. An association with POTS was excluded, although 
no biopsy was performed to rule out small fibre neuropathy.160 We advised lifestyle 
changes, including intake of sufficient fluids and salts and prescribed sodium (Sodium 
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chloride tablets, 1000 mg three times a day). The symptoms of the patient resolved and 
no further pharmacotherapy was required.
Discussion
This paper describes two illustrative cases of patients with POTS. POTS, first described 
by Jacob Mendes Da Costa in 1871, is a clinical syndrome and not a distinct disease entity, 
and has clinical overlap with chronic fatigue syndrome and Ehlers-Danlos syndrome.161 
Clinical diagnostic criteria for POTS are provided in Table 1.
Pathophysiology
Under normal circumstances, heart rate and blood pressure remain stable or change 
only slightly and for a very short period of time in response to changing from a supine 
to an upright position due to a rapid response originating from the baroreceptors. In 
POTS patients however, heart rate increases to very high levels and for a longer time 
period. This is presumably due to different pathways. Hypovolemia is present in 
two-third of patients with POTS, potentially due to less responsiveness of the renin–
angiotensin–aldosterone system.162,163 Elevated (> 600 pg/ml) catecholamine levels upon 
standing are commonly recognized in patients with POTS.164 Poor exercise tolerance and 
deconditioning is also present in the majority of cases. Although this could be a cause 
or a consequence of POTS, the fact that most patients benefit from exercise is an extra 
argument that deconditioning is a causal factor.165 In addition to these common findings, 
two specific subtypes can be distinguished in most studies: the hyperadrenergic and the 
neuropathic subtypes, although in clinical practice this subdivision is less useful and 
difficult to differentiate.150,158,165 A vast majority of POTS patients experience autonomic 
dysfunction in various autonomic domains.166 Additional testing, such as measurement 
of catecholamines in response to standing or assessment of small fibre neuropathy, 
should be preserved for research purposes only or in specific indications – such as in 
case 2, where a relationship with the tremendous weight loss was likely.
Hyperadrenergic phenotype
A hyperadrenergic state, present in approximately 50% of patients with POTS, is due 
to excessive sympathetic discharge characterized by a supraphysiological rise in plasma 
levels of noradrenaline to 600 pg/ml or higher in response to standing as seen in case 
1.152,158,165 Blood pressure may fluctuate or increase heavily (“orthostatic hypertension”) 
during prolonged standing. Symptoms of stress, emotional behaviour and cold pale skin 
may occur upon standing.150 Likewise, the episodes can also be triggered by emotional 
stimuli and physical activity.152 Earlier described hypovolemia may also attribute to the 
hyperadrenergic state. Hyperthyroidism or catecholamine secreting tumours should 
be ruled out as alternative diagnoses in patients presenting with this phenotype. In 
rare cases of familiar occurrence of POTS, a heterozygous variant in the SLC6A2 gene 
encoding the norepinephrine transporter has been found.156
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Hyperadrenergic states have also been suggested to be secondary to immune disorders 
associated with antibodies against components of the voltage-gated potassium channel 
complex.152 Autoantibodies against the nicotinic acetylcholine receptor have been 
described to correlate with the severity of autonomic dysfunction in small patient 
cohorts.164,167,168 Recent studies have shown elevated autoantibodies against adrenergic 
receptors (α1AR) in patients with POTS, resulting in a compensatory autonomic 
vasoconstriction and concurrent α1AR-mediated tachycardia.169,170 Furthermore, 
another study showed Angiotensin II Type 1 Receptor autoantibodies (AT1R) in POTS 
patients.171 However, these are small studies in selected patient populations and therefore 
further research is needed to establish the clinical implications. 
Neuropathic phenotype
The other important mechanism found in POTS is presumably caused by (partial) 
peripheral sympathetic denervation leading to impaired peripheral vasoconstriction.172 
This denervation is thought to be a consequence of a small fibre neuropathy, which may 
be diagnosed by biopsy, impaired sweat testing or sudomotor axon reflex testing.160,164 
There is lack of vasoconstriction resulting in venous pooling in the lower limbs, which is 
reversed when the patient lies down as a result of gravity.151,152 Considering these aspects, 
the second case is expected to have the neuropathic form of POTS potentially related to 
his weight loss 173,174 although biopsy was not performed. Indeed, in a small study over 
one third of patients fulfilled the criteria for POTS after bariatric surgery.175
Table 2: Diagnostic approach150,158,165
Investigation Diagnosis to be excluded
History focused on possible causes of orthostatic tachycar-
dia, salt and fluid intake, impact on daily activities and 
family history
Underlying cardiac disease including  arrhythmia such as 
inappropriate sinus tachycardia  syndrome or conduction 
abnormalities200 
 
Adrenal insufficiency (if suspicion, additional testing)  
 
Triggers inducing tachycardia (drugs, diet)
Physical examination including stand test: BP and 
HR measurement supine and after 1, 3, 5 and 10 minutes of 
standing
ECG
Blood test for other causes of orthostatic intolerance:   
  H b 
 TSH
 
Anaemia 
Hypothyroidism or hyperthyroidism
On indication:
(Nor)metanephrine (plasma or urine) Pheochromocytoma
Tilt table test (most important indication: inability 
to stand)
If combined with catecholamines: autonomic failure
24-hour Holter monitoring, additional cardiac 
screening
Underlying cardiac disease
BP: blood pressure; HR:  heart rate; ECG: electrocardiogram; Hb: haemoglobin; TSH: thyroid stimulating hormone.
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Diagnostic approach
POTS patients present with atypical and rather common symptoms. The diagnostic 
approach is therefore challenging and based on four criteria (Table 1) while excluding 
other causes (Table 2). A key symptom for establishing the diagnosis of POTS within the 
differential diagnosis is worsening of symptoms while standing up. Since epidemiology 
and symptoms may overlap, inappropriate sinus tachycardia and vasovagal syncope must 
be distinguished from POTS, although these diagnoses are not mutually exclusive.16 
Any condition or drug that could be causing orthostatic tachycardia, such as dehydration 
or pheochromocytoma, should be identified and adequately treated.176 The tilt table 
test is commonly used for diagnosing POTS, although this is not strictly necessary: a 
simple stand test might be sufficient to confirm the diagnosis; the same is true for the 
measurement of catecholamines before and after tilting.150,158,165 
Overlap with other conditions
There seems to be an overlap with fibromyalgia (FM) and other medically unexplained 
physical symptoms (e.g. chronic fatigue sleep disturbances).152,177-179 POTS is found in up to 
50% and 60% of patients with chronic fatigue syndrome (CFS) and FM, respectively.154,180 
In patients with CFS, abnormalities of the vascular and autonomic nervous system are 
common.154,180 Similar to POTS patients, small fibre neuropathy also affects a majority of 
FM patients.181,182 Given the similarities between symptoms of FM, CFS and POTS, it is 
reasonable to assume shared aetiology between these conditions.177,180 This may involve 
so-called “somatic hypervigilance” or “central sensitization,” in which relatively mild 
or routine sensory information is experienced more intensely or more distressing than 
usual.159,183-186 This may also lead to a stronger physiological response to exercise, often 
reason to quit exercising.187
Treatment options
Currently, there is no standard treatment for POTS, and treatment strategies should 
be based on clinical presentation, the assumed underlying pathophysiology, potential 
overlapping syndromes, deconditioning and any psychological factors that can 
sustain symptoms. First-line POTS therapy consists of lifestyle recommendations. 
A multidisciplinary approach including physiotherapy and psychological support 
is recommended to optimize lifestyle treatment to avoid overmedicalization (Table 
3).152,157,158,165
Since hypovolemia seems to play a major role in the majority of patients, fluid intake of 
at least 2-3 litres as well as 10 grams of salt per day (studies differ in their advice between 
8-10 or 10-12 grams) should be advised to prevent hypovolemia.150,165,176,188 A 24-hour 
urine measurement of sodium can be helpful since most patients often overestimate their 
current salt intake. Most patients may benefit from wearing support garments such as 
thigh-or waist-high tight support stockings in accordance with recommendations for 
orthostatic hypotension.150,152 Patients should be encouraged to begin a gradual program 
Chapter 6
90
Table 3: Treatment options for POTS patients
Treatment 
option
Recommendation Remarks Level of evidence*165
Lifestyle
Fluid intake 
Salt intake 
At least 2- l daily 
Circa 10 grams daily
When hypovolemia suspected 
(majority of patients)
Expert opinion150,152,158,165
Physical  
conditioning
Preferably horizontal  
activity. 20-30 minutes,  
3 times a week
Moderate189-191
Compression 
stockings
Waist-high style stockings 
(pressure 30 to 40 mmHg)
Expert opinion150,152
Psychological 
interventions
Focused on coping  
mechanisms and somatic 
hypervigilance
Expert opinion152,157,165,192
Pharmacological options
Propranolol 20 mg daily Only if blood pressure is sufficient  
High dose (≥ 80 mg) may worsen 
symptoms
Moderate193
Fludrocortisone Start 50-62.5 mcg/day to max 
300 mcg daily
When hypovolemia suspected. 
Caution in patients with migraine. 
Side effects include hypokalaemia, 
severe headaches and vertigo
Expert opinion150,152,158,161
Desmopressin 0.2 mg Side effects include hyponatremia. 
Only for occasional usage
Moderate194
Ivabradine Start 2.5 mg once or twice 
daily (lower than in case of 
heart failure)
Potentially beneficial for fatigue; 
may result in visual abnormalities
Weak195
Clonidine 
Methyldopa
0.1-0.2 mg bid or tid 
125-250 mg bid
Hyperadrenergic phenotype; 
side effects include drowsiness, 
fatigue and worsening of men-
tal clouding
Weak201
Pyridostigmine 30-60 mg tid Side effects include gastrointestinal 
symptoms
Moderate197,202
Modafinil 100 mg bid Potentially beneficial for “brain 
fog”; orthostatic tachycardia may be 
worsened
Expert opinion150,152,165
Midodrine 2.5 mg tid Neuropathic phenotype; side 
effects include urinary retention 
due to prostatic hypertrophy
Moderate203
bid: twice a day; tid: three times a day. * Scoring of evidence is as follows: moderate: one randomized controlled trial; weak: only small 
non-interventional studies; expert opinion: no specific studies in POTS, in most cases based on experience in orthostatic hypotension.
of physical reconditioning under supervision of a dedicated physical therapist, working 
toward a goal of performing 20 to 30 minutes of aerobic activity (preferably horizontal, 
e.g. cycling) three times a week.189-191
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Psychological treatment including psychotherapy can be helpful, both to improve coping 
mechanisms as well as to address the somatic hypervigilance.157,192 In our centre, every 
POTS patient is offered a visit to a psychologist. The psychologist can assess to which 
extent psychological issues may be involved in the aetiology or maintenance of POTS.157 
Clinical trials to identify the most effective psychological treatment enabling more 
specific referral and treatment are needed. 
Pharmacotherapy may be required for patients who remain symptomatic after three 
months of optimal lifestyle interventions, or for patients whose severe symptoms hamper 
life style modifications even at earlier stages. Several drugs have shown a positive effect 
in POTS treatment, although one should keep in mind that the highest level of evidence 
is moderate and most options are based on non-interventional studies or expert opinions 
only (Table 3). The most relevant options are shortly described below.
The best available evidence exists for low doses of short-acting beta blockers, in particular 
propranolol. It is mainly effective at lowering standing heart rate and improving 
complaints of palpitations.152,157,158,165 Interestingly, in a direct comparison, propranolol was 
inferior to exercise therapy.191 In this study, the combination of exercise and propranolol 
was not studied, contrasting with our recommendation to first optimize lifestyle before 
considering pharmacotherapy. High doses (≥ 80mg) of propranolol fail to show further 
improvement and may even worsen symptoms.193 Fludrocortisone, a mineralocorticoid, 
can be used when hypovolemia is suspected, to enhance sodium retention and to promote 
intravascular volume expansion.150 However, it can exacerbate headaches and vertigo, 
particularly in patients with migraine.152 Incidentally, desmopressin can be used to reach 
rapid volume expansion.194 Ivabradine, a selective sinus node inhibitor can slow heart 
rate without effecting blood pressure and seems to have a beneficial effect on fatigue.195,196 
When symptoms are severe due to high sympathetic nervous system activity, central 
sympatholytic agents, clonidine and methyldopa, can be prescribed. In patients who are 
refractory to other commonly-used medications, the use pyridostigmine, a peripheral 
acetylcholinesterase inhibitor, can be considered.197 Stimulating agents such as modafinil 
or methylphenidate may be considered to improve concentration and reduce mental 
clouding, although its mechanism is unknown. One should keep in mind that modafinil 
may aggravate the orthostatic tachycardia since tachycardia is a well-known side 
effect, although this was not shown in a small trial focused on safety in patients with 
POTS.150,198 The peripheral α1-adrenergic agonist midodrine may elicit vasoconstriction 
by reducing venous pooling, especially in neuropathic POTS.172 As most POTS patients 
are between 20 and 40 years of age, its major side effect (e.g. urinary retention due to 
prostatic hypertrophy) is not an issue.151,155
Quality of life
POTS patients are limited in their physical activities and can become deconditioned over 
time.152,161,191 Unsurprisingly, quality of life in patients with POTS is low. Benrud-Larssen 
et al. reported that patients with POTS and patients with congestive heart failure had 
comparable physical and psychological composite scores.183 No correlation was found 
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between quality of life and the maximal increase in heart rate.192 Despite the low quality 
of life, the prognosis of POTS is favourable, since 60% of the patients return with the 
given lifestyle and pharmacological options within five years to their level of functioning 
before onset; this should be emphasized to patients.151,199 However, resolution of symptoms 
as illustrated in the patients above is not always the case, and may lead to a more complex 
and chronic condition frustrating both patient and physician.
Conclusion
In conclusion, POTS is a heterogeneous clinical syndrome that overlaps with multiple 
syndromes such as chronic fatigue syndrome and Ehlers-Danlos syndrome. The 
diagnosis can be made in most cases by a thorough history, physical examination and a 
limited amount of additional testing to rule out other causes of orthostatic intolerance. 
Currently, there is not one standard treatment, but a treatment plan should entail lifestyle 
recommendations and psychological treatment. Pharmacological treatment is reserved 
for the patients who remain symptomatic despite these interventions. Especially in 
current times of self-diagnosing and ‘self-educated’ patients who are familiar with this 
syndrome, clinicians should not only be well informed and aware of POTS, but also 
familiar with its multifactorial background and treatment options in order to optimize 
therapy options for their patients.
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Abstract
Importance
Although inadequate sleep has a proven negative association with health care outcomes, 
to date, no large-scale studies have examined sleep in general hospital wards.
Objectives 
To assess the subjective quantity and quality of sleep and to identify the hospital-related 
factors associated with sleep disturbances in hospitalized patients.
Design
For this nationwide, single-day, multicentre, cross-sectional, observational study, which 
took place on February 22, 2017, all hospitals in the Netherlands were encouraged by 
word of mouth and conventional and social media to participate in this study. A total of 
39 hospitals participated. Included patients were at least 18 years of age, were able to give 
informed consent, and had spent at least 1 night in a regular-care hospital ward.
Exposures
Hospitalization in a regular-care ward.
Main Outcomes and Measures
Quantity and quality of last night’s sleep in the hospital compared with habitual sleep 
at home the month before hospitalization. The Consensus Sleep Diary and the Dutch-
Flemish Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep 
Disturbance item bank were used. Complementary questions assessed sleep-disturbing 
factors.
Results
A total of 2,005 patients were included (median age, 68 years; interquartile range, 57-77 
years; 994 of 1,935 [51.4%] were male [70 patients did not identify their sex]). Compared 
with habitual sleep at home, the total sleep time in the hospital was 83 minutes (95%CI, 
75-92 minutes; P < .001) shorter. The mean number of nocturnal awakenings was 2.0 
(95%CI, 1.9-2.1) times at home vs 3.3 (95%CI, 3.2-3.5) times during hospitalization 
97
INSOMNIA - Sleep disturbance in hospitalized patients
(P < .001). Patients woke up 44 minutes (95%CI, 44-45 minutes; P < .001) earlier than 
their habitual wake-up time at home. A total of 1,344 patients (70.4%) reported having 
been awakened by external causes, which in 718 (35.8%) concerned hospital staff. All 
aspects of sleep quality measured using PROMIS questions were rated worse during 
hospitalization than at home. The most reported sleep-disturbing factors were noise of 
other patients, medical devices, pain, and toilet visits.
Conclusion and Relevance
This study demonstrated that the duration and quality of sleep in hospitalized patients 
were significantly affected and revealed many potentially modifiable hospital-related 
factors negatively associated with sleep. Raising awareness about the importance of 
adequate sleep in the vulnerable hospital population and introducing interventions to 
target sleep-disturbing factors may improve healing.
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Introduction
Inadequate sleep has a negative association with general health and well-being.204-207 
Small studies 208-212 in selected patient populations suggest that sleep in hospitals is 
suboptimal. However, information about the quantity and quality of sleep in patients 
in general hospital wards is lacking. A good night’s sleep improves cognitive and 
emotional functioning,213 which is important during an often emotionally challenging 
stay in the hospital. Sleep is essential for adequate immune, metabolic, and endocrine 
functioning204,214-216 and may have an association with healing and survival.217 Studies218,219 
suggest that sleep deprivation is a possible key risk factor for development of delirium. 
Patient-related factors, such as pain, and hospital-related factors, such as noises from 
alarms or sleep interruptions attributable to medical procedures, may contribute to 
disturbance of sleep.220-223 However, to date, no large-scale, multicentre studies have 
been performed to investigate how these factors are associated with sleep disturbance 
in hospitals. Identifying relevant and potentially modifiable hospital-related factors 
associated with sleep disturbances can be the key to introducing remedial measures. The 
primary aims of this nationwide, single-day study in the Netherlands were to assess the 
quantity and quality of sleep and to identify the hospital-related factors associated with 
sleep disturbances in hospitalized patients.
Methods
Study Design and Participants
This was a nationwide, single-day, multicentre, cross-sectional, observational study 
using the flash mob research (FMR) method, which allows the investigation of clinically 
relevant questions on a large scale in a short time.224 Flash mob research is based 
on the concept of flash mobs: “a sudden and planned gathering of many people at a 
particular place that has been arranged earlier.”225 With the use of multiple hospitals, it 
is possible to obtain sufficient data with FMR in a short time. After preparing the study, 
the coordinators (H.M.W., E.S.v.d.E., J.A., F.H.B., E.J.W.v.S., and P.W.B.N.) invited acute 
care internists from hospitals throughout the Netherlands to participate in the study 
using word of mouth and conventional and social media. Hospitals were also recruited 
through the professional network of the members of the “Onderzoeks Consortium 
Acute Geneeskunde” Acute Medicine Research Consortium.48 All participating 
hospitals received approval from their local ethics committees to obtain verbal informed 
consent with annotation in the patient record. Patient records were anonymized before 
the coordinators received them. The coordinating centre, the VU University Medical 
Centre in Amsterdam, the Netherlands, provided a standardized protocol, instructions 
on procedures, case report forms, and questionnaires. The study was performed on 
February 22, 2017, between 8 AM and 5 PM. To stimulate participation by health care 
workers and patients, conventional and social media provided some information before 
the study. However, to minimize observer and participant bias, release of the exact study 
date was embargoed until 6 AM February 22, 2017.
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All patients at least 18 years of age, with any disease condition, able to give informed 
consent, and who spent at least the night before the data collection in a regular-care ward 
were eligible for enrolment. Patients from intensive care, coronary care, and stroke units 
were excluded.
Questionnaire
A Consensus Sleep Diary (CSD) was used to asses subjective sleep quantity.226 In 
addition, after reaching consensus among the coordinating members, we selected 5 of 8 
items from the Dutch-Flemish Patient-Reported Outcomes Measurement In- formation 
System (PROMIS), version 1.0, sleep disturbance item bank (Short Form 8a) and a sixth 
item from the complete PROMIS sleep disturbance item bank, which we believed were 
best suitable to measure sleep disturbance in hospitalized patients.227,228 To measure the 
differences in sleep experiences in the hospital vs home, each item was asked twice: once 
with reference to the previous night at the hospital and once with reference to habitual 
sleep at home during the month before hospitalization. These items were complemented 
by questions about hospital-related, personal, and environmental factors that could have 
influenced sleep, including use of sleep medication. 
Sleep Quantity
The CSD items assessed subjective estimates of the clock times of lights out (i.e. closing 
the eyes to fall asleep) and final awakening, sleep-onset latency (i.e. time taken to fall 
asleep), the number of awakenings, and the total duration of wake after sleep onset (i.e. 
time spent awake after going to sleep). The in- formation provided was used to calculate 
total sleep time (i.e. actual time spent asleep) and sleep efficiency (i.e. the proportion of 
sleep relative to the time between lights out and final awakening).
Sleep Disturbance
The included 5-point Likert-type PROMIS items assessed 2 positive (satisfying and 
refreshing) and 3 negative (restless, difficulty falling asleep, and feeling lousy when 
waking up) evaluations of sleep. Each item provided a statement and asked how well it 
suited the patient, from not at all to very much. A sixth item on general sleep quality was 
answered as very poor to very good. The items that assessed positive evaluations were 
re- coded in such a way that a higher score indicated more sleep disturbance. Because 
the time frame was adjusted for the design of this study, we did not calculate PROMIS 
T scores but only used raw summary scores (range, 0-24) that described overall sleep 
disturbance.
Disturbing Factors
The CSD items were complemented by questions on whether sleep was associated with 
a list of disease-related, hospital-related, personal, or environmental sleep-disturbing 
factors. An additional text field allowed patients to fill out other factors.
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Statistical Analysis
Intrinsic to the FMR approach, no fixed sample size was set a priori. However, to 
obtain reliable and generalizable results and based on what was found feasible in a 
previous study, 224 we aimed to include at least 1,000 patients.
Categorical variables are summarized by percentages. Continuous variables are 
summarized by means and 95% CIs or medians and interquartile ranges (IQRs). 
Mean sleep quality and quantity were compared between hospital and home 
using mixed linear models with the patients’ difference scores (hospital relative 
to home) as the dependent variable, with an intercept-only model for the fixed 
part and a random effect of hospital. Means were concluded to differ between 
hospital and home when the fixed intercept differed significantly from 0. To check 
whether differences in mean sleep quality and quantity between hospital and 
home varied across groups of patients, we added a fixed effect for the grouping 
variable to the mixed model. Transformations of the dependent variables were 
considered in case residuals and were not normally distributed. To assess the 
robustness of the conclusions based on mixed-model analysis to deviations from 
normality, additional sensitivity analyses were performed in which we compared 
the individual differences between groups using non-parametric tests (Mann-
Whitney test and Kruskal-Wallis analysis of variance). The nonparametric tests 
ignored the clustering of patients within hospitals, but this clustering was found to 
be ignorable because the variance component for the random effect of hospital in 
the mixed models was often estimated to be 0. Normality of dependent variables 
and residuals from the mixed models was checked using normal probability plots. 
Analyses were performed with SPSS for Windows, version 21 (SPSS Inc.). P < .05 
was considered to be statistically significant. 
Results
An estimated potential population of approximately 2,500 patients was eligible 
for inclusion; however, some patients could not be included because they were 
too sick or could not grant consent because of cognitive disturbances (on clinical 
grounds). The questionnaire was completed by 2,005 patients in 39 of 93 Dutch 
hospitals (median age, 68 years; IQR, 57-77 years; 994 of 1,935 [51.4%] were male [70 
patients did not identify their sex]). Nonsurgical specialties were best represented 
(1,536 [81.0%]) (Table 1). A total of 335 patients (16.7%) had been taking sleep 
medication at home (of which 189 [56.4%] were taking benzodiazepines) and 539 
(26.9%) the previous night (of which 264 [49.0%] were taking benzodiazepines) 
(Supplementary Table 1).
The 1,427 patients (71.2%) who provided complete (home and at hospital) answers 
to all CSD questions were included in the sleep quantity analysis (Figure 1). The 578 
excluded patients (28.8%) did not differ from the included patients with respect to 
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Figure 1: Inclusion Quantitative Sleep Measurements
baseline characteristics (Supplementary 
Table 2). 
Raw summary difference scores for the 
PROMIS questions could be calculated 
in 1,885 patients (94.0%) because of 
few missing answers in some patients. 
However, because many patients only 
forgot to fill out 1 of the 12 questions, we 
also chose to calculate the difference for 
each question separately (Table 2).
Sleep Quantity
Table 3 summarizes the CSD measures of subjective sleep quantity. Mean total sleep 
time was 83 minutes (95%CI, 75-92 minutes) shorter during hospitalization (6 hours 
4 minutes; 95%CI, 5 hours 56 minutes to 6hours 11 minutes) than at home (7 hours 27 
minutes; 95%CI, 7 hours 21 minutes to 7 hours 33 minutes) (P < .001). The difference 
resulted primarily from earlier final awakening in the hospital of a mean of 44 minutes 
(95%CI, 44-45 minutes).There was a higher number of awakenings in the hospital 3.3 
times (95% CI, 3.2-3.5 times) than at home (2.0 times; 95% CI, 1.9-2.1 times) (P < .001). 
Sleep efficiency was lower in the hospital (76%; 95% CI, 75%-77%) than at home (88%; 
95% CI, 88%-89%) (difference, 12%; 95% CI, 14%-11%; P < .001).
Sleep Disturbance
Table 2 summarizes the PROMIS items of subjective sleep disturbance. For all 6 questions 
(Supplementary Table 3 and Supplementary Figure 1), there was a significantly worse 
rating in the hospital (median, 9; IQR, 5-14) vs at home (median, 5; IQR, 3-9) (P <.001). 
Raw summary scores and differences in scores were not significantly associated with sex 
(male: mean, 9.5; 95% CI, 9.1-9.9; female: mean, 10.0; 95% CI, 9.6-10.4; P =.06), length of 
stay (1 day; mean, 10.5; 95% CI, 9.8-11.1; 2 days: mean, 9.6; 95% CI, 8.9-10.2; 3 days: mean, 
9.7; 95% CI, 8.7-10.8; ≥ 4 days: mean, 9.7; 95% CI, 9.3-10.0; P = .14), or number of patients 
sleeping in the same room (single room: mean, 9.7; 95% CI, 9.2-10.3; double room: mean, 
9.3; 95% CI, 8.8-9.9; triple room: mean, 10.0; 95% CI, 9.1-10.9; quadruple room: mean, 
10.0; 95% CI, 9.6-10.5; 5-person room: mean, 10.4; 95% CI, 6.3-14.5; 6-person room: 
mean, 9.1; 95% CI, 6.7-11.5; > 6-person room: mean, 12.0; 95% CI, 0.4-23.5; P = .54). 
More sleep disturbance was experienced by patients admitted to a surgical unit (score, 
10.5; 95% CI, 9.9-11.2) than patients in nonsurgical units (score, 9.6; 95% CI, 9.3-9.9) 
(P = .02), whereas there was no difference in sleep disturbance between these groups 
at home. Older patients experienced less sleep disturbance during hospitalization than 
younger patients. Sleep disturbance at home did not differ across age groups (> 36 years 
old: mean, 6.9; 95% CI, 6.0-7.8; 36-50 years old: mean, 7.0; 95% CI, 6.3-7.7; 51-65 years 
old: mean, 6.7; 95% CI, 6.3-7.2; 66-80 years old: mean, 6.5; 95% CI, 6.2-7.0; > 80 years old: 
mean, 6.6; 95% CI, 6.0-7.1; P = .84) (Supplementary Table 4 and Supplementary  Figure 2).
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Table 1: Characteristics of 2,005 Patients
Characteristic Findinga
Sex (n = 1,935)
 Male 994 (51.4)
 Female 941 (48.6)
Age, y (n = 1,975)
 Median (IQR) 68 (57-77)
 ≤35 117 (5.9)
 36-50 216 (10.9)
 51-65 525 (26.6)
 66-80 765 (38.7)
 ≥81 352 (17.8)
Length of stay (n = 1,773)
 Median (IQR) 4 (2-8)
 1 Night 359 (20.2)
 >1 Nights 1,414 (79.8)
No. of patients in room (n = 1,975)
 Median (IQR) 2 (1-4)
 1 504 (25.5)
 2 514 (26.0)
 3 163 (8.3)
 4 774 (39.2)
 ≥5 35 (1.8)
Ward type (n = 1,945)
 Acute admission unit 269 (13.8)
 Regular ward 1676 (86.2)
Specialty (n = 1,897)
 Surgical specialtiesb 361 (19.0)
 Nonsurgical specialtiesc 1536 (81.0)
Surgery (n = 1,981)
 Yes 451 (22.8)
 No 1,530 (77.2)
Abbreviation: IQR: interquartile range. a: Data are presented as number (percentage) of patients unless otherwise indi-
cated. All 2,005 patients answered the questions concerning demographics and sleep-disturbing factors. In 30 cases, the 
necessary demographic information could not be extracted mainly because we could not read the afor every question 
but only for the ones they did not respond to. b: Surgical specialties included cardiothoracic surgery, vascular surgery, 
plastic surgery, neurosurgery, ophthalmic surgery, general surgery, orthopaedics, urology, gynaecology, traumatology, 
anaesthesiology, and ear, nose, and throat. c: Nonsurgical specialties included cardiology, geriatrics, dermatology, gastro-
enterology, haematology, internal medicine, nephrology, neurology, oncology, psychiatry, pulmonology, and rheumatology.
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Table 2: Subjective Sleep Disturbance Scores (PROMIS)a
Item Median (IQR) Mean Difference (95% CI)
My sleep quality was
  Home (n = 1,958) 3 (2 - 3)
0.58 (0.52 to 0.64)
  Hospital (n = 1,966) 2 (1- 3)
I was satisfied with my sleep
  Home (n = 1,960) 3 (2 - 3)
0.60 (0.53 to 0.67)
  Hospital (n = 1,961) 2 (1 - 3)
My sleep was refreshing
  Home (n = 1,961) 3 (2 - 3)
0.63 (0.56 to 0.70)
  Hospital (n = 1,969) 2 (1- 3)
My sleep was restless
  Home (n = 1,951) 1 (0 - 2)
−0.45 (−0.52 to −0.38)
  Hospital (n = 1,952) 1 (0 - 3)
I had difficulty falling asleep
  Home (n = 1,957) 0 (0 - 1)
−0.51 (−0.59 to −0.44)
  Hospital (n = 1,958) 1 (0 - 3)
I felt lousy when I woke up
  Home (n = 1,952) 0 (0 - 1)
−0.24 (−0.30 to −0.18)
  Hospital (n = 1,956) 0 (0 - 1)
Raw summary score
  Home (n = 1,914) 5 (3 - 9)
−3.0 (−3.4 to −2.7)
  Hospital (n = 1,921) 9 (5 -14)
Abbreviations: IQR: interquartile range; PROMIS: Patient-Reported Outcomes Measurement Information System. a Every 
question was answered using a 5-point scale, scored as follows: 0: very poor/not at all; 1: poor/a little bit; 2: fair/somewhat; 
3: good/quite a bit; and 4: very good/very much. A raw summary PROMIS sleep disturbance score was calculated after 
reverse coding the second and third items. A higher raw summary score indicates more subjective sleep disturbance (range, 
0-24). Differences indicate hospital minus home scores. P < .001 for all comparisons.
Disturbing Factors
Sleep was negatively associated with at least 1 hospital-related factor in 1,276 patients 
(64.6%). Noise of other patients was the most common disturbing factor, interfering with 
sleep onset in 473 patients (23.6%). A total of 1696 patients (84.6%) reported at least 1 
nocturnal awakening, and 65.8% of all reasons given were hospital related, including 
noise of other patients (453 [22.6%]) and being awakened by hospital staff (403 [20.1%]). 
Toilet visits were responsible for nocturnal awakenings in 434 patients (21.6%). Only 566 
patients (28.2%) reported to have awakened spontaneously in the morning. Of patients 
who had not awakened spontaneously, hospital-related reasons were held responsible in 
73.7% of the cases. In 718 patients (35.8%), it concerned awakenings by a member of the 
hospital staff (Table 4, and Supplementary Table 5 and Supplementary Figure 3).
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Table 3: Subjective Sleep Quantity and Timing Measures (Consensus Sleep Diary)a
Measure Home Hospital Difference (95% CI), min P Value
Lights out time 23:05 (23:01 to 23:08)
22:57 
 (22:52 to 23:01)
−8 
(−9 to −8) .002
Sleep onset 23:29 (23:25 to 23:33)
23:41 
(23:35 to 23:46)
12 
 (12 to 12) <.001
Sleep-onset latency, mean 
(95% CI), min
23 
 (21 to 25)
44 
(40 to 47)
21 
 (21 to 21) <.001
Wake after sleep onset, 
mean (95% CI), min
32 
(29 to 34)
61 
(57 to 65)
29 
(29 to 29) <.001
Final wake time 07:28 (07:24 to 07:32)
06:44 
(06:40 to 06:48)
−44 
 (−45 to −44) <.001
Sleep window 08:23  (08:18 to 08:28)
07:47 
(07:42 to 07:52)
−36 
(−36 to −36) <.001
Total sleep time 07:27  (07:21 to 07:33)
06:04 
 (05:56 to 06:11)
−83 
(−92 to −75) <.001
Sleep efficiency, %  
(95% CI)
88 
 (88 to 89)
76 
(75 to 77)
−12 
(−14 to −11) <.001
a: Home and hospital data are presented as mean clock time in hours: minutes (95% CI) unless otherwise indicated. 
Differences indicate hospital minus home scores. The summary measures are based on the 1,427 patients who provided 
compatible answers to all Consensus Sleep Diary questions.
Table 4: Sleep-Disturbing Factors
Sleep Variablea No. (%) With ≥1 Reason
Sleep-Disturbing 
Factors, No. (%)a 
Hospital Related
Patient 
Related
Top 3 Sleep- 
Disturbing Factorsb
Sleep-onset latency  
(n= 1,976)
1,276 
(64.5)
4,144/6,334 
(65.4)
2,190/6,334 
(34.6)
Noise of other patients (23.6%), 
pain (19.9%), and noise of hospital 
equipment (19.4%)
Nocturnal awakenings 
(n = 2,004)
1,696 
 (84.6)
3,978/6,042 
(65.8)
2,064/6,042 
(34.2)
Other reason (36.4%), noise of 
other patients (22.6%), and awak-
ened by hospital staff (20.1%)
Final awakening  
(n = 1,910)
1,344 
(70.4)
3,234/4,389 
(73.7)
1,155/4,389 
(26.3)
Awakened by hospital staff 
(35.8%), other reason (11.6%), 
and noise of other patients 
(10.9%)
a: Hospital-related reasons include awakened by hospital staff, noise of other patients, noise of hospital staff, noise of medical 
instruments, uncomfortable bed or pillow, lights, transfer to new room, and other hospital-related answers to the open-end-
ed question. Patient-related reasons include pain, anxiety, worrying about illness, dyspnoea, alarm clock, and other patient- 
related answers to the open-ended question. b: Percentages are the proportion of all patients (N = 2,005) who experienced the sleep- 
disturbing factor. In the other factors category, 434 (59.5%) of nocturnal awakenings and 120 (51.4%) of final awakenings 
were caused by toilet visits; this was not an option included in the survey.
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Discussion
To our knowledge, this nationwide, single-day, multicente, cross- sectional, observational, 
FMR study is the first large-scale study to examine the prevalence, severity, and factors 
negatively associated with sleep quantity and sleep quality in hospitalized patients. 
We found that hospitalized patients slept shorter times with more interruptions, woke 
up earlier, and experienced poorer sleep quality than at home. In two-thirds of cases, 
disturbances involved hospital-related factors, of which many seem modifiable.
In line with other studies,212,220,223,229,230 we identified noises and awakenings by medical 
staff as the most important hospital-related sleep-disturbing factors. Although not 
included in the list of potential sleep disruptors, an important disturbing factor frequently 
mentioned by the patients was waking up for toilet visits. Continuous intravenous drips 
at night and extra diuretics may have contributed to an increased frequency of toilet 
visits in the hospital. Most of the sleep-disturbing factors found in our study seem easy 
to address by incorporating simple changes in nightly hospital routines. A recent pilot 
study231 demonstrated an increase in total sleep time and subjective sleep quality after 
offering sleep hygiene education to nurses, introducing interventions to minimize light 
and noise disturbances, and reducing care-related disruptions and overnight fluids.
There was no significant difference in the association with sleep quantity and quality 
in patients sleeping in a single room compared with patients sleeping in a room with 
other patients. A probable explanation is that in most Dutch hospitals, the sickest 
patients are prioritized for sleeping in a single room because of scarcity and need for 
more care-related disruptions. Most of our population (57%) was older than 65 years 
and experienced fewer sleep disturbances in the hospital possibly because they are used 
to more disrupted sleep at home. In addition, sleep disturbance at home did not differ 
across age groups, possibly because the younger patients were also likely to have a high 
burden of co-morbidity affecting their sleep at home and in the hospital.
We used national newspapers and social media to promote the study, aiming to raise 
awareness about the existence of sleep disturbances in hospitals and stimulate future 
research. Future investigation on sleep optimization should focus on interventions such 
as dimmed lights in corridors and patient rooms, silent foot- wear, remote alarms in staff 
rooms and in the pockets of the nurses, and distribution of flight packages at admission 
that contain earplugs and eye masks. The possibility of introducing remote measurement 
of vital signs and nocturnal check-ups via webcams should also be explored. In addition, 
changing the timing and minimizing nursing activities early in the morning; avoiding 
unnecessary standard procedures, such as routine vital signs measurements, continuous 
intravenous drips at night, and diuretics in the afternoon, could potentially improve 
sleep. However, to our knowledge, most of these interventions have never been tested in 
general wards; therefore, prospective interventional studies are needed.
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Strengths and Limitations
The main strength of the present study is that by using the FMR design we included a large 
heterogeneous sample of patients within 1 day. The hospitals were in different regions 
of the Netherlands and included academic, non-academic teaching, and nonteaching 
hospitals in urban and rural areas. Therefore, it was likely that we had a representative 
sample of the Dutch hospitals.
The study also had some limitations. For the subjective sleep quantity outcomes, almost 
one-third of the patients had to be excluded because of missing or incompatible data. 
There were no differences in the demographic characteristics of included and excluded 
patients; thus, we assumed that the included population was representative of the total 
study population. In addition, 41 patients reporting “not to have slept at all” the last 
night in the hospital were excluded because of missing exact time data. This exclusion 
may have led to an overestimation of sleep duration during hospitalization.
Furthermore, some admitted patients were not eligible for inclusion because of delirium 
or cognitive problems. Other patients were asleep when the questionnaires were 
distributed, possibly because they did not sleep enough at night. Some were too ill or 
exhausted, which may also have led to a conservative estimate of sleep problems during 
hospitalization.
A downside of using habitual sleep at home during the month before admission is the lack 
of information about the condition that the patients were in during that period. Habitual 
sleep pat- terns may have deviated from usual sleep patterns at home because of illnesses 
before admission. In addition, recall bias may have led to more positive estimates of in-
home sleep and inflated the differences between in-home and in-hospital sleep ratings, 
which could have led to underestimation of sleep quantity and quality difference at home 
vs hospital.
Conclusions
This large-scale, multicentre study is the first, to our knowledge, to demonstrate 
compromised sleep quantity and quality in hospitalized patients and identified many 
potentially preventable hospital-related factors. Increasing awareness among health care 
workers of the importance of adequate sleep and introducing interventions that target 
sleep-disturbing factors in hospitals may lead to better sleep and better health outcomes.
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Supplementary Table 1: Overview of use sleep medication
Home (n=335) Hospital(n=539)
Benzodiazepine 189 (56%) 264 (49%)
Melatonin 12 (4%) 6 (1%)
Antidepressant 10 (3%) 10 (2%)
Antipsychotic 3 (1%) 6 (1%)
Antiepileptic 1 (0%) 1 (0%)
Antihistamine 0 (0%) 8 (2%)
Opioid 8 (2%) 42 (8%)
Paracetamol 39 (12%) 61 (11%)
Other 18 (5%) 14 (3%)
Unknown by patient 55 (16%) 127 (24%)
Of 2,005 patients, 335 (17%) reported the use of sleep medication at home and 539 (26%) in the hospital. This table shows 
frequencies and proportions (n, %) of the different types of sleep medication that was reported by patients within these 
groups. Besides conventional sleep medication, patients indicated medicine like Paracetamol and opioids as medication 
to promote sleep.
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Supplementary Table 2: Characteristics of patients included and excluded in analysis on 
subjective sleep quantity
Included patients Excluded patients
Sex
  Male 657 (47%) 260 (48%)
  Female 734 (53%) 284 (52%)
Age
  <35 94 (7%) 23 (4%)
  36-50 166 (12%) 50 (9%)
  51-65 382 (27%) 143 (25%)
  66-80 533 (38%) 232 (41%)
  81+ 234 (17%) 118 (21%)
Length of stay
  1 day 246 (20%) 113 (22%)
  2 days 213 (17%) 91 (18%)
  3 days 106 (8%) 34 (7%)
  4+ days 693 (55%) 277 (54%)
Number of patients in room
  1 372 (26%) 132 (23%)
  2 369 (26%) 145 (25%)
  3 116 (8%) 47 (8%)
  4 540 (38%) 234 (41%)
  5 4 (0%) 5 (1%)
  ≥ 6 14 (1%) 1 (0%)
Specialty
  Non-surgical unit 1110 (82%) 426 (74%)
  Surgical unit 246 (18%) 115 (20%)
Surgery
  Yes 319 (23%) 132 (23%)
  No 1093 (77%) 437 (77%)
Sleep medication
  Yes 383 (27%) 156 (27%)
  No 1044 (73%) 422 (73%)
Assistance filling out questionnaire
  Yes 403 (30%) 108 (19%)
  No 953 (70%) 440 (76%)
n (%) of included or excluded patients within this specific variable
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Supplementary Table 3: Distribution of answers to PROMIS sleep quality items 
Very poor 
(0)
Poor (1) Fair (2) Good (3) Very good 
(4)
Median 
(IQR)
Difference 
(CI)
My sleep quality was…
 Home 
(n=1,958)
2 % 9 % 25 % 50 % 14 % 3 (2-3) 0·58 
(0·52 - 0·64) 
p<·001 Hospital 
(n=1,966)
8 % 19 % 35 % 31 % 6 % 2 (1-3)
Not at all 
(0)
A little 
(1)
Somewhat 
(2)
Quite a bit 
(3)
Very much 
(4)
Median 
(IQR)
Difference 
(CI)
I was satisfied with my sleep.
 Home 
(n=1,960)
7 % 10 % 17 % 48 % 18 % 3 (2-3) 0·60 
(0·53 - 0·67) 
p<·001 Hospital 
(n=1,961)
19 % 14 % 23 % 35 % 9 % 2 (1-3)
My sleep was refreshing.
 Home 
(n=1,961)
9 % 11 % 22 % 46 % 12 % 3 (2-3) 0·63 
(0·56 - 0·70) 
p<·001 Hospital 
(n=1,969)
22 % 19 % 24 % 30 % 5 % 2 (1-3)
My sleep was restless.
 Home 
(n=1,951)
49 % 21 % 16 % 12 % 3 % 1 (0-2) -0·45 
(-0·52 --0·38) 
p<·001 Hospital 
(n=1,952)
35 % 22 % 17 % 18 % 9 % 1 (0-3)
I had difficulty falling asleep.
 Home 
(n=1,957)
56 % 20 % 13 % 89 % 3 % 0 (0-1) -0·51 
(-0·59 --0·44) 
p<·001 Hospital 
(n=1,958)
40 % 21 % 13 % 15 % 11 % 1 (0-3)
I felt lousy when I woke up.
 Home 
(n=1,952)
69 % 14 % 9 % 6 % 2 % 0 (0-1) -0·24 
(-0·30 --0·18) 
p<·001 Hospital 
(n=1,956)
57 % 20 % 10 % 9 % 4 % 0 (0-1)
Every question is answered using a 5-point scale so a median and inter-quartile range (IQR) could be calculated. The 
‘difference’ is the result of the mean at home minus hospital score.
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Supplementary Table 4: Differences in raw summary Sleep Disturbance scores between 
groups
Hospital Home
Sex
  Male 9.5 (9.1-9.9) 6.0 (5.7-6.4)
  Female 10.0 (9.6-10.4) 7.4 (7.1-7.8)
Age
  <35 11.6 (10.6-12.7) 6.9 (6.0-7.8)
  36-50 11.0 (10.2-11.8) 7.0 (6.2-7.7)
  51-65 10.0 (9.5-10.6) 6.7 (6.3-7.2)
  66-80 9.2 (8.8-9.6) 6.6 (6.2-7.0)
  81+ 9.1 (8.5-9.8) 6.6 (6.0-7.1)
Specialty
  Non-surgical unit 9.6 (9.3-9.9) 6.8 (6.5-7.1)
  Surgical unit 10.5 (9.9-11.2) 6.3 (5.7-6.9)
Operation
  Yes 10.4 (9.8-10.9) 6.5 (6.0-7.0)
  No 9.6 (9.3-9.9) 6.8 (6.4-7.1)
Sleep medication
  Yes 10.5 (10.0-11.0) 9.2 (8.7-9.8)
  No 9.5 (9.2-9.8) 6.2 (5.9-6.5)
Assistance filling out questionnaire
  Yes 9.0 (9.7-10.3) 6.5 (6.0-7.0)
  No 10.0 (8.5-9.5) 6.8 (6.5-7.1)
Mean and (95% CI) of raw summary PROMIS Sleep Disturbance scores (0-24) in different groups. A higher score indicates 
more sleep disturbance.
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Supplementary Table 5: Listing of all disturbing factors
Sleep Onset Latency (n=1,976) Nocturnal Awakenings (n=2,004) Final Awakening (n=1,910)
Noise of other patients (24%) Other answer (36%) Woken by hospital staff (36%)
Pain (20%) Noise of other patients (23%) Other answer (12%)
Noise of hospital equipment (19%) Woken by hospital staff (20%) Noise of other patients (11%)
Worrying about illness (17%) Pain (20%) Pain (11 %)
Other answer (17%) Noise of hospital equipment (18%) Lights (10%)
Uncomfortable bed/pillow (16%) Uncomfortable bed/pillow (14%) Noise of hospital staff (9%)
Woken by hospital staff (16%) Lights (11%) Noise of hospital equipment (7%)
Lights (15%) Worrying about illness (10%) Uncomfortable bed/pillow (6%)
Noise of hospital staff (11%) Dyspnoea (10%) Dyspnoea (5%)
Dyspnoea (11%) Noise of hospital staff (10%) Worrying about illness (5%)
Anxiety (6%) Anxiety (5%) Private alarm (4%)
Transfer (2%) Transfer (2%) Anxiety (3%)
Transfer (1%)
(%) Percentage of patients that suffered from this disturbing factor.
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Supplementary figure 1: Distribution of raw summary Sleep Disturbance scores in the hospital and at home. Distribution of the raw 
summary score of the six PROMIS questions on sleep disturbance (possible range 0 to 24). A higher score indicates more sleep disturbance.
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Supplementary figure 2: Raw summary Sleep Disturbance scores in the hospital and at home in different age groups. 
Box-whisker plots of raw summary PROMIS Sleep Disturbance scores in different age groups. Higher scores indicate more sleep 
disturbance (possible range 0-24).
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Supplementary figure 3: Overview of disturbing factors (before, during, after sleep onset). 
Figure shows the proportion of all patients (n=2,005) who have chosen this specific reason.* Other reasons: toilet visits, room 
temperature, no fresh air, uncomfortable sleeping posture, negative emotions, nausea, unknown environment, drains/IV lines/ 
urinary catheters, coughing, pruritus, noise in general, to many hours of rest during daytime.
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Abstract
We provide a systematic overview of literature on prediction models for mortality in the 
emergency department (ED). We searched various databases for observational studies in 
the ED or similar setting describing prediction models for short-term mortality (up to 
30 days or in-hospital mortality) in a non-trauma population. We used the CHARMS-
checklist for quality assessment. We found a total of 14,768 articles and included 17 
articles, describing 22 models. Model performance ranged from AUC 0.63-0.93. Most 
articles had a moderate risk of bias in one or more domains. The full model and PARIS 
model performed best, but are not yet ready for implementation. There is a need for 
validation studies to compare multiple prediction models and to evaluate their accuracy. 
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Introduction
Rationale
It is important to provide timely and adequate care for patients in the emergency 
department (ED). Triage aids physicians in allocating their time and resources. Triage 
systems, such as the Manchester Triage Score and Emergency Severity Index can identify 
patients who require earlier treatment, but do not adequately forecast mortality.232 There 
is an unmet need for models that objectively determine or forecast which patients have a 
high risk of mortality. In the case of ED crowding – where there are more patients than 
treatment rooms, and the waiting room is congested – this is even more important.233 
ED crowding has detrimental consequences for patients resulting in delay in treatment, 
increased in-hospital length of stay and increased mortality.234,235 
Development and implementation of a prediction tool for mortality could be helpful 
to determine which patients benefit most from early treatment, especially during time 
pressured situations. This can lead to altered treatments regimens, intensified care and 
prevention of adverse outcomes. Currently, early warning scores (EWS) are used for 
mortality prediction at the ED, however they were not designed for this purpose.236,237 
Also, prediction models have been developed and validated for prediction of mortality. 
Presently, due to the diversity of these models, it is unclear which model is best at 
predicting mortality in patients presenting at the ED. 
Objective
The aim of this systematic review was to give an overview of literature on the most 
commonly used scoring systems that predict short-term mortality (i.e. up to 30-day or 
in-hospital mortality) at the ED. 
Methods
Study design
We performed a systematic review on prediction models of short-term mortality in the 
ED. The systematic review was conducted according to Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines.238 The study protocol is 
registered in the International Prospective Register of Systematic Reviews (PROSPERO) 
under reference number CRD42017026119. 
Eligibility criteria
The search was restricted to studies developing or validating a prediction model at EDs 
of European hospitals. This was done to minimize the effect of differences in healthcare 
systems on the EDs, making studies more comparable. Tools developed within a similar 
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setting as the ED, such as an Acute Medical Unit, were also included. Furthermore, the 
article needed to fulfil the following criteria: 1) the article described a model rather than 
merely individual predictors, 2) variables within the prediction models were measured 
at ED presentation, 3) the investigated outcome was short-term mortality (i.e. in-
hospital mortality and up to a maximum of 30-day mortality), 4) the study derived or 
validated a model in a medical (non-trauma) population without selection for specific 
diseases (e.g. myocardial infarction) or symptoms (e.g. dyspnoea). Studies investigating 
the association of a triage system with mortality were excluded, as these studies were 
conducted for another purpose. Where an author published more than one article on 
the same prediction model, the article describing the model best or the article using 
the largest sample size was included. Only articles written in English with full-text 
availability were included. 
Information sources
In attempt to identify all relevant studies, the following databases were searched: Embase.
com, Medline Ovid, Cochrane CENTRAL, Web of Science Core Collection, and Google 
scholar. The latest comprehensive search was conducted on the 20th of June 2018. 
Search
The search terms for searching the databases were ‘prediction models’, ‘mortality’ and 
‘Emergency Department’ and related synonyms. The queries were developed for Embase.
com, and syntax and thesaurus terms were afterwards adjusted for other databases. The 
search strategy was established by a biomedical information specialist (See Appendix 1 
for the complete syntaxes). 
Study selection
Articles were deduplicated using EndNote for Windows (Thomas Reuters, version X7). 
Two investigators (A.F. and A.B.) independently reviewed all identified studies for 
inclusion based on title and abstract. Of the remaining records, full-text was assessed for 
eligibility by the same investigators. Any discordant results in the selection process were 
discussed in consensus meetings with a third investigator (J.A.). 
Data collection process and data items
From each included article, the following data were extracted (if available): authors, year 
and journal of publication, country in which the study was performed, study period, 
study design, inclusion and exclusion criteria for the patient population, hospital setting 
(i.e. regional hospital, tertiary care hospital), patient characteristics (i.e. sex, mean age), 
sample size, the prediction model studied, variable selection of model, time of measuring 
variables, the outcomes studied, number of outcomes in the investigated population, 
handling of missing data, model assessment strategy, performance of the prediction 
model and whether a validation study was executed. If any of this data was missing, it 
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was marked as not specified (NS) in the characteristics table. Data were obtained by two 
researchers (A.F. and A.B.).
Risk of bias in individual studies
The quality of the included articles was assessed according to the Critical Appraisal and 
Data Extraction for Systematic Reviews of Prediction Modelling Studies (CHARMS) 
checklist, which is a guideline that helps to critically evaluate the settings of a study and 
therefore helps to determine the reliability and applicability of the described prediction 
models and their outcomes.239 Only derivation studies were assessed, because they can 
be evaluated on their predictor selection and model development. Using the CHARMS 
checklist, we assessed the risks for bias in the following domains: participant selection, 
predictor assessment, outcome assessment, model development and analysis. Each 
dimension was assigned a low, moderate or high risk of bias. 
Summary measures, data synthesis and analysis 
The main outcome was performance of the prediction models. The principle summary 
measure of model performance was the Area Under the Curve (AUC) in a Receiver 
Operating Characteristic (ROC) (i.e. how well the model discriminates high-risk from 
low-risk population). The AUC ranges from 0.5 (no discrimination ability) to 1.0 (perfect 
discrimination). An AUC > 0.8 is considered to be a reflection of good discrimination.240 
The calibration within model performance is also an area of interest (i.e. agreement 
between expected and observed outcomes). Methods to assess calibration were the 
Hosmer-Lemeshow goodness of fit test,241 Schwarz Bayesian Information Criterion, 
Brier score or calibration slope. Patient characteristics reported in the articles were 
presented as mean with standard deviation (SD), median with interquartile range (IQR) 
or numbers with percentages. If possible, statistics not presented in the articles were 
calculated from the available data. 
Results
Study selection
The electronic literature search identified 14,768 articles. After deduplication 8,099 
records remained of which 78 were selected for full-text assessment. Finally, 17 articles 
were included in the qualitative synthesis of this systematic review (Figure 1). The latest 
search was conducted on 20 June 2018. 
Study characteristics 
Seventeen studies investigating 22 different prediction models were included for further 
analysis (Table 1). Ten studies focused on the development or validation of one model, 
while the remainder developed two or three models. Sample size ranged from 225 to 
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35,646 patients. Age was either noted as mean (SD), varying from 58.0 to 64.7 years, 
or as median (IQR), varying from 56 to 71 years. The ratio of male/female was similar 
in all articles, with percentage of male ranging from 46.1% to 57.7%. Mortality rates 
in the study population varied between 0.6% (40/6,947) and 12.7% (711/5,583). Missing 
data were not always reported, and neither was handling of missing data. Fifteen studies 
excluded cases with missing values or considered missing values to be normal. Only two 
studies used imputation techniques to replace missing values.242,243
Quality assessment
The quality of studies and susceptibility of bias between studies were assessed using 
CHARMS. Three studies did not extensively describe patient selection and therefore 
Figure 1: Flowchart for literature search
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were considered as having moderate risk of bias.236,244
The Simple Clinical Score (SCS) and the Hypotension, Oxygen saturation, low 
Temperature, ECG changes and Loss of independence (HOTEL) score used subjective 
predictors (e.g. breathlessness), which can be difficult to reproduce. Therefore, the articles 
reporting these scores were assigned a moderate risk of bias in predictor assessment.245-247 
Studies that used predictors (e.g. laboratory values) that are not immediately available 
when a patient presents to the ED were also assigned a moderate risk for bias.244,248-251
In the appraisal of outcome two domains were assessed; description of outcome and 
description of loss of follow-up. Outcome was reported in all articles and resulted in 
low risk of bias. However, loss of follow-up was described in only five articles, resulting 
in a moderate risk of bias for the articles that did not provide these data.242,243,245,252,253 
Brabrand et al.242 and Coslovsky et al.243 described the development process of their 
models best. The study by O’Sullivan et al. did not describe the development process 
and was therefore considered having a high risk of bias.248 Most articles entered all the 
variables with a strong predictive ability in a multivariate logistic regression analysis, 
however three studies used a backward stepwise regression procedure to identify the best 
prediction model.242,243,254 
 Studies including continuous variables in the prediction tool were less likely to have 
bias.242,244,249 The majority of studies excluded patients with missing data and were 
therefore assigned a moderate risk of bias. Two studies used imputation methods to 
replace missing values.242,243 Two other studies replaced missing values by normal 
values.236,255
Finally, the quality of analysis used in the articles was assessed. Seven articles did not 
provide a validation study and were therefore scored a high risk of bias.236,248,250,252,254,256,257 
Five studies used internal validation,243,245,246,253,255 resulting in a moderate risk. Four studies 
performed external validation and were scored as having a low risk of bias (Table 2).242-
244,247,251 Overall, none of the models scored a low risk of bias on all individual domains. 
Seven studies had a high risk on one of the domains within CHARMS.236,248,250,252,254,256,257 
The models by Coslovsky and Brabrand scored best with an overall low risk of bias on 
all domains.242,243   
Variables included in the scoring systems
Median number of included predictors was 6 (IQR 5 – 8.5). Most prediction tools 
were primarily based on vital parameters (e.g. heart rate, oxygen saturation and body 
temperature). Eight models included laboratory results. Three prediction tools were 
solely based on biomarkers combined with patients’ age and sex. 248,249,251 Predictors were 
categorized in patient characteristics, ED presentation, vital parameters, laboratory 
values, interventions and tests (Table 3). 
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Outcomes 
Outcomes were defined as mortality up to 30 days or in-hospital mortality. Further 
distinction was made in 24-hour mortality,245-247 five-day mortality,244 seven-day 
mortality,242,244 and 30-day mortality.245,247,248,250-252
Model performance 
Discrimination was described in all studies, except by Groarke et al.236 Based on the 
reported sensitivity and specificity we approximated the AUC for this study. Eleven 
models provided an AUC < 0.8, of which five showed a poor discriminative ability (MEWS 
AUC=0.630, EWS AUC=0.68/0.656, RAPS AUC=0.64/0.652).236,253-256 The MARS model 
had the best discriminative ability (AUC= 0.93, 95% CI [0.92-0.94].244
Calibration was measured for eleven models, of which eight used the Hosmer-Lemeshow 
goodness of fit test.242,244,246,247,253,255 One article combined the calibration by the Hosmer-
Lemeshow goodness of fit test with the Schwarz Bayesian Information Criterion,246 and 
another article developed a calibration curve and reported the calibration slope and 
calculated the Brier score.243 In two studies the Hosmer-Lemeshow goodness of fit test 
Table 2: Risk of bias in the development studies
Participant 
selection
Predictor 
assessment
Outcome 
assessment
Model de-
velopment
Analysis
Alam (2015)252 L L L M H
Brabrand (2015)242 L L L L L
Bulut (2014)254 L L M M H
Coslovsky (2015)243 L L L L L
Cournane (2017)250 M L M M M 
Duckitt (2007)253 L L L M M
Goodacre (2006)256 L L M M H
Groarke (2008)236 M M M M H
Kellett (2006)245 L L L M M
Kellett(2008)246 L L M M M
Kristensen (2017)251 L L M M L
Merz (2011)257 L L M L H
Olsson (2004)255 L L M M M
O’Sullivan (2012) 248 L L M M H
Silke (2010) 244 M M M M L
Slagman (2015) 249 L M M M M
Risk of bias in the development studies. The risk of bias is assessed by the CHARMS checklist, which assesses the do-
mains of participant selection, predictor assessment, outcome assessment, model development and analysis. The results are 
summarized as either low (L) risk of bias, moderate (M) risk of bias or high (H) risk of bias. 
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Table 4: Performance of the developed prediction models
Study Prediction 
model
Mortality, 
N (%)
Discrimination, 
AUC 
(95% CI) / ±SE)
Calibration 
method
Calibration Other 
performance 
measurements
24-hour mortality
Kellett  
(2008)246
HOTEL 40 (0.6), 
19 (0.6)
0.865 
(0.793-0.937)
Schwarz 
BIC, HL 
GOF test
422.89, 
χ2=1.49 
(0.83)
NS
Kellett (2006)245 SCS 40 (0.6), 
19 (0.6)
0.902 (±0.019) NS NS NS
5-day mortality
Silke244 MARS 648 (6.05), 
171 (4.75)
0.93 
(0.92-0.94)
HL GOF test χ2=5.66 
(0.315)
NS
Silke244 MARS lab 
only
648 (6.05) 0.90 
(0.89-0.90)
HL GOF test χ2=11.65 
(0.167)
NS
7-day mortality
Brabrand242 Full model 76 (2.5) 0.87 
(0.82-0.93) 
HL GOF test P = 0.97 NS
Brabrand242 PARIS 76 (2.5) 0.86 
(0.80-0.91)
HL GOF test P = 0.42 NS
Silke244 MARS 788 (5.98) 0.91 
(0.90-0.93)
HL GOF test χ2= 17.98 
(0.02)
NS
30-day mortality
Alam252 NEWS 11 (4.0) 0.768 
(0.618-0.919)
NS NS NS
Kellett (2006)245 SCS 316 (4.7) 0.858 (±0.009) NS NS NS
O’Sullivan248 aAISS (4.8) 0.90 
(0.89-0.90)
NS NS NS
O’Sullivan248 aAISS + co-
morbidity
(4.8) 0.89 
(0.88-0.89)
NS NS NS
Kristensen251 Full model 284 (5.3) 0.886 
(0.861-0.911)
BS BS 4.11 
(3.54-4.70)
NS
Cournane250 Admission 
model
(4.6-7.0) 0.85 
(0.85-0.86)
NS NS NS
In-hospital mortality
Bulut254 MEWS 153 (7.65) 0.630 
(0.608-0.727)
NS NS NS
Bulut254 REMS 153 (7.65) 0.707 
(0.686-0.727)
NS NS NS
Coslovsky243 Full model 398 (4.6) 0.922 
(0.916-0.927)
BS , CS BS 0.028, 
CS 0.95
NS
Coslovsky243 Nurse risk 
estimate 
model
398 (4.6) 0.78 BS BS 0.040 NS
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Duckitt253 Worthing 
PSS
270 (8.0) 0.74 
(0.71-0.77)
HL GOF test P = 0.119 NS
Duckitt253 EWS 270 (8.0) 0.68 
(0.65-0.71)
NS NS NS
Goodacre256 RAPS 711 (12.7) 0.64 
(0.59-0.69)
NS NS NS
Goodacre256 REMS 711 (12.7) 0.74 
(0.70-0.78)
NS NS NS
Goodacre256 Full model 711 (12.7) 0.81 
(0.78-0.84)
NS NS NS
Groarke236 EWS 8 (3.6) 0.656 * NS NS OR 2.19 
(1.41-3.39)
Merz257 VSS 316 (7.2) 0.72 
(0.53-0.91)
NS NS NS
Olsson255 RAPS 285 (2.4) 0.652 (±0.019) NS NS NS
Olsson255 REMS 285 (2.4) 0.852 (±0.014) HL GOF test χ2= 62 
 (< 0.0001)
NS
Slagman249 Full model 634 (1.8) 0.863 
(0.848-0.877) 
NS NS NS
Slagman249 EPICS 634 (1.8) 0.866 
 (0.853-0.878)
NS NS NS
Performance of the developed prediction tools for mortality, divided by the time-frame of mortality. Abbreviations: AISS, 
Acute illness severity score; AUC, Area under the curve; BS, Brier score; CI, Confidence interval; CS, Calibration slope; 
EPICS, Emergency processes in clinical structures; EWS, Early warning score; HL GOF, Hosmer-Lemeshow goodness of 
fit; HOTEL, Hypotension, oxygen saturation, low temperature, ECG changes, loss of independence; MARS, Medical ad-
missions risk system; MEWS, Modified early warning score; NEWS, National early warning score; NS, Not specified; OR, 
Odds ratio; PARIS, Systolic blood pressure, age, respiratory rate, loss of independence, peripheral oxygen saturation; PSS, 
Physiological scoring system; RAPS, Rapid acute physiology score; REMS, Rapid emergency medicine score; SCS, Simple 
clinical score; SE, Standard error; VSS, Vital sign score.*calculated from the available data. 
yielded a significant p-value in the derivation, which proves bad calibration (Table 4, 
Figure 2 a-e).241 
Validation
Six studies performed an internal validation analysis, divided in temporal validation,253 
split-sample validation,243,245,246,255 cross-validation251 and bootstrap resampling 
validation.243  External validation analysis was performed in five studies.242,244,247,249,251 
The AUC for all external validation studies was high, ranging from 0.837 and 0.960. 
Calibration within the validation studies was performed for twelve models, and only the 
PARIS model scored poorly in one validation dataset (Table 5).242 
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Figure 2 a: Discrimination performance of the models predicting 24-h mortality.
Figure 2 b: Discrimination performance of the models predicting 5-day mortality.
Figure 2 c: Discrimination performance of the models predicting 7-day mortality.
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Figure 2 d: Discrimination performance of the models predicting 30-day mortality.
In all figures a distinction is made between derivation studies and validation studies. Abbreviations: AUC: Area under the 
curve; CI: Confidence interval; SCS: Simple clinical score; HOTEL: Hypotension, oxygen saturation, low temperature, ECG 
changes, loss of independence; MARS: Medical admissions risk system; PARIS: Systolic blood pressure, age, respiratory rate, 
loss of independence, peripheral oxygen saturation; aAISS: adjusted Acute illness severity score; NEWS: National early warn-
ing score; EPICS: Emergency processes in clinical structures; REMS: Rapid emergency medicine score; RAPS: Rapid acute 
physiology score; VSS: Vital sign score; EWS: Early warning score; PSS: Physiological scoring system; MEWS: Modified early 
warning score.  
Figure 2 e: Discrimination performance of the models predicting inhospital mortality.
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Table 5: Performance of the validated models
Study Prediction 
model
Mortality, 
N (%)
Validation 
type
Discrimination, 
AUC (95% CI)/
(±SE)
Calibration 
method
Calibration
24 -h mortality
Kellett (2008)246 HOTEL 19 (0.6) split-sample 
validation
0.854 
(0.746-0.962)
NS NS
Kellett (2008)246 SCS 19 (0.6) split-sample 
validation
0.909 
(SE 0.027)
NS NS
Straede247 SCS 26 (0.9) external 
validation
0.960 
(0.932-0.988)
HL GOF χ2=2.68 
(0.998)
Straede247 HOTEL 26 (0.9) external 
validation
0.931 
(0.901-0.962)
HL GOF χ2=5.56 
(0.234)
5-day mortality
Silke 244 MARS 171 (4.75) external 
validation
0.92 
(0.90-0.94)
HL GOF χ2=9.83 
(0.278)
7-day mortality
Brabrand242 Full 
model
1. 57 (2.0) 
2. 111(4.3)
external 
validation
1. 0.90 
 (0.87-0.93) 
2. 0.88 
 (0.84-0.91)
HL GOF P = 1. 0.75 
2. 0.33 
Brabrand242 PARIS 1. 57 (2.0) 
2. 111(4.3)
external 
validation
1. 0.87 
(0.82-0.92) 
2. 0.86 
(0.82-0.90)
HL GOF P =1. 0.74 
2. <0.001
Silke244 MARS 216 (5.11) external 
validation
 0.90 
(0.88-0.928)
HL GOF χ2=4.46 
(0.814)
30-day mortality
Kellett (2006)245 SCS 145 (4.5) split-sample 
validation
 0.856 
(SE 0.013)
NS NS
Straede247 SCS 196 (6.4) external 
validation
0.826 
(0.774-0.879)
HL GOF χ2=4.00 
(0.947)
Kristensen251 Full 
model
234 (4.1) cross-validition 
/external 
validation 
0.908 
(0.892-0.923)
BS 3.40 
(3.08-3.72)
In-hospital mortality
Coslovsky243 Full 
model
398 (4.6) bootstrapping 
/ split-sample 
validation
0.920 CS CS 0.935 
(split sample)
Coslovsky243 Nurse 
risk 
estimate 
model
398 (4.6) bootstrapping negligible 
difference
BS negligible 
difference
Duckitt253 Worthing 
PSS
85 (8.0) temporal 
validation
0.72 
(0.66-0.79)
HL GOF P = 0.565
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Olsson255 REMS 285 (2.4) split-sample 
validation
1. 0.832 
(± 0.016) 
2. 0.862 
 (±0.018)
HL GOF χ2= 1. 35.3
2. 31.7
Slagman249 EPICS 765 (2.1) external 
validation
0.837 
(0.825-0.850)
NS NS
Performance of the different validation prediction tools for mortality, divided by the time-frame of mortality. Abbrevi-
ations: AUC, Area under the curve; BS, Brier score; CI, Confidence interval; CS, Calibration slope; EPICS, Emergency 
processes in clinical structures; HL GOF, Hosmer-Lemeshow goodness of fit; HOTEL, Hypotension, oxygen saturation, low 
temperature, ECG changes, loss of independence; MARS, Medical admissions risk system; NS, Not specified; PARIS, Systolic 
blood pressure, age, respiratory rate, loss of independence, peripheral oxygen saturation; PSS, Physiological scoring system; 
REMS, Rapid emergency medicine score; SCS, Simple clinical score; SE, Standard error; VSS, Vital sign score.
Discussion
In our systematic review we described models that predict short-term mortality of patients 
visiting the ED. To our knowledge, none of these models are currently implemented for 
mortality prediction in clinical practice.  We assessed the methodological quality of 
the prediction models for discrimination, calibration and validation, where available. 
The discrimination of the models, presented by the AUC, ranged between average and 
excellent, with the majority having a good discriminatory performance. The MARS 
model had the highest performance, followed by the model by Coslovsky et al. and 
the SCS.243-245 To determine the level of agreement between the expected and observed 
outcome, calibration is paramount. Calibration was assessed in seven studies, and was 
good in four, which shows that these models are suitable for validation.242-244,246,251,253,255
Validation is needed before a model can be implemented in clinical practice, and 
external validation is preferred. Of the nine articles that described validation, only 
five used external validation. Internal validation was performed either using a split-
sample, cross-validation or a bootstrap resampling technique. One study used bootstrap 
resampling,243 which is considered the best method, as it provides a true representation 
of the population without loss of patients.258 In the studies that provided validation, 
the performance in all models was satisfying, and the highest performance was for the 
HOTEL score (AUC=0.960).247 The PARIS model had insufficient calibration for the 
validation in one of the two validation cohorts.242 This means that the model was not 
generalizable to one of the studied cohorts. 
When we assessed the quality of the prediction models, the models by Coslovsky and 
Brabrand scored best with an overall low risk of bias on all the assessed domains.242,243 
Only in the analysis domain high risk of bias was found, and this is explained by a lack 
of validation in these studies.236,248,250,252,254,256,257 Some of the CHARMS criteria within the 
domains were missing in all studies. First, most studies lacked information on missing 
data or excluded patients with missing information. Excluding these patients, however, 
might limit not only the correctness, but also the usability of the model. In daily practice, 
the parameters of a model are not always available.259 There are multiple options to 
Chapter 8
142
address the issue of missing data. Missing values can be replaced by imputation, by the 
mean or by a normal value dependent on the type of missing data. It is also possible 
to assign a special category to missing values which correlates to a certain regression 
coefficient (thus mortality risk). Multiple imputation is considered to be the best method, 
since it gives reliable results without losing data.12,260  Unfortunately, just two articles 
used imputation methods to address missing values.242,243 
Second, most articles did not describe loss of follow-up. However, it is questionable 
whether there is much influence of this loss of mortality data, since only short-term 
mortality (with a maximum of 30 days) was studied. Third, the number of variables that 
can be used in a model depends on the number of events (i.e. mortality) encountered in 
the study cohort. To limit overfitting in a model, there should be at least ten events per 
variable in order to include a parameter in a model.261 The events per variable were only 
explicitly mentioned by Brabrand et al.242 Fourteen studies had enough events in relation 
to their number of variables.243-249,253-257 However, the studies of Groarke and Alam had 
less than ten events per variable.236,252 This could have been addressed by using a larger 
sample with more events. 
The SCS, PARIS and full model of Coslovsky had a high performance of the model with 
good validation and low risk of bias.242,243,245 However, a model should also be usable in 
clinical practice with a relevant predicted outcome. The relevance of a tool that predicts 
24-hour mortality seems limited, as these patients presumably are more critically ill 
upon ED presentation.  A model that uses parameters with low interrater and intrarater 
variability is reproducible and generally implementable. This can best be achieved by 
using objective measurements. Objective measurements also allow automatic calculation 
of the scores and the subsequent risks in an electronic patient file, and may even trigger 
alarms. Not all models met this prerequisite, as the SCS uses a patient’s complaint of 
subjective breathlessness as a parameter.245
For immediate and effective use a model should use parameters that are readily available 
and easily obtained. Eight of the models included in this systematic review used laboratory 
values as predictors, which entails a waiting time, and thereby delay in prediction.244,248-251 
Six models used parameters requiring (collateral) history, such as loss of independence, 
confinement to bed, and comorbidities.242,243,245-248 In patients with an altered or lowered 
consciousness this information is not always available, which subsequently influences 
the results of the model. Furthermore, parameters such as the presence of seizures and 
APACHE II diagnostic category require both diagnostic testing, which takes time, and 
require patients to be in one of these diagnostic categories, which is not always the case. 
Therefore these parameters are not applicable to all patients, and thus are the models 
not generalizable to the general ED population. We believe that in specific patient 
populations parameters like APACHE II diagnostic category will perform better than 
merely vital parameter. However, Coslovsky et al. showed that the effect of APACHE II 
category was less than vital signs, such as MAP (OR = 0.57 vs OR=0.93).243 Last, models 
with complex calculations require applications (“apps”) or calculation programs, which 
could cause a delay in the risk calculation. 
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We found that for clinical use in the ED the RAPS, REMS, NEWS and EWS are most 
suited, since they use routinely acquired vital parameters, which meets the requirements 
of early, easily obtainable and objective predictors. However, the AUC of these models is 
lower compared to the PARIS and full score. 
Future model development should ideally combine good model performance with 
clinical applicability. The use of a prospective cohort study design is warranted as it 
allows optimal predictor selection and outcome measurement.262 Before implementation, 
a model should be externally validated to prove generalizability. Large datasets allow 
head-to-head comparison of multiple models in order to detect the best model. Most 
importantly, pre- and post-implementation measurements should be performed to 
determine if introduction of a mortality prediction tool leads to earlier identification of 
patients at risk, with subsequent faster initiation of treatment and a decrease in mortality 
as a final result. If introduction of a prediction tool at the ED finally does not yield these 
effects, its further implementation in clinical practice warrants of little use.  
Our study has several strengths and limitations. Strengths of this study include the 
comprehensive search strategy and the methodological quality assessment with 
CHARMS, and both were executed by two researchers. There are also several limitations. 
First, in our review we identified highly heterogeneous studies, making it unfeasible to 
perform a formal meta-analysis. This heterogeneity makes it difficult to reliably rank 
different models, as the different models all have their merits and flaws. Second, selection 
bias might be present. We attempted to minimize this risk by using two researchers 
to select the studies. Third, despite we only selected European studies, practice and 
organization between countries can differ. External validation might make these results 
more generalizable, however, as external validation was mostly done in the same country, 
these risks remain.
Conclusion
In conclusion, we provide an extensive overview of literature concerning prediction 
models for mortality in the ED for an unselected medical population. In general, the 
models performed well to excellent. Models with more and difficult obtainable parameters 
performed better. Most studies had bias due to the reporting of missing values, handling 
of missing data and lack of validation. These issues should be taken into account in future 
models. At this time, the PARIS model and the full-model of Brabrand et al. are the best 
performing models, however, these models require additional information such as loss 
of independence. The EWS and NEWS use readily available parameters, but have lower 
performance. Therefore, the perfect model has yet to be developed.
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Appendix 1: Search strategy for systematic 
review of the identification of prediction models 
for mortality in the Emergency Department
Records identified in various databases
04-01-2017 19-06-2018
Total Unique Total Unique
Embase.com 4,066 3,977 4,909 4,824
Medline Ovid 4,551 1,310 4,917 1,482
Web-of-science 3,603 1,242 4,516 1,585
Cochrane 114 24 231 83
Google scholar 300 204 200 125
Total 12,634 6,757 14,768 8,099
Embase.com 
(‘prediction’/exp OR ‘predictive value’/exp OR ‘predictive validity’/exp OR ‘prediction and 
forecasting’/de OR ‘predictor variable’/exp OR (predict*):ab,ti) AND (mortality/exp OR survival/
exp  OR survivor/de OR ‘fatality’/de OR ((‘intensive care’/exp OR ‘intensive care unit’/exp) AND 
(‘hospital admission’/exp OR ‘hospitalization’/de)) OR (mortalit* OR surviv* OR fatal* OR 
((admission* OR admit*) NEAR/3 (icu OR intensive-care*))):ab,ti) AND (‘emergency care’/exp 
OR ‘emergency patient’/exp OR ‘emergency ward’/exp OR ‘emergency health service’/exp OR 
((emergen* NEAR/3 (ward* OR department* OR patient* OR service* OR admiss* OR admit* OR 
hospital* OR call*))):ab,ti) AND (‘cohort analysis’/exp OR ‘follow up’/exp OR ‘longitudinal study’/
de OR ‘retrospective study’/de OR ‘prospective study’/de OR ‘evaluation study’/de OR model/de 
OR ‘disease model’/de OR  ‘population model’/de OR ‘process model’/de OR simulation/exp OR 
algorithm/de OR ‘validation process’/exp OR ‘sensitivity and specificity’/exp OR ‘scoring system’/
exp OR ‘decision tree’/de OR (model OR simulat* OR cohort* OR (follow* NEXT/1 up*) OR 
followup* OR longitudinal* OR retrospectiv* OR prospectiv* OR evaluation* OR  algorithm* 
OR validat* OR sensitivit* OR specificit* OR score* OR (decision NEXT/1 tree*)):ab,ti) NOT 
([Conference Abstract]/lim OR [Letter]/lim OR [Note]/lim OR [Editorial]/lim) AND [english]/
lim NOT ((child/exp OR childhood/exp OR adolescent/exp OR adolescence/exp ) NOT (adult/exp 
OR adulthood/exp)) NOT (pediatrics/exp OR (picu OR nicu OR picus OR nicus OR pediatric* OR 
paediatric*):ab,ti ) 
Medline ovid 
(“Predictive Value of Tests”/ OR “Forecasting”/ OR (predict*).ab,ti.) AND (exp mortality/ OR 
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mortality.xs. OR survival/  OR survivors/ OR ((“Critical Care”/ OR “Intensive Care Units”/) 
AND (“Patient Admission”/ OR  “hospitalization”/)) OR (mortalit* OR surviv* OR fatal* OR 
((admission* OR admit*) ADJ3 (icu OR intensive-care*))).ab,ti.) AND (“Emergency Medical 
Services”/ OR “emergencies”/ OR exp “Emergency Service, Hospital”/ OR ((emergen* ADJ3 
(ward* OR department* OR patient* OR service* OR admiss* OR admit* OR hospital* OR 
call*))).ab,ti.) AND (exp “cohort studies”/ OR “evaluation study”/ OR exp “Models, Statistical”/ 
OR “Computer Simulation”/ OR “Models, Theoretical”/ OR Algorithms/ OR “Validation Studies”/ 
OR exp “sensitivity and specificity”/ OR “Decision Trees”/ OR (model OR simulat* OR cohort* 
OR (follow* ADJ up*) OR followup* OR longitudinal* OR retrospectiv* OR prospectiv* OR 
evaluation* OR  algorithm* OR validat* OR sensitivit* OR specificit* OR score* OR (decision ADJ 
tree*)).ab,ti.) NOT (letter OR news OR comment OR editorial OR congresses OR abstracts).pt. 
AND english.la. NOT ((exp child/ OR exp Infant/ OR adolescent/ ) NOT (exp adult/ )) NOT (exp 
pediatrics/ OR (picu OR nicu OR picus OR nicus OR pediatric* OR paediatric*).ab,ti. ) 
Cochrane  
((predict* ):ab,ti) AND ((mortalit* OR surviv* OR fatal* OR ((admission* OR admit*) NEAR/3 
(icu OR intensive-care*))):ab,ti) AND (((emergen* NEAR/3 (ward* OR department* OR patient* 
OR service* OR admiss* OR admit* OR hospital* OR call*))):ab,ti) AND ((model OR simulat* 
OR cohort* OR (follow* NEXT/1 up*) OR followup* OR longitudinal* OR retrospectiv* OR 
prospectiv* OR evaluation* OR  algorithm* OR validat* OR sensitivit* OR specificit* OR score* 
OR (decision NEXT/1 tree*)):ab,ti) 
Web-of-science 
TS=(((predict* )) AND ((mortalit* OR surviv* OR fatal* OR ((admission* OR admit*) NEAR/3 
(icu OR intensive-care*)))) AND (((emergen* NEAR/2 (ward* OR department* OR patient* OR 
service* OR admiss* OR admit* OR hospital* OR call*)))) AND ((model OR simulat* OR cohort* 
OR “Follow up” OR followup* OR longitudinal* OR retrospectiv* OR prospectiv* OR evaluation* 
OR  algorithm* OR validat* OR sensitivit* OR specificit* OR score* OR (decision NEAR/1 tree*))) 
NOT ((child* OR infan* OR adolescen* OR newborn* OR neonat*) NOT (adult* OR older* OR 
elder* OR (aged NEAR/3 (person* OR patient*)))))
Google scholar
Prediction|predictivemortality|survival|fatal|fatality|”icu|care  
admission”|”admitted**icu|intensive”|”admitted*icu|intensive””emergency 
ward|department|patient|service” model|simulation|cohort|”follow up”|evaluation
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Abstract
Objective
In hospitalized patients, the risk of sepsis-related mortality can be assessed using the 
quick Sepsis-related Organ Failure Assessment (qSOFA). Currently, different tools that 
predict deterioration such as the National Early Warning Score (NEWS) have been 
introduced in clinical practice in Emergency Departments (ED) worldwide. It remains 
ambiguous which screening tool for mortality at the ED is best. The objective of this 
study was to evaluate the predictive performance for mortality of two sepsis-based 
scores (i.e. qSOFA and Systemic Inflammatory Response Syndrome (SIRS)-criteria) 
compared to the more general NEWS score, in patients with suspected infection directly 
at presentation to the ED.
Methods
We performed a retrospective cohort study. Patients who presented to the ED between 
June 2012 and May 2016 with suspected sepsis in a large tertiary care centre were 
included. Suspected sepsis was defined as initiation of intravenous antibiotics and/or 
collection of any culture in the ED. Outcome was defined as 10-day and 30-day mortality 
after ED presentation. Predictive performance was expressed as discrimination (AUC) 
and calibration using Hosmer-Lemeshow goodness-of-fit test. Subsequently, sensitivity, 
and specificity were calculated.
Results
In total 8,204 patients were included of whom 286 (3.5%) died within ten days and 490 
(6.0%) within 30 days after presentation. NEWS had the best performance, followed by 
qSOFA and SIRS (10-day AUC: 0.837, 0.744, 0.646, 30-day AUC: 0.779, 0.697, 0.631). 
qSOFA (≥2) lacked a high sensitivity versus SIRS (≥2) and NEWS (≥7) (28.5%, 77.2%, 
68.0%), whilst entailing highest specificity versus NEWS and SIRS (93.7%, 66.5%, 37.6%).
Conclusions
NEWS is more accurate in predicting 10- and 30-day mortality than qSOFA and SIRS in 
patients presenting to the ED with suspected sepsis.
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Introduction
Sepsis is a syndrome characterized by both signs of infection and manifestations of a 
systemic host response.16 Sepsis is the primary cause of mortality from infection. The 
definition of sepsis has changed throughout the last decades. In February 2016 the 
Third International Consensus Definition for Sepsis (Sepsis-3) replaced the Sepsis-2 
definition dating from 2001.16,34,36 Sepsis is currently defined as a “life-threatening 
organ dysfunction caused by a dysregulated host response to infection”, in which organ 
dysfunction is represented by an increase of at least two points in the Sequential Organ 
Failure Assessment (SOFA) score.16 The Systemic Inflammatory Response Syndrome 
(SIRS) score, which was part of the definition in Sepsis-1 and -2, has been abandoned.
The quick Sepsis-related Organ Failure Assessment (qSOFA) was introduced with the new 
Sepsis-3 definition.305 However, not all medical societies support this new definition.49,306 
The qSOFA consists of three parameters (i.e. low systolic blood pressure (≤ 100 mmHg), 
tachypnoea (≥ 22 /minute) and altered mental status (Glasgow Coma Scale (GCS) < 15 
/ AVPU<Alert)), with a maximum score of three points. qSOFA is a bedside prompt to 
identify patients with a suspected infection who are at greater risk for a poor outcome. 
It is a simplified score based on the SOFA score. Early identification of these patients 
potentially results in earlier adequate treatment and a decrease in mortality. qSOFA 
aims to prognosticate the course of sepsis and intends to predict sepsis-related mortality 
and adverse events; a score of two points or higher gives a three to 14-fold increase in 
in-hospital mortality.305 The qSOFA score is claimed to be more accurate than SOFA 
in departments outside the intensive care unit (ICU), however the use of qSOFA in 
the Emergency Department (ED) is questionable.305,307-310 The authors of Sepsis-3 also 
consider qSOFA as a prompt to identify possible infection.16
In many patients admitted to the ED with sepsis the severity of their illness is not 
directly clear. The presence of a life-threatening infection can easily be overlooked. The 
use of screening tools in the ED can aid in early recognition of patients with sepsis, 
resulting in early initiation of effective and complete treatment. This requires screening 
tools with a high sensitivity. SIRS has been criticized for being too sensitive, while 
lacking specificity in recognizing sepsis, and it is therefore not an ideal screening tool. 
As qSOFA performed better than SIRS in hospitalized patients, it has been proposed that 
qSOFA is preferred to SIRS. Alternatively, early warning scores, such as the National 
Early Warning Score (NEWS), are already recommended for use in the ED, and should 
therefore also be considered.311 NEWS was introduced in 2012 by the Royal College of 
Physicians, who aimed to provide a standardized early warning score. This score is used 
for early detection of patients at risk for deterioration but is not specific for sepsis. NEWS 
comprises of seven parameters (i.e. respiratory rate, oxygen saturation, supplemental 
oxygen, body temperature, systolic blood pressure, heart rate, AVPU score) with 
a maximum of twenty points. In clinical practice cut-off values of 1–4, 5–6 and ≥ 7, 
respectively for low, medium and high risk are used. NEWS was primarily developed for 
use on the wards, however NEWS was also tested for use in the ED and in the prehospital 
setting.312,313 For use in the ED a cut-off value of ≥ 7 is suggested.
Chapter 10
168
Ta
bl
e 1
: V
ar
ia
bl
es
 w
ith
in
 N
EW
S,
 q
SO
FA
 an
d 
SI
RS
 cr
ite
ri
a N
EW
Sa
qS
O
FA
b
SI
RS
c
3
2
1
0
1
2
3
1
0
1
1
0
1
Bo
dy
 te
m
pe
ra
tu
re
 (˚
C
)
≤
35
.0
35
.1
–
36
.0
36
.1
–
38
.0
38
.1
–
39
.0
≥3
9.
1
<3
6.
0
36
.0
–
38
.0
>3
8.
0
H
ea
rt
 ra
te
 (b
pm
)
≤
40
41
–5
0
51
–9
0
91
–1
10
11
1–
13
0
≥1
31
≤
90
>9
0
Sy
st
ol
ic
 b
lo
od
 p
re
ss
ur
e 
(m
m
H
g)
≤
90
91
–1
00
10
1–
11
0
11
1–
21
9
≥2
20
≤
10
0
>1
00
Re
sp
ir
at
or
y 
ra
te
 (p
er
 m
in
ut
e)
≤
8
9–
11
12
–2
0
21
–2
4
≥2
5
<2
2
≥2
2
≤
20
>2
0
O
xy
ge
n 
sa
tu
ra
tio
n 
(%
)
≤
91
92
–9
3
94
–9
5
≥9
6
Su
pp
le
m
en
ta
l o
xy
ge
n
Ye
s
N
o
AV
PU
 sc
or
e 
 
G
C
S
A
/1
5
V,
P,
U
 
<1
5
A
 
15
V,
P,
U
 
<1
5
W
BC
 (*
10
9 /L
)
≤
4.
0
4.
0–
12
.0
>1
2.
0
Va
ri
ab
le
s w
ith
in
 th
e 
N
at
io
na
l E
ar
ly
 W
ar
ni
ng
 S
co
re
, q
ui
ck
 S
ep
sis
-r
el
at
ed
 O
rg
an
 F
ai
lu
re
 A
ss
es
sm
en
t a
nd
 S
ys
te
m
ic 
In
fla
m
m
at
or
y 
Re
sp
on
se
 S
yn
dr
om
e 
cr
ite
ri
a.
 E
ac
h 
va
ri
ab
le 
is 
m
ea
su
re
d 
an
d 
su
m
m
ed
 u
p.
 a
: N
EW
S 
ra
ng
es
 fr
om
 0
 to
 2
0,
 w
he
re
in
 1
 to
 3
 p
oi
nt
s a
re
 g
iv
en
 fo
r a
be
rr
an
t v
al
ue
s i
n 
th
e f
ol
lo
w
in
g 
va
ri
ab
le
s: 
bo
dy
 te
m
pe
ra
tu
re
, h
ea
rt
 ra
te
, s
ys
to
lic
 b
lo
od
 p
re
ss
ur
e, 
re
sp
ira
to
ry
 ra
te
, 
ox
yg
en
 s
at
ur
at
io
n,
 s
up
pl
em
en
ta
l o
xy
ge
n 
an
d 
AV
PU
 s
co
re
. b
: q
SO
FA
 r
an
ge
s f
ro
m
 0
 to
 3
, i
n 
wh
ic
h 
1 
po
in
t i
s a
ss
ig
ne
d 
to
 a
bn
or
m
al
 v
al
ue
s i
n 
th
e 
fo
llo
w
in
g 
va
ri
ab
le
s: 
sy
sto
lic
 b
lo
od
 p
re
ss
ur
e,  
re
sp
ira
to
ry
 ra
te
 a
nd
 A
V
PU
 sc
or
e. 
c: 
SI
RS
 ra
ng
es
 fr
om
 0
 to
 4
 p
oi
nt
s, 
wh
er
ei
n 
1 
po
in
t i
s a
llo
ca
te
d 
to
 a
be
rr
an
t v
al
ue
s i
n 
th
e f
ol
lo
w
in
g v
ar
ia
bl
es
: b
od
y 
te
m
pe
ra
tu
re
, h
ea
rt
 ra
te
, r
es
pi
ra
to
ry
 ra
te
 a
nd
 
W
BC
. Th
e a
sy
ste
m
ic 
in
fla
m
m
at
or
y r
es
po
ns
e s
yn
dr
om
e;˚
C:
 d
eg
re
es
 ce
nt
ig
ra
de
; b
pm
, b
ea
ts 
pe
r m
in
ut
e; 
m
m
H
g:
 m
ill
im
et
re
 o
f m
er
cu
ry
; A
V
PU
: a
le
rt
, v
er
ba
l, 
pa
in
, u
nr
es
po
ns
iv
e; 
W
BC
: w
hi
te
 b
lo
od
 
ce
ll 
co
un
t.
169
Predicting mortality in patients with suspected sepsis at the emergency department
The aim of this study was to determine the prognostic value of qSOFA in predicting 
mortality in comparison to SIRS and NEWS in patients presenting to the ED with 
suspected sepsis.
Methods
Study design and setting
This was a retrospective cohort study nested in a large anonymous database of patients 
visiting the ED of the Erasmus University Medical Center, Rotterdam, the Netherlands 
(Erasmus MC), which is the largest tertiary referral centre in The Netherlands. The ED 
is an open access department with approximately 30,000 annual visits. Patients are 
strongly encouraged to see a general practitioner before visiting the ED. The database 
of the ED consists of all patients presenting to the ED. This database holds information 
of patients from January 2012 and onwards, on both clinical and vital parameters, 
laboratory results, other diagnostic procedures and treatments. The data was extracted 
from the electronic health records every two weeks through May 2017. Random samples 
were manually checked for concordance. 
Selection of participants
In our consecutive cohort, we included patients with suspected sepsis visiting the ED 
between June 1st 2012 and May 31st 2016. Suspected sepsis was defined as either the 
initiation of non-prophylactic intravenous antibiotic therapy during their ED visit or 
the collection of any culture (i.e. blood cultures, urine cultures, wound cultures, throat 
swabs, sputum cultures and cultures of cerebrospinal fluid) or viral diagnostics (i.e. 
polymerase chain reaction (PCR) on blood and stool samples, on throat swabs and 
on cerebrospinal fluids) during the index visit. Rapid diagnostic testing for viral or 
bacterial infections was not possible during the study period. Patients who presented 
with symptoms directly related to trauma were excluded. A comprehensive search in the 
database identified all patients who met this definition.
Measurements and outcomes
Demographic data (i.e. age, sex), vital parameters (i.e. blood pressure, body temperature, 
respiratory rate, peripheral oxygen saturation, consciousness level according to AVPU 
scale or GCS), laboratory testing performed, acuity level according to Manchester 
Triage System (MTS) category, and supplemental oxygen therapy were derived from the 
database. 
The AVPU scale is a system to score the mental status and is an acronym of ‘Alert, Verbal, 
Pain, Unresponsive’.314 When AVPU was not scored, GCS was used, and vice versa. Only 
the first vital parameters were retrieved as the aim of the study was to assess the ability of 
the different prompts to screen for short-term mortality at ED presentation. White blood 
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cell count was retrieved for all patients when available. Data on all-cause mortality was 
obtained from patient records and 10- and 30-day mortality was calculated. Mortality 
data was retrieved from the patient records, which are linked to municipal mortality 
data. Subsequently, we assessed whether mortality was directly sepsis-related or not. 
We calculated qSOFA, SIRS and NEWS and formed groups using cut-off values most 
indicative for poor outcome (qSOFA ≥ 2, SIRS ≥ 2, and NEWS ≥ 7) (Table 1).34,305,311 The 
Medical Ethics Committee of the Erasmus MC reviewed the study and deemed exempt.
Statistical analysis
Data was summarized using mean, median, interquartile range (IQR) and standard 
deviation (SD) when appropriate. Missing or clinically implausible data was replaced 
by multiple imputation. This method is valid even when large sets of data are missing.315 
Missing values within the parameters were imputed five times using non-missing 
parameters. Furthermore, imputation was based on a distribution of the observed 
data to preclude that implausible values would 
replace the missing value. After imputation, 
five complete datasets were available. In each 
dataset the SIRS, qSOFA and NEWS scores 
were recalculated using the imputed variables. 
Whenever possible, results were pooled. When 
pooling was not possible, single imputation 
was used. The primary outcome was all-cause 
mortality within 10- and 30-days after ED 
presentation.
Patient characteristics were compared using 
the two-sampled t-test, Mann-Whitney U test, 
and chi-squared test based on the distribution 
of the data. Univariate regression analysis 
was used for association between the different 
parameters and 10- and 30-day mortality to 
determine which variable is the best predictor. 
This predictor is characterized by the largest 
LRχ2 and a high explained variance (i.e. R² close 
to one).
Logistic regression was used to obtain 
the odds for 10- and 30-day mortality 
Figure 1. Subject inclusion flowchart. 
based on individual scores. The predictive 
performances of qSOFA, SIRS, and NEWS 
were expressed as discrimination (area under 
the Receiver Operating Characteristic-curve) 
and calibration. Calibration represents how 
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mortality predictions resemble the observed mortality, which was measured by the 
Hosmer-Lemeshow goodness-of-fit test and expressed as a χ2-value and accessory P 
value. Subsequently, sensitivity, specificity and positive- and negative predictive values 
were calculated for the different cut-off points. The Youden’s J statistic was calculated to 
assess the optimal cut-off point for the different scores. A P value < 0.05 was considered 
statistically significant. Analyses were undertaken using Statistical Package for the Social 
Science (SPSS) version 21 and R statistics version 3.1.3. (2015-03-09).
Results
Patient characteristics
A total of 120,177 ED visits in 75,428 unique patients were recorded between June 1st 
2012 and May 31st 2016. 21,326 patient records were excluded as their ED visits were 
related to trauma, leaving 54,102 patients for analysis. 3,351 patients received intravenous 
antibiotic therapy in the ED. Bacterial cultures and viral diagnostics were collected from 
7,302 patients during their ED visit. In total, 8,204 patients were analysed (Figure 1). The 
majority of patients were male (55.9%), and the median age was 57.0 (IQR 41.0–67.0). 
In total, 74.6% of patients were hospitalized (Table 2). 10-day and 30-day mortality was 
3.5% (286) and 6.0% (490), respectively. Of the 490 deceased patients, 64,7% died in the 
hospital. Patients who died were significantly older, and had higher heart rates, lower 
systolic blood pressures, lower oxygen saturation and higher respiratory rates during ED 
presentation. 18,4% of the deceased patients had positive cultures. The cause of death 
could be retrieved from the patient records in all 490 deceased patients. In 63.4% of 
patients their death was directly related to sepsis.
Performance of the models
Univariate regression analysis showed that oxygen therapy during ED presentation—a 
variable within NEWS—was the best predictor for mortality (LRχ2 = 335.73), although 
the explained variation was low (R² = 0.110). Other strong predictors included systolic 
blood pressure and mental status (Table 3).
NEWS performed substantially better than qSOFA and SIRS in predicting both 10-day 
mortality (AUC [95% CI]: 0.837 [0.812, 0.861], 0.744 [0.708, 0.78] and 0.646 [0.613, 0.679] 
respectively) and 30-day mortality (0.779 [0.755, 0.804], 0.697 [0.667, 0.726] and 0.631 
[0.605, 0.656] respectively) (Figure 2 and Figure 3).
Calibration for NEWS showed a χ2 = 10.743 and p-value = 0.217, compared to χ2 = 6.915 
and p-value = 0.032 for qSOFA, and χ2 = 22.827 and P value = 0.004 for SIRS. The non-
significant P value indicates that the mortality rates between the observed and the 
predicted values were statistically equivalent.
qSOFA showed the highest specificity, followed by NEWS and SIRS. Sensitivity was 
highest in SIRS, followed by NEWS and qSOFA. Using Youden’s J statistic, the optimal 
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Figure 2. ROC curve 10-day mortality.
Figure 3. ROC curve 30-day mortality.
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Table 2: Patient characteristics
N (% missing) All patients Died < 10 days Died < 30 days Alive P-value
N (%) 8,204 286 (3.5) 490 (6.0) 7,714 (94.0)
Male, N (%) 8,204 (0) 4,581(55.8) 182 (63.6) 321 (65.5) 4,260 (55.2) <0.0001a
Age, median (IQR) 8,204 (0) 57.0 (41–68) 68.0 (58.75–78) 67.0 (58–77.25) 56.0 (41–67) <0.0001b
Body temperature 
in ˚C, mean (SD)
7,945 (3.2) 37.6 (1.3) 36.9 (1.7) 37.2 (1.5) 37.7 (1.2) <0.0001c
HR in bpm, mean 
(SD)
7,858 (4.2) 97.9 (21.4) 103.7 (26.5) 104.9 (26.1) 97.5 (21.0) <0.0001c
SBP in mmHg, 
mean (SD)
7,764 (5.4) 131.7 (26.1) 119.6 (36.2) 121.3 (34.0) 132.3 (25.4) <0.0001c
RR per minute, 
mean (SD)
4,796 (41.5) 21.3 (8.5) 25.0 (9.1) 24.5 (9.1) 21.0 (8.3) <0.0001c
Oxygen saturation 
in %, mean (SD)
7,578 (7.6) 96.0 (3.6) 93.9 (5.9) 93.9 (5.6) 96.2 (3.4) <0.0001c
AVPU, N (%) 6,643 (19.0) <0.0001d
Alert 6,104 (91.9) 152 (64.7) 291 (72.6) 5,813 (93.1)
Verbal 385 (5.8) 39 (16.6) 57 (14.2) 328 (5.3)
Pain 69 (1.0) 12 (5.1) 16 (4.0) 53 (0.8)
Unresponsive 85 (1.3) 32 (13.6) 37 (9.2) 48 (0.8)
Supplemental 
oxygen, N (%)
8,204 (0) 2,472 (30.1) 223 (78.0) 338 (69.0) 2,134 (27.7) <0.0001a
Laboratory testing 
performed, N (%)
8,204 (0) 6,980 (86.9) 251 (87.8) 437 (89.2) 6,690 (86.7) 0.118a
WBC in *109/L, 
mean (SD)
7,036 (14.2) 11.8(12.9) 17.0 (30.7) 15.4 (24.2) 11.6 (11.6) <0.0001c
SIRS≥2, N (%) 4,387 (46.5) 2,940 (67.0) 178 (62.2) 298 (78.6) 2,642 (65.9) <0.0001a
qSOFA≥2, N (%) 4,318 (47.4) 369 (4.5) 59 (20.6) 87 (17.8) 282 (7.0) <0.0001a
NEWS≥7, N (%) 4,243 (48.3) 1,895 (44.7) 135 (77.1) 212 (70.0) 1,683 (42.7) <0.0001a
MTS, N (%) 7,786 (5.1) <0.0001d
Immediate 168 (2.2) 47 (18.2) 53 (11.8) 115 (1.6)
Very urgent 1,002 (12.9) 87 (33.7) 148 (32.9) 854 (11.6)
Urgent 5,451 (70.0) 115 (44.6) 230 (51.1) 5,221 (71.2)
Standard 1,144 (14.7) 9 (3.5) 19 (4.2) 1,125 (15.3)
Non urgent 16 (0.2) 0 (0.0) 0 (0.0) 16 (0.2)
Admission, N (%) 8,204 (0) 6,117 (74.6) 273 (95.5) 455 (92.9) 5,662 (73.4) <0.0001a
Patient characteristics. Abbreviations: N: number; SBP: systolic blood pressure; RR: respiratory rate; HR: heart rate; AVPU: 
Alert, Verbal, Pain, Unresponsive); WBC white blood cell count; SIRS: systemic inflammatory response syndrome; qSOFA: 
quick sepsis-related organ failure assessment; NEWS: national early warning score; MTS: Manchester Triage System; IQR: 
interquartile range (25–75 percentile); SD: standard deviation; bpm: beats per minute; mmHg: millimetres of mercury; L: 
litre;˚ C: degrees centigrade. a: Chi-squared test b: median test c: independent samples t-test d: Mann-Whitney U test.
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Table 3: Univariate regression on the outcome 30-day mortality
LRχ2 R2
SIRS Body temperature 0.51 0.000
Heart rate 24.05 0.008
Respiratory rate 28.13 0.013
WBC 60.50 0.022
qSOFA Respiratory rate 22.50 0.010
Systolic blood pressure 133.49 0.045
AVPU 142.03 0.060
NEWS Oxygen therapy 335.73 0.110
Oxygen saturation 44.54 0.016
Respiratory rate 30.32 0.014
Body temperature 17.13 0.006
Systolic blood pressure 103.87 0.035
Heart rate 43.04 0.015
AVPU 144.17 0.059
30-day mortality univariate regression. The best parameter in the univariate model has the highest likelihood function 
(LRχ2). R2 is the proportion of the variance in outcome 30-day mortality explained by the univariate model.
cut-off points for 10-day mortality were qSOFA ≥ 1, SIRS ≥ 2 and NEWS ≥ 7, and for 30-
day qSOFA ≥ 1, SIRS ≥ 3 and NEWS ≥ 7 (Table 4).
Discussion
In this retrospective observational study of patients visiting the ED with a suspected 
sepsis we found that NEWS was superior to qSOFA and SIRS in predicting 10- and 30-
day mortality for both discrimination and calibration. The different prompts all have 
different sensitivities and specificities for mortality. qSOFA has the highest specificity 
and lowest sensitivity, SIRS has the lowest specificity and highest sensitivity. NEWS 
has both an intermediate sensitivity and specificity, but is the best overall predictor in 
distinguishing high risk from low risk patients. NEWS has a lower sensitivity resulting 
in a significant number of false negatives, i.e. not all the patients who eventually died 
were identified with NEWS. NEWS was the only model with a good agreement between 
the expected and observed outcomes, i.e. calibration. However, none of the prediction 
models succeeded to fulfil all performance assessments, which would ideally be the 
case. Subsequent measurements of NEWS (e.g. hourly) will potentially identify patients 
who deteriorate during the stay in the ED and may improve sensitivity. We conclude 
that at presentation to the ED NEWS can be used as an alternative screening tool for 
patients with suspected sepsis who are at risk for deterioration, multi-organ failure, and 
subsequently death.
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Our findings support the increasing data that suggests that the NEWS score is a useful 
screening tool in the ED, although its use has not fully been validated in the ED setting. 
Jo et al. studied the NEWS combined with serum lactate in predicting mortality in the 
general adult ED population and found an excellent discrimination (AUC = 0.96) for 
predicting two-day mortality.316 The NEWS score as measured in the prehospital setting 
showed good correlation (P < 0.001) with hospital disposition.317 Our study confirms 
the findings by Churpek et al. which support the introduction of the NEWS score in 
the ED.318 However, they studied patients outside the ICU and not only ED patients. 
And they primarily measured the performance of the different prompts based on the 
worst vital signs. NEWS had the highest performance in predicting in-hospital mortality 
in ED patients compared to qSOFA and SIRS (AUC = 0.77, AUC = 0.69 and AUC = 
0.65 respectively). We used vital parameters at presentation in the ED and found similar 
results. In the Churpek et al. study a NEWS threshold of ≥ 7 is suggested.318 This threshold 
is also recommended by the Royal College of Physicians.311 We were able to confirm 
this threshold using our data. In a cohort study by Sbiti-Rohr et al. in patients with 
community-acquired pneumonia, the NEWS score in the ED was significantly higher 
for those who died within 30 days after presentation than for survivors.319 These results 
are similar to a study of patients presenting to the ED with acute dyspnoea; survivors had 
significantly lower NEWS scores at ED presentation.320
The NEWS was also studied in patients suspected of sepsis. Corfield et al. found that an 
increased NEWS on arrival at the ED was associated with mortality in patients who met 
the sepsis criteria as defined by Bone et al. (odds ratio 1.95 to 5.64).321 
Most prediction scores include measurements which are subject to interpretation. A 
study on the interrater agreement of GCS assessed at the ED yielded low agreement.322 
Semler et al. showed that in hospitalized patients recorded respiratory rates were higher 
than directly observed measurements. Also, the recorded rates were more likely to be 18 
or 20 breaths/minute.68 We expect that parameters that are not acquired automatically 
are subject to confounding by disease severity and were more likely to be measured 
and noted when one would expect a deviant result.323,324 Therefore, for the proper use of 
the NEWS, qSOFA and SIRS these measurements should be routinely performed in a 
structural way.
Specific scoring systems are used as an alternative to the NEWS to predict sepsis-related 
mortality in ED patients. The SIRS criteria, as introduced by Bone in 1992, were studied 
as a prediction tool for mortality and most studies show that an increase in SIRS items 
reflects an increased risk of mortality, ranging from 1.4% to 12% when no SIRS criteria 
were met and increasing to approximately 36% for four SIRS items.325,326 In Sepsis-3, the 
qSOFA was introduced as a simple tool to detect deterioration and predict mortality in 
departments outside the ICU. Simultaneously, SIRS criteria were abandoned from the 
new sepsis definition after criticism of its low specificity. The qSOFA≥ 2 resembles a 
three to 14-fold increase in mortality risk.305
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qSOFA has been challenged as a prompt in the ED to identify patients with an increased 
risk for sepsis-related mortality ever since its introduction. Despite a high specificity 
(84–96%), the qSOFA has low sensitivity (13–53%).308,327 This low sensitivity can be 
explained by the fact that the qSOFA is composed of vital parameters representing late 
symptoms of deterioration (e.g. altered mental status due to inadequate perfusion of 
the brain).49,328 In addition, qSOFA was derived in a cohort of critically ill patients, in 
which 11% of the patients were admitted in the ICU.305 These patients represent a selected 
population compared to all patients who visit the ED, therefore, selection bias may be 
present. Furthermore, qSOFA was developed on the most aberrant results in serial vital 
parameter measurements. This approach may ameliorate the ability to predict mortality, 
but it restricts the utility as a prompt for early identification of patients at risk directly at 
ED presentation. All these arguments mainly affect the sensitivity and can influence the 
predictive performance of qSOFA. To increase sensitivity, Park et al. proposed the use of 
the qSOFA cut-off point of ≥ 1 instead of 2 for patients in the ED, resulting in an increase 
in sensitivity from 53.0% to 82.0%. This is in line with our findings. Changing the cut-
off to 1 would increase the usability of qSOFA as a screening tool at cost of specificity. 
However, NEWS still has a higher sensitivity and a better predictive performance.
Strengths and limitations
This study has a number of strengths and limitations. The major strength of our study is 
that we used a large consecutive dataset with many relevant parameters directly derived 
from electronic patient records with mortality data directly acquired from municipality 
data. 
Our study also has several limitations. The first limitation of this study is its retrospective 
design using data from a single tertiary care centre. In our centre we treat many patients 
with congenital and acquired immunodeficiencies (e.g. patients with organ or bone 
marrow transplantation, chemotherapy), which may limit the generalizability. The 
database contained missing values, which were replaced by multiple imputation. Multiple 
imputation has also been used in other sepsis-related studies.305,308,329 Respiratory rate 
was most frequently missing and, as mentioned earlier, availability of respiratory rate 
might be an indicator of confounding by indication, as it is more often measured in 
patients who are deemed more critically ill.323
A second limitation is the definition of the study population. As there is no gold standard 
for defining an infection, the study population was difficult to determine. We based 
our inclusion criteria on the definition of Seymour et al.305 but modified the criteria to 
incorporate the largest group of patients who were suspected for infection and at risk for 
sepsis. Both microbial diagnostics and initiation of antibiotics were used as a proxy for 
a clinically suspected sepsis. These inclusion criteria could possibly bias against people 
with viral disease, as no antibiotics given and cultures are not routinely performed. 
However, in the most critically ill patients cultures are taken and antibiotics are started 
empirically in clinical practice, regardless of the suspected pathogen (e.g. virus, bacteria). 
Furthermore, we also included viral cultures such as throat swabs and stool cultures, but 
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these were a minority as compared to blood cultures (289 and 46 vs. 6,552). Therefore, 
the chance of bias due viral sepsis is limited.
Last, to determine the best screening tool at presentation in the ED, we chose to use only 
the first recorded vital signs for calculation of NEWS, qSOFA and SIRS. We are aware 
that rapid changes in vital parameters could be indicative for a higher risk for mortality 
and that people may deteriorate during their ED visit. However, the duration of ED stay 
is intended to be very limited. Choosing to only use the first vital parameters may limit 
the predictive ability of the different models. However, in clinical practice the first vital 
parameters are used to determine the severity of the patient’s condition and, therefore, 
to triage patients in urgent and non-urgent. Using first available parameters in this study 
actually reflects clinical practice and in our opinion is a valid method to test predictive 
performance upon ED presentation, with results comparable to using the worst vital 
parameters.318
Conclusions
In conclusion, the NEWS is more accurate in predicting 10- and 30-day mortality 
than qSOFA and SIRS in patients suspected of sepsis on initial presentation to the ED. 
Our finding suggests that the introduction of the NEWS in the ED with subsequent 
measurements should be further studied. This will potentially aid the early detection 
of all patients at risk for deterioration in the ED including those at risk of sepsis-related 
mortality.
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Supporting information
Supporting Table 1: Sensitivity (95% CI), specificity (95% CI), positive predictive value, negative 
predictive value and Youden’s index for different cut-off values for 10- and 30-day mortality.
10-day mortality
Sensitivity 
[95% CI] 
[%]
Specificity 
 [95% CI] 
 [%]
PPV 
 
[%]
NPV 
 
[%]
Youden’s 
index
SIRS 
≥1 98.0 [95.5-99.2] 12.2 [11.5-12.9] 3.9 99.4 0.102
≥2║ 80.4 [75.3-84.9] 37.3 [36.2-38.4] 4.4 98.1 0.177¶
≥3 50.4 [44.4-56.3] 67.0 [66.0-68.0] 5.2 97.3 0.174
4 15.0 [11.1-19.7] 90.8 [90.2-91.4] 5.5 96.7 0.058
qSOFA
≥1 77.2 [72.0-82.0] 59.1 [58.0-60.2] 6.5 98.6 0.362¶
≥2║ 33.1 [27.8-39.0] 93.3 [92.7-93.8] 15.3 97.4 0.264
3 7.8 [4.9-11.4] 99.3[99.1-99.5] 28.2 96.7 0.071
NEWS
≥3 98.3 [96.0-99.4] 17.8 [17.0-18.7] 4.2 99.7 0.161
≥4 94.5 [91.1-96.8] 26.0 [25.0-27.0] 4.5 99.2 0.205
≥5 89.1 [85.0-92.5] 42.1 [41.0-43.2] 5.3 99.1 0.312
≥6 82.1 [77.2-86.4] 57.0 [56.0-58.1] 6.5 98.9 0.391
≥7║ 76.3 [70.9-81.0] 65.9 [64.8-66.9] 7.6 98.7 0.421¶
≥8 59.6 [53.5-65.2] 77.1 [76.2-78.0] 8.7 98.1 0.367
≥9 45.8 [40.0-51.8] 84.0 [83.2-84.8] 9.5 97.7 0.298
≥10 35.1 [29.4-40.8] 89.4 [88.7-90.1] 10.8 97.4 0.245
≥11 22.8 [18.0-28.0] 94.5 [94.0-95.0] 13.2 97.1 0.173
≥12 9.4 [6.3-13.4] 98.3 [98.0-98.6] 17.3 96.7 0.078
≥13 9.4 [6.3-13.4] 98.3 [98.0-98.6] 17.3 96.7 0.078
≥14 4.2 [2.2-7.2] 99.3 [99.1-99.5] 17.9 96.6 0.035
≥15 1.2 [0.2-3.0] 99.7 [99.6-99.8] 14.1 96.5 0.009
≥16 0.3 [0.0-1.9] 99.9 [99.8-100.0] 15.4 96.5 0.003
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30-day mortality
Sensitivity 
[95% CI] 
[%]
Specificity 
 [95% CI] 
 [%]
PPV 
 
[%]
NPV 
 
[%]
Youden’s 
index
SIRS 
≥1 96.3 [94.3-97.8] 12.4 [11.7-13.2] 6.5 98.1 0.087
≥2║ 77.2 [73.2-80.8] 37.6 [36.5-38.7] 7.3 96.3 0.148
≥3 48.1 [43.7-52.7] 67.3 [66.2-68.4] 8.5 95.3 0.154¶
4 14.9 [11.9-18.4] 90.9 [90.2-91.5] 9.4 94.4 0.058
qSOFA
≥1 69.9 [65.7–74.0] 59.5 [58.0-60.2] 10.0 96.9 0.294¶
≥2║ 28.5 [24.6-32.8] 93.7 [92.7-93.8] 22.6 95.3 0.222
3 5.5 [3.7-7.9] 99.3 [99.1-99.5] 34.0 94.2 0.048
NEWS
≥3 95.6 [93.3-97.1] 18.1 [17.2-19.0] 7.0 98.5 0.137
≥4 90.6 [87.7-93.0] 26.3 [25.3-27.3] 7.3 97.8 0.169
≥5 83.0 [79.4-86.3] 42.5 [41.4-43.6] 8.5 97.5 0.255
≥6 75.5 [71.4-79.3] 57.6 [56.5-58.7] 10.2 97.3 0.33
≥7║ 68.0 [63.6-72.1] 66.5 [65.4-67.6] 11.5 97.0 0.345¶
≥8 55.0 [50.6-59.6] 77.8 [76.8-78.7] 13.7 96.4 0.328
≥9 42.0 [37.6-46.5] 84.5 [83.7-85.3] 14.9 95.8 0.266
≥10 31.3 [27.1-35.5] 89.8 [89.1-90.5] 16.5 95.3 0.211
≥11 20.9 [17.3-24.7] 94.8 [94.3-95.3] 20.7 94.9 0.158
≥12 14.7 [11.7-18.1] 96.8 [96.4-97.2] 22.6 94.6 0.114
≥13 8.1 [5.9-11.0] 98.5 [98.2-98.8] 25.3 94.3 0.066
≥14 3.9 [2.4-6.0] 99.4 [99.2-99.6] 28.5 94.1 0.033
≥15 1.0 [0.3-2.4] 99.7 [99.6-99.8] 20.0 94.0 0.007
≥16 0.4 [0.1-1.5] 99.9 [99.8-100.0] 11.3 94.1 0.004
Sensitivity (95% CI), specificity (95% CI), positive predictive value, negative predictive value and Youden’s index for dif-
ferent cut-off values for 10- and 30-day mortality. ║ are the predefined cut-off values which are most indicative for a poor 
outcome. ¶ representing the optimal cut-off points. Abbreviations: CI: confidence interval; PPV: positive predictive value; 
NPV: negative predictive value; SIRS: systemic inflammatory response syndrome; qSOFA: quick sepsis-related organ failure 
assessment; NEWS: national early warning score.
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Abstract
International travel is considered to be an important risk factor for acquisition of 
multidrug-resistant Enterobacteriaceae (MRE). The aim of this systematic review was 
to determine the effect of international travel on the risk of post-travel faecal carriage 
of MRE. Secondary outcomes were risk factors for acquisition of MRE. A systematic 
search for relevant literature in seven international databases was conducted according 
to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines. Articles needed to report on 1) foreign travel, 2) screening of asymptomatic 
participants, 3) antimicrobial susceptibility data and 4) faecal Enterobacteriaceae carriage. 
Two researchers independently screened the abstracts, assessed the full article texts for 
eligibility and selected or rejected them for inclusion in the systematic review. In case of 
disagreement, a third researcher decided on inclusion. Eleven studies were identified. 
In all studies, a high prevalence (> 20%) of carriage of MRE after international travel 
was found. The highest prevalence was observed in travellers returning from southern 
Asia.  Foreign travel was associated with an increased risk of carriage of MRE. Further 
research is needed to assess if this leads to an increase in the number of infections with 
MRE. Systematic review registration number: PROSPERO CRD42015024973.
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Introduction
Rationale
Worldwide, the number of international travellers has grown from 25 million in 1950 to 
1,087 million in 2013.330 According to the World Tourism Organization, this number is 
expected to increase by an average of 3.3% a year.330 Of the international travellers visiting 
developing countries, 22–64% have self-reported health problems and about 8% require 
medical care during or after travel.331,332 Healthy travellers may be exposed to a broad 
range of microorganisms while travelling, including drug-resistant Enterobacteriaceae, 
which may subsequently be introduced into their home country.333,334
Enterobacteriaceae are Gram-negative bacteria that are part of the human body’s normal 
commensal flora, called microbiota. Enterobacteriaceae, such as Escherichia coli and 
Klebsiella species, are capable of causing both healthcare-associated and community-
acquired infections.335 Multidrug-resistant Enterobacteriaceae (MRE), including 
extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) and 
plasmid-mediated Amp C-producing Enterobacteriaceae (pAmp C-E) are emerging 
worldwide.336 Cases of carbapenemase-producing Enterobacteriaceae (CPE) are also 
reported more frequently.337 
Since 2003, community carriage rates of MRE have increased dramatically in various 
regions, such as South-East Asia, the Western Pacific and the Eastern Mediterranean.336 
During visits to such areas, travellers might acquire MRE and become asymptomatic 
carriers of MRE. In their home country, they may cause spread in the community and 
contribute to worldwide emerging antimicrobial resistance.335,338,339 Acquired MRE in the 
digestive tract are considered apathogenic, however carriage of such Enterobacteriaceae 
have resulted in clinically relevant infections.337 International travel has been reported 
as a risk factor for urinary tract infections caused by ESBL-E.340,341 The question arises 
if these observations warrant clinicians being aware of MRE in recently returned 
otherwise healthy, international travellers who seek medical attention even for unrelated 
conditions.
Objectives
The aim of this systematic review was to determine the effect of international travel on 
the risk of acquisition of faecal carriage of MRE. A secondary objective was to determine 
risk factors for acquisition of drug resistance.
Methods
Protocol and registration
A specific protocol was designed and used to conduct the study. The study is registered 
Chapter 11
186
Embase.com (‘Gram negative bacterium’/exp OR ‘Gram negative infection’/de OR Enterobacteriaceae/de OR Escherichia/
exp OR Klebsiella/exp OR Salmonella/exp OR Shigella/exp OR Yersinia/exp OR ‘Enterobacteriaceae infection’/exp OR 
(‘Gram negative’ OR Enterobacteri* OR (Enter* NEXT/1 bacteria*) OR Enterobacter* OR Escherichia* OR ‘e coli’ OR 
Klebsiella* OR Salmonell* OR Shigell* OR Yersinia*):ab,ti) AND (travel/de OR ‘traveller diarrhoea’/de OR aviation/exp 
OR (travel* OR touris* OR turista OR aviation OR ‘air transport’ OR airport*):ab,ti) AND (‘antibiotic resistance’/exp 
OR ‘multidrug resistance’/de OR ‘drug resistance’/de OR ‘antibiotic sensitivity’/de OR ‘bacterial colonization’/exp OR 
‘bacterium carrier’/de OR (resistan* OR coloni* OR ((antibiotic* OR antimicrob*) NEAR/3 sensitivit*) OR susceptib* OR 
carriage* OR carrier*):ab,ti) NOT ([animals]/lim NOT [humans]/lim)
MEDLINE (OvidSP) (exp “Gram-Negative Bacteria”/ OR exp “Gram-Negative Bacterial Infections”/ OR 
Enterobacteriaceae/ OR exp Escherichia/ OR exp Klebsiella/ OR exp Salmonella/ OR exp Shigella/ OR exp Yersinia/ 
OR exp “Enterobacteriaceae infections”/ OR (“Gram negative” OR Enterobacteri* OR (Enter* ADJ bacteria*) OR 
Enterobacter* OR Escherichia* OR “e coli” OR Klebsiella* OR Salmonell* OR Shigell* OR Yersinia*).ab,ti.) AND 
(travel/ OR “Travel Medicine”/ OR exp aviation/ OR (travel* OR touris* OR turista OR aviation OR “air transport” OR 
airport*).ab,ti.) AND (exp “Drug Resistance, Microbial”/ OR exp “Drug Resistance, Multiple”/ OR “drug resistance”/ 
OR “bacterium carrier”/ OR (resistan* OR coloni* OR ((antibiotic* OR antimicrob*) ADJ3 sensitivit*) OR susceptib* OR 
carriage* OR carrier*).ab,ti.) NOT (exp animals/ NOT humans/)
Cochrane Library ((‘Gram negative’ OR Enterobacteri* OR (Enter* NEXT/1 bacteria*) OR Enterobacter* OR Escherichia* 
OR ‘e coli’ OR Klebsiella* OR Salmonell* OR Shigell* OR Yersinia*):ab,ti) AND ((travel* OR touris* OR turista OR 
aviation OR ‘air transport’ OR airport*):ab,ti) AND ((resistan* OR coloni* OR ((antibiotic* OR antimicrob*) NEAR/3 
sensitivit*) OR susceptib* OR carriage* OR carrier*):ab,ti)
Web of Science TS = (((“Gram negative” OR Enterobacteri* OR (Enter* NEAR/1 bacteria*) OR Enterobacter* OR 
Escherichia* OR “e coli” OR Klebsiella* OR Salmonell* OR Shigell* OR Yersinia*)) AND ((travel* OR touris* OR turista 
OR aviation OR “air transport” OR airport*)) AND ((resistan* OR coloni* OR ((antibiotic* OR antimicrob*) NEAR/3 
sensitivit*) OR susceptib* OR carriage* OR carrier*))) 
Scopus TITLE-ABS-KEY(((“Gram negative” OR Enterobacteri* OR (Enter* W/1 bacteria*) OR Enterobacter* OR 
Escherichia* OR “e coli” OR Klebsiella* OR Salmonell* OR Shigell* OR Yersinia*)) AND ((travel* OR touris* OR turista 
OR aviation OR “air transport” OR airport*)) AND ((resistan* OR coloni* OR ((antibiotic* OR antimicrob*) W/3 
sensitivit*) OR susceptib* OR carriage* OR carrier*)))
PubMed ((Gram negative[tiab] OR Enterobacteri*[tiab] OR Entero bacteria*[tiab] OR Enteric bacteria*[tiab] OR 
Enterobacter*[tiab] OR Escherichia*[tiab] OR e coli[tiab] OR Klebsiella*[tiab] OR Salmonell*[tiab] OR Shigell*[tiab] 
OR Yersinia*[tiab])) AND ((travel*[tiab] OR touris*[tiab] OR turista[tiab] OR aviation[tiab] OR air transport*[tiab] OR 
airport*[tiab])) AND ((resistan*[tiab] OR coloni*[tiab] OR ((antibiotic*[tiab] OR antimicrob*[tiab]) AND sensitivit*[tiab]) 
OR susceptib*[tiab] OR carriage*[tiab] OR carrier*[tiab])) AND publisher[sb] 
Google Scholar “Gram negative”|Enterobacteriaceae|Escherichia|Klebsiella|Salmonella|Shigella|Yersinia    
travel|traveller|tourist|tourism|resistance|resistant|colonization|colonisation|susceptibility|carriage |carrier
Box: Search strategy for systematic review of the acquisition of multidrug-resistant Enterobacteriaceae in interna-
tional travel
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in the international prospective register of systematic reviews (PROSPERO) under 
registration number CRD42015024973. 
Search strategy and selection criteria
The systematic review was conducted according to Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines.342 The following databases 
were searched, attempting to identify all relevant studies: Embase, MEDLINE, Web of 
Science, Scopus, Cochrane Library, PubMed and Google Scholar. The latest search was 
conducted on 17 August 2015.
The topic search terms used for searching the databases were ‘Gram negative bacteria’, 
‘Gram negative bacterial infections’, ‘Enterobacteriaceae’, ‘Escherichia’, ‘Klebsiella’, 
‘Campylobacter’, ‘Salmonella’, ‘Shigella’, ’Yersinia’, ‘travel’, ‘traveller’, ‘tourist’, 
‘tourism’, ‘turista’, ‘aviation’, ‘air transport’, ‘airport’, ‘colonisation’, ‘carriage’, ‘carrier’, 
‘susceptibility’ and ‘(multiple) drug resistance’.
The queries differed per database searched and were developed with help of a biomedical 
information specialist (Box). Articles written in English, German, French and Dutch 
were included.
For inclusion the article needed to fulfil the following criteria: 1) It needed to be 
related to foreign travel 2) report on screening in asymptomatic participants 3) present 
antimicrobial susceptibility data and 4) report on faecal Enterobacteriaceae carriage. We 
used the following exclusion criteria: case reports, reviews, meta-analyses, veterinary 
medicine, in vitro studies and studies regarding symptomatic patients. The reference 
lists of reviews were screened to identify studies possibly missed by the search.
Two researchers (R.H. and J.A.) independently performed the screening of the abstracts. 
Any discordant result was discussed in consensus meetings. After screening the abstracts, 
the full text of the articles was assessed for eligibility by the same two researchers and 
selected or rejected for inclusion in the systematic review. In case of disagreement a third 
researcher (A.V.) decided on inclusion.
Data collection process
The following data (if available) were extracted from each article: year of publication, 
country of the study, study period, study design, microorganism studied, study 
population, study size, age, sex, sample time before and after travel, duration of travel, 
travelling in pairs or groups, symptoms during travel, countries visited, MRE prevalence 
before travel, MRE prevalence after travel, MRE resistance acquired during travel, 
resistance to other antibiotic drugs of acquired MRE, risk factors for acquisition (among 
which travel to predefined United Nations geographical regions: southern Asia, Asia 
except southern Asia, Africa, South and Central America, North America, Europe 
and Oceania,343 method of MRE susceptibility determination, phenotypic approaches, 
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genotypic characterization of post-travel MRE isolates, molecular typing of post-travel 
MRE isolates, duration of MRE colonization and MRE transmission to household 
contacts. To obtain missing data, authors of the articles were contacted.
Quality assessment
We assessed the methodological quality and the risk of bias in individual studies that 
may affect the cumulative evidence, using tools for assessing quality and susceptibility 
to bias in observational studies as recommended in the Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE) Statement.344,345
Data synthesis and analysis
As a result of the design of the studies (cohort studies) and the heterogeneity in patient 
populations (e.g. travellers, healthcare workers and healthcare students), a formal meta-
analysis was not possible. Therefore, the study results were summarized to describe the 
main outcomes of interest. The principle summary measure was percentage of MRE 
acquisition during travel, defined as ESBL-E or pAmp C-E. Furthermore, risk factors for 
acquisition of drug resistance were assessed. If possible, percentages not presented in the 
articles were calculated from the available data.
Results
Study selection
A total of 2,398 studies were identified through database searching after duplicates had 
been removed (Figure 1). After screening of titles and summaries, 36 articles were selected 
for full-text assessment. Eleven articles were included in the qualitative synthesis of the 
systematic review (see Figure 1 for reasons for exclusion).346-356
Study characteristics
Eleven prospective cohort studies, conducted in Northern and Western Europe, Australia 
and the United States (US) were included.346-356 The characteristics of these studies are 
shown in Table 1. Nine studies investigated travellers visiting a travel or vaccination 
clinic, one study hospital staff and contacts, and one study healthcare students working 
or studying abroad. The number of study participants ranged from 28 to 574. The median 
age of travellers in the individual studies varied between 25 and 66 years, with the 
youngest group being healthcare students. In all studies, the majority of travellers were 
female (range: 55–78%). The proportion of participants who were lost to follow up varied 
from 3.8% (4/106) [18] to 30% (12/40).350 The mean duration of travel was similar in all 
studies (14–21 days). In the study by Angelin et al. on healthcare students, median length 
of stay was 45 days (range: 13–365 days).351 In four studies, follow-up samples of MRE 
carriers were collected at six months after returning from travel, and in one of these 
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studies, samples were collected monthly in the first three months with further follow-up 
until 12 months after return.354 Ten studies used a phenotypic method for susceptibility 
testing, with genotypic confirmation of ESBL positivity by PCR. 346-351,353-356 One study 
used a PCR-based approach.352 In one study, only isolated E. coli were included, whereas 
the other studies included all isolated Enterobacteriaceae, which mainly consisted of 
E. coli. 346-356
Acquisition of multidrug-resistant Enterobacteriaceae
Faucal carriage of MRE varied from 1 to 12% before travel and acquisition of MRE from 
21% to 51% (Table 2). 346-350,352-356 In the study by Kuenzli et al. on travellers to the Indian 
subcontinent only, a much higher MRE acquisition rate of 69% was demonstrated.355 
Figure 1: Flowchart for literature search on the acquisition of multidrug-resistant Enterobacteriaceae in international 
travel. ESBL: extended-spectrum beta-lactamase.
Chapter 11
190
Ta
bl
e 1
: C
ha
ra
ct
er
ist
ic
s o
f p
ro
sp
ec
tiv
e c
oh
or
t s
tu
di
es
 in
cl
ud
ed
 fo
r s
ys
te
m
at
ic
 re
vi
ew
 o
f t
he
 ac
qu
isi
tio
n 
of
 m
ul
tid
ru
g-
re
sis
ta
nt
  
En
te
ro
ba
ct
er
ia
ce
ae
 in
 in
te
rn
at
io
na
l t
ra
ve
l (
n 
= 
11
)
St
ud
y
C
ou
nt
ry
St
ud
y 
pe
ri
od
Po
pu
la
tio
n 
ch
ar
ac
te
ri
st
ic
sS
tu
dy
 
si
ze
a
M
ed
ia
n 
ag
e 
in
 y
ea
rs
  
(r
an
ge
  
or
 S
D
)
W
om
en
 
(%
)
Id
en
tifi
ca
tio
n 
of
 
M
RE
-p
os
iti
ve
 
or
ga
ni
sm
s i
n 
po
st
-t
ra
ve
l  
is
ol
at
es
Sa
m
pl
e 
m
et
ho
d 
us
ed
Sa
m
pl
e 
tim
e 
(r
an
ge
) 
be
fo
re
/a
fte
r 
tr
av
el
M
ea
n 
du
ra
tio
n 
of
 tr
av
el
 
in
 d
ay
s 
(r
an
ge
)
To
ta
l  
nu
m
be
r o
f 
co
-t
ra
ve
lle
rs
 
pa
rt
ic
ip
at
in
g 
in
 st
ud
y
Fo
llo
w
- 
up
 o
f 
re
sis
ta
nt
 
is
ol
at
es
Tä
ng
dé
n3
46
Sw
ed
en
N
ov
em
be
r 2
00
7 
Ja
nu
ar
y 
20
09
Tr
av
el
 c
lin
ic
10
0
43
 (2
–8
4)
55
En
ter
ob
ac
ter
iac
ea
e 
10
0%
 (2
4/
24
) 
E.
co
li
St
oo
l
U
nk
no
w
n
14
  
(1
–2
6)
23
6 
m
on
th
s
K
en
ne
dy
34
7
A
us
tr
al
ia
Ja
nu
ar
y 
20
08
 
A
pr
il 
20
09
H
os
pi
ta
l s
ta
ff 
an
d 
co
nt
ac
ts
10
2
45
 (1
7–
77
)
62
E.
co
li
Re
ct
al
 o
r 
pe
ri
an
al
 
sw
ab
W
ith
in
 2
 
w
ee
ks
 b
ef
or
e 
an
d 
aft
er
21
  
(9
–1
35
)
U
nk
no
w
n
6 
m
on
th
s
Ö
st
ho
lm
-
Ba
lk
he
d3
48
Sw
ed
en
Se
pt
em
be
r 2
00
8  
A
pr
il 
20
09
Va
cc
in
at
io
n 
cl
in
ic
23
1
54
 (1
8–
76
)
59
En
te
ro
ba
ct
er
ia
ce
ae
 
90
%
 (1
04
/1
16
) 
E.
co
lib
St
oo
l 
sa
m
pl
e
15
 (1
–1
14
) 
da
ys
/3
 (0
–
19
1)
 d
ay
s
16
  
(4
–1
19
)
U
nk
no
w
n
N
on
e
K
an
te
le
34
9
Fi
nl
an
d
M
ar
ch
 2
00
9  
Fe
br
ua
ry
 2
01
0
Tr
av
el
 c
lin
ic
43
0
40
 (0
–7
7)
61
En
te
ro
ba
ct
er
ia
ce
ae
 
97
%
 (9
4/
97
)  
E.
 co
lib
St
oo
l 
sa
m
pl
e
Be
fo
re
 a
nd
 
fir
st
 (o
r 
se
co
nd
) s
to
ol
 
aft
er
19
  
(4
–1
33
)
83
N
on
e
W
ei
se
n-
be
rg
35
0
U
S
Ju
ly
 2
00
9  
Fe
br
ua
ry
 2
01
0
Tr
av
el
 c
lin
ic
28
66
 (4
1–
83
)
68
En
te
ro
ba
ct
er
ia
ce
ae
 
10
0%
 (7
/7
) 
 E
. c
ol
ib
St
oo
l 
sa
m
pl
e
1 
w
ee
k  
be
fo
re
 / 
1 
w
ee
k 
aft
er
16
  
(8
–2
4)
U
nk
no
w
n
N
on
e
A
ng
el
in
35
1
Sw
ed
en
A
pr
il 
20
10
 
Ja
nu
ar
y 
20
14
H
ea
lth
ca
re
 
st
ud
en
ts
99
25
 (1
5–
20
)
78
En
te
ro
ba
ct
er
ia
ce
ae
 
10
0%
 (3
6/
36
)  
E.
 co
lic
St
oo
l 
sa
m
pl
e
C
lo
se
 to
 d
e-
pa
rt
ur
e/
 1
 to
 
2 
w
ee
ks
 a
fte
r 
re
tu
rn
in
g
45
d   
(1
3–
36
5)
U
nk
no
w
n
N
on
e
vo
n 
 
W
in
te
rs
-
do
rff
35
2
N
L
N
ov
em
be
r 2
01
0 
A
ug
us
t 2
01
2
Tr
av
el
 c
lin
ic
12
2
43
 (1
8–
72
)
58
N
ot
 d
on
e
St
oo
l 
sa
m
pl
e
Be
fo
re
 a
nd
 
im
m
ed
ia
te
ly
 
aft
er
21
  
(5
–2
40
)
U
nk
no
w
n
N
on
e
191
International travel and acquisition of multidrug-resistant Enterobacteriaceae
Pa
lta
ns
in
g3
53
N
L
M
ar
ch
 2
01
1 
Se
pt
em
be
r 2
01
1
Tr
av
el
 c
lin
ic
37
0
33
 (1
9–
82
)
63
En
te
ro
ba
ct
er
ia
ce
ae
 
92
%
 (1
46
/1
58
)  
E.
 co
lic
Re
ct
al
 
sw
ab
Im
m
ed
ia
te
ly
 
be
fo
re
 a
nd
 
aft
er
21
  
(6
–9
0)
N
on
e
6 
m
on
th
s
Ru
pp
é3
54
Fr
an
ce
Fe
br
ua
ry
 2
01
2 
A
pr
il 
20
13
Va
cc
in
at
io
n 
ce
nt
re
s
57
4
36
 (S
D
 1
3)
61
En
te
ro
ba
ct
er
ia
ce
ae
 
93
%
 (4
91
/5
26
)  
E.
 co
lib
St
oo
l 
sa
m
pl
e
W
ith
in
 1
 
w
ee
k 
be
fo
re
 
an
d 
aft
er
20
  
(1
5–
30
)
N
on
e
12
 m
on
th
s
Ku
en
zl
i35
5
Sw
itz
er
la
nd
D
ec
em
be
r 2
01
2 
O
ct
ob
er
 2
01
3
Tr
av
el
 c
lin
ic
17
0
41
 (3
0–
53
)
56
En
te
ro
ba
ct
er
ia
ce
ae
 
98
%
 (1
57
/1
61
) 
 E
. c
ol
ib
Re
ct
al
 
sw
ab
1 
w
ee
k  
be
fo
re
/  
di
re
ct
ly
 a
fte
r
18
 
(5
–3
5)
U
nk
no
w
n
N
on
e
Lü
bb
er
t35
6
G
er
m
an
y
M
ay
 2
01
3 
A
pr
il 
20
14
Tr
av
el
 c
lin
ic
20
5
34
 (3
–7
6)
57
En
ter
ob
ac
ter
iac
ea
e 
92
%
 (5
8/
63
) 
 E
. c
ol
ib
St
oo
l 
sa
m
pl
e
Be
fo
re
/ 
w
ith
in
 1
 
w
ee
k 
aft
er
21
 
 (3
–2
18
)
22
6 
m
on
th
s
E.
co
li:
 E
sc
he
ri
ch
ia
 co
li;
 M
RE
: m
ul
tid
ru
g-
re
sis
ta
nt
 E
nt
er
ob
ac
te
ri
ac
ea
e; 
SD
: s
ta
nd
ar
d 
de
vi
at
io
n.
 N
L:
 th
e N
et
he
rla
nd
s; 
U
S:
 U
ni
te
d 
St
at
es
 o
f A
m
er
ic
a 
a:
 N
um
be
r o
f t
ra
ve
lle
rs
 
wh
o 
pr
ov
id
ed
 p
re
- a
nd
 p
os
t-t
ra
ve
l s
wa
b.
 b
: D
at
a 
of
 M
RE
-p
os
iti
ve
 is
ol
at
es
 n
ew
ly
 a
cq
ui
re
d 
du
rin
g t
ra
ve
l. 
c: 
D
at
a 
of
 M
RE
-p
os
iti
ve
 is
ol
at
es
 p
os
t-t
ra
ve
l. 
d:
 H
ea
lth
ca
re
 st
ud
en
ts
, 
m
ed
ia
n 
du
ra
tio
n 
of
 st
ay
.
Chapter 11
192
Ta
bl
e 2
: R
isk
 o
f m
ul
tid
ru
g-
re
sis
ta
nt
 E
nt
er
ob
ac
te
ri
ac
ea
e i
n 
tr
av
el
le
rs
 (n
 =
 1
1 
st
ud
ie
s)
St
ud
y
M
et
ho
d 
of
  M
RE
  
de
te
rm
in
at
io
n
Ph
en
ot
yp
ic
  
ap
pr
oa
ch
es
Re
su
lts
 g
en
ot
yp
ic
  
ch
ar
ac
te
ri
za
tio
n  
po
st
- t
ra
ve
l M
RE
 is
ol
at
es
Re
su
lts
  
m
ol
ec
ul
ar
 
ty
pi
ng
 o
f 
po
st
-tr
av
el
 
M
RE
 is
ol
at
es
M
RE
 
pr
ev
al
en
ce
 
pr
e-
tr
av
el
%
 
(r
at
io
)
M
RE
  
pr
ev
al
en
ce
 
po
st
-tr
av
el
 
%
 (r
at
io
)
N
ew
 M
RE
 
ac
qu
isi
tio
n 
du
ri
ng
 tr
av
el
 
%
 (r
at
io
)a
Pe
rs
ist
en
t 
ne
wl
y a
cq
ui
re
d 
M
RE
 ca
rr
ia
ge
 
6 
m
on
th
s a
fte
r 
tr
av
el
 %
 (r
at
io
)
Re
su
lts
 u
ni
va
ri
at
e 
/m
ul
tiv
ar
ia
te
 ri
sk
 
fa
ct
or
 an
al
ys
is 
fo
r 
M
RE
 ac
qu
isi
tio
n
M
RE
 in
 n
on
- 
tr
av
el
lin
g 
ho
us
eh
ol
d 
co
nt
ac
ts
 %
 
(r
at
io
)
Tä
ng
dé
n3
46
Ph
en
ot
yp
ic
 
ap
pr
oa
ch
 w
ith
 
ge
no
ty
pi
c 
co
nfi
r-
m
at
io
n 
by
 P
C
R
En
ri
ch
m
en
t b
ro
th
, 
se
le
ct
iv
e 
m
ed
ia
 
A
ST
: E
te
s,  
M
RE
 c
on
fir
m
at
io
n:
 
di
sc
 d
iff
us
io
n
TE
M
 (n
 =
 11
),  
SH
V
 (n
 =
 3)
, 
 C
T
X
-M
 gr
ou
p1
 (n
 =
 14
) o
f 
w
hi
ch
 C
T
X
-M
-1
5 (
n 
= 
13
), 
C
T
X
-M
-1
 (n
=1
),  
C
T
X
-M
 gr
ou
p 4
 (n
 =
 10
) 
of
 w
hi
ch
 C
T
X
-M
-9
 (n
 =
 3)
, 
C
T
X
-M
-1
4 (
n 
= 
5)
, 
C
T
X
-M
-2
7 
(n
 =
 2
)b
N
o 
da
ta
1 
(1
/1
05
)
N
o 
da
ta
24
 (2
4/
10
0)
24
 (5
/2
1)
G
as
tr
oe
nt
er
iti
s; 
tr
av
el
 to
 In
di
ac
N
o 
da
ta
K
en
ne
dy
34
7
Ph
en
ot
yp
ic
 
ap
pr
oa
ch
 w
ith
 
ge
no
ty
pi
c 
co
nfi
r-
m
at
io
n 
by
 P
C
R
En
ri
ch
m
en
t b
ro
th
, 
se
le
ct
iv
e 
m
ed
ia
, 
A
ST
: V
ite
k2
, M
RE
 
co
nfi
rm
at
io
n:
 d
is
c 
di
ffu
si
on
TE
M
 o
r S
H
V
 (n
 =
 4)
,  
C
T
X
-M
 gr
ou
p 
1 
(n
 =
 12
), 
C
T
X
-M
 gr
ou
p 
9 (
n 
= 
6)
,  
an
d 
pA
m
p 
C
 g
en
es
(n
 =
4)
d
N
o 
da
ta
2 
(2
/1
06
)
22
 (2
2/
10
2)
21
 (2
1/
10
0)
6 
 (1
/1
8)
G
as
tr
oe
nt
er
iti
s; 
us
e 
of
 a
nt
ib
io
tic
s; 
tr
av
el
lin
g 
to
 A
sia
, 
So
ut
h 
A
m
er
ic
a 
an
d/
or
 M
id
dl
e 
Ea
st
/A
fr
ic
ae
, c
N
o 
da
ta
Ö
st
ho
lm
-
Ba
lk
he
d3
48
Ph
en
ot
yp
ic
 
ap
pr
oa
ch
 w
ith
 
ge
no
ty
pi
c 
co
nfi
r-
m
at
io
n 
by
 P
C
R
Se
le
ct
iv
e 
m
ed
ia
, 
A
ST
: E
te
st
, M
RE
 
co
nfi
rm
at
io
n:
 E
te
st
TE
M
-1
9 (
n 
= 
1)
, S
H
V
 (n
 =
 
6)
, C
T
X
-M
-1
5-
lik
e 
(n
 =
 
36
), 
C
T
X
-M
-1
4-
lik
e 
(n
 =
 
36
), 
C
T
X
-M
-2
7-
lik
e 
(n
 =
 
5)
, C
T
X
-M
-5
3-
lik
e 
(n
 = 
5)
, 
C
T
X
-M
-1
/6
1 l
ik
e (
n 
= 
3)
, 
C
T
X
-M
-2
 li
ke
 (n
 =
 2)
, 
 C
T
X
-M
-3
-li
ke
 (n
 =
 1)
,  
pA
m
pC
 g
en
es
 (n
 =
 1
5)
, 
 n
o 
ge
ne
s d
et
ec
te
d 
(n
 =
 1
3)
b
N
o 
da
ta
2 
(6
/2
51
)
31
 (7
2/
23
1)
30
 (6
8/
22
6)
N
o 
da
ta
A
ge
; d
ia
rr
ho
ea
 o
r 
ot
he
r g
as
tr
oi
nt
es
-
tin
al
 sy
m
pt
om
s; 
tr
av
el
 to
 A
sia
, 
A
fr
ic
a 
(n
or
th
 o
f 
eq
ua
to
r)
, I
nd
ia
n 
su
bc
on
tin
en
tf
N
o 
da
ta
K
an
te
le
34
9
Ph
en
ot
yp
ic
 
ap
pr
oa
ch
 w
ith
 
ge
no
ty
pi
c 
co
nfi
r-
m
at
io
n 
by
 P
C
R
Se
le
ct
iv
e 
m
ed
ia
, 
A
ST
: V
ite
k2
,  
M
RE
 c
on
fir
m
at
io
n:
 
di
sc
 d
iff
us
io
n
79
%
 C
T
X
-M
-t
yp
e 
(C
T
X
-M
-1
 
an
d 
C
T
X
-M
-9
 m
os
t p
re
v-
al
en
t)
,  
ot
he
r c
om
m
on
 st
ra
in
s T
EM
 
an
d 
O
X
A
  
(d
at
a 
no
t p
ub
lis
he
d)
b
N
o 
da
ta
1 (
5/
43
0)
22
 (9
3/
43
0)
21
 (9
0/
43
0)
N
o 
da
ta
Tr
av
el
le
r’s
 d
ia
r-
rh
oe
a;
  a
ge
; u
se
 
of
 a
nt
ib
io
tic
s f
or
 
tr
av
el
le
r’s
  
di
ar
rh
oe
af
N
o 
da
ta
193
International travel and acquisition of multidrug-resistant Enterobacteriaceae
W
ei
se
nb
er
g3
50
Ph
en
ot
yp
ic
 
ap
pr
oa
ch
 w
ith
 
ge
no
ty
pi
c 
co
nfi
r-
m
at
io
n 
by
 P
C
R
Se
le
ct
iv
e 
m
ed
ia
, 
A
ST
: V
ite
k2
,  
M
RE
 c
on
fir
m
at
io
n:
 
di
sc
 d
iff
us
io
n
SH
V
-1
2 (
n 
= 
1)
, C
T
X
-M
-1
4 (
n 
= 
3)
, C
T
X
-M
-1
5 
(n
 =
 2
), 
no
 
ge
ne
 d
et
ec
te
d 
(n
 =
 1
)b
M
LS
T 
ty
pi
ng
 
7 
M
D
R 
E.
 co
li 
is
ol
at
es
: S
T 
39
, 
8 
(n
 =
 2
), 
37
, 
39
9,
 4
37
, 8
3
4 
 (1
/2
8)
25
 (7
/2
8)
26
 (7
/2
7)
N
o 
da
ta
N
o 
da
ta
N
o 
da
ta
A
ng
el
in
35
1
Ph
en
ot
yp
ic
 
ap
pr
oa
ch
 fo
r d
e-
te
ct
io
n 
of
 E
SB
L,
 
pA
m
p 
C
 a
nd
 p
he
-
no
ty
pi
c 
ap
pr
oa
ch
 
w
ith
 g
en
ot
yp
ic
 
ch
ar
ac
te
ri
za
tio
n 
fo
r d
et
ec
tio
n 
of
 
O
X
A
-4
8/
O
X
A
-
18
1
Se
le
ct
iv
e 
m
ed
ia
, 
A
ST
: d
is
c 
di
ffu
sio
n,
 
M
RE
 c
on
fir
m
at
io
n:
 
Et
es
t (
ES
BL
), 
di
sc
 
di
ffu
sio
n 
(p
A
m
pC
)
N
o 
da
ta
N
o 
da
ta
7 
 (7
/9
9)
36
 (3
6/
99
)
35
 (3
5/
99
)
N
o 
da
ta
Tr
av
el
 to
 th
e 
So
ut
h-
Ea
st
 A
sia
 
re
gi
on
 (I
nd
ia
, 
N
ep
al
, V
ie
tn
am
, 
In
do
ne
sia
, S
ri
 
La
nk
a)
; a
nt
ib
io
tic
 
tr
ea
tm
en
t d
ur
in
g 
tr
av
el
g
N
o 
da
ta
vo
n 
 
W
in
te
rs
do
rff
35
2
M
et
ag
en
om
ic
 
ap
pr
oa
ch
 (d
et
ec
-
tio
n 
bl
aC
T
X
-M
)
N
o 
da
ta
bl
a 
C
T
X
-M
 (n
 =
 4
1)
d
N
o 
da
ta
9 
(1
1/
12
2)
34
 (4
1/
12
2)
32
 (3
6/
11
1)
N
o 
da
ta
Tr
av
el
 to
 In
di
an
 
su
bc
on
tin
en
tf
N
o 
da
ta
Pa
lta
ns
in
g3
53
Ph
en
ot
yp
ic
 
ap
pr
oa
ch
 w
ith
 
ge
no
ty
pi
c 
ch
ar
-
ac
te
ri
za
tio
n 
by
 
m
ic
ro
ar
ra
y
En
ri
ch
m
en
t b
ro
th
, 
se
le
ct
iv
e 
m
ed
ia
, 
A
ST
: V
ite
k2
,  
M
RE
 c
on
fir
m
at
io
n:
 
di
sc
 d
iff
us
io
n
SH
V
 (n
 =
 1)
, C
T
X
-M
 gr
ou
p 
1 
(n
 =
 11
0)
 of
 w
hi
ch
 C
T
X
-M
-
1-
lik
e (
n 
= 
4)
, C
T
X
-M
-3
-li
ke
 
(n
 =
 1)
, C
T
X
-M
-1
5-
lik
e (
n 
= 
85
),C
T
X
-M
-3
2-
lik
e (
n 
= 
20
), 
C
T
X
-M
-g
ro
up
 9 
(n
 =
 
42
), 
C
T
X
-M
-g
ro
up
 2 
(n
 = 
2)
, 
C
T
X
-M
-g
ro
up
 8/
25
 (n
 =
 1
), 
pA
m
pC
 ge
ne
s (
n 
= 
3)
d
M
LS
T 
ty
pi
ng
: 
14
6 
M
D
R 
E.
 
co
li 
is
ol
at
es
:  
m
os
t p
re
va
le
nt
  
ST
 3
8 
(n
 =
 1
7)
, 
ST
10
 (n
 =
 1
0)
, 
ST
13
1 
(n
 =
 9
)
9 
(3
2/
37
0)
36
 
(1
33
/3
70
)
33
 (1
13
/3
38
)
17
 (1
9/
11
3)
Tr
av
el
 to
 S
ou
th
 o
r 
Ea
st
 A
sia
f
18
 (2
/1
1)
Ru
pp
é3
54
H
Ph
en
ot
yp
ic
 
ap
pr
oa
ch
 w
ith
 
ge
no
ty
pi
c 
co
nfi
r-
m
at
io
n 
by
 P
C
R
En
ri
ch
m
en
t b
ro
th
, 
se
le
ct
iv
e 
m
ed
ia
, 
A
ST
: d
is
c 
di
ffu
sio
n
Pr
ed
om
in
an
t C
T
X
-M
-t
yp
e 
(9
5.
4%
) a
m
on
g 
w
hi
ch
 C
T
X
-
M
-g
ro
up
 1
 p
re
do
m
in
at
ed
 
(8
3.
7%
 o
f a
ll 
C
T
X
-M
), 
O
X
A
-
18
1 
(n
 =
 2
), 
N
D
M
-1
 (n
 =
 1
)b
N
o 
da
ta
12
 (8
1/
70
0)
N
o 
da
ta
51
 (2
92
/5
74
)
A
fte
r 1
 m
on
th
 
34
 (8
3/
24
5)
; 
aft
er
 2
 m
on
th
s 
19
 (4
5/
23
6)
; 
aft
er
 3
 m
on
th
s 
10
 (2
4/
23
3)
; 
aft
er
 6
 m
on
th
s 5
 
11
/2
30
); 
aft
er
 1
2 
m
on
th
s 
2 
(5
/2
27
)
Tr
av
el
 to
 A
sia
 
or
 su
b-
Sa
ha
ra
n 
A
fr
ic
a;
 b
et
a-
la
c-
ta
m
 u
se
 d
ur
in
g 
tr
av
el
; d
ia
rr
ho
ea
 
du
ri
ng
 tr
av
el
; t
yp
e 
of
 tr
av
el
f
N
o 
da
ta
Chapter 11
194
Ta
bl
e 2
 (c
on
tin
ue
d)
: R
isk
 o
f m
ul
tid
ru
g-
re
sis
ta
nt
 E
nt
er
ob
ac
te
ri
ac
ea
e i
n 
tr
av
el
le
rs
 (n
 =
 1
1 
st
ud
ie
s)
St
ud
y
M
et
ho
d 
of
  M
RE
  
de
te
rm
in
at
io
n
Ph
en
ot
yp
ic
  
ap
pr
oa
ch
es
Re
su
lts
 g
en
ot
yp
ic
  
ch
ar
ac
te
ri
za
tio
n  
po
st
- t
ra
ve
l M
RE
 is
ol
at
es
Re
su
lts
  
m
ol
ec
ul
ar
 
ty
pi
ng
 o
f 
po
st
-tr
av
el
 
M
RE
 is
ol
at
es
M
RE
 
pr
ev
al
en
ce
 
pr
e-
tr
av
el
%
 
(r
at
io
)
M
RE
  
pr
ev
al
en
ce
 
po
st
-tr
av
el
 
%
 (r
at
io
)
N
ew
 M
RE
 
ac
qu
isi
tio
n 
du
ri
ng
 tr
av
el
 
%
 (r
at
io
)a
Pe
rs
ist
en
t 
ne
wl
y a
cq
ui
re
d 
M
RE
 ca
rr
ia
ge
 
6 
m
on
th
s a
fte
r 
tr
av
el
 %
 (r
at
io
)
Re
su
lts
 u
ni
va
ri
at
e 
/m
ul
tiv
ar
ia
te
 ri
sk
 
fa
ct
or
 an
al
ys
is 
fo
r 
M
RE
 ac
qu
isi
tio
n
M
RE
 in
 n
on
- 
tr
av
el
lin
g 
ho
us
eh
ol
d 
co
nt
ac
ts
 %
 
(r
at
io
)
Ku
en
zl
i35
5
Ph
en
ot
yp
ic
 
ap
pr
oa
ch
 w
ith
 
ge
no
ty
pi
c 
sc
re
en
in
g 
by
 
m
ic
ro
ar
ra
y 
an
d 
co
nfi
rm
at
io
n 
by
 
PC
R/
D
N
A
 se
-
qu
en
ce
 a
na
ly
sis
En
ri
ch
m
en
t b
ro
th
, 
se
le
ct
iv
e 
m
ed
ia
, 
A
ST
: V
ite
k2
,  
M
IC
 fo
r m
er
o-
pe
ne
m
 a
nd
 e
rt
ap
-
en
em
: E
te
st
, M
RE
 
co
nfi
rm
at
io
n:
 d
is
c 
di
ffu
sio
n,
  
m
od
ifi
ed
 H
od
ge
 
te
st
TE
M
-1
-li
ke
 (n
 =
 3
3)
, 
SH
V
23
8S
/2
40
K
 (n
 =
 7)
, 
SH
V
23
8S
 (n
 =
 1)
, S
H
V
-5
/1
2-
lik
e 
(n
 =
 1)
, S
H
V
-2
/3
-li
ke
 (n
 
= 
1)
,C
T
X
-M
-1
5-
lik
e 
(n
 =
 
48
), 
C
T
X
-M
 g
ro
up
 9
 (n
 =
 1
), 
C
T
X
-M
 g
ro
up
 1
 (n
 =
 2
4)
, 
pr
ed
om
in
an
t E
SB
L 
ge
ne
 w
as
 
C
T
X
-M
-1
5 
(8
0 
re
pr
es
en
ta
tiv
e 
E.
 co
li 
is
ol
at
es
 a
na
ly
se
d)
 b
, 
N
D
M
-1
 (n
 =
 1
)
80
 re
pr
es
en
ta
-
tiv
e 
E.
 co
li 
is
o-
la
te
s a
na
ly
se
d 
by
 re
p-
PC
R:
 
no
t c
lo
na
lly
 
re
la
te
d.
 M
LS
T 
pe
rf
or
m
ed
 o
n 
34
 ra
nd
om
ly
 
se
le
ct
ed
 E
. c
ol
i 
is
ol
at
es
: o
nl
y 
3 
pa
nd
em
ic
 
st
ra
in
s f
ou
nd
 
(S
T1
31
 n
 =
 2
; 
ST
64
8 
n 
= 
1)
3 
(5
/1
75
)
N
o 
da
ta
70
 (1
18
/1
70
)
N
o 
da
ta
Tr
av
el
 to
 In
di
a,
 
Bh
ut
an
 o
r N
ep
al
; 
vi
sit
in
g 
fr
ie
nd
s 
an
d 
re
la
tiv
es
; c
on
-
su
m
pt
io
n 
of
 ic
e 
cr
ea
m
 a
nd
 p
as
tr
y;
, 
le
ng
th
 o
f s
ta
yf
N
o 
da
ta
Lü
bb
er
t35
6
Ph
en
ot
yp
ic
 
ap
pr
oa
ch
 w
ith
 
ge
no
ty
pi
c 
co
nfi
r-
m
at
io
n 
by
 P
C
R
Se
le
ct
iv
e 
m
ed
ia
,   
A
ST
: m
ic
ro
 b
ro
th
 
di
lu
tio
n 
m
et
ho
d,
 
M
RE
 c
on
fir
m
at
io
n:
 
Et
es
t
SH
V
-1
2 (
n 
= 
1)
, C
T
X
-M
 gr
ou
p 
1 (
n 
= 
37
) o
f w
hi
ch
 C
T
X
-M
-1
5 
(n
 =
 33
), 
C
T
X
-M
-5
5 
(n
 =
 4)
, 
C
T
X
-M
 gr
ou
p 
9 (
n 
= 
19
) o
f 
w
hi
ch
 C
T
X
-M
-1
4 (
n =
 9)
, 
C
T
X
-M
-2
7 (
n =
 1)
, C
T
X
- 
M
-6
5 
(n
 =
 1)
b
7 
(1
4/
20
5)
31
 (6
3/
20
5)
30
 (5
8/
19
1)
9 
(3
/3
5)
Tr
av
el
 to
 In
di
a 
or
 
So
ut
h-
Ea
st
 A
sia
; 
ga
st
ro
en
te
ri
tis
c
N
o 
da
ta
AS
T:
 a
nt
ib
io
tic
 s
us
ce
pt
ib
ili
ty
 te
st
in
g;
 b
la
: b
et
a-
la
ct
am
as
e; 
CT
X-
M
: c
ef
ot
ax
im
as
e; 
E.
 c
ol
i: 
Es
ch
er
ic
hi
a 
co
li;
 E
SB
L:
 e
xt
en
de
d-
sp
ec
tr
um
 b
et
a-
la
ct
am
as
e; 
K
PC
: K
le
bs
ie
lla
 p
ne
um
on
ia
e 
ca
rb
ap
en
-
em
as
e; 
M
LS
T:
 M
ul
til
oc
us
 s
eq
ue
nc
e 
ty
pi
ng
; M
D
R:
 m
ul
ti-
dr
ug
 r
es
ist
an
t; 
M
RE
: m
ul
tid
ru
g-
re
sis
ta
nt
 E
nt
er
ob
ac
te
ri
ac
ea
e; 
N
D
M
: N
ew
 D
el
hi
 m
et
al
lo
-b
et
a-
la
ct
am
as
e; 
O
X
A
: o
xa
ci
lli
na
se
; p
Am
p  
C:
 p
la
sm
id
-b
or
ne
 A
m
pC
; P
CR
: p
ol
ym
er
as
e c
ha
in
 re
ac
tio
n;
 P
FG
E:
 p
ul
se
d-
fie
ld
 g
el 
el
ec
tr
op
ho
re
sis
; r
ep
-P
CR
: r
ep
et
iti
ve
 e
xt
ra
ge
ni
c p
al
in
dr
om
ic 
PC
R;
 S
H
V:
 S
ul
ph
yd
ry
l v
ar
ia
bl
e; 
TE
M
: T
em
on
ie
ra
. 
a:
 P
er
ce
nt
ag
e o
f M
RE
-p
os
iti
ve
 p
os
t-t
ra
ve
l s
am
pl
es
 in
 th
os
e t
ra
ve
lle
rs
 w
ho
se
 p
re
-tr
av
el 
sa
m
pl
e w
as
 M
RE
-n
eg
at
iv
e. 
b:
 A
cq
ui
re
d 
ge
ne
s d
et
ec
te
d 
in
 p
os
t-t
ra
ve
l M
RE
 is
ol
at
es
. c
: U
ni
va
ri
at
e s
ta
tis
tic
s. 
d:
 
Pr
ev
al
en
t g
en
es
 d
et
ec
te
d 
in
 p
os
t-t
ra
ve
l M
RE
 is
ol
at
es
. e
: R
isk
 fa
ct
or
s f
or
 re
sis
ta
nc
e t
o 
ge
nt
am
ic
in
, c
ip
ro
flo
xa
ci
n 
an
d/
or
 th
ird
 ge
ne
ra
tio
n 
ce
ph
al
os
po
ri
ns
. f
: M
ul
tiv
ar
ia
bl
e l
og
ist
ic 
re
gr
es
sio
n 
an
al
ys
is;
 
pa
rt
ic
ip
an
ts 
ES
BL
-p
os
iti
ve
 b
ef
or
e t
ra
ve
l w
er
e e
xc
lu
de
d.
 g:
 B
in
ar
y r
eg
re
ss
io
n 
an
al
ys
is.
 h
: C
ar
ba
pe
ne
m
as
e-
po
sit
iv
e i
so
la
te
s w
er
e i
nc
lu
de
d 
in
 th
e d
efi
ni
tio
n 
M
RE
.
195
International travel and acquisition of multidrug-resistant Enterobacteriaceae
The risk of acquisition of MRE varied with the geographical region (Table 3). 346-350,352-
356 Travel to southern Asia posed the highest risk (range: 29–88%), followed by other 
Asian countries (18-67%) and Northern Africa (range: 31-57%). Acquisition of MRE after 
travelling to sub-Saharan Africa (range: 0-49%) or South and Central America (range: 
0–33%) was less frequent, and three studies did not observe any acquisition of MRE 
after travel to South or Central America (Table 3). Acquisition of MRE after travel to 
North America, Europe and Oceania was rare. Results of the genotypic characterization 
of MRE isolated after travel are presented in Table 2, the majority of the genes belonged 
to the CTX-M type. 
Risk factors for acquisition of multidrug-resistant Enterobacteriaceae
Besides travel destinations, other risk factors for acquiring MRE were age, use of 
antibiotics during travel (beta-lactam use) and gastroenteritis or other gastrointestinal 
symptoms (Table 2). The study of Kantele et al., designed to study these risk factors as 
primary outcome, showed that travel diarrhoea (adjusted odds ratio (AOR) = 31.0; 95% 
confidence interval (CI): 2.7–358.1)) and antibiotic therapy for travel diarrhoea (AOR 
= 3.0; 95% CI: 1.4–6.7) proved to be the most important risk factors for acquiring 
MRE.350 In the study of Kuenzli et al. in which only travellers to southern Asia were 
included, risk factors for MRE acquisition were length of stay, visit to family or friend 
and consumption of ice cream or pastry (Table 2).355 Angelin et al. found a significant 
association for travel to the South-East Asia region (OR = 30; 95% CI: 6.3–147.2), and 
antibiotic treatment during travel (OR = 5; 95% CI: 1.1–26.2), but found no association 
with travellers’ diarrhoea or patient-related healthcare work.351
Resistance of multidrug-resistant Enterobacteriaceae to other antibiotic 
drugs
Resistance of post-travel MRE isolates to various antibiotics was determined in nine 
studies (Table 4).346-348,350-353,355,356 In the study by Wintersdorff et al., a PCR-based 
approach was used, therefore it was not possible to determine which microorganism 
carried the resistance genes.352 The resistance data to other antibiotic drugs in the study 
by Kennedy et al. were not part of the publication, but were provided on request.347 
Antimicrobial resistance was high for ciprofloxacin, varying from 31% to 57%, and for 
cotrimoxazole, varying from 49% to 86%.346-348,350-353,355,356  Aminoglycoside resistance 
was high for gentamicin (range: 17-50%) and tobramycin (range: 18-59%) and low for 
amikacin (range: 2-5%). 346-348,350-353,355,356 Carbapenemase-producing Enterobacteriaceae 
were observed in four travellers who had all visited India (in the study by Ruppé et al., 
two OXA-181 and one New Delhi metallo-beta-lactamase 1 (NDM-1), and in the study by 
Kuenzli et al., one NDM-1 but this strain was not included in the resistance results).354,355 
Resistance to nitrofurantoin, colistin and fosfomycin was only analysed in some of the 
studies (Table 4).347,348,350-352,355
Chapter 11
196
Table 3: Proportion of travellers who acquired multidrug-resistant Enterobacteriaceae, by travel  
destination (n = 11 studies)
Study
Southern 
Asia% 
(ratio)
Asia except 
southern 
Asia% (ratio)
Northern 
Africa% 
(ratio)
Sub-Saharan 
Africa% 
(ratio)
South and 
Central 
America% 
(ratio)
North 
America% 
(ratio)
Europe% 
(ratio)
Oceania% 
(ratio)
Tängdén346 a, b 78 (7/9) 29 (10/34) 33 (4/12) 4 (1/23) 0 (0/7) 0 (0/2) 13 (2/16) -
Kennedy347 a, c 57(8/14) 25 (21/85) 33 (1/3) 0 (0/2) 20 (1/5) 20 (2/10) 14 (3/21) 0 (0/2)
Östholm-
Balkhed 348 a, b
71(10/14) 43 (26/60) 57 (17/30) 21 (15/71) 16 (5/31) 0 (0/15) 0 (0/15) No data
Kantele349 b, d 46 (28/61) 32 (37/116) 67 (2/3) 12 (23/193) 0 (0/40) 0 (0/2) 0 (0/15) No data
Weisenberg350 b 29 (2/7) 25 (1/4) 33 (1/3) 13 (1/8) 33 (2/6) No data No data No data
Angelin351 63 (25/40) 67 (6/9) No data 10 (4/40) 0 (0/5) 0 (0/4) No data No data
von Winters-
dorff352 c
58 (18/31) 20 (6/29) 31 (5/16) 29 (5/17) 0  (0/10) No data 17 (1/6) No data
Paltansing353 
b, e 72 (18/25) 41 (60/146) 40 (4/10) 24 (20/82) 15 (9/60) No data No data No data
Ruppé354 f 88 (53/60) 66 (61/93) No data 49 (89/182) 31 (48/155) No data No data 0 (0/2)
Kuenzli 355 b 69 No data No data No data No data No data No data No data
Lübbert 356 a, b 72 (13/18)g 33 (24/73)g No data 24 (19/78) 8 (6/78) 0 (0/2) 20 (2/10) No data
a: Travelers visiting more than one region are categorized in all the visited geographical regions. b: Study reports data on 
MRE acquisition in travellers. c: Study reports data on MRE prevalence in travellers. d: Travelers visiting more than one 
region are categorized in the geographical region with the longest stay for this study. e: One traveller who visited Iran is 
categorized in Asia instead of Southern Asia. f: 42 travellers visited more than one country in Asia and may be represented 
in more than one column in the Table; 28 of them acquired MRE. g: Exact numbers unpublished. 
Southern Asia: Afghanistan, Bangladesh, Bhutan, India, Iran, Maldives, Nepal, Pakistan, Sri Lanka. Asia (without southern Asia): Armenia, 
Azerbaijan, Bahrain, Brunei, Cambodia, China, Cyprus, Georgia, Hong Kong, Indonesia, Iraq, Israel, Jordan, Japan, Kazakhstan, Kuwait, Kyr-
gyzstan, Laos, Lebanon, Mongolia, Malaysia, Myanmar, North Korea, Oman, Philippines, Qatar, Saudi Arabia, South Korea, Singapore, Palestine, 
Syria, Tajikistan, Thailand, Timor-Leste, Turkey, Turkmenistan, United Arab Emirates, Uzbekistan, Viet Nam, Yemen. Northern Africa: Algeria, 
Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara. Sub-Saharan Africa: Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape 
Verde, Central African Republic, Chad, Comoros,   Congo (Brazzaville), Côte d’Ivoire, Democratic Republic of the Congo, Djibouti, Equatorial 
Guinea, Eritrea, Ethiopia, Gabon, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, 
Mozambique, Namibia, Niger, Nigeria, Réunion, Rwanda, São Tomé and Príncipe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, Su-
dan, Swaziland, Tanzania, The Gambia, Togo, Uganda, Zambia, Zimbabwe. South and Central America: Anguilla, Antigua and Barbuda, Argenti-
na, Aruba, Bahamas, Barbados, Belize, Bolivia, Bonaire, Sint Eustatius and Saba, Brazil, British Virgin Islands, Cayman Islands, Chile, Colombia, 
Costa Rica, Cuba, Curaçao, Dominica, Dominican Republic, Ecuador, El Salvador, Falkland Islands, French Guiana, Grenada, Guadeloupe, 
Guatemala, Guyana, Haiti, Honduras, Jamaica, Martinique, Mexico, Montserrat, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Saint Kitts 
and Nevis, Saint Lucia, Saint Martin, Saint Vincent and the Grenadines, Saint-Barthélemy, Sint Maarten, Suriname, Trinidad and Tobago, Turks 
and Caicos Islands, US Virgin Islands, Uruguay, Venezuela. North America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United 
States. Europe: Åland Islands, Albania, Andorra, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Channel Islands, Croatia, Czech 
Republic, Denmark, Estonia, Faeroe Islands, Finland, the former Yugoslav Republic of Macedonia, France, Germany, Gibraltar, Greece, the Holy 
See, Hungary, Iceland, Ireland, Isle of Man, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Monaco, Montenegro, Netherlands, Nor-
way, Poland, Portugal, Moldova, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Svalbard and Jan Mayen, Sweden, Switzerland, 
Ukraine, United Kingdom. Oceania: American Samoa, Australia, Cook Islands, Fiji, French Polynesia, Guam, Kiribati, Marshall Islands, Mi-
cronesia, Nauru, New Caledonia, New Zealand, Niue, Norfolk Island, Northern Mariana Islands, Palau, Papua New Guinea, Pitcairn Islands, Samoa, 
Solomon Islands, Tokelau, Tonga, Tuvalu, Vanuatu, Wallis and Futuna.
197
International travel and acquisition of multidrug-resistant Enterobacteriaceae
Table 4: Antibiotic drug resistance of newly acquired multidrug-resistant Enterobacteriaceae in  
travellers (n = 11 studies)
Study
Cipro-
floxacin 
 % (ratio)
Cotri-
moxazole 
% (ratio)
Gentami-
cin 
 % (ratio)
Amika-
cin 
 % (ratio)
Tobramy-
cin 
% (ratio)
Carbape-
nem 
% (ratio)
Nitrofu-
rantoin 
% (ratio)
Colistin 
% (ratio)
Fosfomy-
cin 
% (ratio)
Tängdén346 a 50b 79 (19/24) 45
b No data 38b 0b 0b No data 8.0b
Kennedy347 c 55  (12/22) No data 50 (11/22) No data
59 
(13/22) No data No data No data No data
Östholm-
Balkhed348 a
31 
(36/116)
70 
(81/116)
41 
(48/116)
2 
(2/116)
46 
(53/116)
0 
(0/116)
7 
(8/116) No data
3 
(3/116)
Kantele349 No data No data No data No data No data No data No data No data No data
Weisenberg350 
a
43 
(3/7)d
86 
(6/7)
43 
(3/7) No data No data
0 
(0/7) No data No data No data
Angelin351 57 (28/49) 75
b 30b No data No data 0 (0/49) 2b No data No data
von Winters-
dorff 352 e
37 
(45/122) 
qnrB; 
56 
(68/122) 
qnrS
No data
71 
(86/122) 
aac(6’)-
aph(2’’)
71 
(86/122) 
aac(6’)-
aph(2’’)
71 
(86/122) 
aac(6’)- 
aph(2’’)
0 
(0/122) 
blaNDM
No data No data No data
Paltansing 353 f 36 67 35 No data 37 0 29 0 No data
Ruppé354 No data No data No data No data No data 0.6 (3/526)g No data No data No data
Kuenzli355 a 41 (64/157)
49 
(77/157) No data
5 
 (7/157)
18 
(28/157)
0 
(0/157)
2 
(3/157)
0 
(0/157)
0.6 
(1/157)
Lübbert356 a 43 (25/58)
83 
(48/58) 17 (10/58) 2b 22
b 0b No data 0b 16b
bla: beta-lactamase; CPE: carbapenemase-producing Enterobacteriaceae; ESBL: extended-spectrum beta-lactamase. a: Re-
sistance among acquired ESBL-positive isolates detected in post-travel samples. b: Data extracted from bar chart, exact 
numbers unpublished. c: Resistance among prevalent ESBL-positive isolates detected in post-travel samples. d: Percentage 
of susceptibility to levofloxacin. e: Prevalent resistance genes in faecal samples post-travel. f: Resistance among prevalent 
ESBL-positive isolates detected in pre- and post-travel samples. g: Three acquired CPE detected in post-travel samples.
Duration of multidrug-resistant
Enterobacteriaceae carriage after return, risk factors for a long duration and rate of 
infection after travel. Five studies analysed MRE carriage six months after travel, and 
the persistence rate of acquired MRE after six months was 6–24% of travellers (Table 
2).346,347,353,354,356 Ruppé et al. analysed MRE carriage one, two, three, six and twelve 
months after travel, showing persistence of carriage of an acquired MRE in 34, 19, 10, 
5 and 2%, respectively.354 Travelers to Asia showed longer carriage of MRE compared 
with other travel destinations. Carriage of multidrug-resistant E. coli had a lower risk 
for prolonged carriage than other multidrug-resistant species. No other risk factors were 
found for prolonged carriage of MRE. Eight travellers in this study reported an episode 
of urinary tract infection after their return, but no microbiological data were available.354 
In the study by Tängdén et al., five of 21 travellers remained carriers of MRE after six 
months. However, none of these participants reported clinical infections.346 In the study 
of Kennedy et al., one person developed a urinary tract infection with a travel-related 
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organism.347 Kantele et al. performed a one-year laboratory-based follow-up and did not 
find any clinical samples with MRE.349
Rate of transmission to household members
Only one study screened household contacts for MRE after return of the index traveller. 
Household contacts were defined as persons who shared the same household with a 
participant on a regular basis. Two of 11 contacts were found MRE-positive.353 Both 
carried a different ESBL-producing E. coli based on multilocus sequence typing (MLST) 
than the associated traveller.
Limitations of the studies
The quality of the studies and the susceptibility of bias between the studies were assessed. 
In all but one study, participants constituted a non-random sample of the general travelling 
population.346-350,352-356 However, Angelin et al. studied healthcare students working 
or studying abroad.351 Studies were performed on three different continents. Travel 
destinations and travel behaviour may differ considerably between different nationalities 
and age groups. Including co-travellers, as done in all studies except Paltansing et al. and 
Ruppé et al., can result in similar travel behaviour and therefore, similar risk factors. 
Overall, the main outcome was not influenced by recall or interviewer bias. For other 
outcomes such as risk factors, the risk of recall bias or interviewer bias was low because 
of the use of self-administered questionnaires.
Every study had participants lost to follow-up for post-travel stool samples and follow-
up stool samples. Asymptomatic faecal carriage of MRE is probably not related to loss 
to follow-up, therefore, the risk of information bias is small. Ruppé et al. calculated 
posttravel MRE carriage as those travellers with persisting MRE carriage divided by all 
travellers with MRE acquisition plus all travellers without MRE post-travel.354 However, 
travellers without MRE were not included in the follow-up. As a result, local MRE 
acquisition was not included in the calculated post-travel MRE carriage prevalence. 
Therefore the true prevalence can be assumed to be higher. 
In five studies, travellers visited multiple regions or even continents during their 
trip.346-349,356 In these travellers, it was not possible to attribute MRE prevalence or MRE 
acquisition to a certain geographical region. However, travellers in these studies were 
included in the MRE prevalence or MRE acquisition rates of more than one geographical 
region, which may have introduced information bias.
Seven studies used stool samples for detection of MRE346,348-350,352,354,356 and three studies 
used rectal or perianal swabs for detection of MRE.347,353,355 This might have influenced 
detection of MRE carriage. 
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Discussion
In this systematic review we found a high prevalence of faecal carriage of MRE after 
international travel. The highest prevalence of MRE was observed in isolates from 
travellers returning from southern Asia, with up to 88% acquisition of MRE. In addition 
to the antibiotics not effective against MRE, an alarmingly high prevalence of resistance 
to other commonly used antibiotics such as cotrimoxazole (49–86%), ciprofloxacin (31–
57%) and aminoglycosides (gentamicin 17–71%) was observed in ESBL-positive isolates 
in travellers in all studies.346-356
Returning international travellers with MRE may introduce these microorganisms in 
their home countries. This may cause community-onset infections with MRE in patients 
without obvious risk factors transmitted by healthy carriers through food or person-
to-person contact.338 Infections caused by MRE are associated with poorer outcome 
and a higher overall mortality rate than infections caused by susceptible bacteria.357 In 
this review, all studies showed an increased prevalence of faecal carriage of ESBL after 
international travel. It is not possible to evaluate the proportion of travellers who will 
develop infection with these resistant bacteria. However, studies have demonstrated 
that international travel is a risk factor associated with developing an infection with an 
MRE.340,341,358
Many countries have infection prevention and control guidelines to detect and treat 
multidrug-resistant organisms (MDROs) including MRE.359 In countries with low 
prevalence of MRE, infection prevention and control guidelines mainly include 
strategies for early identification and isolation of patients recently hospitalized in foreign 
hospitals.359,360 Patients with a recent history of travel to MRE-endemic areas but not 
admitted to healthcare facilities abroad are not normally considered at risk for carriage 
of MDROs. However, in hospitalized patients with a recent history of travel, increased 
rates of carriage of MRE have been observed.339,358,359 Physicians should be aware of 
the risk that patients with recent travel to areas with high faecal carriage of MRE, as 
presented in this review, may introduce MRE to the hospital. Routine screening for MRE 
seems indicated in such patients. Furthermore, empiric antibiotic therapy may fail when 
an infection by MRE is not taken into account. Therefore, careful recording of travel 
history needs to be incorporated in each patient evaluation. As shown in this review, 
there is also an increased risk of resistance against other antibiotics in travellers with 
MRE carriage. It is likely that this is caused by multiple genes, each encoding resistance 
to different classes of antibiotics, which are often found on the same bacterial mobile 
genetic element (e.g. a plasmid).361 As a result, other antibiotics, such as aminoglycosides, 
will also fail in many MRE-positive patients.
Of all MDROs, emergence of CPE is most worrisome because of the limited treatment 
options for these infections. NDM-1-producing Enterobacteriaceae have been found in 
environmental samples in endemic regions.362 CPE (NDM-1) in patients from the United 
Kingdom with a recent history of travelling or medical tourism to India are already an 
important public health problem.337 Case reports have also demonstrated acquisition of 
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CPE in travellers without contact with medical healthcare facilities.363,364In this review, 
four travellers from India were carrying a carbapenemase-producing E. coli.354,355 
Preliminary results of the Carriage Of Multiresistant Bacteria After Travel (COMBAT) 
study, a large-scale multicentre longitudinal cohort study conducted in the Netherlands 
among 2001 travellers, show acquisition of CPE in four travellers.365
There are, besides the destination of travel, additional risk factors for acquiring MRE 
during travel. Antibiotic therapy was found to increase the risk.349,351 In five studies, 
traveller’s diarrhoea or gastroenteritis were associated with an increased risk of MRE 
acquisition during.346-349,354 Also, in one study, meticulous hand hygiene or strict 
consumption of bottled water did not lower the risk of acquiring MRE.351 Therefore, it 
is not clear whether hygiene-related travel advice will decrease faecal carriage of MRE. 
Surprisingly, healthcare-related activities did not pose an increased risk of acquiring 
MRE in one study.351
MRE and CPE could also be carried by food. International spread of these bacteria 
by food supply has been reported.366 In this review, only one study showed that food 
consumption (ice cream and pastry) was associated with MRE carriage in travellers to 
southern Asia, whereas most of the studies did not focus on dietary patterns during 
travel. 
One limitation of this review is the recruitment of travellers from travel clinics only, 
resulting in inclusion of very few travellers with European destinations. Some European 
countries such as Greece and Cyprus are also endemic for MRE and popular travel 
destinations.363 In addition, travellers visiting their country of origin, especially Morocco 
and Turkey usually do not ask for a pre-travel consultation, although these countries are 
endemic for MRE and CPE.363 It is not clear whether not including these patients may 
have led to an under- or overestimation of MRE acquisition.
Another limitation is the lack of sufficient data regarding the duration of carriage and 
the transmission among non-travelling household members. The study by Ruppé et al. 
suggests that three months after return, MRE carriage is comparable with the baseline 
prevalence before travelling. However, the study did not include baseline prevalence in 
the follow-up. The COMBAT study will address some of these questions.367
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Conclusion
International travel is a major risk factor for acquisition of MRE. This risk is particularly 
high after travelling to (southern) Asia and in persons with travel-related diarrhoea 
and antibiotic use. Carriage of MRE-positive isolates is also associated with a high risk 
of resistance to ciprofloxacin, cotrimoxazole and aminoglycosides. Further research 
is needed to assess duration of carriage, spread to household contacts and whether 
introduction of MRE results in an increase of MRE infections. Our results, combined 
with the worldwide emergence of CPE, further stress the importance of infection 
prevention and control guidelines.
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Abstract
Background
A substantial group of patients visit the emergency department (ED) with complaints of 
urinary tract infections (UTI). Treatment advice is based on national and local public 
health surveillance data. It is unclear whether this advice is adequate for hospitals with 
selected patient populations, such as university hospitals.
Methods
We performed a retrospective study on patients visiting the ED of the Erasmus University 
Medical Center (Erasmus MC) in the Netherlands from January 1st, 2013 until December 
31st, 2014 with a suspected complicated UTI (cUTI) and positive urinary cultures. Patient 
data, data concerning the ED visit and microbiological data were analysed.
Results
439 patients visited the ED, of whom 429 had a cUTI. Our results were compared 
with NethMap data. Distribution of uropathogens was comparable with the overall 
distribution in the Netherlands. Antibiotic susceptibility was comparable for intravenous 
antibiotics, but was lower for oral antibiotics. Susceptibility for empiric antibiotic therapy 
(i.e. cefuroxime and gentamicin) was 96.2%. Pathogens differed from the index culture 
in 56.2% (104/185) of the urinary cultures available from the previous year. Using logistic 
regression, we found that a shorter time between last admission to the initiated antibiotic 
regimen was associated with lower susceptibility of cultured uropathogens.
Conclusion 
The distribution and antibiotic susceptibility of uropathogens for intravenous antibiotics 
in a Dutch university hospital is comparable with overall distribution in the Netherlands. 
Empiric antibiotic therapy in our local guideline appears to be an adequate antibiotic 
regimen for cUTI and we therefore recommend treating patients accordingly. Extension 
of the chosen regimen based on earlier cultured pathogens is advised, and narrowing of 
the antibiotic regimen strongly discouraged.
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Introduction
Background and rationale 
Urinary tract infection (UTI) is suspected in a substantial group of patients visiting the 
emergency department (ED). In the United States, UTIs accounted for approximately 2% 
of ED visits in 2014 for a total of 2.3 million people.368 This percentage is similar in the 
Netherlands.369 There is continuous debate about the appropriate antibiotic treatment 
for patients with UTI, despite guidelines on the subject. The Dutch guidelines for 
antibiotic therapy are based on national resistance data on pathogens causing UTI.370 It 
is questionable if, and to what extent, these data are applicable to the patient population 
encountered in specialized hospitals, such as university hospitals.
Patients in university hospitals often have a complex medical history and in particular, 
patients from nephrology and urology departments are more frequently treated for 
UTIs with antibiotics. These patients are at risk for colonization with antibiotic-resistant 
uropathogens. When UTI occurs, it is likely that the uropathogens are less susceptible 
to routinely prescribed antibiotics.371-373 Data comparing the distribution and antibiotic 
susceptibility of uropathogens in Dutch university hospitals with the overall distribution 
in the Netherlands are currently lacking. 
Dutch national guidelines advise to treat complicated UTIs (cUTI) with amoxicillin 
or a second-generation cephalosporin combined with an aminoglycoside, or with 
a third-generation cephalosporin.370 A cUTI is defined by the ‘The Dutch Working 
Party on Antibiotic Policy’ (SWAB) as all UTIs with the exception of cystitis in non-
immunocompromised, non-pregnant women with no anatomical and functional 
abnormalities of the urogenital tract and no signs of tissue invasion, and in men younger 
than 40 years without a medical history, no previous lower urinary tract symptoms 
and no findings at physical examination.370 In the Erasmus University Medical Center 
Rotterdam, the Netherlands (Erasmus MC), cefuroxime combined with gentamicin is 
the antibiotic regimen of choice for cUTI based on local resistance data. This regimen 
can only be administrated intravenously, which requires hospitalization, regardless 
of the patient’s clinical condition. Furthermore, side effects of gentamicin include 
nephrotoxicity and ototoxicity.374 Although this risk is particularly applicable after 
multiple doses in patients with renal insufficiency, aminoglycosides are frequently left 
out, resulting in inappropriate treatment.375-377 The duration of hospital stay or even 
prevention of admission may be achieved if hospitals can identify patients who can be 
safely treated with other specific antibiotic-regimens, based on their medical history and 
available data from previously obtained cultures.
When initiating adequate antibiotic therapy, physicians should take the increase of 
antibiotic resistance into account. However, there are currently not enough data to enable 
a more tailor-made decision for the first choice of the antibiotic regimen. Recently, a 
study in a university hospital in Israel showed that patients who had a culture with a 
resistant uropathogen had high rates of a repeat resistant uropathogen in a subsequent 
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culture.378 This chance of a repeat resistant uropathogen was reduced with time, or with 
an intervening culture without resistant uropathogens. Data that enables extension 
or narrowing of the empiric regimen in a university hospital ED population are not 
available. However, these data would substantially contribute to more efficient antibiotic 
treatment and prevention of antibiotic resistance.379
Objectives
The primary goal of this research was to study the distribution of uropathogens and their 
antibiotic resistance patterns in a university hospital population. Second, we investigated 
susceptibility to the empiric regimen consisting of cefuroxime and gentamicin in this 
population, and studied the probability of extending or narrowing of this regimen, based 
on previously cultured pathogens. 
Materials and Methods
Study design, setting, and patients
We conducted an observational retrospective study in the Erasmus MC. This is the 
largest university hospital of the Netherlands with approximately 30,000 adult ED visits 
per year. All urinary cultures with at least one pathogen and an available antibiogram 
taken from patients visiting the ED from January 1st, 2013 until December 31st, 2014 
were obtained from the Department of Medical Microbiology and Infectious Disease.
Urine samples were cultured by standard microbiological culture techniques. Bacterial 
species were identified by Matrix Assisted Laser Desorption/Ionization Time-of-Flight 
Analyser Mass Spectrometry (MALDI-TOF MS) analysis (Microflex, Bruker Daltonics, 
Bremen, Germany). Susceptibility testing was performed with VITEK®2 (bioMérieux, 
Marcy l’Etoile, France). Antibiotic resistance was determined according to the European 
Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoints.380 
Only samples from patients 18 years or older having a UTI were included (i.e. index 
culture). Patients were only included once, and the first obtained sample of each patient 
in the abovementioned period was used. Uropathogens were considered to be identical 
(i.e. the same uropathogen), if the index culture and previously cultured uropathogens 
as well as its antibiotic susceptibility were identical. 
Variables
For each patient, demographic data (e.g. age, sex, previous medical history) and data 
concerning their ED visit, such as history, vital parameters (e.g. blood pressure, heart 
rate, respiratory rate, oxygen saturation, temperature), laboratory results (e.g. C-reactive 
protein (CRP), leukocyte count, and presence of pyuria, defined as leukocytes in urine 
dipstick), results of blood cultures, previous urinary cultures acquired within 12 
months prior to the ED-visit with antibiogram available, data on initiated antibiotics, 
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and disposition were obtained from electronic patient records. In patients who were 
previously hospitalized in the Erasmus MC, the dates of the last admission and discharge 
were obtained, and time since last admission and duration of the last admission were 
calculated. The number of admissions in the last year was also obtained. Comorbidities 
considered relevant were renal transplantation, urological anomalies (e.g. recent 
urological interventions, neo-bladder reconstruction, urological tract anomalies), 
and immunocompromised status (defined as patients with congenital or acquired 
immunodeficiency, patients undergoing active treatment for malignancies, patients using 
immunosuppressive medication). Patients were grouped in ‘never hospitalized within 
the Erasmus MC’ (Erasmus MC-naïve), and ‘previously hospitalized in the Erasmus 
MC’. Previously hospitalized patients were categorized based on the time between the 
last admission, either > 12 months or ≥ 12 months ago. We made a subset of patients 
recently hospitalized (defined as < 3 months). Data on hospitalization in other hospitals 
or residing in a nursing home were not available.
We combined the SWAB definition370 and the Centres for Disease Control and Prevention 
(CDC) definition381 to define a cUTI: an urinary culture with no more than two species 
of organisms identified, at least one of which is a bacterium of ≥ 103 colony forming 
units (in contrast to the ≥ 105 colony forming units, as defined in the CDC definition) 
and one of the following criteria: 1) a positive blood culture from the same moment with 
the same micro-organism as in the urinary culture; 2) a body temperature > 38.0 °C; 
3) symptomatology of a UTI (e.g. dysuria, urinary frequency or urgency, suprapubic or 
costovertebral tenderness); or 4) according to the treating physician (i.e. UTI reported 
as (most likely) diagnosis in discharge letter). A UTI was considered to be complicated 
when there were signs of systemic illness. Patients met our definition of cUTI when they 
were fulfilled at least one of the following: being male and older than 39 years,370 having 
a body temperature > 38.0 °C, meeting two or more systemic inflammatory response 
syndrome (SIRS) criteria (of note, missing SIRS criteria were coded as negative),34 having 
costovertebral tenderness, being ill according to the treating physician, having a CRP > 
60 mg/l,382 having a blood culture with the same pathogen as in the urine culture, having 
a renal transplantation in medical history, being immunocompromised, or the decision 
for hospitalization by the treating physician. Cefuroxime combined with gentamicin 
was considered empiric therapy in the ED, and we therefore described the proportion of 
patients having a UTI in whom empiric therapy would have been an adequate antibiotic 
regimen without resistance of the causing pathogen against these agents. We also 
described the population of pathogens cultured with their susceptibility to different, 
frequently prescribed antibiotic regimens, including susceptibility to cefuroxime and 
gentamicin, in Erasmus MC-naïve versus previously hospitalized patients (< 12 versus ≥ 
12 months ago). We compared the index culture and its susceptibility for the prescribed 
antibiotic regimen with previously cultured pathogens. Lastly, we compared prevalence 
susceptibility of uropathogens for frequently prescribed antibiotics in our population 
with national antibiotic susceptibility.383
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Statistical analyses
We presented patient characteristics as mean and interquartile range (IQR), or as an 
absolute number (proportion) with percentage (%) and 95% confidence interval (95% CI). 
Categorical variables were compared using the Pearson chi-squared test. We performed 
one sample t-tests for the comparison of proportions and 95% CIs of susceptibility in 
our population with Dutch national susceptibility data (NethMap).383 We performed 
univariate and multivariate logistic regression analysis on susceptibility of the found 
bacteria for initiated therapy, empiric therapy and cefuroxime monotherapy over days 
since last admission. Other factors included in the models were sex and age. Results are 
presented as odds ratios (ORs) and 95% CIs. All analyses were conducted with IBM SPPS 
Statistics for Windows version 21 (IBM Corp., Armonk, N.Y., USA). A P value < 0.05 was 
considered significant.
Results
Inclusion of patients
A total of 2,481 urinary cultures were obtained in the ED between January 1st, 2013 
and December 31st, 2014, of which 806 (32.5%) contained at least one pathogen. After 
selecting first isolates, 722 (89.6%) cultures of unique patients remained. Of these patients, 
439 (60.8%) had a UTI according to the predefined criteria and 427 had a cUTI. A total 
of 355 (83.1%) patients were admitted to the hospital, and in 348 (98.0%), antibiotics were 
initiated. The flowchart of these results and medical decisions with respect to hospital 
admission and initiation of antibiotics is shown in Figure 1.
Patient characteristics
Of the 427 patients with cUTI, a majority were male (223 patients, 52.2%), with a median 
age of 59 years. The vast majority of patients had relevant comorbidities (72.8%) and 
63.2% were hospitalized the prior year. Only 12.2% of the patients were not previously 
admitted to Erasmus MC. Most frequently cultured pathogen was E. coli (51.3%). Other 
frequently cultured micro-organisms were K. pneumoniae, E. faecalis, P. mirabilis, P. 
aeruginosa, and S. agalactiae (Group B Streptococcus) (9.5%, 9.7%, 6.7%, 5.6% and 2.6%, 
respectively). Patient characteristics are shown in Table 1.
Antibiotic susceptibility
In all patients who were hospitalized after their ED visit with a cUTI, we found 
susceptibility to cefuroxime and/ or gentamicin in 96.2% (228/237) for E. coli, 90.9% 
(40/44) for K. pneumoniae, and of 100% (31/31) for P. mirabilis. These rates are comparable 
to NethMap-data.383 Susceptibility to meropenem was 100%, except for P. aeruginosa 
(susceptibility rate 92.3% (24/26)). Compared to the general resistances rates in the 
Netherlands, we found more resistance of E. coli and K. pneumoniae for trimethoprim-
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sulfamethoxazole and more resistance of E. coli and P. mirabilis for ciprofloxacin. All 
susceptibility patterns can be found in Table 2A.
Using multivariate logistic regression, we found that a shorter time between the last 
admission to Erasmus MC was associated with lower susceptibility rates for initiated 
antibiotic therapy (OR 1.22; 95% CI 1.04, 1.43; p = 0.015). We also found that a shorter 
the time since the last admission was associated with lower susceptibility for cefuroxime 
(OR 1.31; 95% CI 1.14, 1.49; p < 0.001). We found no association between age and sex and 
Figure 1: Flow diagram on selection of patients. 
ED: eemergency department; UTI: urinary tract infection; cUTI = complicated urinary tract infection.
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Table 1: Patient characteristics
Patients with cUTI (n = 427)
Sex, male [n (%)] 223 (52.2)
Age [mean (SD)] 59 (17)
First responsible specialism at ED [n (%)]
  Internal medicine 221 (51.8)
  Surgery 97 (22.7)
  Urology 48 (11.2)
  Emergency medicine 6 (1.4)
  Other 55 (12.9)
Comorbidities [n (%)]
  Yes 311 (72.8)
  Status after renal transplantation 106 (24.8)
  Urological problem 193 (45.2)
  Immunocompromised status 185 (43.3)
  No 115 (26.9)
Time since last admission
  < 3 months [n (%)] 172 (40.3)
  3- 6 months [n (%)] 33 (7.7)
  7-9 months [n (%)] 21 (4.9)
  10-12 months [n (%)] 25 (5.9)
  ≥ 12 months [n (%)] 106 (24.8)
 Never admitted [n (%)] 70 (16.4)
Length of last hospitalization, days*[median (IQR, Range)] 3 (IQR 15, Range 123)
Duration of last hospitalization, days*[median (IQR, Range)] 5 (IQR 7, Range 125)
Number of hospitalizations in the last year*[median (IQR, Range)] 1 (IQR 3, Range 13)
Clinical presentation at ED
  Ill according to physician’s discretion [n (%)] 130 (30.4)
  Pulse rate, b/min [median (IQR)] 99 (85-112)
  SBP, mmHg [median (IQR)] 130 (114-146)
  DBP, mmHg [median (IQR)] 75 (65-85)
  Breathing frequency, n/min [median (IQR)] 20 (16-25)
  Body temperature, °C [median (IQR)] 38.2 (37.2-38.8)
  C-reactive protein, mg/l [median (IQR)] 60.0 (23.8-122.2)
  Leukocyte count, 109/l [median (IQR)] 11.5 (8.1-15.8)
  Pyuria [n (%)] 354 (82.9)
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Number of micro-organisms in urinary culture [n (%)]
  1 392 (91.8)
  2 35 (8.2)
Micro-organism in urinary culture [n (%)] n = 462
  Escherichia coli 237 (51.3)
  Klebsiella pneumoniae 44 (9.5)
  Enterococcus faecalis 45 (9.7)
  Proteus mirabilis 31 (6.7)
  Pseudomonas aeruginosa 26 (5.6)
  Group B Streptococcus 12 (2.6)
 Other 67 (14.5)
cUTI: complicated urinary tract infection; n: number; SD: standard deviation; ED: emergency department; SBP: systolic 
blood pressure; DBP: diastolic blood pressure; IQR: inter quartile range.*Data available for n =357.
susceptibility (OR 1.30; 95% CI 0.73, 2.31; p = 0.364, and OR 0.98; 95% CI 0.97, 1.01; p = 
0.19, respectively). We also found no association between the time in days between the 
last admission to Erasmus MC and susceptibility for empirical therapy (i.e. cefuroxime 
and gentamicin) (OR 1.17; 95% CI 0.95, 1.45; p = 0.14).
We tested non-linearity by adding a quadratic term to the natural logarithm of days since 
the last admission to Erasmus MC. We detected no non-linearity, which implies there 
is no specific cut-off period for losing non-susceptible uropathogens. Susceptibility for 
amoxicillin-clavulanic acid, cefuroxime, gentamicin, trimethoprim-sulfamethoxazole, 
and cefuroxime/gentamicin was lowest if last admission < 3 months ago, and highest for 
never admitted patients (Tables 2B-2E).
In 427 patients with a cUTI, 462 pathogens were cultured (427 single isolates, 35 double 
isolates). Of 185 index cultures, previous cultures were available. Of all urine cultures 
obtained within the last year, 56.2% (104/185) contained pathogens different from the 
index culture. In 71.2%, the current pathogen was susceptible for the initiated antibiotic 
therapy, compared to 91.4% if the pathogen matched previous cultures (p < 0.001, see 
Table 3).
Of the 427 patients with cUTI, 61 were Erasmus MC-naïve, 251 were admitted < 12 
months, and 106 were admitted ≥ 12 months ago. In patients admitted < 12 months ago, 
uropathogens carried higher resistance rates for the initiated treatment than those of 
patients who were last hospitalized ≥ 12 months ago, or were never hospitalized (24.3% 
vs 12.3% vs 12.9%, respectively; p = 0.002, see Table 4). Majority of the patients admitted 
< 12 months ago were admitted in the last three months (68.9%). 
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Table 2 B: Susceptibility rates of cultured pathogens for frequently prescribed antibiotics of 
patients who were admitted < 3 months to Erasmus MC
Cultured pathogens  
(n = 189)
E. coli 
(n = 84)
K. pneumoniae 
(n = 18)
P. mirabilis 
(n = 12)
P. aeruginosa 
(n = 15)
E. faecalis 
(n = 23)
Other 
(n = 45)
Amoxicillin- 
clavulanic acid
62 (73.8) 13 (72.2) 11 (91.7) - 23 (100) *
Cefuroxime 66 (78.6) 12 (66.7) 12 (100) - - *
Meropenem 84 (100) 18 (100) 12 (100) 13 (86.7) - *
Ciprofloxacin 58 (69.0) 14 (77.8) 7 (58.3) 12 (80.0) - *
Gentamicin 76 (90.5) 15 (83.3) 11 (91.7) 14 (93.3) - *
Trimethoprim-  
sulfamethoxazole
41 (48.8) 13 (72.2) 6 (50.0) - - *
Nitrofurantoin 81 (96.4) 3 (17.6) - - 23 (100) *
Cefuroxime/ 
gentamicin
79 (84.0) 15 (83.3) 12 (100) 14 (93.3) - *
Data presented in number and percentage. *Due to the large variation in ‘other’ uropathogens, overall susceptibility in this 
group was not representative and therefore not mentioned.
Table 2 C: Susceptibility rates of cultured pathogens for frequently prescribed antibiotics of 
patients who were admitted < 12 months to Erasmus MC
Cultured pathogens  
(n = 270)
E. coli 
(n = 130)
K. pneumoniae 
(n = 25)
P. mirabilis 
(n = 23)
P. aeruginosa 
(n = 16)
E. faecalis 
 (n = 30)
Other 
(n = 45)
Amoxicillin- 
clavulanic acid
101 (77.7) 18 (72.0) 21 (91.3) - 34 (100) *
Cefuroxime 103 (79.2) 18 (73.0) 23 (100) - - *
Meropenem 130 (100) 25 (100) 23 (100) 14 (87.5) - *
Ciprofloxacin 94 (72.3) 20 (80.0) 13 (56.5) 13 (81.3) - *
Gentamicin 118 (90.8) 22 (88.0) 20 (87.0) 15 (93.8) - *
Trimethoprim- 
sulfamethoxazole
61 (46.9) 18 (72.0) 13 (56.5) - - *
Nitrofurantoin 125 (96.2) 7 (29.2) - - 34 (100) *
Cefuroxime/ 
gentamicin
121(93.1) 22 (88.0) 23 (100) 15 (93.8) - *
Data presented in number and percentage. *Due to the large variation in ‘other’ uropathogens, overall susceptibility in this 
group was not representative and therefore not mentioned.
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Table 2 D: Susceptibility rates of cultured pathogens for frequently prescribed antibiotics of 
patients who were admitted ≥ 12 months to Erasmus MC
Cultured pathogens  
(n =  117)
E. coli 
(n = 65)
K. pneumoniae 
(n = 15)
P. mirabilis 
(n = 6)
P. aeruginosa 
(n = 6)
E. faecalis 
 (n = 7)
Other 
(n = 17)
Amoxicillin- 
clavulanic acid
53 (81.5) 14 (93.3) 5 (83.3) - 7 (100) *
Cefuroxime 58 (89.2) 14 (93.3) 6 (100) - - *
Meropenem 65 (100) 15 (100) 6 (100) 6 (100) - *
Ciprofloxacin 50 (76.9) 12 (80.0) 4 (66.7) 5 (83.3) - *
Gentamicin 62 (95.4) 14 (93.3) 5 (83.3) 5 (83.3) - *
Trimethoprim-  
sulfamethoxazole
41 (63.1) 9 (60.0) 4 (66.7) - - *
Nitrofurantoin 61 (95.3) 4 (26.7) - - 7 (100) *
Cefuroxime/ 
gentamicin
65 (100) 12 (92.3) 6 (100) 5 (83.3) - *
Data presented in number and percentage. *Due to the large variation in ‘other’ uropathogens, overall susceptibility in this 
group was not representative and therefore not mentioned.
Table 2 E:  Susceptibility rates of cultured pathogens for frequently prescribed antibiotics of 
patients who were never admitted to Erasmus MC
Cultured pathogens  
(n = 74)
E. coli 
(n = 42)
K. pneumoniae 
(n = 4)
P. mirabilis 
 (n = 2)
P. aeruginosa 
(n = 4)
E. faecalis 
(n = 8)
Other 
(n = 14)
Amoxicillin- 
clavulanic acid
40 (95.2) 4 (100) 2 (100) - 8 (100) *
Cefuroxime 38 (90.5) 4 (100) 2 (100) - - *
Meropenem 42 (100) 4 (100) 2 (100) 4 (100) - *
Ciprofloxacin 36 (85.7) 4 (100) 2 (100) 3 (75) - *
Gentamicin 42 (100) 4 (100) 2 (100) 4 (100) - *
Trimethoprim-  
sulfamethoxazole
29 (69.0) 4 (100) 2 (100) - - *
Nitrofurantoin 40 (95.2) 1 (25) - - 8 (100) *
Cefuroxime/ 
gentamicin
42 (100) 4 (100) 2 (100) 4 (100) - *
Data presented in number and percentage. Due to the large variation in ‘other’ uropathogens, overall susceptibility in this 
group was not representative and therefore not mentioned.
 
Chapter 12
216
Discussion
Our study shows that susceptibility rates to empirical intravenous antibiotic therapy in 
our cohort of patients visiting the ED of a Dutch university hospital are comparable to 
national epidemiological data. However, resistance to orally available antibiotics is higher 
for the most frequently cultured pathogens. A shorter time between presentation in the 
ED and the last admission was associated with lower susceptibility of uropathogens for 
initiated antibiotic therapy.
As in most studies, we found higher susceptibility rates for meropenem than for 
cefuroxime and/or gentamicin, which is aligned with NethMap 2018,383 and are most 
likely the result of restricted use of carbapenems, since they are considered last-resort 
antibiotics. In line with the principles of antimicrobial stewardship, carbapenems should 
continuously be prescribed with caution.384
We also found that susceptibility of prevalent uropathogens to frequently prescribed oral 
antibiotics was lower than nationwide susceptibility rates, especially for ciprofloxacin 
and trimethoprim-sulfamethoxazole. This difference is most explicit within the 
subgroup of patients who were admitted within one year before presentation at the ED. 
It is likely that this discrepancy is due to the specific patient population encountered 
in university hospitals. Patients who are using immunosuppressive medication or who 
have anatomical anomalies frequently require treatment with antibiotics and are more 
often admitted. These patients are not only at risk for UTIs in general, but also for UTIs 
with more uncommon and more resistant uropathogens.385,386 Notably, the NethMap 
report calculates resistance percentages for all hospitals combined and not for university 
hospitals separately, which probably resulted in higher susceptibility rates. 
More than half of the cultured uropathogens differed from previously cultured 
uropathogens. This finding suggests a high prevalent heterogeneity of uropathogens 
in single individuals. There was significantly higher resistance for initiated antibiotics 
in patients who were admitted < 12 months ago, compared to patients admitted ≥ 12 
months ago. This confirms the evidence that patients who are frequently admitted to the 
hospital carry more resistant uropathogens than patients who are less frequently or never 
admitted.378,387 We were not able to define a safe cut-off point, since we found a linear 
association over time, and the longer the time since last hospitalization, the smaller the 
risk. A cross-sectional study of Teunis et al. on duration of carriership of multi drug 
resistant E. coli in a subset of a general adult population showed that the estimated time 
to lose carriership was approximately 400 days.388 In the prospective COMBAT (Carriage 
Of Multiresistant Bacteria After Travel) study, 633 individuals acquired multi drug 
resistant E. coli during travel, in whom median duration of colonization after travel was 
30 days, and of whom 11.3% remained colonized 12 months after return; however, this 
was performed predominantly with individuals without comorbidity and infections.389 
In clinical practice, the results of previously obtained cultures contribute to the decision 
to initiate an antibiotic regimen, but information from earlier obtained cultures should 
be applied with caution. Based on our data, we suggest treatment with empiric therapy, 
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including gentamicin, in all patients – also those who were admitted recently. Antibiotic 
regimen should be extended and not narrowed, based on cultures obtained in the year 
before presentation at the ED.
In kidney transplant recipients or patients with severe pre-existent renal insufficiency 
(eGFR < 30 ml/min) there is continuous discussion on the safety of gentamicin. Evidence 
for significant nephrotoxicity after a single dose of aminoglycosides is controversial, 
374,390 but most physicians are cautious with prescribing aminoglycosides in patients with 
kidney transplants or severe renal insufficiency.387,391
However, these patients accounted for a substantial part of our study population, and 
for this group, monotherapy with cefuroxime or ciprofloxacin is not advisable, since 
susceptibility rates were below the threshold of 90%. In these selected groups another 
empiric regimen, like meropenem, may be justified. Especially in tertiary hospitals, 
where decision-making regarding the choice for antibiotic treatment in an aging, multi-
morbid patient population is often complex, antimicrobial stewardship is recommended. 
However, we also show that guidelines on empiric therapy based on local resistance data 
are effective, as long as they are followed.
Due to the retrospective nature of our study we encountered several limitations. We 
selected patients based on positive urinary cultures and subsequently selected patients 
with cUTIs. In a small but substantial group, this led to misclassification of cUTI: 
antibiotics were initiated in only six of the 72 patients who met our criteria for cUTI and 
who were discharged from the ED. Patients with cUTI without positive urinary cultures, 
for example, due to pre-treatment with antibiotics or due to a negative urinalysis and no 
subsequent culture, were not selected. This might have led to a selection bias. However, our 
data (i.e. the cultured uropathogens and their antibiotic susceptibility) were selected are 
used in the national NethMap data. We also have no information on antibiotic treatment 
of patients in general practice or in other hospitals, and if antibiotics would have been 
used, this could potentially have caused an increase in resistance in our population.
Also, important differences between our data and NethMap 2018 results are seen in the 
susceptibility rates of E. coli and K. pneumoniae for amoxicillin-clavulanic acid. This 
is a result of a new test panel for Gram-negative bacteria, resulting in higher minimal 
inhibitory concentrations for amoxicillin-clavulanic acid and higher resistance levels 
from 2016 onwards. For our data, susceptibility rates from the period 2013-2014 are 
applicable. Therefore, we compared our data with NethMap reports for this period and 
our resistance percentages for amoxicillin-clavulanic acid are comparable.383
In conclusion, the distribution and antibiotic susceptibility for intravenous antibiotics of 
uropathogens in a Dutch university hospital is comparable with overall distribution in 
the Netherlands. Cefuroxime in combination with gentamicin is therefore an adequate 
antibiotic regimen for cUTI, and we recommend treating patients accordingly. Extension 
of the chosen regimen based on earlier cultured pathogens is advised, and narrowing 
of the antibiotic regimen strongly discouraged, especially the omission of gentamicin. 
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In a strictly selected population (e.g. recently admitted renal transplant recipients, 
pre-existing severe kidney insufficiency), prescription of meropenem as an alternative 
empiric therapy could be considered.
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Abstract
Objective
Clinical practice universally assumes that appropriate empirical antibiotic therapy 
improves survival in patients with bloodstream infection. However, this is not generally 
supported by previous studies. We examined the association between appropriate 
therapy and 30-day mortality, while minimizing bias due to confounding by indication.
Methods
We conducted a retrospective cohort study between 2012 and 2017 at a tertiary university 
hospital in the Netherlands. Adult patients with bloodstream infection attending the 
emergency department were included. Based on in vitro susceptibility, antibiotic therapy 
was scored as appropriate or inappropriate. Primary outcome was 30-day mortality. To 
control for confounding, we performed conventional multivariable logistic regression 
and propensity score methods. Additionally, we performed an analysis in a more 
homogeneous subgroup (i.e. antibiotic monotherapy).
Results 
We included 1,039 patients, 729 (70.2%) received appropriate therapy. Overall 30-
day mortality was 10.4%. Appropriately treated patients had more unfavourable 
characteristics, indicating more severe illness. Despite adjustments, we found no 
association between appropriate therapy and mortality. For the antibiotic monotherapy 
subgroup (n = 449), patient characteristics were more homogeneous. Within this 
subgroup, appropriate therapy was associated with lower mortality (Odds Ratios [95% 
Confidence Intervals] ranging from: 0.31 [0.14; 0.67] to 0.40 [0.19; 0.85]). 
Conclusions 
Comparing heterogeneous treatment groups distorts associations despite use of common 
methods to prevent bias. Consequently, conclusions of such observational studies 
should be interpreted with care. If possible, future investigators should use our method 
of attempting to identify and analyse the most homogeneous treatment groups nested 
within their study objective, because this minimizes residual confounding.
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Introduction
Bacterial infections can result in considerable mortality and have a profound global 
burden.392-394. Patients with a severe infection (e.g. sepsis) often present in an acute 
care setting, such as the emergency department (ED). Initiation of targeted antibiotic 
therapy in the ED is important in patients with a suspected bacterial infection and is 
possible when the causative pathogen is proven by cultures with determination of the 
antibiogram.395 However, this process usually takes over 24 hours and therefore empirical 
therapy is initiated in the ED. Appropriate empirical antibiotic therapy (i.e. appropriate 
therapy) is defined as applying the antibiotic agent which matches in vitro susceptibility 
of the isolated bacteria, but was initially provided without evidence on the causative 
pathogen or its antibiogram.396 Clinical practice universally assumes that appropriate 
therapy improves survival in patients with bloodstream infection (BSI).
Although an overall beneficial outcome of appropriate antibiotic therapy in patients 
with BSI was demonstrated by meta-analyses,397,398 studies that did not find lower 
mortality continued to be published.48,396,399-404 An explanation for these conflicting data 
is confounding by indication,405 yet this was not investigated in these studies.48,396,399-404 
Confounding by indication arises because patients at risk of dying of BSI are more 
likely to receive broad spectrum antibiotic therapy – thus more often appropriate – as 
physicians want to ensure appropriateness most in severely ill patients.394 This results in 
an imbalance in – measured and unmeasured – patient characteristics (i.e. underlying 
risk profile) between appropriately and inappropriately treated patients, thereby biasing 
the genuine relation between appropriate therapy and mortality.406
The main objective of this study was to examine whether administration of appropriate 
empirical antibiotic therapy affects 30-day mortality in adult patients with BSI attending 
the ED, while minimizing bias due to confounding by indication. Subsequently, we 
focused on methodologically explaining why prior investigators suggested no impact of 
appropriate therapy on survival.
Materials and methods
Study design and setting
We conducted a retrospective cohort study at the Erasmus University Medical Center 
Rotterdam (Erasmus MC), which is a tertiary university hospital in the Netherlands. We 
used data from all patients attending the ED with BSI from July 2012 through December 
2017. Blood cultures are taken in patients suspected for BSI, and subsequently empiric 
antibiotic therapy is started. Antibiotic advice is protocolized in guidelines based on 
local and national prevalence and resistance data.407,408 These guidelines provide an 
advice depending on the suspected source of infection and clinical judgement of severity 
of disease, e.g. working diagnosis.  The Medical Ethics Committee of the Erasmus MC 
concluded that our study did not fall under the scope of the Medical Research Involving 
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Human Subjects Act and therefore no informed consent needed to be obtained. Our 
study is registered under MEC-2018-1450.
Selection of participants
Patients were eligible for inclusion if they were at least 18 years of age and had a laboratory 
proven bacterial BSI at the ED. BSI was defined as presence of a known pathogen in 
one blood culture or a common commensal (e.g. S. epidermidis)409 in at least two blood 
cultures collected on separate occasions within two days from ED admission.409,410 Only 
the first episode of BSI was included to prevent domination of results by individuals that 
frequently visited the ED. 
Data collection and processing
We combined electronic databases with data from the ED and the department of Medical 
Microbiology and Infectious Diseases. The ED database included empiric antibiotic 
therapy administered during the ED visit, potentially relevant and retrospectively 
available patient characteristics (serving as proxies for severity of disease), and mortality. 
Treatment strategy was either no antibiotic therapy, antibiotic monotherapy (if only one 
drug was administered), or antibiotic combination therapy (if more than one drug was 
administered). Also, patient charts were reviewed to assess dosage errors. General and 
demographic patients characteristics collected were: sex, age, arrival (by ambulance 
or other mode of transportation), triage category (according to the Manchester Triage 
System), 411 disposition (direct intensive care unit admittance or other), chills ,412 
vomiting, 412 need for vasopressors, suspected site of infection (unknown, respiratory, 
abdominal, urogenital, skin or soft tissue, intravascular or thorax, central nervous system, 
other), and origin of infection (nosocomial or community-acquired).413 To account for 
severity of disease we used the first recorded vital signs (i.e. body temperature, heart 
rate, respiratory rate, systolic blood pressure, oxygen saturation, and consciousness), 
whether there was need for any supplemental oxygen, and calculated the National early 
warning score (NEWS)(Methods S1). 414,415 Additionally, to account for comorbidity 
we collected all components of the age-adjusted Charlson comorbidity index (CCI) 
(Methods S1).416  The primary outcome was 30-day mortality, because we expected 30 
days to be a biologically plausible window to represent the effect of appropriate therapy 
on mortality.405 For mortality data we used municipal death registration records.
The Medical Microbiology and Infectious Diseases database contained data about 
type of pathogen and their susceptibility (antibiogram) for all positive blood cultures 
collected at the ED. Type of pathogen was identified directly in one millilitre of blood 
by MALDI-TOF MS analysis (Microflex, Bruker Daltonics, Bremen, Germany). 
The in vitro susceptibility to antibiotic agents testing was performed with VITEK 2 
(bioMérieux, Marcy l’Etoile, France). Based on earlier applied antibiotic therapy at the 
ED and established susceptibility of the isolated pathogen, appropriateness of empirical 
therapy administered at the ED was scored. In accordance with previous studies, no 
empiric antibiotic therapy, ineffective antibiotic therapy (based on antibiogram or if a 
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dosage error was reported), or not intravenously administered antibiotic therapy (except 
for antibiotics with high bioavailability, i.e. metronidazole and ciprofloxacin) were all 
considered inappropriate.396-405 
Data analysis and control for confounding bias
For descriptive statistics we examined all patient characteristics among appropriately 
versus (vs.) inappropriately treated patients. Based on distribution data were tested with 
an unpaired t-test, chi-squared test, or Fisher’s exact test.
We considered patient characteristics as confounders during further analyses if, based 
on expert knowledge, controlling for the variable would reduce bias when studying the 
relation between appropriate therapy and 30-day mortality.406 To improve our propensity 
score methods, we only included potential confounding variables in our models that 
were statistically related to outcome, as this decreases variance without increasing bias 
(Methods S2).417
We conducted inferential statistics to investigate the association between appropriate 
therapy and 30-day mortality while attempting to control for confounding by indication. 
Results were presented as odds ratios (OR) with 95% confidence intervals (CI). We 
handled missing data using multiple imputations. For efficiency purposes we imputed 20 
datasets using the chained equations method.418
To limit confounding by indication, we controlled for measured proxies of disease severity 
(e.g. arrival mode, triage category, direct intensive care unit admittance, components of 
NEWS, components of CCI) with multiple statistical techniques. First, we performed 
a conventional multivariable logistic regression analysis. However, this method is 
known to fall short in case of confounding by indication.419 Therefore, secondly, we 
used propensity score methods. Propensity score methods directly focus on indication 
for treatment under study and potentially provide more precise estimates in studies in 
which confounding by indication may occur.419 We applied three analytical procedures 
with the obtained propensity scores, namely 1) adjustment by logistic regression, 2) 
stratification, and 3) inverse probability of treatment weighting (Methods S2).420-422 To 
assess the impact of potential contaminated BSI (i.e. those with a common commensal 
on multiple blood cultures), we subsequently performed a sensitivity analysis after 
exclusion of these patients.
Finally, we attempted to limit confounding bias by selecting patients treated with 
– appropriate or inappropriate – antibiotic monotherapy. When comparing the 
total appropriately to inappropriately treated group, we expected various degrees of 
confounding bias for different treatment strategies (i.e. no antibiotic therapy, antibiotic 
combination therapy, antibiotic monotherapy). We expected that patients with the lowest 
acuity and the lowest risk of dying would more often receive no – thus inappropriate – 
antibiotic therapy. We also expected that severely ill patients with high chance of dying 
are more likely to receive antibiotic combination therapy to broaden the spectrum, 
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Table 1: Patient characteristics in appropriately versus inappropriately treated patients  
(total population)
Appropriate 
n = 729 (70.2)
Inappropriate 
n = 310 (29.8)
P-value
Characteristic
Sex, male 425 (58.3) 201 (64.8) .06
Age, mean (SD), years* 60.9 (15.5) 60.1 (15.9) .44
Arrival by ambulance* 202 (27.7) 47 (15.2) <.001
Triage category, acute/highly urgent*,† 205 (29.6) 33 (11.1) <.001
Direct intensive care unit admittance* 66 (9.1) 8 (2.6) <.001
Chills* 311 (42.7) 134 (43.2) .92
Vomiting 178 (24.4) 68 (21.9) .43
Need for vasopressors* 36 (4.9) 5 (1.6) .02
Suspected site of infection, unknown 169 (23.2) 70 (22.6) .90
Origin, nosocomial 384 (52.7) 175 (56.5) .29
Comorbidities, any‡‡ 673 (92.3) 277 (89.4) .15
Antibiotic treatment strategy
Combination therapy 382 (52.4) 22 (7.1) <.001
Monotherapy 347 (47.6) 102 (32.9) <.001
No antibiotic therapy 0 (0.0) 186 (60.0) <.001
Vital signs
Body temperature, mean (SD), °C*,‡ 38.4 (1.2) 38.0 (1.1) <.001
Heart rate, mean (SD), /min§ 108 (23.8) 100 (19.6) <.001
Respiratory rate, mean (SD), /min*,‖ 24 (8.5) 21 (7.1) <.001
Systolic blood pressure, mean (SD), mmHg*,¶ 125 (28.5) 125 (24.5) .77
Oxygen saturation, mean (SD), %** 95 (5.8) 96 (2.4) <.001
Any supplemental oxygen* 339 (46.5) 62 (20.0) <.001
Consciousness, not alert*,†† 96 (15.5) 16 (6.5) <.001
NEWS, mean (SD) 6.0 (3.8) 3.8 (3.1) <.001
Data are presented as No. (%) unless otherwise indicated. Data in this table is not imputed yet. NEWS, national early warn-
ing score. *Confounding variables. †Data on triage category were missing for 50 (4.6%) patients. ‡Data on body temperature 
were missing for 9 (0.9%) patients. §Data on heart rate were missing for 24 (2.3%) patients. ‖Data on respiratory rate were 
missing for 370 (35.5%) patients. ¶Data on systolic blood pressure were missing for 20 (1.9%) patients. **Data on oxygen 
saturation were missing for 43 (4.3%) patients. ††Data on consciousness were missing for 175 (16.8%) patients. ‡‡Table S1.
resulting in more often appropriate therapy. Therefore, when studying the relation 
between appropriate therapy and mortality in the total population, including these 
treatment strategies potentially contributes to large heterogeneity between appropriately 
and inappropriately treated patients, which increases risk of confounding bias. We 
expected that the subset of patients who received antibiotic monotherapy was the least 
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confounded group with more homogeneous measured and unmeasured confounders. 
All hypothesis tests were 2-sided, with a significance level of P <.05. Statistical analyses 
were performed using R version 3.4.4. 
Results
Patient characteristics 
We identified 1.286 adult patients with a positive laboratory proven blood culture 
taken at the ED. We excluded 247 patients with recurrent BSI, resulting in 1.039 unique 
patients of whom 729 (70.2%) received appropriate therapy and 310 (29.8%) received 
inappropriate therapy. Mortality was 10.4%. Patient characteristics are shown in Table 1. 
Patients receiving appropriate therapy had less favourable measured characteristics than 
patients receiving inappropriate antibiotic therapy: they more frequently arrived by 
ambulance (27.7% vs. 15.2%), had higher triage categories (29.6 % vs. 11.1%), were more 
often admitted directly to the intensive care unit (9.1% vs. 2.6%), needed vasopressors 
more frequently (4.9% vs. 1.6%), and received more antibiotic combination therapy 
(52.4% vs. 7.1%). In addition, appropriately treated patients had more abnormal vital 
signs and on average a higher NEWS of 6.0 (± 3.8) vs. 3.8 (± 3.1). 
Appropriate empirical antibiotic therapy and 30-day mortality 
Crude 30-day mortality for appropriately treated patients was 11.1% (81 patients) vs. 
8.7% (27 patients) for inappropriately treated patients (OR [95%CI]: 1.31 [0.84; 2.10]). 
There was no association between appropriate therapy and 30-day mortality after 
conventional adjustment for confounders, adjustment for propensity score, propensity 
score stratification and inverse probability of treatment weighting (OR[95%CI] ranging 
from: 0.71 [0.43; 1.19] to 1.03 [0.76; 1.40], Fig 1). 
For sensitivity analysis, we examined the impact of excluding patients with common 
commensal bacteria on multiple blood cultures collected on separate occasions within 
two days from ED admission. In our study, 24 patients had at least two subsequent blood 
cultures with a common commensal (17 Staphylococcus epidermidis, 3 Staphylococcus 
hominis, 1 Bacillus licheniformis, 1 Rhodococcus equi, 1 Staphylococcus capitis, and 1 
Staphylococcus lugdunensis). Appropriate therapy was administered in 9 (37.5%) patients. 
Excluding these patients did not affect our results.
Subgroup analysis antibiotic monotherapy
There were 449 patients treated with antibiotic monotherapy of whom 347 (77.3%) 
received appropriate therapy. Mortality was 7.1%. Patient characteristics were comparable 
for appropriately and inappropriately treated patients, indicating more homogeneity in 
the monotherapy subgroup compared to the total population (Table 2). 
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Figure 1. Estimates of appropriate empirical antibiotic therapy on 30-day mortality (total population).
CI: confidence interval. Confounding variables: age, arrival, triage category, direct intensive care unit admittance, chills, need 
for vasopressors, body temperature, respiratory rate, systolic blood pressure, supplemental oxygen, consciousness, diabetes 
mellitus with end-organ damage, mild liver disease, malignancy, chronic kidney disease, chronic obstructive pulmonary 
 disease, cerebrovascular accident or transient ischemic attack, and dementia. For a detailed description of statistical 
adjustment techniques, see Methods S2. This figure shows attenuation of estimates after adjustment for confounders.
Figure 2. Estimates of appropriate empirical antibiotic therapy on 30-day mortality (antibiotic monotherapy).
CI: confidence interval. Confounding variables: age, arrival, triage category, direct intensive care unit admittance, chills, 
need for vasopressors, body temperature, respiratory rate, systolic blood pressure, supplemental oxygen, consciousness, 
diabetes mellitus with end-organ damage, mild liver disease, malignancy, chronic kidney disease, chronic obstructive pulmonary 
disease, cerebrovascular accident or transient ischemic attack, and dementia. For a detailed description of statistical 
adjustment techniques, see Methods S2. This figure shows attenuation of estimates after adjustment for confounders.
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In the monotherapy subgroup, crude 30-day mortality for appropriately treated patients 
was 5.5% (19 patients) vs. 12.7% (13 patients) for inappropriately treated patients. 
Appropriate therapy was associated with lower 30-day mortality after crude estimation, 
adjustment for propensity score, propensity score stratification, and inverse probability 
of treatment weighting (OR [95%CI] ranging from: 0.31 [0.14; 0.67] to 0.40 [0.19; 0.85], 
Figure 2). Conventional adjustment for confounders had an OR with 95%CI of 0.41 [0.14; 
1.18].
Table 2: Patient characteristics in appropriately versus inappropriately treated patients  
(antibiotic monotherapy)
Appropriate 
n = 347 (77.3)
Inappropriate 
n = 102 (22.7)
P-value
Characteristic
Sex, male 200 (57.6) 67 (65.7) .18
Age, mean (SD), years* 60.1 (15.4) 63.0 (15.1) .09
Arrival by ambulance* 55 (15.9) 14 (13.7) .71
Triage category, acute/highly urgent* 52 (15.7) 12 (12.2) .49
Direct intensive care unit admittance* 10 (2.9) 2 (1.9) >.99
Chills* 164 (47.3) 47 (46.1) .92
Vomiting 86 (24.8) 21 (20.6) .46
Need for vasopressors* 3 (0.9) 2 (2.0) .70
Suspected site of infection, unknown 86 (24.8) 20 (19.6) .34
Origin, nosocomial 207 (59.7) 63 (61.8) .79
Comorbidities, any† 322 (92.8) 95 (93.1) >.99
Vital signs
Body temperature, mean (SD), °C* 38.3 (1.1) 38.1 (1.2) .05
Heart rate, mean (SD), beats/min 103 (20.6) 100 (21.6) .21
Respiratory rate, mean (SD), breaths/min* 21 (7.0) 20 (6.4) .21
Systolic blood pressure, mean (SD), mmHg* 128 (25.7) 123 (21.1) .05
Oxygen saturation, mean (SD), % 96 (5.5) 96 (2.3) .67
Any supplemental oxygen* 106 (30.5) 33 (32.4) .82
Consciousness, not alert* 18 (6.3) 7 (8.5) .65
NEWS, mean (SD) 4.5 (3.0) 4.3 (3.4) .48
Data are presented as No. (%) unless otherwise indicated. Data in this table is not imputed yet. NEWS: national early 
warning score. *Confounding variables. †Table S2.
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Discussion
This study aimed to address the confounding that exists in establishing the effects 
of antibiotic appropriateness in patients with BSI. Despite extensive adjustment for 
confounding, we found no association between appropriate empirical antibiotic therapy 
and mortality when assessing all patients. This finding – in line with previous studies 
396,399-404 – remains counterintuitive and is in contrast to fundamentals of current clinical 
practice. 394
We hypothesized that confounding by indication was the explanation for finding no 
association between appropriate therapy and mortality in previous studies. Patients 
at risk of dying of BSI are more likely to receive broad spectrum antibiotic – thus 
more often appropriate – therapy as physicians want to ensure appropriateness most 
in severely ill patients. As a result, the association between appropriate therapy and 
mortality is biased. In our study, the first clue for confounding by indication was more 
unfavourable patient characteristics in the appropriately treated group. We noticed this 
heterogeneity as well in the study of Anderson et al., which also found no association 
between appropriate therapy and mortality. 404 However, the authors did not consider 
confounding by indication as a potential explanation for their findings. 404 A second 
clue for confounding was attenuation of estimates when controlling for bias – with both 
conventional multivariable logistic regression and propensity score methods. We noticed 
that in prior studies, that also found no association, there was attenuation of estimates 
after adjustment for confounders. 401,402 Since we only adjusted for observed confounders, 
unmeasured – residual – confounders could still be of potential bias. 
Chance of residual confounding is absent in totally homogenous groups (e.g. as in 
an ideal randomized controlled trial). 406 Our total population was heterogeneous in 
measured patient characteristics and we expected various degrees of confounding 
bias for different treatment strategies. We expected that patients receiving antibiotic 
combination – thus more often appropriate – therapy were the most ill and patients 
receiving no antibiotic therapy – thus inappropriate therapy – were the lower acuity 
patients. The remainder of patients received antibiotic monotherapy. Therefore, to obtain 
more homogeneous patient groups we performed a subgroup analysis for patients treated 
with antibiotic monotherapy. Physicians chose to treat these patients with antibiotic 
monotherapy, presumably based on a more comparable judgment of illness. In addition, 
the severely confounded treatment strategies – i.e. antibiotic combination therapy and 
no antibiotic therapy – are per definition excluded during this subgroup analysis. We 
found that for antibiotic monotherapy measured patient characteristics of appropriately 
and inappropriately treated patients were more homogeneous, lowering the chance of 
residual confounding. In this subgroup appropriate therapy was associated with lower 
30-day mortality. This finding is in line with our expectations and current practice, and 
supports our hypothesis that residual confounding distorts associations when comparing 
heterogeneous treatment groups.
Reducing confounding by indication through analysing homogeneous subgroups – in 
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our study antibiotic monotherapy – is not often done. Previous studies on appropriate 
therapy and mortality disregarded severely confounded treatment strategies (i.e. 
antibiotic combination therapy, no antibiotic therapy), which resulted in comparison of 
heterogeneous groups. 396,399-404 Therefore, the conclusions of these studies are potentially 
not trustworthy.
To prevent confounding, we adjusted for validated risk scores (e.g. NEWS, CCI) and 
applied several adjustment techniques (i.e. conventional multivariable logistic regression 
and propensity score methods). However, for the total population, these techniques 
fell short and we were unable to prevent bias. Apparently, a physicians’ decision to 
initiate a certain therapy is not only based on findings that are represented by such risk 
score systems, hence statistical adjustment techniques fall short. Thus, conclusions of 
observational studies comparing heterogeneous groups should be interpreted with care. 
If possible, future investigators should use our method of attempting to identify and 
analyse the most homogeneous treatment groups nested within their study objective, as 
we demonstrated that this minimizes residual confounding. 
Limitations
Our study has limitations. First, we used retrospectively collected data making our study 
prone to bias. However, the quality of available data was assumed to be high as all data 
used was essential for daily clinical practice. For only 13 patients (1.3%) documentation 
was unclear on whether antibiotic therapy was administered at the ED or after discharge, 
therefore we scored them as inappropriate therapy. 
Also, we want to emphasize that we considered the association between empiric 
antibiotic treatment at the ED and 30-day mortality, as this was our main study objective. 
Depending on disease course and culture results, antibiotic treatment could have been 
modified later on resulting in a different definitive antibiotic treatment. Aside from 
empiric antibiotic treatment at the ED, this may have altered survival as well. 
Conclusions
We initially found that appropriate empirical antibiotic therapy was not beneficial in 
patients with BSI. We showed that this counterintuitive finding was presumably the 
result of residual confounding. Analysing heterogeneous treatment groups results in 
confounding, which distorts associations and subsequent conclusions despite the use 
of common methods to prevent bias. With a subgroup analysis in a more homogeneous 
population (i.e. antibiotic monotherapy), we found the expected benefit of appropriate 
therapy. Our study underlines the complexities of performing clinical observational 
research. In case of heterogeneous groups results should always be interpreted with 
care. If possible, future investigators should attempt to identify and analyse the most 
homogeneous treatment groups nested within their study objective, because this 
minimizes residual confounding.
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Supporting information files 
Methods S1. Detailed description variables 
National early warning score 
We collected all vital signs of the National early warning score (NEWS):414 body 
temperature, heart rate, respiratory rate, systolic blood pressure, oxygen saturation, any 
supplemental oxygen, and consciousness (AVPU score: alert, voice, pain, unresponsive).414
Each vital sign was graded 0-3.414 Scores for vital signs were added to obtain a total score. 
A NEWS over 7 triggers urgent clinical review. See supplementary methods S1 Table 1 
for more information about grading of vital signs.414 
Methods S1 Table 1: National early warning score grading
Grading of vital signs 3 2 1 0 1 2 3
Body temperature, °C < 35.0 35.1–36.0 36.1–38.0 38.1–39.0 > 39.0
Heart rate, beats/min < 41 41–50 51–90 91–110 111–130 > 130
Respiratory rate, breaths/min < 91 91–100 101–110 111–219 > 219
Systolic blood pressure < 9 9–11 12–20 21–24 > 25
Oxygen saturation < 92 92–93 94–95 > 96
Any supplemental oxygen Yes No
Consciousness AVPU  
(Alert, Verbal, Pain, Unresponsive)
Alert Not alert
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Table S1: Comorbidities of Charlson comorbidity index (total population)
Comorbidities Appropriate 
n = 729 (70.2)
Inappropriate 
 n = 310 (29.8)
P value
Diabetes mellitus, uncomplicated 147 (20.2) 53 (17.1) .29
Diabetes mellitus, end-organ damage* 10 (1.4) 3 (1.0) .77
Liver disease, mild* 93 (12.8) 47 (15.2) . 35
Liver disease, moderate to severe 6 (0.8) 3 (1.0) >.99
Malignancy, leukaemia, lymphoma, localized solid 
tumour* 
120 (16.5) 61 (19.7) .25
Malignancy, metastatic solid tumour* 93 (12.8) 40 (12.9) >.99
Acquired immunodeficiency syndrome 2 (0.3) 1 (0.3) >.99
Chronic kidney disease* 124 (17.0) 45 (14.5) .37
Congestive heart failure 96 (13.2) 37 (11.9) .66
Myocardial infarction 103 (14.1) 36 (11.6) .32
Chronic obstructive pulmonary disease* 95 (13.0) 39 (12.6) .92
Perivascular disease 77 (10.6) 44 (14.2) .12
Cerebrovascular accident or transient ischemic attack* 115 (15.8) 26 (8.4) .002
Dementia* 30 (4.1) 6 (1.9) .12
Hemiplegia 3 (0.4) 0 (0.0) .62
Connective tissue disease 57 (7.8) 20 (6.5) .52
Peptic ulcer disease 17 (2.3) 8 (2.6) >.99
Data are presented as No. (%) unless otherwise indicated. *Confounding variables.
Charlson comorbidity index 
We collected all comorbidities of the Charlson comorbidity index (CCI):416 diabetes 
mellitus (uncomplicated or end-organ damage), liver disease (mild or moderate to severe), 
malignancy (leukaemia, lymphoma, localized solid tumour, or metastatic solid tumour), 
acquired immunodeficiency syndrome, chronic kidney disease, congestive heart failure, 
myocardial infarction, chronic obstructive pulmonary disease, peripheral vascular 
disease, cerebrovascular accident or transient ischemic attack, dementia, hemiplegia, 
connective tissue disease, and peptic ulcer disease.
Chapter 13
234
Methods S2. Statistical appendix
Propensity score methods 
We obtained the propensity score by multivariable logistic regression, with appropriate 
empirical antibiotic therapy (AEAT) as dependent variable and all confounders as 
independent variables. The propensity score is a balancing score, ranging from 0 to 1, 
representing probability of AEAT assignment conditional on observed confounders.420
We applied three analytical procedures with the obtained propensity score. First, we used 
the propensity score as single independent covariate representing all confounders during 
logistic regression. Then we stratified on propensity score by bins of 0.1. For patients 
within the same bin, distribution of observed confounders is conditionally similar for 
appropriately and inappropriately treated patients if there is overlap in propensity score. 
This concept mimics process of randomization. After trimming all patients with non-
overlapping propensity scores we obtained odds ratios with standard comparison and 
performed Mantel-Haenszel pooling.420 Finally, we used inverse probability of treatment 
weighting as adjustment technique, which uses the propensity score as a weight during 
subsequent standard comparison.417
Based on previous simulation studies, we only included potential confounding variables 
in our statistical models that were statistically related to outcome (relative risk > 1.3) 
as this decreases variance without increasing bias]. 417 This is mainly important for 
our propensity score model. Including variables not associated with outcome (30-day 
mortality), but with exposure (AEAT) can lead to overseparation.
Propensity scores were estimated in our total population and subsequently used in 
subgroup analyses (i.e. antibiotic monotherapy). Recent simulation studies showed this 
is a feasible approach.422
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Table S2: Comorbidities of Charlson comorbidity index (antibiotic monotherapy)
Comorbidities Appropriate 
n = 347 (77.3)
Inappropriate 
 n = 102 (22.7)
P value
Diabetes mellitus, uncomplicated 64 (18.4) 17 (16.7) .79
Diabetes mellitus, end-organ damage* 5 (1.4) 0 (0.0) .59
Liver disease, mild* 53 (15.3) 15 (14.7) >.99
Liver disease, moderate to severe 2 (0.6) 2 (2.0) .22
Malignancy, leukaemia, lymphoma, localized solid tumour* 64 (18.4) 20 (19.6) .90
Malignancy, metastatic solid tumour* 45 (13.0) 19 (18.6) .20
Acquired immunodeficiency syndrome 2 (0.6) 1 (1.0) .54
Chronic kidney disease* 85 (24.5) 21 (20.6) .49
Congestive heart failure 52 (15.0) 11 (10.8) .36
Myocardial infarction 48 (13.8) 16 (15.7) .76
Chronic obstructive pulmonary disease* 39 (11.2) 19 (18.6) .07
Perivascular disease 31 (8.9) 13 (12.7) .34
Cerebrovascular accident or transient ischemic attack* 57 (16.4) 11 (10.8) .21
Dementia* 11 (3.2) 1 (1.0) .39
Hemiplegia 1 (0.3) 0 (0.0) >.99
Connective tissue disease 27 (7.8) 6 (5.9) .67
Peptic ulcer disease 9 (2.6) 3 (2.9) .88
Data are presented as No. (%) unless otherwise indicated. *Confounding variables. 
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Discussion
In 2012, acute medicine was recognized as a subspecialty of internal medicine in the 
Netherlands. Acute medicine has evolved since then and is nowadays a fully-fledged 
specialisation of internal medicine.  However, compared to most other subspecialties 
in internal medicine, research in acute medicine is still in its infancy. The research 
described in this thesis addresses the diversity of pathology encountered in the 
Emergency Department (ED) in order to improve quality of patient care in the acute care 
chain. This thesis aims to add to this area by studying: 1) the value of history, physical 
examination, and additional testing in the early identification of severity of illness in 
individual patients; 2) prediction models for risk of admission, mortality or catastrophic 
deterioration and early warning systems to identify the most severely ill; 3) factors 
that influence the choice of antibiotic therapy in patients with suspected infection and 
predictors of antibiotic susceptibility, in order to achieve appropriate antibiotic treatment 
in the severely ill. 
In this chapter we summarize the main findings of this thesis, discuss these findings and 
place them under a unifying perspective. Last, we give suggestions for further research. 
The value of history taking, clinical examination and additional 
testing in the early identification of illness in individual patients
Despite an ongoing increase in readily available technology in medicine, evidence still 
supports the importance of history taking and physical examination in diagnosis in 
the ED, in order to ensure appropriate treatment.423 The timing and sequence of history 
taking and physical examination as part of the overall assessment differ between acutely 
and non-acutely ill patients. Ideally, in acutely ill patients the ABCDE approach is used 
to assess the patient and initiate treatment, while in non-acutely ill patients a complete 
history and physical examination is performed. In the ABCDE approach each step life-
threatening problems should be treated before continuing to the next, following the 
principles “Treat first what kills first” and “Do no further harm”. This approach was first 
used in the Advanced Trauma Life Support, which was developed by James Styner in 
1976,22 and are incorporated in many courses for management of acutely ill patients, such 
as the ALS course.424 Despite its more than 30 years history, there remains insufficient 
evidence that use of the ABCDE approach in acutely ill patients reduces death rates and 
disability, being supported primarily by expert consensus.383 There is a positive effect of 
training the ABCDE approach on cognitive knowledge, critical decision making and 
practical skills.425   
In this first part of this thesis we studied the value of history, physical examination and 
additional testing in the early identification of severity of illness in individual patients.
In the ABCDE approach, ‘Circulation’ is assessed in order to identify a patient in 
shock. Physicians use clinical examination, vital signs and laboratory testing and other 
diagnostic findings, in order to predict the type and severity of shock.426-428 A low systolic 
blood pressure is commonly associated with shock, and hypotension (i.e. systolic blood 
pressure ≤ 90 mmHg) is widely accepted as a potential sign of circulatory failure. However, 
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hypotensive patients can have normal tissue perfusion, and, as we show in Chapter 
6, hypotension can have a benign aetiology, as in patients with postural orthostatic 
tachycardia syndrome (POTS), where a change to supine position leads to hypotension 
and tachycardia. Also, normotension does not rule out shock since in some patients 
with shock the blood pressure can be normal, as the result of habitual hypertension, 
or when compensation mechanisms are still intact (i.e. compensated shock).24,429  In 
compensated shock heart rate increases, but this increase can be influenced by patient 
factors (e.g. anxiety, resting heart rate) as well as medications.429 In patients with shock, 
respiratory rate increases first, even before an increase in heart rate or a drop in blood 
pressure. This makes respiratory rate a clinically strong and early indicator of (worsening 
of) illness and shock.430 However, the reliability of measurements of respiratory rate is 
mostly poor. In the ED, respiratory rates are often estimated instead of actually counted, 
431 resulting in inaccurate measurements. When it is counted for an abbreviated period 
rather than a full minute (e.g. 15 or 30 seconds), measurements are less accurate.432,433 
Individuals who are aware that their respiratory rate is being assessed tend to breathe 
more slowly.432 A study in six large tertiary-care centres in the United States showed that 
72% of the respiratory rates recorded in patient charts were 18 or 20 per minute. When 
they counted respiratory rates for 60 seconds, these rates were found in only 13% of 
the patients and they concluded that respiratory rates of 18 and 20 are overrepresented 
in patient charts.68 Thus, in order to be of use in the early detection of severe illness 
respiratory rate should be properly measured, preferably by both nurses and physicians, 
and it should be counted for a longer period of time, or appropriate adjuncts should be 
used (e.g. stopwatch, mobile applications) . 
Physicians do not only rely on vital signs; they also make use of clinical parameters 
such as altered mentation, cold, clammy, mottled skin and oliguria. These clinical 
parameters are the consequences of microvascular alterations. In the early phases 
of shock compensatory mechanisms lead to reduced blood flow in skin and muscle, 
resulting in a cold and mottled skin. Sweating stops in order to maintain sufficient fluid 
for the circulation. These parameters can be non-invasively assessed using the capillary 
refill time, mottling scores (e.g. the knee mottling score) and temperature assessment 
of the extremities or an increased peripheral temperature gradient – all of these reflect 
an impaired circulation.27,426,434  Most of these parameters have been validated in studies 
within intensive care units (ICUs) 27 but validation studies in the ED are lacking, despite 
also being frequently used in this setting. Unfortunately, even when using these clinical 
parameters the accuracy of physicians for recognizing a compromised circulation hovers 
around 50%.27 
To improve diagnostic accuracy, physicians also employ laboratory testing (clinical 
chemistry) for biochemical parameters. The most used marker for hypoperfusion is 
lactate,426 and hyperlactatemia (i.e. lactate > 2mEq/L) is part of the latest definition 
of septic shock.16 In the ICU, hyperlactatemia is associated with worse outcomes.435 
This association was initially confirmed in the ED.436,437 However, a study of Lee et 
al. on septic patients showed that lactic acidosis was better than hyperlactatemia in 
predicting in hospital mortality438 and a study of van den Nouland et al. showed that 
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outcome of patients with an elevated lactate was related to the underlying cause of the 
hyperlactatemia (i.e. type A (tissue hypoxia) or type B (non-hypoxia)).439 Hohenstein et 
al. showed that the use of lactate in an unselected population is limited, as an elevated 
lactate was only associated with hospitalization.440 Thus, there is little value derived from 
a single elevated lactate measurement in an unselected population – especially in the ED, 
except potentially among patients in whom shock is suspected. 
In order to assess the usability of capillary refill time (CRT) as part of initial assessment 
of the circulation, we studied in Chapter 2 the interobserver agreement on CRT, which 
was moderate at best. We confirmed that CRT should be corrected for age and sex, as it 
increases with age and differs between sexes. Although already published in 1988,50 these 
corrections are not generally used, as most assessments still use a dichotomized cut-off 
value of 2 seconds.424 The low interobserver agreement, the variability between different 
sexes and age groups and the low discriminative power all make CRT an unsuitable 
screening test in the assessment of circulation. However, repeated measurements of 
CRT can be used as a parameter for the monitoring of circulation. In a study among 
patients with septic shock admitted at the ICU a resuscitation strategy that targeted 
normalization of capillary refill time was shown to be as good as a strategy targeting 
serum lactate levels. Despite the fact that all patients were admitted to the ICU, in 25% 
of them the CRT was not prolonged, also illustrating that CRT is not appropriate as a 
screening test to predict severity of illness in the ED.441
Another parameter that is used to assess the circulation is an increased peripheral 
temperature gradient: an underarm to fingertip difference of more than 4 degrees Celsius 
is associated with both increased mortality and morbidity in ICU patients,442 but this 
temperature gradient should not be used without other hemodynamic parameters.434 In 
Chapter 3 we were unable to validate the association between an increased temperature 
gradient and potential shock in an ED population. We also studied the perfusion 
index (PI) and the pleth variability index (PVI), which are both derived from the pulse 
oximeter, and are therefore easy to obtain. Changes in the PI reflect changes in peripheral 
temperature and can potentially be used to more objectively assess peripheral perfusion 
in critically ill patients.443 PVI is an automatic measurement of the respiratory variation 
of the plethysmographic waveform, and is therefore potentially useful in predicting 
fluid deficit and fluid responsiveness.444 Unfortunately both PI and PVI were unable to 
distinguish patients with a decreased cardiac output. 
There are several explanations for the conflicting results between our findings and 
existing literature. First, patients in the ED are more influenced by ambient factors in 
comparison to hospitalized patients. Assessment takes place shortly after admission 
in the ED and patients come from their homes or in less controlled environments 
(e.g. ambulance, car, open air). This is in contrast with the ICU and operating rooms, 
which often have strictly controlled environments. Ambient temperature has an effect 
both on skin temperature and peripheral circulation and it also affects the usefulness 
of measurements CRT, temperature gradients, PI and PVI. Another explanation is that 
patients presenting in the ED more likely to be in the earlier phases of illness, and shock 
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is still being compensated, making diagnosis more difficult. Lastly, patients are more 
mobile in the ED than in the ICU or during surgery. In the ED they are most often 
not sedated, whereas patients who are acutely ill often have impaired consciousness 
(as a consequence of illness or medication) and they are harder to instruct, resulting 
in artefacts and interference with measurements. This  shows that not all the results of 
studies performed in the ICU can be directly applied in the ED, and that studies that 
proved beneficial in the ICU should be first be validated outside the ICU, for example, in 
the ED or the wards.
Of the potential indices we evaluated in the ED, only axillary humidity – measured by a 
hygrometer - showed an association with fluid deficit. Measurement with a hygrometer 
is an improvement compared to the older studies on axillary humidity, where it was 
subjectively measured by assessing the moistness of a patient’s armpits, or by weighing 
tissues which absorbed sweat.26 We see the potential of hygrometer-derived axillary 
humidity for use within the in-hospital and prehospital settings and for both screening 
and monitoring. This is particularly useful for monitoring patient groups that have a 
greater risk for dehydration, such as elderly and children. Measuring axillary humidity 
can potentially yield more useful insights on fluid deficit compared to using physical 
signs, such as blood pressure, heart rate, CRT, skin turgor and dry mucous membranes. 
However, its current form prevents it from being directly put in to practice, and improved 
and validated sensors are needed.
Patients suspected of fluid deficit (i.e. dehydration and volume depletion) are treated with 
fluid therapy. The use of fluid therapy is already changing from liberal to restrictive. Still, 
the surviving sepsis campaign guidelines advise rapid administration of crystalloids 
(30mL/kg body weight).44 This is a strong recommendation; however, evidence from the 
literature is sparse and in the management of patients with septic shock this early goal-
directed therapy failed to reduce mortality compared to usual care.445,446 Aggressive fluid 
therapy is not without risks. There is an association between a positive fluid balance and 
an increased risk of acute kidney injury.445 In many patients in the ED fluids are initiated, 
and, as we show in Chapter 7, this affects further course of hospitalization. Patients who 
received intravenous fluids urinated more frequently in the hospital than at home. This 
is a sign that their fluid status did not require that much additional fluids and that the 
amount of intravenous fluids potentially could have been lowered or even stopped. It 
might be better to do more fluid resuscitation more aggressively for patients in the ED, 
but more judiciously when they go to the wards in order to prevent iatrogenic damage. It 
will also contribute to a better quality of sleep. 
In Chapter 4, we studied patients with severely elevated blood pressure in the ED. We 
found that hypertensive urgency and emergency could not be ruled out based on history 
and physical examination alone. The Dutch clinical practice guideline on hypertensive 
urgency and emergency which advises additional tests was inconsistently followed. 
Although guidelines are developed to improve the quality of care received by patients, 
not all recommendations in guidelines seem appropriate and valid, and there are more 
guidelines that are not strictly followed.447,448 Physicians can – and should - deviate from 
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guidelines, based on proper arguments. However, when deviating from the guidelines 
based on history and physical examination, physicians should know the probability 
of disease and the sensitivity, specificity and diagnostic accuracy of history, physical 
examination and additional testing and, ideally, guidelines should be based on studies 
containing such information. Benabbas et al. systematically reviewed paediatric acute 
appendicitis and found that no single finding during history and physical examination 
could eliminate the need for imaging. A negative ultrasound should be followed by a CT 
or MRI,449 and this is implemented in Dutch guidelines, for both children and adults.50,451 
In a review on  ED patients with suspected acute coronary syndromes (ACS), Dezman et 
al. concluded that findings in history and physical examination can be used to identify 
high and low risk groups for acute coronary syndrome, but further investigation with 
laboratory measurements and electrocardiogram is required to safely rule it out,452 
and this is also implemented in primary and secondary healthcare guidelines.453,454 We 
recommend not to deviate from the guideline on severe hypertension solely based on 
history taking and physical examination. 
In Chapter 5 we describe patients in the ED with medically unexplained physical 
symptoms (MUPS). In this study, the patient characteristics of in-patients with MUPS 
were similar to those of outpatients with MUPS. On the other hand, characteristics of 
patients referred by a GP differed from those who self-presented at the ED. Referred 
patients had more cardiorespiratory complaints, while self-presenting patients presented 
more with (abdominal) pain and fatigue. These differences might be the result of 
guidelines. GP guidelines state that patients with suspected ACS or pulmonary embolism 
should be (immediately) referred to a hospital, whereas watchful waiting can be done in 
patients with abdominal pain that is unlikely to be an acute abdomen. It is possible that 
GPs followed these guidelines, but it could also be a result of a physician’s judgement 
that patients presenting with (abdominal) pain and fatigue are “not sick” or are “low 
acuity” patients, which is in line with studies on GPs and MUPS. This is supported by 
the finding that self-referred patients with MUPS received less medication and follow up 
appointments compared to other patients. If it was a result of judgment, the question is 
whether this is based on intuitive or informed decisions.
In the ED, physicians often need to make decisions within a limited time and using 
limited information. They are focused on swiftly distinguishing patients who are 
“sick” from those who are “not sick”.455 This process, also known as ‘system 1’, or ‘gut 
feeling’, is a fast, automatic and unconscious process which requires minimal effort, 
and is in contrast to  ‘system 2’, which is a slow, controlled and conscious process.456 
In a study on ‘system 1’ thinking, Wiswell et al. found that emergency physicians are 
able to accurately predict patient disposition based on short observation of patients in 
combination with demographics and vital signs, but the prognostic accuracy and the 
assessment of acuity were limited.455 System 1 frequently makes use of heuristics – a term 
for an “aid to problem solving which is learned from experience”.456 The speediness in 
diagnostics might result in lower accuracy, and heuristics are often linked to cognitive 
bias.456 Cognitive bias is a risk for the quality of care, especially in situations with limited 
time.457 Kline et al. showed in a study on patients suspect for pulmonary embolism that 
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if physicians recalled that patients were smiling, they overestimated the probability of 
an alternative diagnosis, which was associated with a less accurate Wells' criteria.458 
Cognitive bias might  also partially explain deviation of the guidelines in Chapter 4, as it 
occurred in patients in the ED with severe hypertension but without complaints, making 
them “not sick” or “at risk”. 
To prevent errors as a result of cognitive bias, physicians should be trained in recognising 
bias and in measures to prevent (or mitigate) bias, so that they can optimally use both 
subconscious and deliberate decisions in their final diagnoses.  
To conclude the findings in first part of the thesis, physicians rely on history and physical 
examination in the management of both low and high acuity patients, and they should 
continue to do so. They are aided in this process by diagnostic tests. Additional tests 
that have proven to be valuable in non-ED setting (e.g. ICU, operating rooms) should be 
validated first in the ED before use, as studies on diagnostic testing in the ED were not 
always able to replicate findings. Physicians should, as much as possible, be informed or 
educated on sensitivity, specificity and diagnostic accuracy of the tools they use, and on 
factors that may bias their decision making. This knowledge, will provide better insight 
on which negative findings rule out certain diagnosis and can result in omitting further 
testing, as well as which positive findings are true positive and can result in ruling out 
other diagnoses. 
Early identification of illness using triage, early warning scores and 
prediction models
In 2017, there were approximately 2 million ED visits in the Netherlands. Approximately 
45% of these patients were classified as surgical, followed by 13 % classified for internal 
medicine.459,460 In the ED, patients with the highest acuity should be seen before low acuity 
patients. Emergency departments rely on triage systems that determine the priority 
in which patients must be seen, based on a combination of vital signs and presenting 
symptoms. Many triage models exist, which are used prehospital by GPs, and in EDs.461 
Ideally, the outcome of triage is close to the “true” acuity of a patient.7 Unfortunately, in 
the ED under- and over-triage often occurs with most systems (e.g. Manchester Triage 
System, Emergency Severity Index).462 
To improve the quality of triage or to aid decision making by physicians and nurses, 
prediction models can be used as a complement, or an alternative, to triage systems. 
Prediction models can improve patient care and increase efficient use of resources.463 
Treatment sequence or treatment decisions  (e.g. admission, level of care, choice of 
medication) could be based on the outcome of such models for the whole population or 
specific patient groups (e.g. medical patients, elderly). 
In the second part of this thesis, we studied how triage, early warning scores and 
prediction models aid in the early identification of illness and further clinical decision 
making. In Chapter 8, we reviewed 22 models that predict short-term mortality in a 
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non-trauma population in a European setting for quality, usability and risk of bias. 
Most of these models had a good to excellent discriminatory performance.  However, 
not all the models we reviewed are suitable for direct use on arrival at the ED and are 
not appropriate for use in triage. These models frequently employ additional parameters, 
such as laboratory results, or relied on subjective assessments requiring history taking 
and physical examination. Laboratory results can improve performance of both triage 
and prediction models, and some laboratory test can be performed as point-of-care 
testing (POCT). Using POCT results are available within minutes. This can be beneficial 
for both individuals and for patient flow. Singer et al. showed that early POCT at triage 
reduced ED care time by approximately one hour,464 which reduces the chance of ED 
crowding. In a study by Abualeanain et al., POCT at triage changed triage level in 
more than 10% of the cases, thus improving the quality of triage and optimizing use 
of resources.465 Laboratory testing can also improve performance of models even when 
it is not performed as POCT, however, the outcome of such models are available after a 
certain period of time, and can result in retriage or other treatment decisions. However, 
not all patients routinely require laboratory testing. 
These patients could benefit from models that use vital signs - with or without easily 
acquired additional parameters. The performance of these models is lower than 
the performance of models that use more (complex) parameters, but these simpler 
models have the advantage that they can be directly used on arrival, and most can be 
automatically calculated using data from electronic healthcare records.  In Chapter 10, 
we compared the predictive performance of such a simple prediction model, namely the 
NEWS, with qSOFA and SIRS in patients with sepsis. The NEWS had already proven 
its value in the wards in both predicting deterioration and outcome, and similar results 
were observed later in studies in the ED.466 The NEWS can potentially be used for 
continuously monitoring patients for deterioration during their stay in the ED, as was 
shown by Alam et al.381 In specific populations, such as patients with pneumonia, as a 
higher NEWS is associated with poorer outcome, and it could be used to replace the 
CURB-65.380 SIRS was part of the sepsis definition until 2015, and was used as a screening 
tool for sepsis. With the introduction of Sepsis 3, the use of SIRS was abandoned and 
qSOFA was introduced.16 qSOFA is derived from hospital data, and data for the use in 
the ED was lacking. There has been a debate on whether and how qSOFA should be 
used in screening for sepsis, as it is just a bedside prompt to quickly assess the risk for 
mortality.467 It was suggested to use a NEWS ≥ 7 combined with a (suspected) infection 
the ED as a screening tool for sepsis, replacing SIRS and qSOFA.468 With our finding that 
NEWS had the highest performance in predicting mortality in patients with suspected 
sepsis, we support this suggestion. Unfortunately, studies on NEWS as a general triage 
tool – as a replacement of, or supplement to an existing triage system - are lacking. It is 
of great interest to perform such studies, as it can improve the quality of triage, can be 
used for retriage and to continuously monitor patients for deterioration, while reducing 
the number of prediction models used in the ED.  
Prediction models are continuously developed and existing models are continuously 
improved. Validation of these models is required before they can be introduced in the 
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ED. Models derived from data of hospitalized patients – such as the NEWS – should be 
validated and when needed, cut-off values should be changed. Models that are derived 
from single centre ED data should be externally validated before implementing, and 
preferably in different countries, as the organization of healthcare varies even within 
Europe. In Chapter 9 we developed and validated the CLEARED tool, which predicts the 
chance that an elderly patient will get admitted using readily available parameters. With 
an aging population and crowding of EDs, models predicting admission can improve 
patient care, as longer stay in the ED potentially increases chances of delirium and other 
negative outcome. A patient with a high chance of admission could await full evaluation 
in an acute medical unit. There are continuously new models developed, and existing 
models improved, resulting in better performing models. These developments benefit 
from machine learning. Hong et al. used machine learning models in combination with 
big data to develop model that could predict hospital admission with an AUC of 0.91 and 
0.92, which is higher than the AUC of 0.8 we found in Chapter 9.463 However it was only 
internally validated and it requires 972 variables. Therefore, it can only be implemented 
in an electronic patient record, and its implementation relies on automation.  Raita et al. 
used machine learning models to predict critical care and hospitalisation outcome, and 
found that machine learning models outperformed the reference model based on the ESI 
triage categories, making it a potential alternative for ESI triage and improving patient 
care.469  When a prediction model is properly validated and is ready to be  implemented, 
a ‘before and after’ study for effects on outcome would be feasible, to study whether such 
a model has effect on mortality or on other secondary outcomes, such as duration of stay.
To conclude the findings in the second part of this thesis, physicians use prediction 
models and early warning scores to aid them in patient care, and with more complex 
and elderly patients encountered in the ED, such models are becoming increasingly 
important. While simple models are easier to use, for example as a bedside prompt, use 
of machine learning and big data can result in more accurate models. Before large-scale 
implementation of any model, however, studies that assess the effects on outcome are 
warranted. 
Adequate treatment of patient with infections and sepsis
A large number of patients that visit the ED for the internal medicine have infections. 
These infections range from mild and self-limiting to severe and fatal, i.e. sepsis. 
Mortality of sepsis is high, and some studies say it is the leading cause of in-hospital 
mortality in the United States. The cornerstone of treatment of sepsis remains early 
initiation of antibiotic therapy. As in most cases the causative bacteria is not known, 
antibiotic therapy in sepsis should be empirical, based on national and local surveillance 
data, and are described in antibiotic guidelines.470,471 
In the third part of this thesis we studied factors that influence antibiotic susceptibility. 
With an increase in antibiotic resistance and a dearth of newly developed antibiotics, 
physicians in the ED should be restrictive in their use with antibiotics, whilst ensuring 
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their initiated empirical therapy in the ED is appropriate.
If physicians prescribe according to the guidelines, empirical therapy aims to reach 
appropriateness in more than 90% of the patients. Antibiotic guidelines are based on 
surveillance data from the whole of the Netherlands, and it is unclear whether these data 
are applicable for specific patients groups found in hospitals with a selected population, 
such as a university hospitals. In Chapter 12 we studied patients with complicated 
urinary tract infections consulting at Erasmus MC. We found that even in our selected 
population empiric therapy reached the threshold of 90% susceptibility. Susceptibility 
for oral antibiotics was lower, but oral antibiotics were mainly prescribed to patients 
who were discharged from the ED. In Chapter 13 we studied if appropriate antibiotic 
therapy was associated with lower mortality. Physicians are more likely to prescribe 
broad spectrum antibiotics in accordance with the guidelines to patients who they think 
are at risk of dying of infections, as they want to ensure appropriateness in these patients. 
Patients who were sent home, or received inappropriate therapy – often as a result of non-
adherence to the guidelines – presumably appeared less ill and had a lower risk of dying. 
We were unable to demonstrate the association between appropriate therapy and lower 
mortality, but showed this was a result of residual confounding. Residual confounding 
is of importance in retrospective studies, as it biases the genuine relationship between 
two factors, such as appropriate therapy and mortality. For example, in Chapter 12 we 
also found that gentamicin was often omitted, often because of the potential toxicity, and 
this was mostly done in low acuity patients, where the risk of dying was assessed as low. 
However, in Chapter 13 we showed that in a patient group with more balanced patient 
characteristics, appropriate treatment was associated with reduced mortality. Therefore, 
deviating from the guidelines is – even in low acuity patients – is associated with a higher 
risk of mortality.
Not only non-adherence to the guidelines can result in inappropriate therapy, this 
can also be the result of multidrug resistant (MDR) bacteria. The Netherlands has low 
resistance rates compared to other European countries. One of the best known risks 
for MDR bacteria is frequent treatment with antibiotics. Antibiotic prescription by 
Dutch GPs is the lowest of Europe.472 There is a correlation between outpatient antibiotic 
use and antibiotic resistance. Patients frequently using antibiotics are more at risk for 
colonisation with MDR bacteria, and these mostly are patients with chronic illnesses, 
or immunocompromised patients, e.g. as a result of chemotherapy in patients with 
hematologic and oncologic illness, patients with organ transplants and patients with 
autoimmune diseases. The number of patients with chronic illnesses is increasing, and 
so is the number of chronic illnesses per patient.473 Patients with chronic illnesses and 
recurrent or long-standing use of antibiotics (e.g. patients with renal transplants, or 
urologic anomalies) are encountered more frequently in university hospitals than non-
university hospitals, which can explain the higher resistance for oral antibiotics we found 
in Chapter 12. Physicians relying on previous urinary cultures should realize that other 
microorganisms are found in newly obtained cultures of more than half of the patients, 
and broadening – not narrowing – of the antibiotic regimen based on earlier cultured 
pathogens is advised. 
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In international studies, recent hospitalization and residency in a nursing home are 
also risk factors for carriage of MDR bacteria.474,475 These results cannot directly be 
extrapolated to the Netherlands, as the prevalence of MDR in the community is much 
lower as a result of the restrictive antibiotic use and of ‘search and destroy’ policies for 
certain MDR bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA). 
High-risk groups (e.g. patients recently hospitalized in a foreign hospital, seamen, pig 
farmers) are actively screened and pre-emptively isolated. Patients who are infected or 
colonized with MDR bacteria are also isolated during hospitalisation until decolonisation 
is established successfully.476 Although the risk for infections with MDR bacteria after 
recent hospitalization is low, there is a higher risk for infection with certain other 
microorganisms (e.g. Pseudomonas in hospital acquired pneumonia), and our guidelines 
distinguish community acquired infections from hospital acquired infections. 
Individuals carrying MDR bacteria can pass on this antibiotic resistance to household 
contacts, or further spread this resistance into the community via the faeco-oral 
transmission.472,477  This risk for transmission is higher in countries with poor 
sanitation.478 Some of the countries with poor sanitation, are considered to be excellent 
travel destinations.479 In Chapter 11, we studied post-travel faecal carriage of MDR 
Enterobacteriaceae. We found that after travelling to countries with high MDR in the 
community, the risk of carriage of MDR is also very high. These findings were confirmed 
in the ‘Carriage Of Multiresistant Bacteria After Travel’ (COMBAT) Study. This study 
also showed that after one year 11.3% of the individuals were still carriers of MDR 
bacteria.389 With an increase of outbound international travel, both of healthy young 
individuals and elderly individuals with chronic illnesses, and an increase in inbound 
international travel from rapidly developing countries such as China, the number of 
tourists is expected to double in 2030. It is likely that physicians in the ED will encounter 
patients colonized with MDR bacteria.480,481 Currently, Dutch hospitals only screen for 
certain MDR bacteria (e.g. MRSA). The Dutch antibiotic guidelines do consider patients 
with known colonisation with MDR bacteria at risk, resulting in isolation of these 
patients. However, international travel or residency in a country with high resistance 
is not considered as such.471 There have been cases that show sepsis with MDR bacteria 
after travel related colonization; however, the exact risk has not been properly studied. 
In patients with known healthcare related colonisation with MDR bacteria, Rottier 
et al. found that blood cultures were positive in 18% of the cases in patients receiving 
empiric therapy for suspected gram negative sepsis. In these blood cultures, in 46% 
positive Enterobacteriaceae were found, and MDR bacteria as a result of colonisation 
only contributed to 8.3% of these blood cultures (i.e. 3.8% of the total number of positive 
blood cultures).482 The authors conclude that prior colonisation with MDR bacteria and 
prior antibiotic use have low positive predictive value for the presence of MDR bacteria. 
Unfortunately, no patient characteristics are provided in this study, and sepsis was 
defined by initiation of antibiotics and obtaining blood cultures. However, with the 
low number of positive cultures and no data on mortality, these results are harder to 
interpret for clinical practice. The findings of Chapters 12 and 13 suggest that in case 
of high acuity patients with know or presumed colonisation with MDR bacteria it is 
better to achieve appropriate therapy by broadening the antibiotic spectrum, despite the 
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findings of Rottier et al., however, more studies are required.
To conclude the findings in the third part of this thesis, patients with bacterial infections 
who are appropriately treated have lower chance of mortality. Physicians appear be less 
likely to conform to antibiotic use guidelines when managing low acuity patients or when 
drug toxicity is a huge concern. As a result, there is a lower likelihood of appropriate 
therapy and higher risk for mortality. Appropriate therapy is also affected by emerging 
antimicrobial resistance, which can be the result of recurrent use of antibiotics, increase 
in international travel, and prolonged colonization (can last for more than one year). 
More studies are needed to examine the relationship between colonization with MDR 
and subsequent risk of infection.
Future research directions
Acute physicians are trained for the immediate and early management of adult patients 
who present in hospital as emergencies, and for the coordination of care of multiple 
patients. Patients are getting older and pathology is increasingly becoming more complex. 
They encounter demanding patients - who want certainty – and insurers, who want to 
keep costs as low as possible. Research should further focus on distinguishing those who 
are acutely ill from those who are not so that appropriate intervention can be initiated 
early for those who will benefit most, whilst limiting overtreatment for those who are 
unlikely to benefit. This requires evidence-based assessment of patients, safe discharge 
when possible, and swift admission when needed. The supportive value of diagnostic 
aides, such as prediction models, should be explored further. 
Assessment of illness in individual patients
Research on assessment of illness in individual patients in the ED should focus recognising 
illness as early as possible, using readily available parameters and point-of-care testing. 
Currently, the parameters we use (e.g. vital signs, laboratory testing) have reasonable 
sensitivity and specificity, however, there is room for improvement. In 2019, point-of-
care ultrasound (POCUS) was implemented in the Dutch internal medicine residency 
training program and it is expected that POCUS will improve the quality of physical 
examination in both acutely ill patients as well as in patients with other illnesses. It is 
important to study not only the value of ultrasound in clinical decision-making, but also 
whether it has an effect on outcome. Furthermore, since there is no standard ultrasound 
curriculum, research on methods of training and implementation is also feasible. 
Another factor that should be used in assessment of patients is loss of mobility. Loss 
of mobility contributes to worse outcomes after hospitalization, and some suggest that 
mobility is a vital parameter.483 Unfortunately, most patients are assessed while lying 
on hospital beds and impaired mobility is not always tested or noted in patient records. 
There are several ways of measuring mobility, varying from simple to complex. Currently, 
there is no consensus which of the available methods to use. The method should be easy 
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to perform, be applicable for most patients, including the sickest, and the results should 
be reproducible.  When these criteria are met, and the results on outcome are confirmed, 
then it can be used as a new vital parameter. 
Axillary humidity, as we showed in this thesis, is associated with hydration state of 
patients. It has potential to become a novel index for hydration, as was already shown 
in previous studies, as well as for fluid deficit. Research is needed to find the optimal 
sensors, and for new sensors the diagnostic accuracy for specific groups of patients and 
individuals should be studied.  The sensors we used were – despite the fact they worked 
– not designed for this purpose, and more appropriate sensors are required. With 
improvement in sensor building, it is likely that better and smaller sensors will become 
available. Collaboration between university hospitals and technical universities will aid 
such improvements. Also, the type of sensors that is used to measure skin moisture – as 
a proxy for hydration – can vary. We used a sensor using hygrometry, but potentially bio-
electrical impedance analysis, spectroscopy, or other methods could be used. If possible, 
such techniques should not only be used in hospital, but they should also be integrated in 
wearables. Wearables with heart rate monitoring, ECG, and pulse oximetry are already 
available. This allows measurement in a non-hospital setting, making this technique 
available for a broader public with interest in humidity state, such as athletes, which can 
use it to optimize their fluid balance. A positive effect of such developments is that the 
price of such techniques lowers, making it available for other care settings (e.g. elderly 
homes, third world countries).
Assessment of patient disposition – admission or safe discharge
Patients should not only be assessed for illness, but also for the probability of admission 
or discharge. The chance of admittance can be predicted with models that use readily 
available parameters, such as the CLEARED tool.  However, prediction models that use 
POCT laboratory in combination with triage results might even perform better, and this 
is worth investigating. If a model identifies patients who are likely to get admitted – 
especially elderly –  these patients might benefit from early admission to acute medical 
units or wards, where there are less disturbing factors, they can have proper beds, and 
basic physiological needs are met (e.g. food and drinks, assistance with toileting). Such 
interventions might also reduce crowding, especially in EDs with an AMU or short stay 
departments. 
Most patients who visit the ED get directly discharged, and these are mostly the low 
acuity patients. In Erasmus MC, the one-week mortality rate of patients who were 
discharged with near normal vital signs is approximately 0.4%. Despite the fact that 
this percentage is low, it accounted for 362 deaths in a five-year period. Physicians 
that assess patients based on available data (e.g. vital signs, triage category, additional 
testing) cannot fully identify those without risk of dying.484 Several studies have been 
performed to identify low risk of mortality. There are models for specific patients groups 
(e.g. patients with pulmonary embolism, acute heart failure, pneumonia), or for all ED 
patients. A prospective study of Lyngholm et al. showed that ED patients with a normal 
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d-dimer had a 30-day mortality of 0.4%, which was significantly lower than patients with 
abnormal d-dimers. A retrospective study in Erasmus MC had similar findings, but also 
showed that a severely elevated d-dimer (i.e. upper decile) is associated with increased 
mortality.485,486 Despite these results, it seems impractical to perform a d-dimer test in all 
patients to distinguish patients with low and high risk of mortality; what then should be 
done with an elevated d-dimer in a patient without complaints? Therefore, there remains 
a need for studies that attempt to identify patients – especially those with near normal 
vital signs - and an increased chance of dying, as they might benefit from additional 
intervention, while patients with near normal vital sign and low risk of dying can be 
safely discharged from the ED.
Prediction models and early warning scores 
Computer learning and big data will help identify that patients that are – or are not - at 
risk. Complex models containing many variables will greatly improve the diagnostic 
accuracy of these models. However, these models are based on information found in in 
the electronic patient charts, and not all observations that influence a physician’s decision 
making are not noted in the charts. These unmeasured and unmeasurable factors may 
impact decision making, which can result in residual confounding in retrospective 
analysis. In patients suspect for pulmonary embolism, a recollection of a smiling patient 
was associated with a higher chance of a probable alternative diagnosis.458 In patients 
with stroke, crossed legs seems to be associated with outcome. Remi et al. found a more 
favourable outcome, while Bazan et al. found an association with unilateral neglect.487,488 
Patients with crossed legs might seem more at ease, resulting in an assessment of lower 
acuity. Even in the famous book The House of God, Samuel Shem describes signs 
associated with outcome: “These are classic signs: the O sign on the left and the Q sign on 
the right. The O sign is reversible, but once they get to the Q sign, they never come back.” 
These signs have never been confirmed in studies, and while most clinicians know the 
signs, they are hardly ever noted in charts. Future research should also target decision 
making, and should try to identify factors that physicians (unconsciously or unwittingly) 
use in their decision making, such as the crossed legs sign, or distractions such as the use 
of mobile phone while in the ED. Documenting these signs in health records makes them 
usable for machine learning and provide opportunities for improvement of prediction 
models. 
Adequate treatment of patient with infections and sepsis
Even in a country with low antibiotic resistance as the Netherlands, it is likely that acute 
physicians will encounter more and more patients with MDR bacteria, as most patients 
with infections are admitted via the ED. Physicians in the ED should remain rational in 
use of antibiotics, whilst ensuring appropriate empirical therapy in the ED, as adequate 
antibiotic treatment remains the cornerstone of treatment of patients with bacterial 
sepsis. This requires collaboration of acute physicians and infectious disease specialists in 
patient care, research and in implementing guidelines.  The guidelines used in the ED are 
based on national and local surveillance data. However, as we have shown, guidelines are 
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not always followed. It is important to study if, and to what extent, antibiotic guidelines 
are followed. If physicians deviate from these guidelines, the factors involved in such 
decision should be identified. Interventions to improve following guidelines should be 
based on these findings.
Currently, the antibiotic guidelines do not take into account travel to, or residence in, 
countries with high percentages of community dwelling MDR bacteria. However, with 
the continuous increase in inbound and outbound international travel, further studies 
should also focus on the risk that community acquired MDR bacteria form as potential 
pathogens, as this field remains partly unexplored.  
Research methods
Research in acute medicine will benefit from local, national and international 
collaboration, as research fields overlap with other fields of internal medicine, as well 
as with other specialties. We have started a research collaboration with our first Flash 
Mob Research study, and we demonstrated that it is possible to obtain much data in 
short periods of time when working together. Using Flash Mob Research we were 
able to involve many hospitals, with both acute and emergency physicians acting as 
ambassadors, and it formed the foundation of formalizing a study consortium.  We have 
further collaborated with the participants of this network in subsequent studies, and the 
first international study using the Flash Mob method has already been performed. This 
research network is a solid base for future research and should not only be used for cross 
sectional studies in a short amount of time, but also for prospective studies. Not all the 
hospitals need to participate for each study and still high numbers of inclusion can be 
reached. Participants of this consortium can find other interested parties performing 
similar studies, facilitating collaboration. The different hospital settings (e.g. university 
hospitals, large teaching hospitals) also allow for better internal and external validation 
of results. International collaboration can help identify practice differences between-
countries and within-country, and will make outcome of studies more generalizable. 
Therefore, we expect that this research networks will prove very powerful. 
In conclusion, the time is now for research in acute medicine! 
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In Chapter 1 we provide a general introduction to the different topics that we studied in 
this thesis. We give a brief history of acute medicine. We discuss the history, development 
and usability of triage, various prediction models and early warning systems and last, we 
discuss the assessment and treatment of patients with potentially critical illnesses. We 
conclude this chapter with the outline of the thesis.
In the first part of this thesis, consisting of chapters 2 to 7 contains studies on the value of 
history, clinical examination and additional testing in the early identification of illness.
In Chapter 2 we used novel method of research, called Flash Mob Research to study 
interobserver agreement of various methods to measure capillary refill time (CRT). CRT 
is a clinical test used to assess the circulatory status of patients by measuring the time 
it takes for the colour of the skin to change back to normal after applying a pressure 
on a capillary bed. Different methods and normal values are in place in daily clinical 
practice. Physicians in the Netherlands were recruited by using word-of-mouth referrals, 
conventional media, and social media to participate in this nationwide, single-day, 
“nine-to-five,” multicentre, cross-sectional, observational study to evaluate CRT.
We found that interobserver agreement on CRT is, at best, moderate. The results of CRT 
measured at the sternum and phalanx cannot be used interchangeable, and different 
duration of applying pressure results in different CRTs. Age and sex influence CRT, and 
a single cut-of value cannot be used. The Flash Mob Research study method we used 
was a success, as we were able to investigate a relatively simple research question in 38 
hospitals, using an inexpensive, quick and reliable method and also generate positive 
reactions of patients, laymen and press. We concluded that the use of CRT in the initial 
assessment of patients can be omitted.
In Chapter 3 we studied four indices that can potentially be used for assessment of the 
circulation, namely the pulse oximetry derived perfusion index (PI) and pleth variability 
index (PVI), the iButton® derived axillary humidity, and peripheral temperature 
gradients. In studies in settings others than the ED, such as the intensive care unit (ICU) 
and during surgery, these indices have been used in diagnosing dehydration and volume 
depletion. We performed a study using a convenience sample of patients visiting the ED 
of the Erasmus University Medical Center. Patients were dichotomized in having volume 
depletion or not based on physicians judgement who used all available parameters.  Only 
axillary humidity differed significantly between these patients and can potentially be of 
additional value in diagnosing volume depletion. However, further development of the 
sensor, as well as further research are needed before axillary humidity measurements 
can be used in daily practice.
In Chapter 4 we present the results of both a prospective and a retrospective study on 
hypertensive urgency and emergency in the emergency department (ED). Hypertension 
is common in the ED, and there is always debate if patients with asymptomatic severe 
hypertension should be evaluated for the presence of hypertensive urgency and 
emergency. Hypertensive emergency is distinguished from urgency by the presence of 
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acute hypertensive end-organ damage and therefore is an indication for prompt and 
aggressive treatment, while in hypertensive urgency there is no acute organ-damage. 
First, we retrospectively analysed patients with severe hypertension in the ED, and found 
that 22% met criteria for hypertensive urgency (i.e. end-organ damage present or pending) 
and 31% met the criteria for hypertensive emergency (i.e. no end-organ damage present 
or pending, and no pain or stress induced hypertension). Anamnestic non-adherence 
for antihypertensive drugs was recorded in only 6% of the patients as an attributing 
factor. Second, we prospectively studied adherence for antihypertensive drugs in 53 
patients with a hypertensive urgency or emergency by measuring drug plasma levels. 
Approximately 5% of the patients who visited the ED with severe hypertension were 
asymptomatic, but were diagnosed as hypertensive urgency or emergency after extensive 
testing, showing the lack of symptoms cannot be used to rule out urgency or emergency. 
Whilst patients who admitted to nonadherence were excluded from this sample, still 
22.6% were non-adherent for at least one of the prescribed antihypertensive drugs. This 
illustrates that in patients with hypertensive urgency and emergency drug nonadherence 
is common, but often overlooked and drug-adherence should be assessed in the ED. 
In Chapter 5 we performed an international multicentre study on patients who visit the 
ED with medically unexplained physicals symptoms (MUPS). MUPS form a high burden 
for both general practice and outpatients clinics. Diagnostic and treatment strategies 
between patients with and without MUPS should differ, and in patients with MUPS 
focus should lie on validating symptoms and provide explanations. Not much is known 
about patients with MUPS in the ED. We therefore retrospectively studied the incidence 
of MUPS and characteristics of patients presenting with MUPS. In a significant number 
of patients, physical symptoms remain unexplained after assessment in the ED, although 
follow up studies are needed to see how these symptoms evolve over time. We found a 
resemblance in patient characteristics of patients with unexplained symptoms presenting 
in the ED compared to patients at the general physician and outpatient clinics.
In Chapter 6 we provide a review on the postural orthostatic tachycardia syndrome 
(POTS), based on two patients who present with different complaints. In POTS a change 
from a supine to an upright position causes an abnormally large increase in heart 
rate and orthostatic hypertension, resulting in or accompanied by various physical 
and psychological complaints. Although POTS is relatively common, it is relatively 
unfamiliar. The first step in treatment are lifestyle measures, which can be followed by 
pharmacotherapy. 
In Chapter 7 we performed a second Flash Mob Research on the quality and quantity 
of sleep in hospitalized patients. In one day we included more than 2,000 patients from 
39 hospitals. Overall, sleep quality was lower and 70% of patients reported to have been 
awakened by external causes, which in half of the cases concerned hospital staff. Sleep 
disturbing factors that were mostly reported were noises of other patients and staff, 
medical devices, pain and toilet visits. With this study we aimed to raise awareness for the 
importance of adequate sleep. It also shows how decisions made in the ED influence the 
course of hospitalization and provides targets for interventions to minimize disturbing 
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factors, in order to improve quality of sleep.
In the second part of this thesis, consisting of chapters 8 to 10, contains studies on 
prediction models and early warning scores.
In Chapter 8 we provide a systematic review of prediction models for mortality that can be 
used to identify patients that visit the ED at risk for deterioration and mortality, in order 
to timely treat these patients. We identified 15 articles, of which the majority investigated 
in-hospital mortality. These models had discriminative abilities ranging from Area 
Under the Curve between 0.63 and 0.93. However, our quality analysis revealed that most 
studies had a moderate risk of bias in one or more domains. Two models performed best; 
the PARIS model and the full model. However, these models are not yet implemented 
and generalizability to non-European EDs is limited. We concluded that there is a need 
for large validation studies comparing models on both discriminative abilities and if 
it has effect on mortality. In subsequent model development, methodological quality 
should be improved. 
In Chapter 9 we describe the development and validation of a clinical prediction tool for 
admission for elderly in the ED. As length of stay in the ED is correlated to an extended 
in-hospital length of stay, prediction of admission and subsequent early admission 
might be beneficial for both individual patients as well as patient flow. We developed 
and validated the CLEARED-tool, which uses parameters that are easily obtainable at 
presentation in the ED, including vital signs, referral status, Manchester Triage Score 
category and the need for laboratory testing and radiology. We validated this tool both 
internally and externally, with Areas Under the Curve of 0.73 – 0.80.  However, before 
implementation prospective evaluation of the effect on length of stay and outcome is 
necessary. 
In Chapter 10 we retrospectively studied three scores in patients with suspected infection 
presenting to the ED using a database containing all ED visits with demographics, vital 
parameters, results of laboratory testing, disposition and mortality data. The scores we 
studied were the quick Sepsis Related Organ Failure Assessment (qSOFA), Systemic 
Inflammatory Response Syndrome (SIRS) criteria and National Early Warning Score 
(NEWS). We found that qSOFA had highest sensitivity but lacked specificity, while SIRS 
had highest specificity but lacked sensitivity. Overall NEWS performed best, followed 
by qSOFA and SIRS. Our findings suggest that the NEWS – with a suggested cut-off of 
7 - might be eligible for use in the ED, despite the fact it was not designed for this use, 
however, this requires conformation by prospective studies.
In the third part of this thesis, consisting of chapters 11 to 13 contains studies on 
antibiotic susceptibility.
In Chapter 11 we provide a systematic review on international travel and the risk of post-
travel faecal carriage of multidrug-resistant Enterobacteriaceae (MRE). International 
travel is major risk factor for acquisition of MRE, and individuals travelling to (southern) 
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Asia had the highest risk (up to 88% acquisition of MRE). Travelers with travel-related 
diarrhoea and travelers who used antibiotics also had an increased risk. Further studies 
to assess the duration of carriage of MRE and to assess the chance of contaminating 
household contacts. It also remains unclear if carriage of MRE results in an increase in 
infections, but we do suggest to adapt the choice of antibiotic drugs to these findings when 
treating recent travellers with infections which might be caused by Enterobacteriaceae, 
such as urinary tract infections. Our results also show the importance of infection 
prevention and control guidelines. 
In Chapter 12 we studied patients visiting the ED with a suspected complicated urinary 
tract infection. We analysed our results and compared these data with national data 
from the NethMap report. We found that antibiotic susceptibility for intravenous 
antibiotics was comparable to NethMap data, however, susceptibility was lower for oral 
antibiotics. This last finding is probably the result of a population at risk for recurrent 
complicated urinary tract infections and subsequent antibiotic use, e.g. patients with 
anatomic anomalies and renal transplant. We also found a linear relation between the 
time of the last hospitalization and the susceptibility of antibiotics given in the ED – the 
shorter the time, the lower the susceptibility. However, despite this finding empirical 
therapy (i.e. cefuroxime and gentamicin) reached susceptibility over 90%, and to achieve 
acceptable susceptibility the guidelines on empirical therapy should be followed. We also 
found that urinary cultures differed from previous cultures in more than 56% of the 
patients. We therefore advice broadening, but not narrowing, of the antibiotic regimen 
based on earlier cultured pathogens.
In Chapter 13 we studied whether administration of appropriate antibiotic therapy is 
associated with reduced mortality in patients with a blood stream infection in the ED. We 
also wanted to explain why prior investigators were unable to confirm this association. 
We were unable to demonstrate lower mortality in patients receiving appropriate 
therapy in the entire study population, despite multiple adjustments for confounding. 
We assumed this was the result of residual confounding. We then studied a subset of our 
population, namely patients only receiving one antibiotic drug. In this monotherapy-
only group, characteristics of patients who did or did not receive appropriate therapy 
were more homogeneous, and within these groups we showed that appropriate therapy 
reduced mortality. With this study we also show that it is not always possible to correct 
unbalanced groups, and that residual confounding is a serious risk for retrospective 
studies when comparing unbalanced groups. We therefore advise when comparing 
retrospective data, the most homogeneous groups should be used. 
In Chapter 14 we discussed these findings, provided conclusions per part of this thesis 
and provided further research directives. In Chapter 15 we summarize the findings of 
this thesis.
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Hoofdstuk 1 geeft een algemene introductie over de verschillende onderwerpen die in dit 
proefschrift aan de orde komen. Er wordt een kort overzicht gegeven van de geschiedenis 
van de acute geneeskunde. Daarna volgt een beschrijving van de geschiedenis, de 
ontwikkeling en de bruikbaarheid van triage, van diverse voorspelmodellen en van Early 
Warning Systems. Hierna volgt een beschrijving van de beoordeling en behandeling van 
patiënten die potentieel ernstig ziek zijn. Dit hoofdstuk eindigt met de indeling van dit 
proefschrift.
Het eerste deel van dit proefschrift, bestaand uit de hoofdstukken 2 tot en met 7, bevat 
studies die gaan over de waarde van anamnese, lichamelijk onderzoek en aanvullend 
onderzoek bij het vroegtijdig herkennen van ziekte.
In Hoofdstuk 2 wordt met behulp van een nieuwe onderzoeksmethode, genaamd Flash 
Mob Research, de overeenstemming tussen waarnemers bij de verschillende methoden 
om capillaire vullingstijd te meten bestudeerd. De capillaire vullingstijd is een klinisch 
onderzoek wat wordt gebruikt om de bloedsomloop te beoordelen. Bij de test wordt de 
tijd gemeten die de huid nodig heeft om weer de normale kleur te krijgen na een periode 
van druk op het capillaire bed. In de dagelijkse praktijk worden verschillende methoden 
met verschillende normaalwaardes gebruikt. Artsen in Nederland werden mondeling, 
via reguliere kanalen en via sociale media uitgenodigd om mee te doen aan dit ééndaagse, 
landelijke, ‘negen-tot-vijf ’, multicenter, cross-sectionele, observationele onderzoek naar 
capillaire vullingstijd.
De overeenstemming tussen waarnemers bij het beoordelen van capillaire vullingstijd 
is op zijn best redelijk. De uitkomsten van de capillaire vullingstijd gemeten op het 
borstbeen en de vinger zijn niet onderling uitwisselbaar. Een verschillende duur van het 
uitoefenen van druk geeft een verschil in capillaire vullingstijd. De Flash Mob Research 
methode die gebruikt is was een succes; het stelde ons in staat om op een goedkope, 
snelle en betrouwbare manier een relatief eenvoudige onderzoeksvraag te onderzoeken 
in 38 ziekenhuizen. Patiënten, leken en de media reageerden positief. De conclusie van 
dit hoofdstuk is dat het gebruik van de capillaire vullingstijd bij de initiële beoordeling 
van patiënten achterwege gelaten kan worden.
In Hoofdstuk 3 zijn vier parameters bestudeerd die mogelijk van toegevoegde waarde zijn 
bij de beoordeling van de circulatie, namelijk de perfusion index en de pleth variability 
index – beide parameters kunnen worden bepaald met behulp van een pulseoximeter, 
de vochtigheid van de oksel – gemeten met een iButton® en de temperatuurgradiënt 
tussen de elleboog en de vinger. In studies buiten de spoedeisende hulp, zoals op de 
intensive care of rondom operaties zijn deze parameters gebruikt in de beoordeling van 
ondervulling en dehydratie. Dit werd onderzocht met behulp van een steekproef op de 
spoedeisende hulp van het Erasmus MC. Patiënten werden aan de hand van het klinische 
oordeel van de arts – die gebruik kon maken van alle beschikbare gegevens – verdeeld in 
twee groepen: wel of geen vochttekort. Alleen de vochtigheid van de oksel was significant 
verschillend tussen beide patiëntengroepen en is mogelijk van toegevoegde waarde bij 
het diagnosticeren van vochttekort.  Echter, zowel doorontwikkeling van de sensor, als 
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verder onderzoek zijn nodig voordat het meten van de vochtigheid van de oksel gebruikt 
kan worden in de dagelijks praktijk.
Hoofdstuk 4 beschrijft de resultaten van zowel een prospectieve als een retrospectieve 
studie naar hypertensieve noodgevallen en urgenties op de spoedeisende hulp. 
Hypertensie komt veel voor op de spoedeisende hulp, en er is blijvende discussie of 
patiënten met een asymptomatische ernstige hypertensie beoordeeld moeten worden 
op de aanwezigheid van een hypertensief noodgeval of urgentie. Bij een hypertensief 
noodgeval is er sprake van eindorgaanschade op basis van de verhoogde bloeddruk, en 
is er een indicatie voor snelle en agressieve behandeling, terwijl er bij een hypertensieve 
urgentie geen acute eindorgaanschade is. 
Als eerste werden patiënten met een ernstige hypertensie op de SEH retrospectief 
geanalyseerd, waarbij er in 22% van de gevallen werd voldaan aan de criteria van een 
hypertensief spoedgeval, waarbij er sprake was van (dreigende) eindorgaanschade. In 31% 
van de gevallen was er sprake van een hypertensieve urgentie, waarbij er geen sprake was 
van (dreigende) orgaanschade, en waarbij de bloeddrukverhoging niet door pijn en stress 
werd veroorzaakt. In slechts 6% van de gevallen werd in de anamnese therapieontrouw 
voor de antihypertensieve medicijnen als deel van de oorzaak beschreven.
In het tweede deel werd de therapietrouw voor antihypertensieve medicatie in 53 patiënten 
met een hypertensief noodgeval of hypertensieve urgentie bestudeerd door het meten van 
plasmaspiegels van de medicijnen. Ondanks dat patiënten die toegaven therapieontrouw 
te zijn waren geexcludeerd, was 22.6% van de patiënten therapieontrouw voor tenminste 
een van de antihypertensieve medicijnen. Dit toont aan dat therapieontrouw bij patiënten 
met een hypertensief noodgeval of hypertensieve urgentie veelvoorkomend is, maar dat 
er te weinig aan gedacht wordt op de spoedeisende hulp, en dat therapieontrouw moet 
worden nagevraagd op de spoedeisende hulp.
Hoofdstuk 5 beschrijft een internationale multicenter studie naar patiënten die de 
spoedeisende hulp bezochten met somatisch onvoldoende verklaarde lichamelijke 
klachten (SOLK). SOLK is een veelvoorkomend probleem in zowel de huisartsenpraktijk 
als op poliklinieken. Bij patiënten met SOLK dient zowel het diagnostisch traject als 
de behandelstrategie te verschillen van patiënten zonder SOLK, waarbij bij patiënten 
met SOLK de aandacht moet liggen op het valideren van de klachten en het geven van 
adequate uitleg. Er is weinig bekend over patiënten met SOLK op de spoedeisende hulp. 
Met behulp van een retrospectief onderzoek werden de incidentie van SOLK, alsmede de 
patiënt karakteristieken bestudeerd. Bij een groot aantal patiënten bleef de klachten na 
beoordeling op de spoedeisende hulp onverklaard, alhoewel vervolgstudies nodig zijn 
naar het beloop van deze klachten in de tijd. 
Hoofdstuk 6 geeft aan de hand van twee patiënten die zich presenteerden met 
verschillende klachten een review naar het posturaal orthostatisch tachycardie syndroom 
(POTS). Bij POTS geeft een verandering van een liggende naar staande houding een 
abnormale verhoging van de hartslag en orthostatische hypotensie, wat resulteert in 
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of gepaard gaat met verschillende lichamelijke en geestelijke klachten. Alhoewel POTS 
relatief veelvoorkomend is, is het nog vrij onbekend. De eerste stap in behandeling is 
leefstijladvies, gevolgd door farmacologische interventies.
Hoofdstuk 7 beschrijft een tweede Flash Mob Research naar de kwaliteit en kwantiteit van 
slaap bij in het ziekenhuis opgenomen patiënten. In één dag werden in 39 ziekenhuizen 
meer dan 2,000 patiënten geïncludeerd. In de gehele populatie was de kwaliteit van slaap 
lager en 70% van de patiënten rapporteerden te zijn wakker geworden door externe 
oorzaken – in de helft van de gevallen betrof dit ziekenhuispersoneel. Factoren die van 
invloed waren op de slaap werden geluiden van medepatiënten, ziekenhuispersoneel, 
medische apparaten, pijn en toiletbezoek. Het doel van deze studie is om bewustwording 
te creëren voor het belang van voldoende, goede slaap. Het geeft ook aan hoe beslissingen 
gemaakt op de spoedeisende hulp het verdere beloop van een ziekenhuisopname 
beïnvloeden. Het biedt mogelijkheden voor interventies om factoren die slaap verstoren 
te minimaliseren, om zo de kwaliteit van slaap te verbeteren.
Het tweede deel van dit proefschrift, bestaand uit de hoofdstukken 8 tot en met 10, 
bevat studies over voorspelmodellen en Early Warning Scores.
Hoofdstuk 8 geeft met een systematische review een overzicht van modellen die 
mortaliteit voorspellen van patiënten die opgenomen worden via de spoedeisende hulp. 
Deze modellen  kunnen worden gebruikt om patiënten te identificeren die een risico 
lopen op achteruitgang en mortaliteit, om idealiter deze patiënten zo snel mogelijk te 
kunnen behandelen. Er werden 15 artikelen gevonden, waarvan de meerderheid van de 
studies mortaliteit in het ziekenhuis bestudeerde. Het discriminerende vermogen van 
deze modellen -  uitgedrukt met de Area under the Curve - varieerde tussen 0.63 en 0.93. 
Bij analyse van de kwaliteit van deze studies bleek dat de meeste studies het risico op bias 
gemiddeld was. De twee beste modellen waren het 'Paris model’ en het ‘ full model’. Echter, 
deze modellen zijn nog nergens ingevoerd en de generaliseerbaarheid naar andere niet-
Europese spoedeisende hulp afdelingen is beperkt. De conclusie van dit hoofdstuk is dat 
het noodzakelijk is om zowel de discriminerende vermogens als het effect op mortaliteit 
van dezer deze modellen in grote studies te vergelijken. Bij het ontwikkelen van nieuwe 
modellen moet de methodologische kwaliteit worden verbeterd. 
Hoofdstuk 9 beschrijft de ontwikkeling en validatie van een instrument om opname van 
ouderen vanaf de spoedeisende hulp te voorspellen. Langer verblijf op de spoedeisende 
hulp is gecorreleerd met een verlengde opname, en het voorspellen van een opname 
gevolgd door een directe opname heeft mogelijk een gunstig effect voor zowel de 
individuele patiënt als voor de patiëntenstroom. Dit resulteerde in de CLEARED-tool. 
Dit instrument maakt gebruik van parameters die gemakkelijk te verkrijgen zijn bij 
aankomst op de spoedeisende hulp, zoals vitale parameters, manier van verwijzing, triage 
categorie en de noodzaak tot het verrichten van laboratorium onderzoek en radiologisch 
onderzoek. Dit instrument is zowel intern als extern gevalideerd, met daarbij Areas 
under the Curve tussen 0.73 en 0.80. Echter, voor invoering is een prospectieve evaluatie 
van het effect op de opnameduur en op de uitkomst noodzakelijk.
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In Hoofdstuk 10 worden drie scores bestudeerd in patiënten die de spoedeisende 
hulp bezochten en waarbij er het vermoeden op een infectie bestond. Er werd gebruik 
gemaakt van een database met alle spoedeisende hulp bezoeken met demografische 
gegevens, vitale parameters, uitslagen van laboratorium diagnostiek, opname- en ontslag 
gegevens en mortaliteitsdata. De bestudeerdescores waren de quick Sepsis Related Organ 
Failure Assessment (qSOFA), het Systemic Inflammatory Response Syndrome (SIRS) en 
de National Early Warning Score (NEWS). qSOFA had de hoogste sensitiviteit, waarbij 
het ontbrak aan specificiteit, terwijl SIRS de hoogste specificiteit had, maar waarbij het 
ontbrak aan sensitiviteit. De NEWS presteerde  globaal het beste, gevolgd door qSOFA en 
SIRS. De bevindingen suggereren dat de NEWS, met een aangeraden afkapwaarde van 7, 
geschikt kan zijn voor gebruik op de spoedeisende hulp, ondanks dat deze score hiervoor 
initieel niet ontwikkeld is. Echter, dit vereist bevestiging met behulp van prospectieve 
studies.
Het derde deel van dit proefschrift, bestaand uit de hoofdstukken 11 tot en met 13, 
bevat studies over gevoeligheid voor antibiotica.
Hoofdstuk 11 geeft middels een systematische review overzicht van het risico op 
fecaal dragerschap van multiresistente Enterobacteriaceae na internationale reizen. 
Internationale reizen zijn een zeer groot risico voor het oplopen resistentie, en het risico 
was het grootst voor reizigers naar (zuidelijk) Azia, waarbij tot 88% een multiresistente 
Enterobacteriaceae opliep. Reizigers met reizigersdiarree of reizigers die antibiotica 
gebruikten hadden ook een verhoogd risico op dragerschap. Er zijn meer studies nodig 
naar de duur van dragerschap van multiresistente Enterobacteriaceae, en naar de kans 
op besmetting van huisgenoten. Het is er ook geen duidelijkheid of dragerschap van 
multiresistente Enterobacteriaceae meer infecties veroorzaakt, maar bij patiënten die 
recent op reis zijn geweest die zich presenteren met een infectie die mogelijk veroorzaakt 
wordt door Enterobacteriaceae, zoals urineweginfecties, is het advies het antibiotisch 
regime aan te passen. Onze resultaten bevestigen ook het belang van richtlijnen voor 
infectie preventie en controle.
In Hoofdstuk 12 worden patiënten die de spoedeisende hulp bezoeken met een mogelijke 
gecompliceerde urineweginfectie bestudeerd. De gegevens van deze studie werden 
vergeleken met landelijke gegevens, verkregen uit het NethMap rapport. De gevoeligheid 
voor intraveneuze antibiotica is vergelijkbaar met de landelijke gevoeligheid, zoals 
beschreven in het NethMap rapport. De gevoeligheid voor orale antibiotica was 
echter lager, wat waarschijnlijk het gevolg is van de populatie die het risico loopt op 
gecompliceerde urineweginfecties, zoals patiënten die een niertransplantatie ondergingen 
of met anatomische afwijkingen. Er was een lineaire relatie tussen de laatste opname en 
de gevoeligheid voor antibiotica, waarbij een recentere opname meer kans op resistentie 
werd gevonden. Ondanks deze bevinding gaf de empirische therapie (cefuroxim en 
gentamicine) voldoende antibiotische dekking om meer dan 90% gevoeligheid te 
bereiken, wat pleit voor het volgen van de richtlijnen. Positieve urinekweken verschilden 
in meer dan 56% van de gevallen van eerdere kweken, en daarom is het advies om het 
antibiotisch beleid niet te versmallen, maar wel te verbreden op basis van de oude kweken.
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Hoofdstuk 13 bestudeert of het toedienen van adequate antibiotica is geassocieerd met 
verlaging van sterfte in patiënten met een bloedbaaninfectie op de spoedeisende hulp. 
Daarnaast was het doel om te verklaren waarom deze associatie in eerdere studies niet 
altijd gevonden werd. In de gehele populatie was het niet mogelijk om lagere sterfte aan 
te tonen in patiënten die adequaat antibiotisch werden behandeld, ondanks meerdere 
correcties voor verstorende factoren. Er werd verondersteld dat dit het gevolg was van 
residual confounding. Vervolgens werd een subgroep van de populatie gekozen, te weten 
patiënten die slechts één antibioticum kregen. In deze antibiotica monotherapie groep 
waren de karakteristieken van patiënten die adequaat en inadequaat werden behandeld 
meer homogeen, en binnen deze groepen werd aangetoond dat adequate therapie 
mortaliteit verlaagd. Deze studie toont ook aan dat het niet altijd mogelijk is om te 
corrigeren voor ongebalanceerde groepen. Het advies is daarom om bij het vergelijken 
van retrospectieve data de meest homogene groepen te gebruiken. 
In Hoofdstuk 14 worden deze bevindingen per deel van dit proefschrift bediscussieerd, 
en worden richtingen voor toekomstig onderzoek aangestipt. In Hoofdstuk 15 worden 
de bevindingen van dit proefschrift samengevat. 
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DBP Diastolic Blood Pressure
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ED Emergency Department
EDMUPS Medically Unexplained Physical Symptoms in the Emergency Department
EGDT Early Goal Directed Therapy
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Erasmus MC Erasmus University Medical Center, Rotterdam , The Netherlands
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ICC Intraclass Correlation Coefficient
ICU Intensive Care Unit
IQR Inter Quartile Range
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KPC Klebsiella Pneumoniase Carbapenemase
LC-MS/MS Liquid Chromatography - Tandem Mass Spectrometry
LOS Length Of Stay
Lrm Logistic Regression Model
LRχ2 Likelihood Ratio chi squared
LUMC Leiden University Medical Center , Leiden, The Netherlands 
LVH Left Ventricular Hypertrophy
MALDI-TOF MS Matrix Assisted Laser Desorption/Ionization Time-of-Flight Analyser Mass Spectrometry 
MAP Mean Arterial Pressure
MARS Medical Admissions Risk System
MASCC Multinational Association for Supportive Care in Cancer
MAU Medical Assessment Unit
MDR Multi-drug Resistent
MDRO Mulit-drug Resistent Organism
MEWS Modified Early Warning Score
Min Minute
MLST Multilocus Sequence Typing
mmHg Millimetres mercury 
MRE Multidrug-resistant Enterobacteriaceae
MRI Magnetic Resonance Imaging
MRSA Methicillin-resistant Staphylococcus Aureus
MST Medisch Spectrum Twente, Enschede, The Netherlands
MTS Manchester Triage System
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N Number
NA Not Applicable
NDM New Delhi Metallo-beta-lactamase
NEWS National Early Warning Score 
NL The Netherlands
NPV Negative Predicting Value
NS Not Specified
OR Odds Ratio
OXA Oxacillinase
pAmp C Plasmid-borne AmpC
pAmp C-E Plasmid-mediated Amp C-producing Enterobacteriaceae
PaO2 Partial Pressure of Oxygen
PARIS Systolic Blood Pressure, Age, Respiratory Rate, Loss of Independence, Peripheral 
Oxygen Saturation
PATHWAY-2 Prevention And Treatment of Hypertension With Algorithm Based Therapy-2
PCI Percutaneous Coronary Intervention
PCR Polymerase Chain Reaction
PFGE Pulsed-Field Gel Electrophoresis
PI Perfusion Index
POCT Point-of-Care Testing
POCUS Point-of-Care Ultrasound
POTS Postural Orthostatic Tachycardia Syndrome
PPV Positive Predicting Value
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
ProCESS Protocolized Care for Early Septic Shock
PROMIS Patient-Reported Outcomes Measurement Information System 
ProMISe Protocolised Management in Sepsis
PROSPERO Prospective Register of Systematic Reviews
PSI Pneumonia Severity Index
PSS Physiological Scoring System
PVI Pleth Variable Index
qSOFA quick Sepsis Related Organ Failure Assessment
RAPS Rapid Acute Physiology Score
RBC Red Blood Cell Count
RDW Red Cell Distribution Width
REMS Rapid Emergency Medicine Score
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RR Respiratory Rate
S Seconds
SaO2 Arterial Oxygen Saturation
SBP Systolic Blood Pressure
SCS Simple Clinical Score
SD Standard Deviation
SE Standard Error
SET Signal Extraction Technology 
SHV Sulphydryl Variable
SIRS Systemic Inflammatory Response Syndrome 
SOFA Sepsis Related Organ Failure Assessment
SpO2 Peripheral Oxygen Saturation
SPSS Statistical Package for the Social Sciences
SSC Surviving Sepsis Campaign
STROBE Strengthening the Reporting of Observational Studies in Epidemiology
SWAB Stichting Werkgroep AntibioticaBeleid (Dutch Working Party on Antibiotic Policy)
TEM Temoniera
TIA Transient Ischemic Attack
Tid Three Times a Day
TRST Triage Risk Screening Tool
UK United Kingdom
US United States
USA United States of America
UTI Urinary Tract Infections
UZG Ghent University Hospital, Ghent, Belgium 
VSS Vital Sign Score
WBC White Blood Cell Count
WMO Wet Medisch-wetenschappelijk Onderzoek met Mensen  
(Medical Research Involving Human Subjects Act)
α1AR Autoantibodies Against Adrenergic Receptors
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